BLASTP 2.2.26 [Sep-21-2011]
Reference: Altschul, Stephen F., Thomas L. Madden, Alejandro A. Schaffer,
Jinghui Zhang, Zheng Zhang, Webb Miller, and David J. Lipman (1997),
"Gapped BLAST and PSI-BLAST: a new generation of protein database search
programs", Nucleic Acids Res. 25:3389-3402.
Reference for compositional score matrix adjustment: Altschul, Stephen F.,
John C. Wootton, E. Michael Gertz, Richa Agarwala, Aleksandr Morgulis,
Alejandro A. Schaffer, and Yi-Kuo Yu (2005) "Protein database searches
using compositionally adjusted substitution matrices", FEBS J. 272:5101-5109.
Query= 017763
(366 letters)
Database: pdbaa
62,578 sequences; 14,973,337 total letters
Searching..................................................done
>pdb|2NRU|A Chain A, Crystal Structure Of Irak-4
pdb|2NRU|B Chain B, Crystal Structure Of Irak-4
pdb|2NRU|C Chain C, Crystal Structure Of Irak-4
pdb|2NRU|D Chain D, Crystal Structure Of Irak-4
Length = 307
Score = 81.3 bits (199), Expect = 8e-16, Method: Compositional matrix adjust.
Identities = 61/166 (36%), Positives = 91/166 (54%), Gaps = 20/166 (12%)
Query: 176 NFFSDRCIS-------EGLSSVMYRASFGDDASTSKKFEATVTRLNPSSQGVKE-FINDV 227
N F +R IS EG V+Y+ + KK A V + +++ +K+ F ++
Sbjct: 25 NNFDERPISVGGNKMGEGGFGVVYKGYVNNTTVAVKKLAAMV---DITTEELKQQFDQEI 81
Query: 228 NTLASLQHPNLCKLLGFHARDGSDQRMLIYERLFHGSL-DRLIYGRSDG-PPIDWNTRVK 285
+A QH NL +LLGF + DG D L+Y + +GSL DRL DG PP+ W+ R K
Sbjct: 82 KVMAKCQHENLVELLGF-SSDGDD-LCLVYVYMPNGSLLDRL--SCLDGTPPLSWHMRCK 137
Query: 286 IALCAAQGLTFLHEEGPFQAMYNEFSTANIQIDKDFSAKLSGYGCA 331
IA AA G+ FLHE ++ + +ANI +D+ F+AK+S +G A
Sbjct: 138 IAQGAANGINFLHEN---HHIHRDIKSANILLDEAFTAKISDFGLA 180
>pdb|2NRY|A Chain A, Crystal Structure Of Irak-4
pdb|2NRY|B Chain B, Crystal Structure Of Irak-4
pdb|2NRY|C Chain C, Crystal Structure Of Irak-4
pdb|2NRY|D Chain D, Crystal Structure Of Irak-4
Length = 307
Score = 81.3 bits (199), Expect = 8e-16, Method: Compositional matrix adjust.
Identities = 61/166 (36%), Positives = 91/166 (54%), Gaps = 20/166 (12%)
Query: 176 NFFSDRCIS-------EGLSSVMYRASFGDDASTSKKFEATVTRLNPSSQGVKE-FINDV 227
N F +R IS EG V+Y+ + KK A V + +++ +K+ F ++
Sbjct: 25 NNFDERPISVGGNKMGEGGFGVVYKGYVNNTTVAVKKLAAMV---DITTEELKQQFDQEI 81
Query: 228 NTLASLQHPNLCKLLGFHARDGSDQRMLIYERLFHGSL-DRLIYGRSDG-PPIDWNTRVK 285
+A QH NL +LLGF + DG D L+Y + +GSL DRL DG PP+ W+ R K
Sbjct: 82 KVMAKCQHENLVELLGF-SSDGDD-LCLVYVYMPNGSLLDRL--SCLDGTPPLSWHMRCK 137
Query: 286 IALCAAQGLTFLHEEGPFQAMYNEFSTANIQIDKDFSAKLSGYGCA 331
IA AA G+ FLHE ++ + +ANI +D+ F+AK+S +G A
Sbjct: 138 IAQGAANGINFLHEN---HHIHRDIKSANILLDEAFTAKISDFGLA 180
>pdb|2OIB|A Chain A, Crystal Structure Of Irak4 Kinase Domain Apo Form
pdb|2OIB|B Chain B, Crystal Structure Of Irak4 Kinase Domain Apo Form
pdb|2OIB|C Chain C, Crystal Structure Of Irak4 Kinase Domain Apo Form
pdb|2OIB|D Chain D, Crystal Structure Of Irak4 Kinase Domain Apo Form
pdb|2OIC|A Chain A, Crystal Structure Of Irak4 Kinase Domain Complexed With
Staurosporine
pdb|2OIC|B Chain B, Crystal Structure Of Irak4 Kinase Domain Complexed With
Staurosporine
pdb|2OIC|C Chain C, Crystal Structure Of Irak4 Kinase Domain Complexed With
Staurosporine
pdb|2OIC|D Chain D, Crystal Structure Of Irak4 Kinase Domain Complexed With
Staurosporine
pdb|2OID|A Chain A, Crystal Structure Of Irak4 Kinase Domain Complexed With
Amppnp
pdb|2OID|B Chain B, Crystal Structure Of Irak4 Kinase Domain Complexed With
Amppnp
pdb|2OID|C Chain C, Crystal Structure Of Irak4 Kinase Domain Complexed With
Amppnp
pdb|2OID|D Chain D, Crystal Structure Of Irak4 Kinase Domain Complexed With
Amppnp
Length = 301
Score = 81.3 bits (199), Expect = 8e-16, Method: Compositional matrix adjust.
Identities = 61/166 (36%), Positives = 91/166 (54%), Gaps = 20/166 (12%)
Query: 176 NFFSDRCIS-------EGLSSVMYRASFGDDASTSKKFEATVTRLNPSSQGVKE-FINDV 227
N F +R IS EG V+Y+ + KK A V + +++ +K+ F ++
Sbjct: 19 NNFDERPISVGGNKMGEGGFGVVYKGYVNNTTVAVKKLAAMV---DITTEELKQQFDQEI 75
Query: 228 NTLASLQHPNLCKLLGFHARDGSDQRMLIYERLFHGSL-DRLIYGRSDG-PPIDWNTRVK 285
+A QH NL +LLGF + DG D L+Y + +GSL DRL DG PP+ W+ R K
Sbjct: 76 KVMAKCQHENLVELLGF-SSDGDD-LCLVYVYMPNGSLLDRL--SCLDGTPPLSWHMRCK 131
Query: 286 IALCAAQGLTFLHEEGPFQAMYNEFSTANIQIDKDFSAKLSGYGCA 331
IA AA G+ FLHE ++ + +ANI +D+ F+AK+S +G A
Sbjct: 132 IAQGAANGINFLHEN---HHIHRDIKSANILLDEAFTAKISDFGLA 174
>pdb|2O8Y|A Chain A, Apo Irak4 Kinase Domain
pdb|2O8Y|B Chain B, Apo Irak4 Kinase Domain
Length = 298
Score = 78.2 bits (191), Expect = 6e-15, Method: Compositional matrix adjust.
Identities = 61/166 (36%), Positives = 89/166 (53%), Gaps = 20/166 (12%)
Query: 176 NFFSDRCIS-------EGLSSVMYRASFGDDASTSKKFEATVTRLNPSSQGVKE-FINDV 227
N F +R IS EG V+Y+ + KK A V + +++ +K+ F ++
Sbjct: 16 NNFDERPISVGGNKXGEGGFGVVYKGYVNNTTVAVKKLAAMV---DITTEELKQQFDQEI 72
Query: 228 NTLASLQHPNLCKLLGFHARDGSDQRMLIYERLFHGSL-DRLIYGRSDG-PPIDWNTRVK 285
A QH NL +LLGF + DG D L+Y +GSL DRL DG PP+ W+ R K
Sbjct: 73 KVXAKCQHENLVELLGF-SSDGDD-LCLVYVYXPNGSLLDRL--SCLDGTPPLSWHXRCK 128
Query: 286 IALCAAQGLTFLHEEGPFQAMYNEFSTANIQIDKDFSAKLSGYGCA 331
IA AA G+ FLHE ++ + +ANI +D+ F+AK+S +G A
Sbjct: 129 IAQGAANGINFLHEN---HHIHRDIKSANILLDEAFTAKISDFGLA 171
>pdb|2QKW|B Chain B, Structural Basis For Activation Of Plant Immunity By
Bacterial Effector Protein Avrpto
Length = 321
Score = 74.3 bits (181), Expect = 1e-13, Method: Compositional matrix adjust.
Identities = 55/175 (31%), Positives = 95/175 (54%), Gaps = 13/175 (7%)
Query: 166 PLDEVAAACHNFFSDRCISEGLSSVMYRASFGDDASTSKKFEATVTRLNPSSQGVKEFIN 225
PL ++ A +NF I G+ +Y+ D A + K R SSQG++EF
Sbjct: 30 PLVDLEEATNNFDHKFLIGHGVFGKVYKGVLRDGAKVALK-----RRTPESSQGIEEFET 84
Query: 226 DVNTLASLQHPNLCKLLGFHARDGSDQRMLIYERLFHGSLDRLIYGRSDGP--PIDWNTR 283
++ TL+ +HP+L L+GF D ++ +LIY+ + +G+L R +YG SD P + W R
Sbjct: 85 EIETLSFCRHPHLVSLIGFC--DERNEMILIYKYMENGNLKRHLYG-SDLPTMSMSWEQR 141
Query: 284 VKIALCAAQGLTFLHEEGPFQAMYNEFSTANIQIDKDFSAKLSGYGCAGHIPETD 338
++I + AA+GL +LH ++ + + NI +D++F K++ +G + E D
Sbjct: 142 LEICIGAARGLHYLHTRA---IIHRDVKSINILLDENFVPKITDFGISKKGTELD 193
>pdb|3HGK|A Chain A, Crystal Structure Of Effect Protein Avrptob Complexed With
Kinase Pto
pdb|3HGK|B Chain B, Crystal Structure Of Effect Protein Avrptob Complexed With
Kinase Pto
pdb|3HGK|C Chain C, Crystal Structure Of Effect Protein Avrptob Complexed With
Kinase Pto
pdb|3HGK|D Chain D, Crystal Structure Of Effect Protein Avrptob Complexed With
Kinase Pto
Length = 327
Score = 73.2 bits (178), Expect = 2e-13, Method: Compositional matrix adjust.
Identities = 53/168 (31%), Positives = 93/168 (55%), Gaps = 13/168 (7%)
Query: 166 PLDEVAAACHNFFSDRCISEGLSSVMYRASFGDDASTSKKFEATVTRLNPSSQGVKEFIN 225
PL ++ A +NF I G+ +Y+ D A + K R SSQG++EF
Sbjct: 30 PLVDLEEATNNFDHKFLIGHGVFGKVYKGVLRDGAKVALK-----RRTPESSQGIEEFET 84
Query: 226 DVNTLASLQHPNLCKLLGFHARDGSDQRMLIYERLFHGSLDRLIYGRSDGP--PIDWNTR 283
++ TL+ +HP+L L+GF D ++ +LIY+ + +G+L R +YG SD P + W R
Sbjct: 85 EIETLSFCRHPHLVSLIGFC--DERNEMILIYKYMENGNLKRHLYG-SDLPTMSMSWEQR 141
Query: 284 VKIALCAAQGLTFLHEEGPFQAMYNEFSTANIQIDKDFSAKLSGYGCA 331
++I + AA+GL +LH ++ + + NI +D++F K++ +G +
Sbjct: 142 LEICIGAARGLHYLHTRA---IIHRDVKSINILLDENFVPKITDFGIS 186
>pdb|3UIM|A Chain A, Structural Basis For The Impact Of Phosphorylation On
Plant Receptor- Like Kinase Bak1 Activation
pdb|3ULZ|A Chain A, Crystal Structure Of Apo Bak1
Length = 326
Score = 73.2 bits (178), Expect = 2e-13, Method: Compositional matrix adjust.
Identities = 48/172 (27%), Positives = 84/172 (48%), Gaps = 11/172 (6%)
Query: 163 RNFPLDEVAAACHNFFSDRCISEGLSSVMYRASFGDDASTSKKFEATVTRLNP--SSQGV 220
+ F L E+ A NF + + G +Y+ D + V RL + G
Sbjct: 18 KRFSLRELQVASDNFXNKNILGRGGFGKVYKGRLADGXLVA------VKRLKEERTQGGE 71
Query: 221 KEFINDVNTLASLQHPNLCKLLGFHARDGSDQRMLIYERLFHGSLDRLIYGRSDG-PPID 279
+F +V ++ H NL +L GF +R+L+Y + +GS+ + R + PP+D
Sbjct: 72 LQFQTEVEMISMAVHRNLLRLRGFCMT--PTERLLVYPYMANGSVASCLRERPESQPPLD 129
Query: 280 WNTRVKIALCAAQGLTFLHEEGPFQAMYNEFSTANIQIDKDFSAKLSGYGCA 331
W R +IAL +A+GL +LH+ + ++ + ANI +D++F A + +G A
Sbjct: 130 WPKRQRIALGSARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLA 181
>pdb|3TL8|A Chain A, The Avrptob-Bak1 Complex Reveals Two Structurally Similar
Kinaseinteracting Domains In A Single Type Iii Effector
pdb|3TL8|D Chain D, The Avrptob-Bak1 Complex Reveals Two Structurally Similar
Kinaseinteracting Domains In A Single Type Iii Effector
pdb|3TL8|G Chain G, The Avrptob-Bak1 Complex Reveals Two Structurally Similar
Kinaseinteracting Domains In A Single Type Iii Effector
pdb|3TL8|H Chain H, The Avrptob-Bak1 Complex Reveals Two Structurally Similar
Kinaseinteracting Domains In A Single Type Iii Effector
Length = 349
Score = 72.8 bits (177), Expect = 3e-13, Method: Compositional matrix adjust.
Identities = 48/172 (27%), Positives = 83/172 (48%), Gaps = 11/172 (6%)
Query: 163 RNFPLDEVAAACHNFFSDRCISEGLSSVMYRASFGDDASTSKKFEATVTRLNPSSQ--GV 220
+ F L E+ A NF + + G +Y+ D + V RL G
Sbjct: 26 KRFSLRELQVASDNFSNKNILGRGGFGKVYKGRLADGTLVA------VKRLKEERXQGGE 79
Query: 221 KEFINDVNTLASLQHPNLCKLLGFHARDGSDQRMLIYERLFHGSLDRLIYGRSDG-PPID 279
+F +V ++ H NL +L GF +R+L+Y + +GS+ + R + PP+D
Sbjct: 80 LQFQTEVEMISMAVHRNLLRLRGFCMT--PTERLLVYPYMANGSVASCLRERPESQPPLD 137
Query: 280 WNTRVKIALCAAQGLTFLHEEGPFQAMYNEFSTANIQIDKDFSAKLSGYGCA 331
W R +IAL +A+GL +LH+ + ++ + ANI +D++F A + +G A
Sbjct: 138 WPKRQRIALGSARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLA 189
>pdb|3PPZ|A Chain A, Crystal Structure Of Ctr1 Kinase Domain In Complex With
Staurosporine
pdb|3PPZ|B Chain B, Crystal Structure Of Ctr1 Kinase Domain In Complex With
Staurosporine
Length = 309
Score = 55.5 bits (132), Expect = 5e-08, Method: Compositional matrix adjust.
Identities = 37/150 (24%), Positives = 70/150 (46%), Gaps = 9/150 (6%)
Query: 183 ISEGLSSVMYRASF-GDDASTSKKFEATVTRLNPSSQGVKEFINDVNTLASLQHPNLCKL 241
I G ++RA + G D + E ++ V EF+ +V + L+HPN+
Sbjct: 45 IGAGSFGTVHRAEWHGSDVAVKILMEQDF-----HAERVNEFLREVAIMKRLRHPNIVLF 99
Query: 242 LGFHARDGSDQRMLIYERLFHGSLDRLIYGRSDGPPIDWNTRVKIALCAAQGLTFLHEEG 301
+G A ++ E L GSL RL++ +D R+ +A A+G+ +LH
Sbjct: 100 MG--AVTQPPNLSIVTEYLSRGSLYRLLHKSGAREQLDERRRLSMAYDVAKGMNYLHNRN 157
Query: 302 PFQAMYNEFSTANIQIDKDFSAKLSGYGCA 331
P ++ + + N+ +DK ++ K+ +G +
Sbjct: 158 P-PIVHRDLKSPNLLVDKKYTVKVCDFGLS 186
>pdb|3P86|A Chain A, Crystal Structure Of Ctr1 Kinase Domain Mutant D676n In
Complex With Staurosporine
pdb|3P86|B Chain B, Crystal Structure Of Ctr1 Kinase Domain Mutant D676n In
Complex With Staurosporine
Length = 309
Score = 54.7 bits (130), Expect = 8e-08, Method: Compositional matrix adjust.
Identities = 37/150 (24%), Positives = 69/150 (46%), Gaps = 9/150 (6%)
Query: 183 ISEGLSSVMYRASF-GDDASTSKKFEATVTRLNPSSQGVKEFINDVNTLASLQHPNLCKL 241
I G ++RA + G D + E ++ V EF+ +V + L+HPN+
Sbjct: 45 IGAGSFGTVHRAEWHGSDVAVKILMEQDF-----HAERVNEFLREVAIMKRLRHPNIVLF 99
Query: 242 LGFHARDGSDQRMLIYERLFHGSLDRLIYGRSDGPPIDWNTRVKIALCAAQGLTFLHEEG 301
+G A ++ E L GSL RL++ +D R+ +A A+G+ +LH
Sbjct: 100 MG--AVTQPPNLSIVTEYLSRGSLYRLLHKSGAREQLDERRRLSMAYDVAKGMNYLHNRN 157
Query: 302 PFQAMYNEFSTANIQIDKDFSAKLSGYGCA 331
P ++ + N+ +DK ++ K+ +G +
Sbjct: 158 P-PIVHRNLKSPNLLVDKKYTVKVCDFGLS 186
>pdb|3PLS|A Chain A, Ron In Complex With Ligand Amp-Pnp
Length = 298
Score = 50.1 bits (118), Expect = 2e-06, Method: Compositional matrix adjust.
Identities = 38/157 (24%), Positives = 69/157 (43%), Gaps = 8/157 (5%)
Query: 179 SDRCISEGLSSVMYRASFGDDASTSKKFEATVTRLNPSSQGVKEFINDVNTLASLQHPNL 238
SDR I +G V+Y + D A + Q V+ F+ + + L HPN+
Sbjct: 25 SDRVIGKGHFGVVYHGEYIDQAQNRIQCAIKSLSRITEMQQVEAFLREGLLMRGLNHPNV 84
Query: 239 CKLLGFHA-RDGSDQRMLIYERLFHGSLDRLIYGRSDGPPIDWNTRVKIALCAAQGLTFL 297
L+G +G +L Y + HG L + I P + + L A+G+ +L
Sbjct: 85 LALIGIMLPPEGLPHVLLPY--MCHGDLLQFIRSPQRNPTV--KDLISFGLQVARGMEYL 140
Query: 298 HEEGPFQAMYNEFSTANIQIDKDFSAKLSGYGCAGHI 334
E+ + ++ + + N +D+ F+ K++ +G A I
Sbjct: 141 AEQ---KFVHRDLAARNCMLDESFTVKVADFGLARDI 174
>pdb|3CTH|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The
Hepatocyte Growth Factor Receptor C-Met In Complex With
A Aminopyridine Based Inhibitor
pdb|3CTJ|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The
Hepatocyte Growth Factor Receptor C-Met In Complex With
A Aminopyridine Based Inhibitor
pdb|3CE3|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The
Hepatocyte Growth Factor Receptor C-Met In Complex With
A Pyrrolopyridinepyridone Based Inhibitor
pdb|3F82|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The
Hepatocyte Growth Factor Receptor C-Met In Complex With
N-
(4-(2-Amino-3-Chloropyridin-4-Yloxy)-3-Fluorophenyl)-4-
Ethoxy-1-(4-Fluorophenyl)-2-Oxo-1,2-Dihydropyridine-3-
Carboxamide
pdb|3L8V|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The
Hepat Growth Factor Receptor C-Met In Complex With A
Biarylamine Inhibitor
Length = 314
Score = 46.6 bits (109), Expect = 2e-05, Method: Compositional matrix adjust.
Identities = 38/155 (24%), Positives = 68/155 (43%), Gaps = 12/155 (7%)
Query: 180 DRCISEGLSSVMYRASFGDDASTSKKFEATVTRLNPSSQ--GVKEFINDVNTLASLQHPN 237
+ I G +Y + D+ KK V LN + V +F+ + + HPN
Sbjct: 35 NEVIGRGHFGCVYHGTLLDN--DGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPN 92
Query: 238 LCKLLGFHAR-DGSDQRMLIYERLFHGSLDRLIYGRSDGPPIDWNTRVKIALCAAQGLTF 296
+ LLG R +GS +L Y + HG L I + P + + L A+G+ F
Sbjct: 93 VLSLLGICLRSEGSPLVVLPYMK--HGDLRNFIRNETHNPTV--KDLIGFGLQVAKGMKF 148
Query: 297 LHEEGPFQAMYNEFSTANIQIDKDFSAKLSGYGCA 331
L + + ++ + + N +D+ F+ K++ +G A
Sbjct: 149 LASK---KFVHRDLAARNCMLDEKFTVKVADFGLA 180
>pdb|3QTI|A Chain A, C-Met Kinase In Complex With Nvp-Bvu972
pdb|3QTI|B Chain B, C-Met Kinase In Complex With Nvp-Bvu972
Length = 314
Score = 46.6 bits (109), Expect = 2e-05, Method: Compositional matrix adjust.
Identities = 38/155 (24%), Positives = 68/155 (43%), Gaps = 12/155 (7%)
Query: 180 DRCISEGLSSVMYRASFGDDASTSKKFEATVTRLNPSSQ--GVKEFINDVNTLASLQHPN 237
+ I G +Y + D+ KK V LN + V +F+ + + HPN
Sbjct: 35 NEVIGRGHFGCVYHGTLLDN--DGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPN 92
Query: 238 LCKLLGFHAR-DGSDQRMLIYERLFHGSLDRLIYGRSDGPPIDWNTRVKIALCAAQGLTF 296
+ LLG R +GS +L Y + HG L I + P + + L A+G+ F
Sbjct: 93 VLSLLGICLRSEGSPLVVLPYMK--HGDLRNFIRNETHNPTV--KDLIGFGLQVAKGMKF 148
Query: 297 LHEEGPFQAMYNEFSTANIQIDKDFSAKLSGYGCA 331
L + + ++ + + N +D+ F+ K++ +G A
Sbjct: 149 LASK---KFVHRDLAARNCMLDEKFTVKVADFGLA 180
>pdb|3C1X|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The
Hepatocyte Growth Factor Receptor C-Met In Complex With
A Pyrrolotriazine Based Inhibitor
Length = 373
Score = 46.6 bits (109), Expect = 2e-05, Method: Compositional matrix adjust.
Identities = 38/155 (24%), Positives = 68/155 (43%), Gaps = 12/155 (7%)
Query: 180 DRCISEGLSSVMYRASFGDDASTSKKFEATVTRLNPSSQ--GVKEFINDVNTLASLQHPN 237
+ I G +Y + D+ KK V LN + V +F+ + + HPN
Sbjct: 94 NEVIGRGHFGCVYHGTLLDN--DGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPN 151
Query: 238 LCKLLGFHAR-DGSDQRMLIYERLFHGSLDRLIYGRSDGPPIDWNTRVKIALCAAQGLTF 296
+ LLG R +GS +L Y + HG L I + P + + L A+G+ F
Sbjct: 152 VLSLLGICLRSEGSPLVVLPYMK--HGDLRNFIRNETHNPTV--KDLIGFGLQVAKGMKF 207
Query: 297 LHEEGPFQAMYNEFSTANIQIDKDFSAKLSGYGCA 331
L + + ++ + + N +D+ F+ K++ +G A
Sbjct: 208 LASK---KFVHRDLAARNCMLDEKFTVKVADFGLA 239
>pdb|3DKG|A Chain A, Sgx Clone 5698a109kfg1h1
Length = 317
Score = 46.6 bits (109), Expect = 2e-05, Method: Compositional matrix adjust.
Identities = 38/155 (24%), Positives = 68/155 (43%), Gaps = 12/155 (7%)
Query: 180 DRCISEGLSSVMYRASFGDDASTSKKFEATVTRLNPSSQ--GVKEFINDVNTLASLQHPN 237
+ I G +Y + D+ KK V LN + V +F+ + + HPN
Sbjct: 36 NEVIGRGHFGCVYHGTLLDN--DGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPN 93
Query: 238 LCKLLGFHAR-DGSDQRMLIYERLFHGSLDRLIYGRSDGPPIDWNTRVKIALCAAQGLTF 296
+ LLG R +GS +L Y + HG L I + P + + L A+G+ F
Sbjct: 94 VLSLLGICLRSEGSPLVVLPYMK--HGDLRNFIRNETHNPTV--KDLIGFGLQVAKGMKF 149
Query: 297 LHEEGPFQAMYNEFSTANIQIDKDFSAKLSGYGCA 331
L + + ++ + + N +D+ F+ K++ +G A
Sbjct: 150 LASK---KFVHRDLAARNCMLDEKFTVKVADFGLA 181
>pdb|3A4P|A Chain A, Human C-Met Kinase Domain Complexed With
6-Benzyloxyquinoline Inhibitor
Length = 319
Score = 46.6 bits (109), Expect = 2e-05, Method: Compositional matrix adjust.
Identities = 38/155 (24%), Positives = 68/155 (43%), Gaps = 12/155 (7%)
Query: 180 DRCISEGLSSVMYRASFGDDASTSKKFEATVTRLNPSSQ--GVKEFINDVNTLASLQHPN 237
+ I G +Y + D+ KK V LN + V +F+ + + HPN
Sbjct: 40 NEVIGRGHFGCVYHGTLLDN--DGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPN 97
Query: 238 LCKLLGFHAR-DGSDQRMLIYERLFHGSLDRLIYGRSDGPPIDWNTRVKIALCAAQGLTF 296
+ LLG R +GS +L Y + HG L I + P + + L A+G+ F
Sbjct: 98 VLSLLGICLRSEGSPLVVLPYMK--HGDLRNFIRNETHNPTV--KDLIGFGLQVAKGMKF 153
Query: 297 LHEEGPFQAMYNEFSTANIQIDKDFSAKLSGYGCA 331
L + + ++ + + N +D+ F+ K++ +G A
Sbjct: 154 LASK---KFVHRDLAARNCMLDEKFTVKVADFGLA 185
>pdb|3DKC|A Chain A, Sgx Clone 5698a65kfg1h1
pdb|3DKF|A Chain A, Sgx Clone 5698a65kfg1h1
Length = 317
Score = 46.6 bits (109), Expect = 2e-05, Method: Compositional matrix adjust.
Identities = 38/155 (24%), Positives = 68/155 (43%), Gaps = 12/155 (7%)
Query: 180 DRCISEGLSSVMYRASFGDDASTSKKFEATVTRLNPSSQ--GVKEFINDVNTLASLQHPN 237
+ I G +Y + D+ KK V LN + V +F+ + + HPN
Sbjct: 36 NEVIGRGHFGCVYHGTLLDN--DGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPN 93
Query: 238 LCKLLGFHAR-DGSDQRMLIYERLFHGSLDRLIYGRSDGPPIDWNTRVKIALCAAQGLTF 296
+ LLG R +GS +L Y + HG L I + P + + L A+G+ F
Sbjct: 94 VLSLLGICLRSEGSPLVVLPYMK--HGDLRNFIRNETHNPTV--KDLIGFGLQVAKGMKF 149
Query: 297 LHEEGPFQAMYNEFSTANIQIDKDFSAKLSGYGCA 331
L + + ++ + + N +D+ F+ K++ +G A
Sbjct: 150 LASK---KFVHRDLAARNCMLDEKFTVKVADFGLA 181
>pdb|1R0P|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The
Hepatocyte Growth Factor Receptor C-Met In Complex With
The Microbial Alkaloid K-252a
pdb|1R1W|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The
Hepatocyte Growth Factor Receptor C-Met
Length = 312
Score = 46.6 bits (109), Expect = 2e-05, Method: Compositional matrix adjust.
Identities = 38/155 (24%), Positives = 68/155 (43%), Gaps = 12/155 (7%)
Query: 180 DRCISEGLSSVMYRASFGDDASTSKKFEATVTRLNPSSQ--GVKEFINDVNTLASLQHPN 237
+ I G +Y + D+ KK V LN + V +F+ + + HPN
Sbjct: 33 NEVIGRGHFGCVYHGTLLDN--DGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPN 90
Query: 238 LCKLLGFHAR-DGSDQRMLIYERLFHGSLDRLIYGRSDGPPIDWNTRVKIALCAAQGLTF 296
+ LLG R +GS +L Y + HG L I + P + + L A+G+ F
Sbjct: 91 VLSLLGICLRSEGSPLVVLPYMK--HGDLRNFIRNETHNPTV--KDLIGFGLQVAKGMKF 146
Query: 297 LHEEGPFQAMYNEFSTANIQIDKDFSAKLSGYGCA 331
L + + ++ + + N +D+ F+ K++ +G A
Sbjct: 147 LASK---KFVHRDLAARNCMLDEKFTVKVADFGLA 178
>pdb|4E4L|A Chain A, Jak1 Kinase (Jh1 Domain) In Complex With Compound 30
pdb|4E4L|B Chain B, Jak1 Kinase (Jh1 Domain) In Complex With Compound 30
pdb|4E4L|E Chain E, Jak1 Kinase (Jh1 Domain) In Complex With Compound 30
pdb|4E4L|D Chain D, Jak1 Kinase (Jh1 Domain) In Complex With Compound 30
pdb|4E4N|A Chain A, Jak1 Kinase (Jh1 Domain) In Complex With Compound 49
pdb|4E4N|B Chain B, Jak1 Kinase (Jh1 Domain) In Complex With Compound 49
pdb|4E5W|A Chain A, Jak1 Kinase (Jh1 Domain) In Complex With Compound 26
pdb|4E5W|B Chain B, Jak1 Kinase (Jh1 Domain) In Complex With Compound 26
pdb|4EHZ|A Chain A, The Jak1 Kinase Domain In Complex With Inhibitor
pdb|4EHZ|B Chain B, The Jak1 Kinase Domain In Complex With Inhibitor
pdb|4EHZ|C Chain C, The Jak1 Kinase Domain In Complex With Inhibitor
pdb|4EHZ|D Chain D, The Jak1 Kinase Domain In Complex With Inhibitor
pdb|4EI4|A Chain A, Jak1 Kinase (jh1 Domain) In Complex With Compound 20
pdb|4EI4|B Chain B, Jak1 Kinase (jh1 Domain) In Complex With Compound 20
pdb|4FK6|A Chain A, Jak1 Kinase (Jh1 Domain) In Complex With Compound 72
pdb|4FK6|B Chain B, Jak1 Kinase (Jh1 Domain) In Complex With Compound 72
Length = 302
Score = 45.8 bits (107), Expect = 3e-05, Method: Compositional matrix adjust.
Identities = 35/134 (26%), Positives = 61/134 (45%), Gaps = 8/134 (5%)
Query: 207 EATVTRLNPSSQG--VKEFINDVNTLASLQHPNLCKLLGFHARDGSDQRMLIYERLFHGS 264
+ V L P S G + + ++ L +L H N+ K G DG + LI E L GS
Sbjct: 52 QVAVKSLKPESGGNHIADLKKEIEILRNLYHENIVKYKGICTEDGGNGIKLIMEFLPSGS 111
Query: 265 LDRLIYGRSDGPPIDWNTRVKIALCAAQGLTFLHEEGPFQAMYNEFSTANIQIDKDFSAK 324
L Y + I+ ++K A+ +G+ +L G Q ++ + + N+ ++ + K
Sbjct: 112 LKE--YLPKNKNKINLKQQLKYAVQICKGMDYL---GSRQYVHRDLAARNVLVESEHQVK 166
Query: 325 LSGYGCAGHIPETD 338
+ +G I ETD
Sbjct: 167 IGDFGLTKAI-ETD 179
>pdb|3EYG|A Chain A, Crystal Structures Of Jak1 And Jak2 Inhibitor Complexes
pdb|3EYH|A Chain A, Crystal Structures Of Jak1 And Jak2 Inhibitor Complexes
Length = 290
Score = 45.8 bits (107), Expect = 4e-05, Method: Compositional matrix adjust.
Identities = 35/134 (26%), Positives = 61/134 (45%), Gaps = 8/134 (5%)
Query: 207 EATVTRLNPSSQG--VKEFINDVNTLASLQHPNLCKLLGFHARDGSDQRMLIYERLFHGS 264
+ V L P S G + + ++ L +L H N+ K G DG + LI E L GS
Sbjct: 40 QVAVKSLKPESGGNHIADLKKEIEILRNLYHENIVKYKGICTEDGGNGIKLIMEFLPSGS 99
Query: 265 LDRLIYGRSDGPPIDWNTRVKIALCAAQGLTFLHEEGPFQAMYNEFSTANIQIDKDFSAK 324
L Y + I+ ++K A+ +G+ +L G Q ++ + + N+ ++ + K
Sbjct: 100 LKE--YLPKNKNKINLKQQLKYAVQICKGMDYL---GSRQYVHRDLAARNVLVESEHQVK 154
Query: 325 LSGYGCAGHIPETD 338
+ +G I ETD
Sbjct: 155 IGDFGLTKAI-ETD 167
>pdb|3Q6W|A Chain A, Structure Of Dually-phosphorylated Met Receptor Kinase In
Complex With An Mk-2461 Analog With Specificity For The
Activated Receptor
pdb|3R7O|A Chain A, Structure Of Dually Phosphorylated C-Met Receptor Kinase
In Complex With An Mk-2461 Analog
Length = 307
Score = 45.4 bits (106), Expect = 4e-05, Method: Compositional matrix adjust.
Identities = 37/155 (23%), Positives = 68/155 (43%), Gaps = 12/155 (7%)
Query: 180 DRCISEGLSSVMYRASFGDDASTSKKFEATVTRLNPSSQ--GVKEFINDVNTLASLQHPN 237
+ I G +Y + D+ KK V LN + V +F+ + + HPN
Sbjct: 34 NEVIGRGHFGCVYHGTLLDN--DGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPN 91
Query: 238 LCKLLGFHAR-DGSDQRMLIYERLFHGSLDRLIYGRSDGPPIDWNTRVKIALCAAQGLTF 296
+ LLG R +GS +L Y + HG L I + P + + L A+G+ +
Sbjct: 92 VLSLLGICLRSEGSPLVVLPYMK--HGDLRNFIRNETHNPTV--KDLIGFGLQVAKGMKY 147
Query: 297 LHEEGPFQAMYNEFSTANIQIDKDFSAKLSGYGCA 331
L + + ++ + + N +D+ F+ K++ +G A
Sbjct: 148 LASK---KFVHRDLAARNCMLDEKFTVKVADFGLA 179
>pdb|2WD1|A Chain A, Human C-Met Kinase In Complex With Azaindole Inhibitor
Length = 292
Score = 45.4 bits (106), Expect = 4e-05, Method: Compositional matrix adjust.
Identities = 37/155 (23%), Positives = 68/155 (43%), Gaps = 12/155 (7%)
Query: 180 DRCISEGLSSVMYRASFGDDASTSKKFEATVTRLNPSSQ--GVKEFINDVNTLASLQHPN 237
+ I G +Y + D+ KK V LN + V +F+ + + HPN
Sbjct: 27 NEVIGRGHFGCVYHGTLLDN--DGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPN 84
Query: 238 LCKLLGFHAR-DGSDQRMLIYERLFHGSLDRLIYGRSDGPPIDWNTRVKIALCAAQGLTF 296
+ LLG R +GS +L Y + HG L I + P + + L A+G+ +
Sbjct: 85 VLSLLGICLRSEGSPLVVLPYMK--HGDLRNFIRNETHNPTV--KDLIGFGLQVAKGMKY 140
Query: 297 LHEEGPFQAMYNEFSTANIQIDKDFSAKLSGYGCA 331
L + + ++ + + N +D+ F+ K++ +G A
Sbjct: 141 LASK---KFVHRDLAARNCMLDEKFTVKVADFGLA 172
>pdb|2RFN|A Chain A, X-ray Structure Of C-met With Inhibitor.
pdb|2RFN|B Chain B, X-ray Structure Of C-met With Inhibitor.
pdb|2RFS|A Chain A, X-Ray Structure Of Su11274 Bound To C-Met
pdb|3CCN|A Chain A, X-Ray Structure Of C-Met With Triazolopyridazine
Inhibitor.
pdb|3CD8|A Chain A, X-Ray Structure Of C-Met With Triazolopyridazine
Inhibitor.
pdb|3EFJ|A Chain A, Structure Of C-Met With Pyrimidone Inhibitor 7
pdb|3EFJ|B Chain B, Structure Of C-Met With Pyrimidone Inhibitor 7
pdb|3EFK|A Chain A, Structure Of C-Met With Pyrimidone Inhibitor 50
pdb|3EFK|B Chain B, Structure Of C-Met With Pyrimidone Inhibitor 50
Length = 310
Score = 45.4 bits (106), Expect = 5e-05, Method: Compositional matrix adjust.
Identities = 37/155 (23%), Positives = 68/155 (43%), Gaps = 12/155 (7%)
Query: 180 DRCISEGLSSVMYRASFGDDASTSKKFEATVTRLNPSSQ--GVKEFINDVNTLASLQHPN 237
+ I G +Y + D+ KK V LN + V +F+ + + HPN
Sbjct: 35 NEVIGRGHFGCVYHGTLLDN--DGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPN 92
Query: 238 LCKLLGFHAR-DGSDQRMLIYERLFHGSLDRLIYGRSDGPPIDWNTRVKIALCAAQGLTF 296
+ LLG R +GS +L Y + HG L I + P + + L A+G+ +
Sbjct: 93 VLSLLGICLRSEGSPLVVLPYMK--HGDLRNFIRNETHNPTV--KDLIGFGLQVAKGMKY 148
Query: 297 LHEEGPFQAMYNEFSTANIQIDKDFSAKLSGYGCA 331
L + + ++ + + N +D+ F+ K++ +G A
Sbjct: 149 LASK---KFVHRDLAARNCMLDEKFTVKVADFGLA 180
>pdb|4GG5|A Chain A, Crystal Structure Of Cmet In Complex With Novel Inhibitor
pdb|4GG7|A Chain A, Crystal Structure Of Cmet In Complex With Novel Inhibitor
Length = 319
Score = 45.4 bits (106), Expect = 5e-05, Method: Compositional matrix adjust.
Identities = 37/155 (23%), Positives = 68/155 (43%), Gaps = 12/155 (7%)
Query: 180 DRCISEGLSSVMYRASFGDDASTSKKFEATVTRLNPSSQ--GVKEFINDVNTLASLQHPN 237
+ I G +Y + D+ KK V LN + V +F+ + + HPN
Sbjct: 54 NEVIGRGHFGCVYHGTLLDN--DGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPN 111
Query: 238 LCKLLGFHAR-DGSDQRMLIYERLFHGSLDRLIYGRSDGPPIDWNTRVKIALCAAQGLTF 296
+ LLG R +GS +L Y + HG L I + P + + L A+G+ +
Sbjct: 112 VLSLLGICLRSEGSPLVVLPYMK--HGDLRNFIRNETHNPTV--KDLIGFGLQVAKGMKY 167
Query: 297 LHEEGPFQAMYNEFSTANIQIDKDFSAKLSGYGCA 331
L + + ++ + + N +D+ F+ K++ +G A
Sbjct: 168 LASK---KFVHRDLAARNCMLDEKFTVKVADFGLA 199
>pdb|3LQ8|A Chain A, Structure Of The Kinase Domain Of C-Met Bound To Xl880
(Gsk1
Length = 302
Score = 45.4 bits (106), Expect = 5e-05, Method: Compositional matrix adjust.
Identities = 37/155 (23%), Positives = 68/155 (43%), Gaps = 12/155 (7%)
Query: 180 DRCISEGLSSVMYRASFGDDASTSKKFEATVTRLNPSSQ--GVKEFINDVNTLASLQHPN 237
+ I G +Y + D+ KK V LN + V +F+ + + HPN
Sbjct: 33 NEVIGRGHFGCVYHGTLLDN--DGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPN 90
Query: 238 LCKLLGFHAR-DGSDQRMLIYERLFHGSLDRLIYGRSDGPPIDWNTRVKIALCAAQGLTF 296
+ LLG R +GS +L Y + HG L I + P + + L A+G+ +
Sbjct: 91 VLSLLGICLRSEGSPLVVLPYMK--HGDLRNFIRNETHNPTV--KDLIGFGLQVAKGMKY 146
Query: 297 LHEEGPFQAMYNEFSTANIQIDKDFSAKLSGYGCA 331
L + + ++ + + N +D+ F+ K++ +G A
Sbjct: 147 LASK---KFVHRDLAARNCMLDEKFTVKVADFGLA 178
>pdb|2WGJ|A Chain A, X-Ray Structure Of Pf-02341066 Bound To The Kinase Domain
Of C-Met
pdb|2WKM|A Chain A, X-Ray Structure Of Pha-00665752 Bound To The Kinase Domain
Of C-Met
pdb|3ZXZ|A Chain A, X-Ray Structure Of Pf-04217903 Bound To The Kinase Domain
Of C-Met
pdb|3ZZE|A Chain A, Crystal Structure Of C-Met Kinase Domain In Complex With
N'-
((3z)-4-Chloro-7-Methyl-2-Oxo-1,2-Dihydro-3h-Indol-3-
Ylidene)-2-(4-Hydroxyphenyl)propanohydrazide
pdb|4AOI|A Chain A, Crystal Structure Of C-Met Kinase Domain In Complex With
4-( 3-((1h-
Pyrrolo(2,3-B)pyridin-3-Yl)methyl)-(1,2,4)triazolo(
4,3-B)(1,2,4) Triazin-6-Yl)benzonitrile
pdb|4AP7|A Chain A, Crystal Structure Of C-Met Kinase Domain In Complex With
4-( (6-(4-
Fluorophenyl)-(1,2,4)triazolo(4,3-B)(1,2,
4)triazin-3-Yl)methyl) Phenol
Length = 306
Score = 45.4 bits (106), Expect = 5e-05, Method: Compositional matrix adjust.
Identities = 37/155 (23%), Positives = 68/155 (43%), Gaps = 12/155 (7%)
Query: 180 DRCISEGLSSVMYRASFGDDASTSKKFEATVTRLNPSSQ--GVKEFINDVNTLASLQHPN 237
+ I G +Y + D+ KK V LN + V +F+ + + HPN
Sbjct: 32 NEVIGRGHFGCVYHGTLLDN--DGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPN 89
Query: 238 LCKLLGFHAR-DGSDQRMLIYERLFHGSLDRLIYGRSDGPPIDWNTRVKIALCAAQGLTF 296
+ LLG R +GS +L Y + HG L I + P + + L A+G+ +
Sbjct: 90 VLSLLGICLRSEGSPLVVLPYMK--HGDLRNFIRNETHNPTV--KDLIGFGLQVAKGMKY 145
Query: 297 LHEEGPFQAMYNEFSTANIQIDKDFSAKLSGYGCA 331
L + + ++ + + N +D+ F+ K++ +G A
Sbjct: 146 LASK---KFVHRDLAARNCMLDEKFTVKVADFGLA 177
>pdb|2G15|A Chain A, Structural Characterization Of Autoinhibited C-Met Kinase
pdb|3RHK|A Chain A, Crystal Structure Of The Catalytic Domain Of C-Met Kinase
In Complex With Arq 197
pdb|3RHK|B Chain B, Crystal Structure Of The Catalytic Domain Of C-Met Kinase
In Complex With Arq 197
Length = 318
Score = 45.4 bits (106), Expect = 5e-05, Method: Compositional matrix adjust.
Identities = 37/155 (23%), Positives = 68/155 (43%), Gaps = 12/155 (7%)
Query: 180 DRCISEGLSSVMYRASFGDDASTSKKFEATVTRLNPSSQ--GVKEFINDVNTLASLQHPN 237
+ I G +Y + D+ KK V LN + V +F+ + + HPN
Sbjct: 53 NEVIGRGHFGCVYHGTLLDN--DGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPN 110
Query: 238 LCKLLGFHAR-DGSDQRMLIYERLFHGSLDRLIYGRSDGPPIDWNTRVKIALCAAQGLTF 296
+ LLG R +GS +L Y + HG L I + P + + L A+G+ +
Sbjct: 111 VLSLLGICLRSEGSPLVVLPYMK--HGDLRNFIRNETHNPTV--KDLIGFGLQVAKGMKY 166
Query: 297 LHEEGPFQAMYNEFSTANIQIDKDFSAKLSGYGCA 331
L + + ++ + + N +D+ F+ K++ +G A
Sbjct: 167 LASK---KFVHRDLAARNCMLDEKFTVKVADFGLA 198
>pdb|3I5N|A Chain A, Crystal Structure Of C-Met With Triazolopyridazine
Inhibitor 13
pdb|3U6H|A Chain A, Crystal Structure Of C-Met In Complex With Pyrazolone
Inhibitor 26
pdb|3U6I|A Chain A, Crystal Structure Of C-Met In Complex With Pyrazolone
Inhibitor 58a
pdb|4DEG|A Chain A, Crystal Structure Of C-Met In Complex With
Triazolopyridazine Inhibitor 2
pdb|4DEH|A Chain A, Crystal Structure Of C-Met In Complex With
Triazolopyridinone Inhibitor 3
pdb|4DEI|A Chain A, Crystal Structure Of C-Met In Complex With
Triazolopyridinone Inhibitor 24
Length = 309
Score = 45.4 bits (106), Expect = 5e-05, Method: Compositional matrix adjust.
Identities = 37/155 (23%), Positives = 68/155 (43%), Gaps = 12/155 (7%)
Query: 180 DRCISEGLSSVMYRASFGDDASTSKKFEATVTRLNPSSQ--GVKEFINDVNTLASLQHPN 237
+ I G +Y + D+ KK V LN + V +F+ + + HPN
Sbjct: 34 NEVIGRGHFGCVYHGTLLDN--DGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPN 91
Query: 238 LCKLLGFHAR-DGSDQRMLIYERLFHGSLDRLIYGRSDGPPIDWNTRVKIALCAAQGLTF 296
+ LLG R +GS +L Y + HG L I + P + + L A+G+ +
Sbjct: 92 VLSLLGICLRSEGSPLVVLPYMK--HGDLRNFIRNETHNPTV--KDLIGFGLQVAKGMKY 147
Query: 297 LHEEGPFQAMYNEFSTANIQIDKDFSAKLSGYGCA 331
L + + ++ + + N +D+ F+ K++ +G A
Sbjct: 148 LASK---KFVHRDLAARNCMLDEKFTVKVADFGLA 179
>pdb|3Q6U|A Chain A, Structure Of The Apo Met Receptor Kinase In The
Dually-Phosphorylated, Activated State
Length = 308
Score = 45.4 bits (106), Expect = 5e-05, Method: Compositional matrix adjust.
Identities = 37/155 (23%), Positives = 68/155 (43%), Gaps = 12/155 (7%)
Query: 180 DRCISEGLSSVMYRASFGDDASTSKKFEATVTRLNPSSQ--GVKEFINDVNTLASLQHPN 237
+ I G +Y + D+ KK V LN + V +F+ + + HPN
Sbjct: 35 NEVIGRGHFGCVYHGTLLDN--DGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPN 92
Query: 238 LCKLLGFHAR-DGSDQRMLIYERLFHGSLDRLIYGRSDGPPIDWNTRVKIALCAAQGLTF 296
+ LLG R +GS +L Y + HG L I + P + + L A+G+ +
Sbjct: 93 VLSLLGICLRSEGSPLVVLPYMK--HGDLRNFIRNETHNPTV--KDLIGFGLQVAKGMKY 148
Query: 297 LHEEGPFQAMYNEFSTANIQIDKDFSAKLSGYGCA 331
L + + ++ + + N +D+ F+ K++ +G A
Sbjct: 149 LASK---KFVHRDLAARNCMLDEKFTVKVADFGLA 180
>pdb|3F66|A Chain A, Human C-Met Kinase In Complex With Quinoxaline Inhibitor
pdb|3F66|B Chain B, Human C-Met Kinase In Complex With Quinoxaline Inhibitor
Length = 298
Score = 45.4 bits (106), Expect = 5e-05, Method: Compositional matrix adjust.
Identities = 37/155 (23%), Positives = 68/155 (43%), Gaps = 12/155 (7%)
Query: 180 DRCISEGLSSVMYRASFGDDASTSKKFEATVTRLNPSSQ--GVKEFINDVNTLASLQHPN 237
+ I G +Y + D+ KK V LN + V +F+ + + HPN
Sbjct: 30 NEVIGRGHFGCVYHGTLLDN--DGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPN 87
Query: 238 LCKLLGFHAR-DGSDQRMLIYERLFHGSLDRLIYGRSDGPPIDWNTRVKIALCAAQGLTF 296
+ LLG R +GS +L Y + HG L I + P + + L A+G+ +
Sbjct: 88 VLSLLGICLRSEGSPLVVLPYMK--HGDLRNFIRNETHNPTV--KDLIGFGLQVAKGMKY 143
Query: 297 LHEEGPFQAMYNEFSTANIQIDKDFSAKLSGYGCA 331
L + + ++ + + N +D+ F+ K++ +G A
Sbjct: 144 LASK---KFVHRDLAARNCMLDEKFTVKVADFGLA 175
>pdb|3SXR|A Chain A, Crystal Structure Of Bmx Non-Receptor Tyrosine Kinase
Complex With Dasatinib
pdb|3SXR|B Chain B, Crystal Structure Of Bmx Non-Receptor Tyrosine Kinase
Complex With Dasatinib
pdb|3SXS|A Chain A, Crystal Structure Of Bmx Non-Receptor Tyrosine Kinase
Complexed With Pp2
Length = 268
Score = 44.7 bits (104), Expect = 8e-05, Method: Compositional matrix adjust.
Identities = 29/130 (22%), Positives = 60/130 (46%), Gaps = 7/130 (5%)
Query: 205 KFEATVTRLNPSSQGVKEFINDVNTLASLQHPNLCKLLGFHARDGSDQRMLIYERLFHGS 264
+++ V + S EF + T+ L HP L K G +++ ++ E + +G
Sbjct: 32 QYDVAVKMIKEGSMSEDEFFQEAQTMMKLSHPKLVKFYGVCSKEYP--IYIVTEYISNGC 89
Query: 265 LDRLIYGRSDGPPIDWNTRVKIALCAAQGLTFLHEEGPFQAMYNEFSTANIQIDKDFSAK 324
L L Y RS G ++ + +++ +G+ FL Q ++ + + N +D+D K
Sbjct: 90 L--LNYLRSHGKGLEPSQLLEMCYDVCEGMAFLESH---QFIHRDLAARNCLVDRDLCVK 144
Query: 325 LSGYGCAGHI 334
+S +G ++
Sbjct: 145 VSDFGMTRYV 154
>pdb|2HK5|A Chain A, Hck Kinase In Complex With Lck Targetted Inhibitor Pg-
1009247
Length = 270
Score = 43.5 bits (101), Expect = 2e-04, Method: Compositional matrix adjust.
Identities = 35/140 (25%), Positives = 64/140 (45%), Gaps = 9/140 (6%)
Query: 200 ASTSKKFEATVTRLNPSSQGVKEFINDVNTLASLQHPNLCKLLGFHARDGSDQRMLIYER 259
A+ +K + V + P S V+ F+ + N + +LQH L KL HA + +I E
Sbjct: 34 ATYNKHTKVAVKTMKPGSMSVEAFLAEANVMKTLQHDKLVKL---HAVVTKEPIYIITEF 90
Query: 260 LFHGSLDRLIYGRSD-GPPIDWNTRVKIALCAAQGLTFLHEEGPFQAMYNEFSTANIQID 318
+ GSL L + +SD G + + A+G+ F+ + ++ + ANI +
Sbjct: 91 MAKGSL--LDFLKSDEGSKQPLPKLIDFSAQIAEGMAFIEQRN---YIHRDLRAANILVS 145
Query: 319 KDFSAKLSGYGCAGHIPETD 338
K++ +G A I + +
Sbjct: 146 ASLVCKIADFGLARVIEDNE 165
>pdb|4EOI|A Chain A, Thr 160 Phosphorylated Cdk2 K89d, Q131e - Human Cyclin A3
Complex With The Inhibitor Ro3306
pdb|4EOI|C Chain C, Thr 160 Phosphorylated Cdk2 K89d, Q131e - Human Cyclin A3
Complex With The Inhibitor Ro3306
Length = 299
Score = 43.1 bits (100), Expect = 2e-04, Method: Compositional matrix adjust.
Identities = 40/160 (25%), Positives = 68/160 (42%), Gaps = 11/160 (6%)
Query: 173 ACHNFFSDRCISEGLSSVMYRASFGDDASTSKKFEATVTRLNPSSQGV-KEFINDVNTLA 231
+ NF I EG V+Y+A + T + RL+ ++GV I +++ L
Sbjct: 1 SMENFQKVEKIGEGTYGVVYKAR---NKLTGEVVALKKIRLDTETEGVPSTAIREISLLK 57
Query: 232 SLQHPNLCKLLGFHARDGSDQRMLIYERLFHGSLDRLIYGRSDGPPIDWNTRVKIALCAA 291
L HPN+ KLL ++ L++E L D + G P+ L
Sbjct: 58 ELNHPNIVKLLD--VIHTENKLYLVFEFLHQDLKDFMDASALTGIPLPLIKSYLFQLL-- 113
Query: 292 QGLTFLHEEGPFQAMYNEFSTANIQIDKDFSAKLSGYGCA 331
QGL F H + ++ + N+ I+ + + KL+ +G A
Sbjct: 114 QGLAFCHSH---RVLHRDLKPENLLINTEGAIKLADFGLA 150
>pdb|4EOP|A Chain A, Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3
Complex With The Inhibitor Ro3306
pdb|4EOP|C Chain C, Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3
Complex With The Inhibitor Ro3306
Length = 300
Score = 43.1 bits (100), Expect = 3e-04, Method: Compositional matrix adjust.
Identities = 41/162 (25%), Positives = 71/162 (43%), Gaps = 13/162 (8%)
Query: 172 AACHNFFSDRCISEGLSSVMYRASFGDDASTSKKFEATVTRLNPSSQGV-KEFINDVNTL 230
+ NF I EG V+Y+A + T + RL+ ++GV I +++ L
Sbjct: 2 GSMENFQKVEKIGEGTYGVVYKAR---NKLTGEVVALKKIRLDTETEGVPSTAIREISLL 58
Query: 231 ASLQHPNLCKLLGFHARDGSDQRMLIYERLFHGSLDRLIYGRS-DGPPIDWNTRVKIALC 289
L HPN+ KLL ++ L++E L H L + + + G P+ L
Sbjct: 59 KELNHPNIVKLLD--VIHTENKLYLVFEFL-HQDLKKFMDASALTGIPLPLIKSYLFQLL 115
Query: 290 AAQGLTFLHEEGPFQAMYNEFSTANIQIDKDFSAKLSGYGCA 331
QGL F H + ++ + N+ I+ + + KL+ +G A
Sbjct: 116 --QGLAFCHSH---RVLHRDLKPENLLINTEGAIKLADFGLA 152
>pdb|4EOQ|A Chain A, Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Complex
With Atp
pdb|4EOQ|C Chain C, Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Complex
With Atp
Length = 301
Score = 43.1 bits (100), Expect = 3e-04, Method: Compositional matrix adjust.
Identities = 41/162 (25%), Positives = 71/162 (43%), Gaps = 13/162 (8%)
Query: 172 AACHNFFSDRCISEGLSSVMYRASFGDDASTSKKFEATVTRLNPSSQGV-KEFINDVNTL 230
+ NF I EG V+Y+A + T + RL+ ++GV I +++ L
Sbjct: 3 GSMENFQKVEKIGEGTYGVVYKAR---NKLTGEVVALKKIRLDTETEGVPSTAIREISLL 59
Query: 231 ASLQHPNLCKLLGFHARDGSDQRMLIYERLFHGSLDRLIYGRS-DGPPIDWNTRVKIALC 289
L HPN+ KLL ++ L++E L H L + + + G P+ L
Sbjct: 60 KELNHPNIVKLLD--VIHTENKLYLVFEFL-HQDLKKFMDASALTGIPLPLIKSYLFQLL 116
Query: 290 AAQGLTFLHEEGPFQAMYNEFSTANIQIDKDFSAKLSGYGCA 331
QGL F H + ++ + N+ I+ + + KL+ +G A
Sbjct: 117 --QGLAFCHSH---RVLHRDLKPQNLLINTEGAIKLADFGLA 153
>pdb|4BCQ|A Chain A, Structure Of Cdk2 In Complex With Cyclin A And A
2-amino-4- Heteroaryl-pyrimidine Inhibitor
pdb|4BCQ|C Chain C, Structure Of Cdk2 In Complex With Cyclin A And A
2-amino-4- Heteroaryl-pyrimidine Inhibitor
Length = 301
Score = 43.1 bits (100), Expect = 3e-04, Method: Compositional matrix adjust.
Identities = 41/162 (25%), Positives = 71/162 (43%), Gaps = 13/162 (8%)
Query: 172 AACHNFFSDRCISEGLSSVMYRASFGDDASTSKKFEATVTRLNPSSQGV-KEFINDVNTL 230
+ NF I EG V+Y+A + T + RL+ ++GV I +++ L
Sbjct: 2 GSMENFQKVEKIGEGTYGVVYKAR---NKLTGEVVALKKIRLDTETEGVPSTAIREISLL 58
Query: 231 ASLQHPNLCKLLGFHARDGSDQRMLIYERLFHGSLDRLIYGRS-DGPPIDWNTRVKIALC 289
L HPN+ KLL ++ L++E L H L + + + G P+ L
Sbjct: 59 KELNHPNIVKLLD--VIHTENKLYLVFEFL-HQDLKKFMDASALTGIPLPLIKSYLFQLL 115
Query: 290 AAQGLTFLHEEGPFQAMYNEFSTANIQIDKDFSAKLSGYGCA 331
QGL F H + ++ + N+ I+ + + KL+ +G A
Sbjct: 116 --QGLAFCHSH---RVLHRDLKPQNLLINTEGAIKLADFGLA 152
>pdb|4EOS|A Chain A, Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Complex
With The Inhibitor Ro3306
pdb|4EOS|C Chain C, Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Complex
With The Inhibitor Ro3306
Length = 300
Score = 42.7 bits (99), Expect = 3e-04, Method: Compositional matrix adjust.
Identities = 41/162 (25%), Positives = 71/162 (43%), Gaps = 13/162 (8%)
Query: 172 AACHNFFSDRCISEGLSSVMYRASFGDDASTSKKFEATVTRLNPSSQGV-KEFINDVNTL 230
+ NF I EG V+Y+A + T + RL+ ++GV I +++ L
Sbjct: 2 GSMENFQKVEKIGEGTYGVVYKAR---NKLTGEVVALKKIRLDTETEGVPSTAIREISLL 58
Query: 231 ASLQHPNLCKLLGFHARDGSDQRMLIYERLFHGSLDRLIYGRS-DGPPIDWNTRVKIALC 289
L HPN+ KLL ++ L++E L H L + + + G P+ L
Sbjct: 59 KELNHPNIVKLLD--VIHTENKLYLVFEFL-HQDLKKFMDASALTGIPLPLIKSYLFQLL 115
Query: 290 AAQGLTFLHEEGPFQAMYNEFSTANIQIDKDFSAKLSGYGCA 331
QGL F H + ++ + N+ I+ + + KL+ +G A
Sbjct: 116 --QGLAFCHSH---RVLHRDLKPQNLLINTEGAIKLADFGLA 152
>pdb|1H1P|A Chain A, Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMPLEXED
With The Inhibitor Nu2058
pdb|1H1P|C Chain C, Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMPLEXED
With The Inhibitor Nu2058
pdb|1H1Q|A Chain A, Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMPLEXED
With The Inhibitor Nu6094
pdb|1H1Q|C Chain C, Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMPLEXED
With The Inhibitor Nu6094
pdb|1H1R|A Chain A, Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMPLEXED
With The Inhibitor Nu6086
pdb|1H1R|C Chain C, Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMPLEXED
With The Inhibitor Nu6086
pdb|1H1S|A Chain A, Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMPLEXED
With The Inhibitor Nu6102
pdb|1H1S|C Chain C, Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMPLEXED
With The Inhibitor Nu6102
pdb|1H24|A Chain A, Cdk2CYCLIN A IN COMPLEX WITH A 9 RESIDUE RECRUITMENT
Peptide From E2f
pdb|1H24|C Chain C, Cdk2CYCLIN A IN COMPLEX WITH A 9 RESIDUE RECRUITMENT
Peptide From E2f
pdb|1H25|A Chain A, Cdk2CYCLIN A IN COMPLEX WITH AN 11-Residue Recruitment
Peptide From Retinoblastoma-Associated Protein
pdb|1H25|C Chain C, Cdk2CYCLIN A IN COMPLEX WITH AN 11-Residue Recruitment
Peptide From Retinoblastoma-Associated Protein
pdb|1H26|A Chain A, Cdk2CYCLIN A IN COMPLEX WITH AN 11-Residue Recruitment
Peptide From P53
pdb|1H26|C Chain C, Cdk2CYCLIN A IN COMPLEX WITH AN 11-Residue Recruitment
Peptide From P53
pdb|1H27|A Chain A, Cdk2CYCLIN A IN COMPLEX WITH AN 11-Residue Recruitment
Peptide From P27
pdb|1H27|C Chain C, Cdk2CYCLIN A IN COMPLEX WITH AN 11-Residue Recruitment
Peptide From P27
pdb|1H28|A Chain A, Cdk2/cyclin A In Complex With An 11-residue Recruitment
Peptide From P107
pdb|1H28|C Chain C, Cdk2/cyclin A In Complex With An 11-residue Recruitment
Peptide From P107
pdb|2WMA|A Chain A, Structural And Thermodynamic Consequences Of Cyclization
Of Peptide Ligands For The Recruitment Site Of Cyclin A
pdb|2WMA|C Chain C, Structural And Thermodynamic Consequences Of Cyclization
Of Peptide Ligands For The Recruitment Site Of Cyclin A
pdb|2WMB|A Chain A, Structural And Thermodynamic Consequences Of Cyclization
Of Peptide Ligands For The Recruitment Site Of Cyclin A
pdb|2WMB|C Chain C, Structural And Thermodynamic Consequences Of Cyclization
Of Peptide Ligands For The Recruitment Site Of Cyclin A
Length = 303
Score = 42.7 bits (99), Expect = 3e-04, Method: Compositional matrix adjust.
Identities = 41/162 (25%), Positives = 71/162 (43%), Gaps = 13/162 (8%)
Query: 172 AACHNFFSDRCISEGLSSVMYRASFGDDASTSKKFEATVTRLNPSSQGV-KEFINDVNTL 230
+ NF I EG V+Y+A + T + RL+ ++GV I +++ L
Sbjct: 4 GSMENFQKVEKIGEGTYGVVYKAR---NKLTGEVVALKKIRLDTETEGVPSTAIREISLL 60
Query: 231 ASLQHPNLCKLLGFHARDGSDQRMLIYERLFHGSLDRLIYGRS-DGPPIDWNTRVKIALC 289
L HPN+ KLL ++ L++E L H L + + + G P+ L
Sbjct: 61 KELNHPNIVKLLD--VIHTENKLYLVFEFL-HQDLKKFMDASALTGIPLPLIKSYLFQLL 117
Query: 290 AAQGLTFLHEEGPFQAMYNEFSTANIQIDKDFSAKLSGYGCA 331
QGL F H + ++ + N+ I+ + + KL+ +G A
Sbjct: 118 --QGLAFCHSH---RVLHRDLKPQNLLINTEGAIKLADFGLA 154
>pdb|1OIT|A Chain A, Imidazopyridines: A Potent And Selective Class Of
Cyclin-dependent Kinase Inhibitors Identified Through
Structure-based Hybridisation
Length = 299
Score = 42.7 bits (99), Expect = 3e-04, Method: Compositional matrix adjust.
Identities = 41/158 (25%), Positives = 71/158 (44%), Gaps = 13/158 (8%)
Query: 176 NFFSDRCISEGLSSVMYRASFGDDASTSKKFEATVTRLNPSSQGV-KEFINDVNTLASLQ 234
NF I EG V+Y+A + T + RL+ ++GV I +++ L L
Sbjct: 4 NFQKVEKIGEGTYGVVYKAR---NKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELN 60
Query: 235 HPNLCKLLGFHARDGSDQRMLIYERLFHGSLDRLIYGRS-DGPPIDWNTRVKIALCAAQG 293
HPN+ KLL ++ L++E L H L + + + G P+ L QG
Sbjct: 61 HPNIVKLLD--VIHTENKLYLVFEFL-HQDLKKFMDASALTGIPLPLIKSYLFQLL--QG 115
Query: 294 LTFLHEEGPFQAMYNEFSTANIQIDKDFSAKLSGYGCA 331
L+F H + ++ + N+ I+ + + KL+ +G A
Sbjct: 116 LSFCHSH---RVLHRDLKPQNLLINTEGAIKLADFGLA 150
>pdb|4EOO|A Chain A, Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3
Complex With Atp
pdb|4EOO|C Chain C, Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3
Complex With Atp
Length = 299
Score = 42.7 bits (99), Expect = 3e-04, Method: Compositional matrix adjust.
Identities = 41/162 (25%), Positives = 71/162 (43%), Gaps = 13/162 (8%)
Query: 172 AACHNFFSDRCISEGLSSVMYRASFGDDASTSKKFEATVTRLNPSSQGV-KEFINDVNTL 230
+ NF I EG V+Y+A + T + RL+ ++GV I +++ L
Sbjct: 1 GSMENFQKVEKIGEGTYGVVYKAR---NKLTGEVVALKKIRLDTETEGVPSTAIREISLL 57
Query: 231 ASLQHPNLCKLLGFHARDGSDQRMLIYERLFHGSLDRLIYGRS-DGPPIDWNTRVKIALC 289
L HPN+ KLL ++ L++E L H L + + + G P+ L
Sbjct: 58 KELNHPNIVKLLD--VIHTENKLYLVFEFL-HQDLKKFMDASALTGIPLPLIKSYLFQLL 114
Query: 290 AAQGLTFLHEEGPFQAMYNEFSTANIQIDKDFSAKLSGYGCA 331
QGL F H + ++ + N+ I+ + + KL+ +G A
Sbjct: 115 --QGLAFCHSH---RVLHRDLKPENLLINTEGAIKLADFGLA 151
>pdb|1OGU|A Chain A, Structure Of Human Thr160-phospho Cdk2/cyclin A Complexed
With A
2-arylamino-4-cyclohexylmethyl-5-nitroso-6-
aminopyrimidine Inhibitor
pdb|1OGU|C Chain C, Structure Of Human Thr160-phospho Cdk2/cyclin A Complexed
With A
2-arylamino-4-cyclohexylmethyl-5-nitroso-6-
aminopyrimidine Inhibitor
pdb|1OI9|A Chain A, Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMPLEXED
With A 6-Cyclohexylmethyloxy-2-Anilino-Purine Inhibitor
pdb|1OI9|C Chain C, Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMPLEXED
With A 6-Cyclohexylmethyloxy-2-Anilino-Purine Inhibitor
pdb|1OIU|A Chain A, Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMPLEXED
With A 6-Cyclohexylmethyloxy-2-Anilino-Purine Inhibitor
pdb|1OIU|C Chain C, Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMPLEXED
With A 6-Cyclohexylmethyloxy-2-Anilino-Purine Inhibitor
pdb|1OIY|A Chain A, Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMPLEXED
With A 6-Cyclohexylmethyloxy-2-Anilino-Purine Inhibitor
pdb|1OIY|C Chain C, Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMPLEXED
With A 6-Cyclohexylmethyloxy-2-Anilino-Purine Inhibitor
Length = 302
Score = 42.7 bits (99), Expect = 3e-04, Method: Compositional matrix adjust.
Identities = 41/162 (25%), Positives = 71/162 (43%), Gaps = 13/162 (8%)
Query: 172 AACHNFFSDRCISEGLSSVMYRASFGDDASTSKKFEATVTRLNPSSQGV-KEFINDVNTL 230
+ NF I EG V+Y+A + T + RL+ ++GV I +++ L
Sbjct: 3 GSMENFQKVEKIGEGTYGVVYKAR---NKLTGEVVALKKIRLDTETEGVPSTAIREISLL 59
Query: 231 ASLQHPNLCKLLGFHARDGSDQRMLIYERLFHGSLDRLIYGRS-DGPPIDWNTRVKIALC 289
L HPN+ KLL ++ L++E L H L + + + G P+ L
Sbjct: 60 KELNHPNIVKLLD--VIHTENKLYLVFEFL-HQDLKKFMDASALTGIPLPLIKSYLFQLL 116
Query: 290 AAQGLTFLHEEGPFQAMYNEFSTANIQIDKDFSAKLSGYGCA 331
QGL F H + ++ + N+ I+ + + KL+ +G A
Sbjct: 117 --QGLAFCHSH---RVLHRDLKPQNLLINTEGAIKLADFGLA 153
>pdb|2P0C|A Chain A, Catalytic Domain Of The Proto-Oncogene Tyrosine-Protein
Kina
pdb|2P0C|B Chain B, Catalytic Domain Of The Proto-Oncogene Tyrosine-Protein
Kina
pdb|3BRB|A Chain A, Crystal Structure Of Catalytic Domain Of The
Proto-Oncogene Tyrosine- Protein Kinase Mer In Complex
With Adp
pdb|3BRB|B Chain B, Crystal Structure Of Catalytic Domain Of The
Proto-Oncogene Tyrosine- Protein Kinase Mer In Complex
With Adp
pdb|3BPR|A Chain A, Crystal Structure Of Catalytic Domain Of The
Proto-Oncogene Protein Kinase Mer In Complex With
Inhibitor C52
pdb|3BPR|B Chain B, Crystal Structure Of Catalytic Domain Of The
Proto-Oncogene Protein Kinase Mer In Complex With
Inhibitor C52
pdb|3BPR|C Chain C, Crystal Structure Of Catalytic Domain Of The
Proto-Oncogene Protein Kinase Mer In Complex With
Inhibitor C52
pdb|3BPR|D Chain D, Crystal Structure Of Catalytic Domain Of The
Proto-Oncogene Protein Kinase Mer In Complex With
Inhibitor C52
pdb|3TCP|A Chain A, Crystal Structure Of The Catalytic Domain Of The
Proto-Oncogene Tyrosine-Protein Kinase Mer In Complex
With Inhibitor Unc569
pdb|3TCP|B Chain B, Crystal Structure Of The Catalytic Domain Of The
Proto-Oncogene Tyrosine-Protein Kinase Mer In Complex
With Inhibitor Unc569
Length = 313
Score = 42.7 bits (99), Expect = 3e-04, Method: Compositional matrix adjust.
Identities = 39/179 (21%), Positives = 78/179 (43%), Gaps = 10/179 (5%)
Query: 167 LDEVAAACHNFFSDRCISEGLSSVMYRASFGDDASTSKKFEATVTRLNPSSQ-GVKEFIN 225
L++V + + + EG + + + TS K +L+ SSQ ++EF++
Sbjct: 26 LEDVVIDRNLLILGKILGEGEFGSVMEGNLKQEDGTSLKVAVKTMKLDNSSQREIEEFLS 85
Query: 226 DVNTLASLQHPNLCKLLGF---HARDGSDQRMLIYERLFHGSLD-RLIYGRSDGPP--ID 279
+ + HPN+ +LLG + G + M+I + +G L L+Y R + P I
Sbjct: 86 EAACMKDFSHPNVIRLLGVCIEMSSQGIPKPMVILPFMKYGDLHTYLLYSRLETGPKHIP 145
Query: 280 WNTRVKIALCAAQGLTFLHEEGPFQAMYNEFSTANIQIDKDFSAKLSGYGCAGHIPETD 338
T +K + A G+ +L ++ + + N + D + ++ +G + I D
Sbjct: 146 LQTLLKFMVDIALGMEYLSNR---NFLHRDLAARNCMLRDDMTVCVADFGLSKKIYSGD 201
>pdb|3PXF|A Chain A, Cdk2 In Complex With Two Molecules Of
8-Anilino-1-Naphthalene Sulfonate
pdb|3PXQ|A Chain A, Cdk2 In Complex With 3 Molecules Of
8-Anilino-1-Naphthalene Sulfonate
pdb|3PXR|A Chain A, Apo Cdk2 Crystallized From Jeffamine
pdb|3PXY|A Chain A, Cdk2 In Complex With Inhibitor Jws648
pdb|3PXZ|A Chain A, Cdk2 Ternary Complex With Jws648 And Ans
pdb|3PY0|A Chain A, Cdk2 In Complex With Inhibitor Su9516
pdb|3PY1|A Chain A, Cdk2 Ternary Complex With Su9516 And Ans
pdb|3QL8|A Chain A, Cdk2 In Complex With Inhibitor Jws-6-260
pdb|3QQF|A Chain A, Cdk2 In Complex With Inhibitor L1
pdb|3QQG|A Chain A, Cdk2 In Complex With Inhibitor L2-5
pdb|3QQH|A Chain A, Cdk2 In Complex With Inhibitor L2-2
pdb|3QQJ|A Chain A, Cdk2 In Complex With Inhibitor L2
pdb|3QQL|A Chain A, Cdk2 In Complex With Inhibitor L3
pdb|3QRT|A Chain A, Cdk2 In Complex With Inhibitor Nsk-Mc2-55
pdb|3QRU|A Chain A, Cdk2 In Complex With Inhibitor Nsk-Mc1-12
pdb|3QWJ|A Chain A, Cdk2 In Complex With Inhibitor Kvr-1-142
pdb|3QWK|A Chain A, Cdk2 In Complex With Inhibitor Kvr-1-150
pdb|3QX2|A Chain A, Cdk2 In Complex With Inhibitor Kvr-1-190
pdb|3QX4|A Chain A, Cdk2 In Complex With Inhibitor Kvr-1-78
pdb|3QXO|A Chain A, Cdk2 In Complex With Inhibitor Kvr-1-84
pdb|3QZF|A Chain A, Cdk2 In Complex With Inhibitor Jws-6-52
pdb|3QZG|A Chain A, Cdk2 In Complex With Inhibitor Jws-6-76
pdb|3QZH|A Chain A, Cdk2 In Complex With Inhibitor Kvr-1-124
pdb|3QZI|A Chain A, Cdk2 In Complex With Inhibitor Kvr-1-126
pdb|3R1Q|A Chain A, Cdk2 In Complex With Inhibitor Kvr-1-102
pdb|3R1S|A Chain A, Cdk2 In Complex With Inhibitor Kvr-1-127
pdb|3R1Y|A Chain A, Cdk2 In Complex With Inhibitor Kvr-1-134
pdb|3R28|A Chain A, Cdk2 In Complex With Inhibitor Kvr-1-140
pdb|3R6X|A Chain A, Cdk2 In Complex With Inhibitor Kvr-1-158
pdb|3R71|A Chain A, Cdk2 In Complex With Inhibitor Kvr-1-162
pdb|3R73|A Chain A, Cdk2 In Complex With Inhibitor Kvr-1-164
pdb|3R7E|A Chain A, Cdk2 In Complex With Inhibitor Kvr-1-67
pdb|3R7I|A Chain A, Cdk2 In Complex With Inhibitor Kvr-1-74
pdb|3R7U|A Chain A, Cdk2 In Complex With Inhibitor Kvr-1-75
pdb|3R7V|A Chain A, Cdk2 In Complex With Inhibitor Kvr-1-9
pdb|3R7Y|A Chain A, Cdk2 In Complex With Inhibitor Kvr-2-88
pdb|3R83|A Chain A, Cdk2 In Complex With Inhibitor Kvr-2-92
pdb|3R8L|A Chain A, Cdk2 In Complex With Inhibitor L3-4
pdb|3R8M|A Chain A, Cdk2 In Complex With Inhibitor L3-3
pdb|3R8P|A Chain A, Cdk2 In Complex With Inhibitor Nsk-Mc1-6
pdb|3RAI|A Chain A, Cdk2 In Complex With Inhibitor Kvr-1-160
pdb|3RM6|A Chain A, Cdk2 In Complex With Inhibitor Kvr-2-80
pdb|3RM7|A Chain A, Cdk2 In Complex With Inhibitor Kvr-1-91
pdb|3ROY|A Chain A, Cdk2 In Complex With Inhibitor Kvr-1-154
pdb|3RPO|A Chain A, Cdk2 In Complex With Inhibitor Kvr-1-156
pdb|4EZ3|A Chain A, Cdk2 In Complex With Nsc 134199
pdb|4EZ7|A Chain A, Cdk2 In Complex With Staurosporine And 2 Molecules Of
8-Anilino-1- Naphthalene Sulfonic Acid
pdb|3QQK|A Chain A, Cdk2 In Complex With Inhibitor L4
pdb|3QTQ|A Chain A, Cdk2 In Complex With Inhibitor Rc-1-137
pdb|3QTR|A Chain A, Cdk2 In Complex With Inhibitor Rc-1-148
pdb|3QTS|A Chain A, Cdk2 In Complex With Inhibitor Rc-2-12
pdb|3QTU|A Chain A, Cdk2 In Complex With Inhibitor Rc-2-132
pdb|3QTW|A Chain A, Cdk2 In Complex With Inhibitor Rc-2-13
pdb|3QTX|A Chain A, Cdk2 In Complex With Inhibitor Rc-2-35
pdb|3QTZ|A Chain A, Cdk2 In Complex With Inhibitor Rc-2-36
pdb|3QU0|A Chain A, Cdk2 In Complex With Inhibitor Rc-2-38
pdb|3QXP|A Chain A, Cdk2 In Complex With Inhibitor Rc-3-89
pdb|3R8U|A Chain A, Cdk2 In Complex With Inhibitor Rc-1-132
pdb|3R8V|A Chain A, Cdk2 In Complex With Inhibitor Rc-1-135
pdb|3R8Z|A Chain A, Cdk2 In Complex With Inhibitor Rc-1-136
pdb|3R9D|A Chain A, Cdk2 In Complex With Inhibitor Rc-2-135
pdb|3R9H|A Chain A, Cdk2 In Complex With Inhibitor Rc-2-142
pdb|3R9N|A Chain A, Cdk2 In Complex With Inhibitor Rc-2-21
pdb|3R9O|A Chain A, Cdk2 In Complex With Inhibitor Rc-2-143
pdb|3RAH|A Chain A, Cdk2 In Complex With Inhibitor Rc-2-22
pdb|3RAK|A Chain A, Cdk2 In Complex With Inhibitor Rc-2-32
pdb|3RAL|A Chain A, Cdk2 In Complex With Inhibitor Rc-2-34
pdb|3RJC|A Chain A, Cdk2 In Complex With Inhibitor L4-12
pdb|3RK5|A Chain A, Cdk2 In Complex With Inhibitor Rc-2-72
pdb|3RK7|A Chain A, Cdk2 In Complex With Inhibitor Rc-2-71
pdb|3RK9|A Chain A, Cdk2 In Complex With Inhibitor Rc-2-74
pdb|3RKB|A Chain A, Cdk2 In Complex With Inhibitor Rc-2-73
pdb|3RMF|A Chain A, Cdk2 In Complex With Inhibitor Rc-2-33
pdb|3RNI|A Chain A, Cdk2 In Complex With Inhibitor Rc-3-86
pdb|3RPR|A Chain A, Cdk2 In Complex With Inhibitor Rc-2-49
pdb|3RPV|A Chain A, Cdk2 In Complex With Inhibitor Rc-2-88
pdb|3RPY|A Chain A, Cdk2 In Complex With Inhibitor Rc-2-40
pdb|3RZB|A Chain A, Cdk2 In Complex With Inhibitor Rc-2-23
pdb|3S00|A Chain A, Cdk2 In Complex With Inhibitor L4-14
pdb|3S0O|A Chain A, Cdk2 In Complex With Inhibitor Rc-1-138
pdb|3S1H|A Chain A, Cdk2 In Complex With Inhibitor Rc-2-39
pdb|3SQQ|A Chain A, Cdk2 In Complex With Inhibitor Rc-3-96
pdb|4GCJ|A Chain A, Cdk2 In Complex With Inhibitor Rc-3-89
Length = 306
Score = 42.7 bits (99), Expect = 3e-04, Method: Compositional matrix adjust.
Identities = 41/158 (25%), Positives = 70/158 (44%), Gaps = 13/158 (8%)
Query: 176 NFFSDRCISEGLSSVMYRASFGDDASTSKKFEATVTRLNPSSQGV-KEFINDVNTLASLQ 234
NF I EG V+Y+A + T + RL+ ++GV I +++ L L
Sbjct: 11 NFQKVEKIGEGTYGVVYKAR---NKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELN 67
Query: 235 HPNLCKLLGFHARDGSDQRMLIYERLFHGSLDRLIYGRS-DGPPIDWNTRVKIALCAAQG 293
HPN+ KLL ++ L++E L H L + + + G P+ L QG
Sbjct: 68 HPNIVKLLD--VIHTENKLYLVFEFL-HQDLKKFMDASALTGIPLPLIKSYLFQLL--QG 122
Query: 294 LTFLHEEGPFQAMYNEFSTANIQIDKDFSAKLSGYGCA 331
L F H + ++ + N+ I+ + + KL+ +G A
Sbjct: 123 LAFCHSH---RVLHRDLKPQNLLINTEGAIKLADFGLA 157
>pdb|3EZR|A Chain A, Cdk-2 With Indazole Inhibitor 17 Bound At Its Active Site
pdb|3EZV|A Chain A, Cdk-2 With Indazole Inhibitor 9 Bound At Its Active Site
Length = 300
Score = 42.7 bits (99), Expect = 3e-04, Method: Compositional matrix adjust.
Identities = 41/162 (25%), Positives = 71/162 (43%), Gaps = 13/162 (8%)
Query: 172 AACHNFFSDRCISEGLSSVMYRASFGDDASTSKKFEATVTRLNPSSQGV-KEFINDVNTL 230
+ NF I EG V+Y+A + T + RL+ ++GV I +++ L
Sbjct: 1 GSMENFQKVEKIGEGTYGVVYKAR---NKLTGEVVALKKIRLDTETEGVPSTAIREISLL 57
Query: 231 ASLQHPNLCKLLGFHARDGSDQRMLIYERLFHGSLDRLIYGRS-DGPPIDWNTRVKIALC 289
L HPN+ KLL ++ L++E L H L + + + G P+ L
Sbjct: 58 KELNHPNIVKLLD--VIHTENKLYLVFEFL-HQDLKKFMDASALTGIPLPLIKSYLFQLL 114
Query: 290 AAQGLTFLHEEGPFQAMYNEFSTANIQIDKDFSAKLSGYGCA 331
QGL F H + ++ + N+ I+ + + KL+ +G A
Sbjct: 115 --QGLAFCHSH---RVLHRDLKPQNLLINTEGAIKLADFGLA 151
>pdb|1W98|A Chain A, The Structural Basis Of Cdk2 Activation By Cyclin E
pdb|4EOR|A Chain A, Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Complex
With The Inhibitor Nu6102
pdb|4EOR|C Chain C, Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Complex
With The Inhibitor Nu6102
Length = 298
Score = 42.7 bits (99), Expect = 3e-04, Method: Compositional matrix adjust.
Identities = 41/161 (25%), Positives = 71/161 (44%), Gaps = 13/161 (8%)
Query: 173 ACHNFFSDRCISEGLSSVMYRASFGDDASTSKKFEATVTRLNPSSQGV-KEFINDVNTLA 231
+ NF I EG V+Y+A + T + RL+ ++GV I +++ L
Sbjct: 1 SMENFQKVEKIGEGTYGVVYKAR---NKLTGEVVALKKIRLDTETEGVPSTAIREISLLK 57
Query: 232 SLQHPNLCKLLGFHARDGSDQRMLIYERLFHGSLDRLIYGRS-DGPPIDWNTRVKIALCA 290
L HPN+ KLL ++ L++E L H L + + + G P+ L
Sbjct: 58 ELNHPNIVKLLD--VIHTENKLYLVFEFL-HQDLKKFMDASALTGIPLPLIKSYLFQLL- 113
Query: 291 AQGLTFLHEEGPFQAMYNEFSTANIQIDKDFSAKLSGYGCA 331
QGL F H + ++ + N+ I+ + + KL+ +G A
Sbjct: 114 -QGLAFCHSH---RVLHRDLKPQNLLINTEGAIKLADFGLA 150
>pdb|4ERW|A Chain A, Cdk2 In Complex With Staurosporine
Length = 306
Score = 42.7 bits (99), Expect = 3e-04, Method: Compositional matrix adjust.
Identities = 41/158 (25%), Positives = 70/158 (44%), Gaps = 13/158 (8%)
Query: 176 NFFSDRCISEGLSSVMYRASFGDDASTSKKFEATVTRLNPSSQGV-KEFINDVNTLASLQ 234
NF I EG V+Y+A + T + RL+ ++GV I +++ L L
Sbjct: 11 NFQKVEKIGEGTYGVVYKAR---NKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELN 67
Query: 235 HPNLCKLLGFHARDGSDQRMLIYERLFHGSLDRLIYGRS-DGPPIDWNTRVKIALCAAQG 293
HPN+ KLL ++ L++E L H L + + + G P+ L QG
Sbjct: 68 HPNIVKLLD--VIHTENKLYLVFEFL-HQDLKKFMDASALTGIPLPLIKSYLFQLL--QG 122
Query: 294 LTFLHEEGPFQAMYNEFSTANIQIDKDFSAKLSGYGCA 331
L F H + ++ + N+ I+ + + KL+ +G A
Sbjct: 123 LAFCHSH---RVLHRDLKPQNLLINTEGAIKLADFGLA 157
>pdb|3DTC|A Chain A, Crystal Structure Of Mixed-Lineage Kinase Mlk1 Complexed
With Compound 16
Length = 271
Score = 42.7 bits (99), Expect = 3e-04, Method: Compositional matrix adjust.
Identities = 35/130 (26%), Positives = 60/130 (46%), Gaps = 14/130 (10%)
Query: 191 MYRASFGDDASTSKKFEATVTRLNPS---SQGVKEFINDVNTLASLQHPNLCKLLGFHAR 247
+YRA + D K R +P SQ ++ + A L+HPN+ L G +
Sbjct: 23 VYRAFWIGDEVAVK-----AARHDPDEDISQTIENVRQEAKLFAMLKHPNIIALRGVCLK 77
Query: 248 DGSDQRMLIYERLFHGSLDRLIYGRSDGPPIDWNTRVKIALCAAQGLTFLHEEGPFQAMY 307
+ L+ E G L+R++ G+ P I N V+IA +G+ +LH+E ++
Sbjct: 78 E--PNLCLVMEFARGGPLNRVLSGKRIPPDILVNWAVQIA----RGMNYLHDEAIVPIIH 131
Query: 308 NEFSTANIQI 317
+ ++NI I
Sbjct: 132 RDLKSSNILI 141
>pdb|3BHT|A Chain A, Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN COMPLEX
WITH THE Inhibitor Meriolin 3
pdb|3BHT|C Chain C, Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN COMPLEX
WITH THE Inhibitor Meriolin 3
pdb|3BHU|A Chain A, Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN COMPLEX
WITH THE Inhibitor Meriolin 5
pdb|3BHU|C Chain C, Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN COMPLEX
WITH THE Inhibitor Meriolin 5
pdb|3BHV|A Chain A, Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN COMPLEX
With The Inhibitor Variolin B
pdb|3BHV|C Chain C, Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN COMPLEX
With The Inhibitor Variolin B
pdb|3MY5|A Chain A, Cdk2CYCLINA IN COMPLEX WITH DRB
pdb|3MY5|C Chain C, Cdk2CYCLINA IN COMPLEX WITH DRB
pdb|3TNW|A Chain A, Structure Of Cdk2CYCLIN A IN COMPLEX WITH CAN508
pdb|3TNW|C Chain C, Structure Of Cdk2CYCLIN A IN COMPLEX WITH CAN508
pdb|4BCO|A Chain A, Structure Of Cdk2 In Complex With Cyclin A And A
2-amino-4- Heteroaryl-pyrimidine Inhibitor
pdb|4BCO|C Chain C, Structure Of Cdk2 In Complex With Cyclin A And A
2-amino-4- Heteroaryl-pyrimidine Inhibitor
Length = 300
Score = 42.7 bits (99), Expect = 3e-04, Method: Compositional matrix adjust.
Identities = 41/162 (25%), Positives = 71/162 (43%), Gaps = 13/162 (8%)
Query: 172 AACHNFFSDRCISEGLSSVMYRASFGDDASTSKKFEATVTRLNPSSQGV-KEFINDVNTL 230
+ NF I EG V+Y+A + T + RL+ ++GV I +++ L
Sbjct: 1 GSMENFQKVEKIGEGTYGVVYKAR---NKLTGEVVALKKIRLDTETEGVPSTAIREISLL 57
Query: 231 ASLQHPNLCKLLGFHARDGSDQRMLIYERLFHGSLDRLIYGRS-DGPPIDWNTRVKIALC 289
L HPN+ KLL ++ L++E L H L + + + G P+ L
Sbjct: 58 KELNHPNIVKLLD--VIHTENKLYLVFEFL-HQDLKKFMDASALTGIPLPLIKSYLFQLL 114
Query: 290 AAQGLTFLHEEGPFQAMYNEFSTANIQIDKDFSAKLSGYGCA 331
QGL F H + ++ + N+ I+ + + KL+ +G A
Sbjct: 115 --QGLAFCHSH---RVLHRDLKPQNLLINTEGAIKLADFGLA 151
>pdb|1QCF|A Chain A, Crystal Structure Of Hck In Complex With A Src Family-
Selective Tyrosine Kinase Inhibitor
pdb|2C0I|A Chain A, Src Family Kinase Hck With Bound Inhibitor A-420983
pdb|2C0I|B Chain B, Src Family Kinase Hck With Bound Inhibitor A-420983
pdb|2C0O|A Chain A, Src Family Kinase Hck With Bound Inhibitor A-770041
pdb|2C0O|B Chain B, Src Family Kinase Hck With Bound Inhibitor A-770041
pdb|2C0T|A Chain A, Src Family Kinase Hck With Bound Inhibitor A-641359
pdb|2C0T|B Chain B, Src Family Kinase Hck With Bound Inhibitor A-641359
Length = 454
Score = 42.7 bits (99), Expect = 3e-04, Method: Compositional matrix adjust.
Identities = 35/140 (25%), Positives = 64/140 (45%), Gaps = 9/140 (6%)
Query: 200 ASTSKKFEATVTRLNPSSQGVKEFINDVNTLASLQHPNLCKLLGFHARDGSDQRMLIYER 259
A+ +K + V + P S V+ F+ + N + +LQH L KL HA + +I E
Sbjct: 207 ATYNKHTKVAVKTMKPGSMSVEAFLAEANVMKTLQHDKLVKL---HAVVTKEPIYIITEF 263
Query: 260 LFHGSLDRLIYGRSD-GPPIDWNTRVKIALCAAQGLTFLHEEGPFQAMYNEFSTANIQID 318
+ GSL L + +SD G + + A+G+ F+ + ++ + ANI +
Sbjct: 264 MAKGSL--LDFLKSDEGSKQPLPKLIDFSAQIAEGMAFIEQR---NYIHRDLRAANILVS 318
Query: 319 KDFSAKLSGYGCAGHIPETD 338
K++ +G A I + +
Sbjct: 319 ASLVCKIADFGLARVIEDNE 338
>pdb|1OIR|A Chain A, Imidazopyridines: A Potent And Selective Class Of
Cyclin-Dependent Kinase Inhibitors Identified Through
Structure-Based Hybridisation
Length = 299
Score = 42.7 bits (99), Expect = 3e-04, Method: Compositional matrix adjust.
Identities = 41/158 (25%), Positives = 70/158 (44%), Gaps = 13/158 (8%)
Query: 176 NFFSDRCISEGLSSVMYRASFGDDASTSKKFEATVTRLNPSSQGV-KEFINDVNTLASLQ 234
NF I EG V+Y+A + T + RL+ ++GV I +++ L L
Sbjct: 4 NFQKVEKIGEGTYGVVYKAR---NKLTGEVVALXKIRLDTETEGVPSTAIREISLLKELN 60
Query: 235 HPNLCKLLGFHARDGSDQRMLIYERLFHGSLDRLIYGRS-DGPPIDWNTRVKIALCAAQG 293
HPN+ KLL ++ L++E L H L + + + G P+ L QG
Sbjct: 61 HPNIVKLLD--VIHTENKLYLVFEFL-HQDLKKFMDASALTGIPLPLIKSYLFQLL--QG 115
Query: 294 LTFLHEEGPFQAMYNEFSTANIQIDKDFSAKLSGYGCA 331
L F H + ++ + N+ I+ + + KL+ +G A
Sbjct: 116 LAFCHSH---RVLHRDLKPQNLLINTEGAIKLADFGLA 150
>pdb|1H01|A Chain A, Cdk2 In Complex With A Disubstituted 2, 4-Bis Anilino
Pyrimidine Cdk4 Inhibitor
Length = 298
Score = 42.7 bits (99), Expect = 3e-04, Method: Compositional matrix adjust.
Identities = 41/158 (25%), Positives = 70/158 (44%), Gaps = 13/158 (8%)
Query: 176 NFFSDRCISEGLSSVMYRASFGDDASTSKKFEATVTRLNPSSQGV-KEFINDVNTLASLQ 234
NF I EG V+Y+A + T + RL+ ++GV I +++ L L
Sbjct: 3 NFQKVEKIGEGTYGVVYKAR---NKLTGEVVALXKIRLDTETEGVPSTAIREISLLKELN 59
Query: 235 HPNLCKLLGFHARDGSDQRMLIYERLFHGSLDRLIYGRS-DGPPIDWNTRVKIALCAAQG 293
HPN+ KLL ++ L++E L H L + + + G P+ L QG
Sbjct: 60 HPNIVKLLD--VIHTENKLYLVFEFL-HQDLKKFMDASALTGIPLPLIKSYLFQLL--QG 114
Query: 294 LTFLHEEGPFQAMYNEFSTANIQIDKDFSAKLSGYGCA 331
L F H + ++ + N+ I+ + + KL+ +G A
Sbjct: 115 LAFCHSH---RVLHRDLKPQNLLINTEGAIKLADFGLA 149
>pdb|1E9H|A Chain A, Thr 160 Phosphorylated Cdk2-Human Cyclin A3 Complex With
The Inhibitor Indirubin-5-Sulphonate Bound
pdb|1E9H|C Chain C, Thr 160 Phosphorylated Cdk2-Human Cyclin A3 Complex With
The Inhibitor Indirubin-5-Sulphonate Bound
pdb|1PKD|A Chain A, The Crystal Structure Of Ucn-01 In Complex With Phospho-
Cdk2CYCLIN A
pdb|1PKD|C Chain C, The Crystal Structure Of Ucn-01 In Complex With Phospho-
Cdk2CYCLIN A
Length = 297
Score = 42.7 bits (99), Expect = 4e-04, Method: Compositional matrix adjust.
Identities = 41/161 (25%), Positives = 71/161 (44%), Gaps = 13/161 (8%)
Query: 173 ACHNFFSDRCISEGLSSVMYRASFGDDASTSKKFEATVTRLNPSSQGV-KEFINDVNTLA 231
+ NF I EG V+Y+A + T + RL+ ++GV I +++ L
Sbjct: 1 SMENFQKVEKIGEGTYGVVYKAR---NKLTGEVVALKKIRLDTETEGVPSTAIREISLLK 57
Query: 232 SLQHPNLCKLLGFHARDGSDQRMLIYERLFHGSLDRLIYGRS-DGPPIDWNTRVKIALCA 290
L HPN+ KLL ++ L++E L H L + + + G P+ L
Sbjct: 58 ELNHPNIVKLLD--VIHTENKLYLVFEFL-HQDLKKFMDASALTGIPLPLIKSYLFQLL- 113
Query: 291 AQGLTFLHEEGPFQAMYNEFSTANIQIDKDFSAKLSGYGCA 331
QGL F H + ++ + N+ I+ + + KL+ +G A
Sbjct: 114 -QGLAFCHSH---RVLHRDLKPQNLLINTEGAIKLADFGLA 150
>pdb|1QMZ|A Chain A, Phosphorylated Cdk2-Cyclyin A-Substrate Peptide Complex
pdb|1QMZ|C Chain C, Phosphorylated Cdk2-Cyclyin A-Substrate Peptide Complex
pdb|1GY3|A Chain A, Pcdk2CYCLIN A IN COMPLEX WITH MGADP, NITRATE AND PEPTIDE
SUBSTRATE
pdb|1GY3|C Chain C, Pcdk2CYCLIN A IN COMPLEX WITH MGADP, NITRATE AND PEPTIDE
SUBSTRATE
pdb|1P5E|A Chain A, The Strucure Of Phospho-Cdk2CYCLIN A IN COMPLEX WITH THE
Inhibitor 4,5,6,7-Tetrabromobenzotriazole (Tbs)
pdb|1P5E|C Chain C, The Strucure Of Phospho-Cdk2CYCLIN A IN COMPLEX WITH THE
Inhibitor 4,5,6,7-Tetrabromobenzotriazole (Tbs)
pdb|2CCH|A Chain A, The Crystal Structure Of Cdk2 Cyclin A In Complex With A
Substrate Peptide Derived From Cdc Modified With A
Gamma- Linked Atp Analogue
pdb|2CCH|C Chain C, The Crystal Structure Of Cdk2 Cyclin A In Complex With A
Substrate Peptide Derived From Cdc Modified With A
Gamma- Linked Atp Analogue
pdb|2CCI|A Chain A, Crystal Structure Of Phospho-Cdk2 Cyclin A In Complex With
A Peptide Containing Both The Substrate And Recruitment
Sites Of Cdc6
pdb|2CCI|C Chain C, Crystal Structure Of Phospho-Cdk2 Cyclin A In Complex With
A Peptide Containing Both The Substrate And Recruitment
Sites Of Cdc6
pdb|2G9X|A Chain A, Structure Of Thr 160 Phosphorylated Cdk2CYCLIN A IN
COMPLEX WITH THE Inhibitor Nu6271
pdb|2G9X|C Chain C, Structure Of Thr 160 Phosphorylated Cdk2CYCLIN A IN
COMPLEX WITH THE Inhibitor Nu6271
pdb|3DDP|A Chain A, Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN COMPLEX
With The Inhibitor Cr8
pdb|3DDP|C Chain C, Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN COMPLEX
With The Inhibitor Cr8
pdb|3DDQ|A Chain A, Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN COMPLEX
With The Inhibitor Roscovitine
pdb|3DDQ|C Chain C, Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN COMPLEX
With The Inhibitor Roscovitine
pdb|3DOG|A Chain A, Structure Of Thr 160 Phosphorylated Cdk2CYCLIN A IN
Complex With The Inhibitor N-&-N1
pdb|3DOG|C Chain C, Structure Of Thr 160 Phosphorylated Cdk2CYCLIN A IN
Complex With The Inhibitor N-&-N1
Length = 299
Score = 42.7 bits (99), Expect = 4e-04, Method: Compositional matrix adjust.
Identities = 41/161 (25%), Positives = 71/161 (44%), Gaps = 13/161 (8%)
Query: 173 ACHNFFSDRCISEGLSSVMYRASFGDDASTSKKFEATVTRLNPSSQGV-KEFINDVNTLA 231
+ NF I EG V+Y+A + T + RL+ ++GV I +++ L
Sbjct: 1 SMENFQKVEKIGEGTYGVVYKAR---NKLTGEVVALKKIRLDTETEGVPSTAIREISLLK 57
Query: 232 SLQHPNLCKLLGFHARDGSDQRMLIYERLFHGSLDRLIYGRS-DGPPIDWNTRVKIALCA 290
L HPN+ KLL ++ L++E L H L + + + G P+ L
Sbjct: 58 ELNHPNIVKLLD--VIHTENKLYLVFEFL-HQDLKKFMDASALTGIPLPLIKSYLFQLL- 113
Query: 291 AQGLTFLHEEGPFQAMYNEFSTANIQIDKDFSAKLSGYGCA 331
QGL F H + ++ + N+ I+ + + KL+ +G A
Sbjct: 114 -QGLAFCHSH---RVLHRDLKPQNLLINTEGAIKLADFGLA 150
>pdb|4I3Z|A Chain A, Structure Of Pcdk2CYCLINA BOUND TO ADP AND 2 MAGNESIUM
IONS
pdb|4I3Z|C Chain C, Structure Of Pcdk2CYCLINA BOUND TO ADP AND 2 MAGNESIUM
IONS
Length = 296
Score = 42.4 bits (98), Expect = 4e-04, Method: Compositional matrix adjust.
Identities = 41/158 (25%), Positives = 70/158 (44%), Gaps = 13/158 (8%)
Query: 176 NFFSDRCISEGLSSVMYRASFGDDASTSKKFEATVTRLNPSSQGV-KEFINDVNTLASLQ 234
NF I EG V+Y+A + T + RL+ ++GV I +++ L L
Sbjct: 3 NFQKVEKIGEGTYGVVYKAR---NKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELN 59
Query: 235 HPNLCKLLGFHARDGSDQRMLIYERLFHGSLDRLIYGRS-DGPPIDWNTRVKIALCAAQG 293
HPN+ KLL ++ L++E L H L + + + G P+ L QG
Sbjct: 60 HPNIVKLLD--VIHTENKLYLVFEFL-HQDLKKFMDASALTGIPLPLIKSYLFQLL--QG 114
Query: 294 LTFLHEEGPFQAMYNEFSTANIQIDKDFSAKLSGYGCA 331
L F H + ++ + N+ I+ + + KL+ +G A
Sbjct: 115 LAFCHSH---RVLHRDLKPQNLLINTEGAIKLADFGLA 149
>pdb|1GZ8|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The
Inhibitor 2-Amino-6-(3'-Methyl-2'-Oxo)butoxypurine
pdb|2R3Q|A Chain A, Crystal Structure Of Cyclin-Dependent Kinase 2 With
Inhibitor
pdb|2R3M|A Chain A, Crystal Structure Of Cyclin-Dependent Kinase 2 With
Inhibitor
pdb|2R3I|A Chain A, Crystal Structure Of Cyclin-Dependent Kinase 2 With
Inhibitor
pdb|2R3N|A Chain A, Crystal Structure Of Cyclin-Dependent Kinase 2 With
Inhibitor
pdb|2R3O|A Chain A, Crystal Structure Of Cyclin-Dependent Kinase 2 With
Inhibitor
pdb|2R3P|A Chain A, Crystal Structure Of Cyclin-Dependent Kinase 2 With
Inhibitor
pdb|2R3K|A Chain A, Crystal Structure Of Cyclin-Dependent Kinase 2 With
Inhibitor
pdb|2R3J|A Chain A, Crystal Structure Of Cyclin-Dependent Kinase 2 With
Inhibitor
pdb|2R3L|A Chain A, Crystal Structure Of Cyclin-Dependent Kinase 2 With
Inhibitor
pdb|1W8C|A Chain A, Co-crystal Structure Of
6-cyclohexylmethoxy-8-isopropyl-9h- Purin-2-ylamine And
Monomeric Cdk2
Length = 299
Score = 42.4 bits (98), Expect = 4e-04, Method: Compositional matrix adjust.
Identities = 41/158 (25%), Positives = 70/158 (44%), Gaps = 13/158 (8%)
Query: 176 NFFSDRCISEGLSSVMYRASFGDDASTSKKFEATVTRLNPSSQGV-KEFINDVNTLASLQ 234
NF I EG V+Y+A + T + RL+ ++GV I +++ L L
Sbjct: 4 NFQKVEKIGEGTYGVVYKAR---NKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELN 60
Query: 235 HPNLCKLLGFHARDGSDQRMLIYERLFHGSLDRLIYGRS-DGPPIDWNTRVKIALCAAQG 293
HPN+ KLL ++ L++E L H L + + + G P+ L QG
Sbjct: 61 HPNIVKLLD--VIHTENKLYLVFEFL-HQDLKKFMDASALTGIPLPLIKSYLFQLL--QG 115
Query: 294 LTFLHEEGPFQAMYNEFSTANIQIDKDFSAKLSGYGCA 331
L F H + ++ + N+ I+ + + KL+ +G A
Sbjct: 116 LAFCHSH---RVLHRDLKPQNLLINTEGAIKLADFGLA 150
>pdb|1PF8|A Chain A, Crystal Structure Of Human Cyclin-dependent Kinase 2
Complexed With A Nucleoside Inhibitor
Length = 298
Score = 42.4 bits (98), Expect = 4e-04, Method: Compositional matrix adjust.
Identities = 41/158 (25%), Positives = 70/158 (44%), Gaps = 13/158 (8%)
Query: 176 NFFSDRCISEGLSSVMYRASFGDDASTSKKFEATVTRLNPSSQGV-KEFINDVNTLASLQ 234
NF I EG V+Y+A + T + RL+ ++GV I +++ L L
Sbjct: 3 NFQKVEKIGEGTYGVVYKAR---NKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELN 59
Query: 235 HPNLCKLLGFHARDGSDQRMLIYERLFHGSLDRLIYGRS-DGPPIDWNTRVKIALCAAQG 293
HPN+ KLL ++ L++E L H L + + + G P+ L QG
Sbjct: 60 HPNIVKLLD--VIHTENKLYLVFEFL-HQDLKKFMDASALTGIPLPLIKSYLFQLL--QG 114
Query: 294 LTFLHEEGPFQAMYNEFSTANIQIDKDFSAKLSGYGCA 331
L F H + ++ + N+ I+ + + KL+ +G A
Sbjct: 115 LAFCHSH---RVLHRDLKPQNLLINTEGAIKLADFGLA 149
>pdb|1VYW|A Chain A, Structure Of Cdk2CYCLIN A WITH PNU-292137
pdb|1VYW|C Chain C, Structure Of Cdk2CYCLIN A WITH PNU-292137
pdb|2C4G|A Chain A, Structure Of Cdk2-Cyclin A With Pha-533514
pdb|2C4G|C Chain C, Structure Of Cdk2-Cyclin A With Pha-533514
pdb|2BPM|A Chain A, Structure Of Cdk2-Cyclin A With Pha-630529
pdb|2BPM|C Chain C, Structure Of Cdk2-Cyclin A With Pha-630529
pdb|2BKZ|A Chain A, Structure Of Cdk2-Cyclin A With Pha-404611
pdb|2BKZ|C Chain C, Structure Of Cdk2-Cyclin A With Pha-404611
pdb|2WIH|A Chain A, Structure Of Cdk2-Cyclin A With Pha-848125
pdb|2WIH|C Chain C, Structure Of Cdk2-Cyclin A With Pha-848125
pdb|2WIP|A Chain A, Structure Of Cdk2-Cyclin A Complexed With 8-Anilino-1-
Methyl-4,5-Dihydro-1h-Pyrazolo[4,3-H] Quinazoline-3-
Carboxylic Acid
pdb|2WIP|C Chain C, Structure Of Cdk2-Cyclin A Complexed With 8-Anilino-1-
Methyl-4,5-Dihydro-1h-Pyrazolo[4,3-H] Quinazoline-3-
Carboxylic Acid
pdb|2WPA|A Chain A, Optimisation Of 6,6-Dimethyl Pyrrolo 3,4-C Pyrazoles:
Identification Of Pha-793887, A Potent Cdk Inhibitor
Suitable For Intravenous Dosing
pdb|2WPA|C Chain C, Optimisation Of 6,6-Dimethyl Pyrrolo 3,4-C Pyrazoles:
Identification Of Pha-793887, A Potent Cdk Inhibitor
Suitable For Intravenous Dosing
pdb|2WXV|A Chain A, Structure Of Cdk2-Cyclin A With A Pyrazolo(4,3-H)
Quinazoline-3-Carboxamide Inhibitor
pdb|2WXV|C Chain C, Structure Of Cdk2-Cyclin A With A Pyrazolo(4,3-H)
Quinazoline-3-Carboxamide Inhibitor
Length = 309
Score = 42.4 bits (98), Expect = 4e-04, Method: Compositional matrix adjust.
Identities = 41/158 (25%), Positives = 70/158 (44%), Gaps = 13/158 (8%)
Query: 176 NFFSDRCISEGLSSVMYRASFGDDASTSKKFEATVTRLNPSSQGV-KEFINDVNTLASLQ 234
NF I EG V+Y+A + T + RL+ ++GV I +++ L L
Sbjct: 8 NFQKVEKIGEGTYGVVYKAR---NKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELN 64
Query: 235 HPNLCKLLGFHARDGSDQRMLIYERLFHGSLDRLIYGRS-DGPPIDWNTRVKIALCAAQG 293
HPN+ KLL ++ L++E L H L + + + G P+ L QG
Sbjct: 65 HPNIVKLLD--VIHTENKLYLVFEFL-HQDLKKFMDASALTGIPLPLIKSYLFQLL--QG 119
Query: 294 LTFLHEEGPFQAMYNEFSTANIQIDKDFSAKLSGYGCA 331
L F H + ++ + N+ I+ + + KL+ +G A
Sbjct: 120 LAFCHSH---RVLHRDLKPQNLLINTEGAIKLADFGLA 154
>pdb|3PJ8|A Chain A, Structure Of Cdk2 In Complex With A
Pyrazolo[4,3-D]pyrimidine Bioisostere Of Roscovitine
Length = 299
Score = 42.4 bits (98), Expect = 4e-04, Method: Compositional matrix adjust.
Identities = 41/158 (25%), Positives = 70/158 (44%), Gaps = 13/158 (8%)
Query: 176 NFFSDRCISEGLSSVMYRASFGDDASTSKKFEATVTRLNPSSQGV-KEFINDVNTLASLQ 234
NF I EG V+Y+A + T + RL+ ++GV I +++ L L
Sbjct: 4 NFQKVEKIGEGTYGVVYKAR---NKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELN 60
Query: 235 HPNLCKLLGFHARDGSDQRMLIYERLFHGSLDRLIYGRS-DGPPIDWNTRVKIALCAAQG 293
HPN+ KLL ++ L++E L H L + + + G P+ L QG
Sbjct: 61 HPNIVKLLD--VIHTENKLYLVFEFL-HQDLKKFMDASALTGIPLPLIKSYLFQLL--QG 115
Query: 294 LTFLHEEGPFQAMYNEFSTANIQIDKDFSAKLSGYGCA 331
L F H + ++ + N+ I+ + + KL+ +G A
Sbjct: 116 LAFCHSH---RVLHRDLKPQNLLINTEGAIKLADFGLA 150
>pdb|2W17|A Chain A, Cdk2 In Complex With The Imidazole Pyrimidine Amide,
Compound (S)-8b
pdb|3IG7|A Chain A, Novel Cdk-5 Inhibitors - Crystal Structure Of Inhibitor
Efp With Cdk-2
pdb|3IGG|A Chain A, Novel Cdk-5 Inhibitors - Crystal Structure Of Inhibitor
Efq With Cdk-2
pdb|1B38|A Chain A, Human Cyclin-Dependent Kinase 2
pdb|1B39|A Chain A, Human Cyclin-Dependent Kinase 2 Phosphorylated On Thr 160
pdb|1E1V|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The
Inhibitor Nu2058
pdb|1E1X|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The
Inhibitor Nu6027
pdb|1H00|A Chain A, Cdk2 In Complex With A Disubstituted 4, 6-Bis Anilino
Pyrimidine Cdk4 Inhibitor
pdb|1H07|A Chain A, Cdk2 In Complex With A Disubstituted 4, 6-Bis Anilino
Pyrimidine Cdk4 Inhibitor
pdb|1H08|A Chain A, Cdk2 In Complex With A Disubstituted 2, 4-Bis Anilino
Pyrimidine Cdk4 Inhibitor
pdb|2R3R|A Chain A, Crystal Structure Of Cyclin-Dependent Kinase 2 With
Inhibitor
pdb|4ACM|A Chain A, Cdk2 In Complex With
3-Amino-6-(4-{[2-(Dimethylamino)ethyl]
Sulfamoyl}-Phenyl)-N-Pyridin-3-Ylpyrazine-2-Carboxamide
pdb|3SW4|A Chain A, Crystal Structure Of The Cdk2 In Complex With
Thiazolylpyrimidine Inhibitor
pdb|3SW7|A Chain A, Crystal Structure Of The Cdk2 In Complex With
Thiazolylpyrimidine Inhibitor
pdb|1OIQ|A Chain A, Imidazopyridines: A Potent And Selective Class Of
Cyclin-Dependent Kinase Inhibitors Identified Through
Structure-Based Hybridisation
pdb|1V1K|A Chain A, Cdk2 In Complex With A Disubstituted 4, 6-Bis Anilino
Pyrimidine Cdk4 Inhibitor
pdb|1URW|A Chain A, Cdk2 In Complex With An Imidazo[1,2-B]pyridazine
pdb|2VV9|A Chain A, Cdk2 In Complex With An Imidazole Piperazine
pdb|2W06|A Chain A, Structure Of Cdk2 In Complex With An Imidazolyl
Pyrimidine, Compound 5c
pdb|2R3G|A Chain A, Crystal Structure Of Cyclin-Dependent Kinase 2 With
Inhibitor
pdb|2R3H|A Chain A, Crystal Structure Of Cyclin-Dependent Kinase 2 With
Inhibitor
pdb|2R3F|A Chain A, Crystal Structure Of Cyclin-dependent Kinase 2 With
Inhibitor
Length = 299
Score = 42.4 bits (98), Expect = 4e-04, Method: Compositional matrix adjust.
Identities = 41/158 (25%), Positives = 70/158 (44%), Gaps = 13/158 (8%)
Query: 176 NFFSDRCISEGLSSVMYRASFGDDASTSKKFEATVTRLNPSSQGV-KEFINDVNTLASLQ 234
NF I EG V+Y+A + T + RL+ ++GV I +++ L L
Sbjct: 4 NFQKVEKIGEGTYGVVYKAR---NKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELN 60
Query: 235 HPNLCKLLGFHARDGSDQRMLIYERLFHGSLDRLIYGRS-DGPPIDWNTRVKIALCAAQG 293
HPN+ KLL ++ L++E L H L + + + G P+ L QG
Sbjct: 61 HPNIVKLLD--VIHTENKLYLVFEFL-HQDLKKFMDASALTGIPLPLIKSYLFQLL--QG 115
Query: 294 LTFLHEEGPFQAMYNEFSTANIQIDKDFSAKLSGYGCA 331
L F H + ++ + N+ I+ + + KL+ +G A
Sbjct: 116 LAFCHSH---RVLHRDLKPQNLLINTEGAIKLADFGLA 150
>pdb|1JST|A Chain A, Phosphorylated Cyclin-Dependent Kinase-2 Bound To Cyclin A
pdb|1JST|C Chain C, Phosphorylated Cyclin-Dependent Kinase-2 Bound To Cyclin A
pdb|1JSU|A Chain A, P27(Kip1)CYCLIN ACDK2 COMPLEX
pdb|1FQ1|B Chain B, Crystal Structure Of Kinase Associated Phosphatase (Kap)
In Complex With Phospho-Cdk2
pdb|2C6T|A Chain A, Crystal Structure Of The Human Cdk2 Complexed With The
Triazolopyrimidine Inhibitor
pdb|2C6T|C Chain C, Crystal Structure Of The Human Cdk2 Complexed With The
Triazolopyrimidine Inhibitor
pdb|2CJM|A Chain A, Mechanism Of Cdk Inhibition By Active Site
Phosphorylation: Cdk2 Y15p T160p In Complex With Cyclin
A Structure
pdb|2CJM|C Chain C, Mechanism Of Cdk Inhibition By Active Site
Phosphorylation: Cdk2 Y15p T160p In Complex With Cyclin
A Structure
pdb|2UZB|A Chain A, Crystal Structure Of Human Cdk2 Complexed With A
Thiazolidinone Inhibitor
pdb|2UZB|C Chain C, Crystal Structure Of Human Cdk2 Complexed With A
Thiazolidinone Inhibitor
pdb|2UZD|A Chain A, Crystal Structure Of Human Cdk2 Complexed With A
Thiazolidinone Inhibitor
pdb|2UZD|C Chain C, Crystal Structure Of Human Cdk2 Complexed With A
Thiazolidinone Inhibitor
pdb|2UZE|A Chain A, Crystal Structure Of Human Cdk2 Complexed With A
Thiazolidinone Inhibitor
pdb|2UZE|C Chain C, Crystal Structure Of Human Cdk2 Complexed With A
Thiazolidinone Inhibitor
pdb|2UZL|A Chain A, Crystal Structure Of Human Cdk2 Complexed With A
Thiazolidinone Inhibitor
pdb|2UZL|C Chain C, Crystal Structure Of Human Cdk2 Complexed With A
Thiazolidinone Inhibitor
pdb|4II5|A Chain A, Structure Of Pcdk2/cyclina Bound To Adp And 1 Magnesium
Ion
pdb|4II5|C Chain C, Structure Of Pcdk2/cyclina Bound To Adp And 1 Magnesium
Ion
Length = 298
Score = 42.4 bits (98), Expect = 4e-04, Method: Compositional matrix adjust.
Identities = 41/158 (25%), Positives = 70/158 (44%), Gaps = 13/158 (8%)
Query: 176 NFFSDRCISEGLSSVMYRASFGDDASTSKKFEATVTRLNPSSQGV-KEFINDVNTLASLQ 234
NF I EG V+Y+A + T + RL+ ++GV I +++ L L
Sbjct: 3 NFQKVEKIGEGTYGVVYKAR---NKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELN 59
Query: 235 HPNLCKLLGFHARDGSDQRMLIYERLFHGSLDRLIYGRS-DGPPIDWNTRVKIALCAAQG 293
HPN+ KLL ++ L++E L H L + + + G P+ L QG
Sbjct: 60 HPNIVKLLD--VIHTENKLYLVFEFL-HQDLKKFMDASALTGIPLPLIKSYLFQLL--QG 114
Query: 294 LTFLHEEGPFQAMYNEFSTANIQIDKDFSAKLSGYGCA 331
L F H + ++ + N+ I+ + + KL+ +G A
Sbjct: 115 LAFCHSH---RVLHRDLKPQNLLINTEGAIKLADFGLA 149
>pdb|1FIN|A Chain A, Cyclin A-Cyclin-Dependent Kinase 2 Complex
pdb|1FIN|C Chain C, Cyclin A-Cyclin-Dependent Kinase 2 Complex
pdb|1CKP|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The
Inhibitor Purvalanol B
pdb|1BUH|A Chain A, Crystal Structure Of The Human Cdk2 Kinase Complex With
Cell Cycle-Regulatory Protein Ckshs1
pdb|1DM2|A Chain A, Human Cyclin-Dependent Kinase 2 Complexed With The
Inhibitor Hymenialdisine
pdb|1DI8|A Chain A, The Structure Of Cyclin-Dependent Kinase 2 (Cdk2) In
Complex With
4-[3-Hydroxyanilino]-6,7-Dimethoxyquinazoline
pdb|1F5Q|A Chain A, Crystal Structure Of Murine Gamma Herpesvirus Cyclin
Complexed To Human Cyclin Dependent Kinase 2
pdb|1F5Q|C Chain C, Crystal Structure Of Murine Gamma Herpesvirus Cyclin
Complexed To Human Cyclin Dependent Kinase 2
pdb|1FVT|A Chain A, The Structure Of Cyclin-Dependent Kinase 2 (Cdk2) In
Complex With An Oxindole Inhibitor
pdb|1FVV|A Chain A, The Structure Of Cdk2CYCLIN A IN COMPLEX WITH AN OXINDOLE
Inhibitor
pdb|1FVV|C Chain C, The Structure Of Cdk2CYCLIN A IN COMPLEX WITH AN OXINDOLE
Inhibitor
pdb|1JSV|A Chain A, The Structure Of Cyclin-dependent Kinase 2 (cdk2) In
Complex With 4-[(6-amino-4-pyrimidinyl)
Amino]benzenesulfonamide
pdb|1G5S|A Chain A, Crystal Structure Of Human Cyclin Dependent Kinase 2
(Cdk2) In Complex With The Inhibitor H717
pdb|1JVP|P Chain P, Crystal Structure Of Human Cdk2 (Unphosphorylated) In
Complex With Pkf049-365
pdb|1GIH|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The Cdk4
Inhibitor
pdb|1KE5|A Chain A, Cdk2 Complexed With N-methyl-4-{[(2-oxo-1,2-dihydro-3h-
Indol-3-ylidene)methyl]amino}benzenesulfonamide
pdb|1KE6|A Chain A, Cyclin-Dependent Kinase 2 (Cdk2) Complexed With
N-Methyl-{4-
[2-(7-Oxo-6,7-Dihydro-8h-[1,3]thiazolo[5,4-E]indol-8-
Ylidene)hydrazino]phenyl}methanesulfonamide
pdb|1KE7|A Chain A, Cyclin-Dependent Kinase 2 (Cdk2) Complexed With 3-{[(2,2-
Dioxido-1,
3-Dihydro-2-Benzothien-5-Yl)amino]methylene}-5-
(1,3-Oxazol-5-Yl)-1,3-Dihydro-2h-Indol-2-One
pdb|1KE8|A Chain A, Cyclin-Dependent Kinase 2 (Cdk2) Complexed With
4-{[(2-Oxo-
1,2-Dihydro-3h-Indol-3-Ylidene)methyl]amino}-N-(1,3-
Thiazol-2-Yl)benzenesulfonamide
pdb|1KE9|A Chain A, Cyclin-Dependent Kinase 2 (Cdk2) Complexed With 3-{[4-
({[amino(Imino)methyl]aminosulfonyl)anilino]methylene}-
2- Oxo-2,3-Dihydro-1h-Indole
pdb|1H0V|A Chain A, Human Cyclin Dependent Protein Kinase 2 In Complex With
The Inhibitor
2-Amino-6-[(R)-Pyrrolidino-5'-Yl]methoxypurine
pdb|1H0W|A Chain A, Human Cyclin Dependent Protein Kinase 2 In Complex With
The Inhibitor 2-Amino-6-[cyclohex-3-Enyl]methoxypurine
pdb|1P2A|A Chain A, The Structure Of Cyclin Dependent Kinase 2 (Ckd2) With A
Trisubstituted Naphthostyril Inhibitor
pdb|1OKV|A Chain A, Cyclin A Binding Groove Inhibitor
H-Arg-Arg-Leu-Ile-Phe-Nh2
pdb|1OKV|C Chain C, Cyclin A Binding Groove Inhibitor
H-Arg-Arg-Leu-Ile-Phe-Nh2
pdb|1OKW|A Chain A, Cyclin A Binding Groove Inhibitor
Ac-Arg-Arg-Leu-Asn-(M-Cl-Phe)-Nh2
pdb|1OKW|C Chain C, Cyclin A Binding Groove Inhibitor
Ac-Arg-Arg-Leu-Asn-(M-Cl-Phe)-Nh2
pdb|1OL1|A Chain A, Cyclin A Binding Groove Inhibitor
H-Cit-Cit-Leu-Ile-(P-F-Phe)-Nh2
pdb|1OL1|C Chain C, Cyclin A Binding Groove Inhibitor
H-Cit-Cit-Leu-Ile-(P-F-Phe)-Nh2
pdb|1OL2|A Chain A, Cyclin A Binding Groove Inhibitor
H-Arg-Arg-Leu-Asn-(P-F-Phe)-Nh2
pdb|1OL2|C Chain C, Cyclin A Binding Groove Inhibitor
H-Arg-Arg-Leu-Asn-(P-F-Phe)-Nh2
pdb|1PW2|A Chain A, Apo Structure Of Human Cyclin-Dependent Kinase 2
pdb|1PXI|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The
Inhibitor 4-(2,5-dichloro-thiophen-3-yl)-pyrimidin-2-
Ylamine
pdb|1PXJ|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The
Inhibitor
4-(2,4-Dimethyl-Thiazol-5-Yl)-Pyrimidin-2-Ylamine
pdb|1PXK|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The
Inhibitor
N-[4-(2,4-dimethyl-thiazol-5-yl)pyrimidin-2-yl]-
N'-hydroxyiminoformamide
pdb|1PXL|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The
Inhibitor
[4-(2,4-dimethyl-thiazol-5-yl)-pyrimidin-2-yl]-
(4-trifluoromethyl-phenyl)-amine
pdb|1R78|A Chain A, Cdk2 Complex With A 4-alkynyl Oxindole Inhibitor
pdb|1PXM|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The
Inhibitor 3-[4-(2,4-Dimethyl-Thiazol-5-Yl)-Pyrimidin-2-
Ylamino]-Phenol
pdb|1PXN|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The
Inhibitor 4-[4-(4-Methyl-2-Methylamino-Thiazol-5-Yl)-
Pyrimidin-2-Ylamino]-Phenol
pdb|1PXO|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The
Inhibitor
[4-(2-Amino-4-Methyl-Thiazol-5-Yl)-Pyrimidin-2-
Yl]-(3-Nitro-Phenyl)-Amine
pdb|1PXP|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The
Inhibitor
N-[4-(2,4-Dimethyl-Thiazol-5-Yl)-Pyrimidin-2-Yl]-
N',N'-Dimethyl-Benzene-1,4-Diamine
pdb|1VYZ|A Chain A, Structure Of Cdk2 Complexed With Pnu-181227
pdb|1PYE|A Chain A, Crystal Structure Of Cdk2 With Inhibitor
pdb|1URC|A Chain A, Cyclin A Binding Groove Inhibitor Ace-Arg-Lys-Leu- Phe-Gly
pdb|1URC|C Chain C, Cyclin A Binding Groove Inhibitor Ace-Arg-Lys-Leu- Phe-Gly
pdb|1W0X|C Chain C, Crystals Structure Of Human Cdk2 In Complex With The
Inhibitor Olomoucine.
pdb|1WCC|A Chain A, Screening For Fragment Binding By X-Ray Crystallography
pdb|1Y8Y|A Chain A, Crystal Structure Of Human Cdk2 Complexed With A
Pyrazolo[1, 5-A]pyrimidine Inhibitor
pdb|1Y91|A Chain A, Crystal Structure Of Human Cdk2 Complexed With A
Pyrazolo[1, 5-A]pyrimidine Inhibitor
pdb|2BHE|A Chain A, Human Cyclin Dependent Protein Kinase 2 In Complex With
The Inhibitor 5-Bromo-Indirubine
pdb|2BHH|A Chain A, Human Cyclin Dependent Protein Kinase 2 In Complex With
The Inhibitor 4-Hydroxypiperindinesulfonyl-Indirubine
pdb|2B52|A Chain A, Human Cyclin Dependent Kinase 2 (Cdk2) Complexed With Dph-
042562
pdb|2B53|A Chain A, Human Cyclin Dependent Kinase 2 (Cdk2) Complexed With Din-
234325
pdb|2B54|A Chain A, Human Cyclin Dependent Kinase 2 (Ckd2)complexed With Din-
232305
pdb|2B55|A Chain A, Human Cyclin Dependent Kinase 2 (Cdk2) Complexed With
Indenopyraxole Din-101312
pdb|2BTR|A Chain A, Structure Of Cdk2 Complexed With Pnu-198873
pdb|2BTS|A Chain A, Structure Of Cdk2 Complexed With Pnu-230032
pdb|2C68|A Chain A, Crystal Structure Of The Human Cdk2 Complexed With The
Triazolopyrimidine Inhibitor
pdb|2C69|A Chain A, Crystal Structure Of The Human Cdk2 Complexed With The
Triazolopyrimidine Inhibitor
pdb|2C6I|A Chain A, Crystal Structure Of The Human Cdk2 Complexed With The
Triazolopyrimidine Inhibitor
pdb|2C6K|A Chain A, Crystal Structure Of The Human Cdk2 Complexed With The
Triazolopyrimidine Inhibitor
pdb|2C6L|A Chain A, Crystal Structure Of The Human Cdk2 Complexed With The
Triazolopyrimidine Inhibitor
pdb|2C6M|A Chain A, Crystal Structure Of The Human Cdk2 Complexed With The
Triazolopyrimidine Inhibitor
pdb|2C6O|A Chain A, Crystal Structure Of The Human Cdk2 Complexed With The
Triazolopyrimidine Inhibitor
pdb|2EXM|A Chain A, Human Cdk2 In Complex With Isopentenyladenine
pdb|1YKR|A Chain A, Crystal Structure Of Cdk2 With An Aminoimidazo Pyridine
Inhibitor
pdb|2A0C|X Chain X, Human Cdk2 In Complex With Olomoucine Ii, A Novel 2,6,9-
Trisubstituted Purine Cyclin-Dependent Kinase Inhibitor
pdb|2C5N|A Chain A, Differential Binding Of Inhibitors To Active And Inactive
Cdk2 Provides Insights For Drug Design
pdb|2C5N|C Chain C, Differential Binding Of Inhibitors To Active And Inactive
Cdk2 Provides Insights For Drug Design
pdb|2C5O|A Chain A, Differential Binding Of Inhibitors To Active And Inactive
Cdk2 Provides Insights For Drug Design
pdb|2C5O|C Chain C, Differential Binding Of Inhibitors To Active And Inactive
Cdk2 Provides Insights For Drug Design
pdb|2C5V|A Chain A, Differential Binding Of Inhibitors To Active And Inactive
Cdk2 Provides Insights For Drug Design
pdb|2C5V|C Chain C, Differential Binding Of Inhibitors To Active And Inactive
Cdk2 Provides Insights For Drug Design
pdb|2C5X|A Chain A, Differential Binding Of Inhibitors To Active And Inactive
Cdk2 Provides Insights For Drug Design
pdb|2C5X|C Chain C, Differential Binding Of Inhibitors To Active And Inactive
Cdk2 Provides Insights For Drug Design
pdb|2C5Y|A Chain A, Differential Binding Of Inhibitors To Active And Inactive
Cdk2 Provides Insights For Drug Design
pdb|2A4L|A Chain A, Human Cyclin-Dependent Kinase 2 In Complex With
Roscovitine
pdb|2FVD|A Chain A, Cyclin Dependent Kinase 2 (Cdk2) With Diaminopyrimidine
Inhibitor
pdb|2I40|A Chain A, Cdk2CYCLIN A COMPLEXED WITH A THIOPHENE CARBOXAMIDE
INHIBITOR
pdb|2I40|C Chain C, Cdk2CYCLIN A COMPLEXED WITH A THIOPHENE CARBOXAMIDE
INHIBITOR
pdb|2CLX|A Chain A, 4-Arylazo-3,5-Diamino-1h-Pyrazole Cdk Inhibitors: Sar
Study, Crystal Structure In Complex With Cdk2,
Selectivity, And Cellular Effects
pdb|2DUV|A Chain A, Structure Of Cdk2 With A 3-Hydroxychromones
pdb|2UUE|A Chain A, Replace: A Strategy For Iterative Design Of Cyclin Binding
Groove Inhibitors
pdb|2UUE|C Chain C, Replace: A Strategy For Iterative Design Of Cyclin Binding
Groove Inhibitors
pdb|2UZN|A Chain A, Crystal Structure Of Human Cdk2 Complexed With A
Thiazolidinone Inhibitor
pdb|2UZO|A Chain A, Crystal Structure Of Human Cdk2 Complexed With A
Thiazolidinone Inhibitor
pdb|2V0D|A Chain A, Crystal Structure Of Human Cdk2 Complexed With A
Thiazolidinone Inhibitor
pdb|1AQ1|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The
Inhibitor Staurosporine
pdb|1HCK|A Chain A, Human Cyclin-Dependent Kinase 2
pdb|1HCL|A Chain A, Human Cyclin-Dependent Kinase 2
pdb|2J9M|A Chain A, Crystal Structure Of Cdk2 In Complex With Macrocyclic
Aminopyrimidine
pdb|2V22|A Chain A, Replace: A Strategy For Iterative Design Of Cyclin Binding
Groove Inhibitors
pdb|2V22|C Chain C, Replace: A Strategy For Iterative Design Of Cyclin Binding
Groove Inhibitors
pdb|2VTA|A Chain A, Identification Of N-(4-Piperidinyl)-4-(2,6-
Dichlorobenzoylamino)-1h-Pyrazole-3-Carboxamide
(At7519), A Novel Cyclin Dependent Kinase Inhibitor
Using Fragment- Based X-Ray Crystallography And
Structure Based Drug Design.
pdb|2VTH|A Chain A, Identification Of N-(4-Piperidinyl)-4-(2,6-
Dichlorobenzoylamino)-1h-Pyrazole-3-Carboxamide
(At7519), A Novel Cyclin Dependent Kinase Inhibitor
Using Fragment- Based X-Ray Crystallography And
Structure Based Drug Design
pdb|2VTI|A Chain A, Identification Of N-(4-Piperidinyl)-4-(2,6-
Dichlorobenzoylamino)-1h-Pyrazole-3-Carboxamide
(At7519), A Novel Cyclin Dependent Kinase Inhibitor
Using Fragment- Based X-Ray Crystallography And
Structure Based Drug Design.
pdb|2VTJ|A Chain A, Identification Of N-(4-Piperidinyl)-4-(2,6-
Dichlorobenzoylamino)-1h-Pyrazole-3-Carboxamide
(At7519), A Novel Cyclin Dependent Kinase Inhibitor
Using Fragment- Based X-Ray Crystallography And
Structure Based Drug Design.
pdb|2VTL|A Chain A, Identification Of N-(4-Piperidinyl)-4-(2,6-
Dichlorobenzoylamino)-1h-Pyrazole-3-Carboxamide
(At7519), A Novel Cyclin Dependent Kinase Inhibitor
Using Fragment- Based X-Ray Crystallography And
Structure Based Drug Design.
pdb|2VTM|A Chain A, Identification Of N-(4-Piperidinyl)-4-(2,6-
Dichlorobenzoylamino)-1h-Pyrazole-3-Carboxamide
(At7519), A Novel Cyclin Dependent Kinase Inhibitor
Using Fragment- Based X-Ray Crystallography And
Structure Based Drug Design.
pdb|2VTN|A Chain A, Identification Of N-(4-Piperidinyl)-4-(2,6-
Dichlorobenzoylamino)-1h-Pyrazole-3-Carboxamide
(At7519), A Novel Cyclin Dependent Kinase Inhibitor
Using Fragment- Based X-Ray Crystallography And
Structure Based Drug Design.
pdb|2VTO|A Chain A, Identification Of N-(4-Piperidinyl)-4-(2,6-
Dichlorobenzoylamino)-1h-Pyrazole-3-Carboxamide
(At7519), A Novel Cyclin Dependent Kinase Inhibitor
Using Fragment- Based X-Ray Crystallography And
Structure Based Drug Design.
pdb|2VTP|A Chain A, Identification Of N-(4-Piperidinyl)-4-(2,6-
Dichlorobenzoylamino)-1h-Pyrazole-3-Carboxamide
(At7519), A Novel Cyclin Dependent Kinase Inhibitor
Using Fragment- Based X-Ray Crystallography And
Structure Based Drug Design.
pdb|2VTQ|A Chain A, Identification Of N-(4-Piperidinyl)-4-(2,6-
Dichlorobenzoylamino)-1h-Pyrazole-3-Carboxamide
(At7519), A Novel Cyclin Dependent Kinase Inhibitor
Using Fragment- Based X-Ray Crystallography And
Structure Based Drug Design.
pdb|2VTR|A Chain A, Identification Of N-(4-Piperidinyl)-4-(2,6-
Dichlorobenzoylamino)-1h-Pyrazole-3-Carboxamide
(At7519), A Novel Cyclin Dependent Kinase Inhibitor
Using Fragment- Based X-Ray Crystallography And
Structure Based Drug Design.
pdb|2VTS|A Chain A, Identification Of N-(4-Piperidinyl)-4-(2,6-
Dichlorobenzoylamino)-1h-Pyrazole-3-Carboxamide
(At7519), A Novel Cyclin Dependent Kinase Inhibitor
Using Fragment- Based X-Ray Crystallography And
Structure Based Drug Design.
pdb|2VTT|A Chain A, Identification Of N-(4-Piperidinyl)-4-(2,6-
Dichlorobenzoylamino)-1h-Pyrazole-3-Carboxamide
(At7519), A Novel Cyclin Dependent Kinase Inhibitor
Using Fragment- Based X-Ray Crystallography And
Structure Based Drug Design.
pdb|2VU3|A Chain A, Identification Of N-(4-Piperidinyl)-4-(2,6-
Dichlorobenzoylamino)-1h-Pyrazole-3-Carboxamide
(At7519), A Novel Cyclin Dependent Kinase Inhibitor
Using Fragment- Based X-Ray Crystallography And
Structure Based Drug Design.
pdb|2R64|A Chain A, Crystal Structure Of A 3-Aminoindazole Compound With Cdk2
pdb|2W05|A Chain A, Structure Of Cdk2 In Complex With An Imidazolyl
Pyrimidine, Compound 5b
pdb|3EID|A Chain A, Cdk2CYCLINA COMPLEXED WITH A PYRAZOLOPYRIDAZINE INHIBITOR
pdb|3EID|C Chain C, Cdk2CYCLINA COMPLEXED WITH A PYRAZOLOPYRIDAZINE INHIBITOR
pdb|3EJ1|A Chain A, Cdk2CYCLINA COMPLEXED WITH A PYRAZOLOPYRIDAZINE INHIBITOR
pdb|3EJ1|C Chain C, Cdk2CYCLINA COMPLEXED WITH A PYRAZOLOPYRIDAZINE INHIBITOR
pdb|3EOC|A Chain A, Cdk2/cyclina Complexed With A Imidazo Triazin-2-amine
pdb|3EOC|C Chain C, Cdk2/cyclina Complexed With A Imidazo Triazin-2-amine
pdb|2W1H|A Chain A, Fragment-Based Discovery Of The Pyrazol-4-Yl Urea
(At9283), A Multi-Targeted Kinase Inhibitor With Potent
Aurora Kinase Activity
pdb|3F5X|A Chain A, Cdk-2-Cyclin Complex With Indazole Inhibitor 9 Bound At
Its Active Site
pdb|3F5X|C Chain C, Cdk-2-Cyclin Complex With Indazole Inhibitor 9 Bound At
Its Active Site
pdb|3FZ1|A Chain A, Crystal Structure Of A Benzthiophene Inhibitor Bound To
Human Cyclin-Dependent Kinase-2 (Cdk-2)
pdb|2WEV|A Chain A, Truncation And Optimisation Of Peptide Inhibitors Of Cdk2,
Cyclin A Through Structure Guided Design
pdb|2WEV|C Chain C, Truncation And Optimisation Of Peptide Inhibitors Of Cdk2,
Cyclin A Through Structure Guided Design
pdb|2WFY|A Chain A, Truncation And Optimisation Of Peptide Inhibitors Of Cdk2,
Cyclin A Through Structure Guided Design
pdb|2WFY|C Chain C, Truncation And Optimisation Of Peptide Inhibitors Of Cdk2,
Cyclin A Through Structure Guided Design
pdb|2WHB|A Chain A, Truncation And Optimisation Of Peptide Inhibitors Of Cdk2,
Cyclin A Through Structure Guided Design
pdb|2WHB|C Chain C, Truncation And Optimisation Of Peptide Inhibitors Of Cdk2,
Cyclin A Through Structure Guided Design
pdb|2X1N|A Chain A, Truncation And Optimisation Of Peptide Inhibitors Of Cdk2,
Cyclin A Through Structure Guided Design
pdb|2X1N|C Chain C, Truncation And Optimisation Of Peptide Inhibitors Of Cdk2,
Cyclin A Through Structure Guided Design
pdb|3LFN|A Chain A, Crystal Structure Of Cdk2 With Sar57, An Aminoindazole
Type Inhibitor
pdb|3LFQ|A Chain A, Crystal Structure Of Cdk2 With Sar60, An Aminoindazole
Type Inhibitor
pdb|3LFS|A Chain A, Crystal Structure Of Cdk2 With Sar37, An Aminoindazole
Type Inhibitor
pdb|2XMY|A Chain A, Discovery And Characterisation Of
2-Anilino-4-(Thiazol-5-Yl) Pyrimidine Transcriptional
Cdk Inhibitors As Anticancer Agents
pdb|2XNB|A Chain A, Discovery And Characterisation Of
2-Anilino-4-(Thiazol-5-Yl) Pyrimidine Transcriptional
Cdk Inhibitors As Anticancer Agents
pdb|3LE6|A Chain A, The Structure Of Cyclin Dependent Kinase 2 (Ckd2) With A
Pyrazolobenzodiazepine Inhibitor
pdb|3NS9|A Chain A, Crystal Structure Of Cdk2 In Complex With Inhibitor Bs-194
pdb|3S2P|A Chain A, Crystal Structure Of Cdk2 With A 2-Aminopyrimidine
Compound
pdb|3UNJ|A Chain A, Cdk2 In Complex With Inhibitor Yl1-038-31
pdb|3UNK|A Chain A, Cdk2 In Complex With Inhibitor Yl5-083
pdb|3TI1|A Chain A, Cdk2 In Complex With Sunitinib
pdb|3TIY|A Chain A, Cdk2 In Complex With Nsc 35676
pdb|3TIZ|A Chain A, Cdk2 In Complex With Nsc 111848
Length = 298
Score = 42.4 bits (98), Expect = 4e-04, Method: Compositional matrix adjust.
Identities = 41/158 (25%), Positives = 70/158 (44%), Gaps = 13/158 (8%)
Query: 176 NFFSDRCISEGLSSVMYRASFGDDASTSKKFEATVTRLNPSSQGV-KEFINDVNTLASLQ 234
NF I EG V+Y+A + T + RL+ ++GV I +++ L L
Sbjct: 3 NFQKVEKIGEGTYGVVYKAR---NKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELN 59
Query: 235 HPNLCKLLGFHARDGSDQRMLIYERLFHGSLDRLIYGRS-DGPPIDWNTRVKIALCAAQG 293
HPN+ KLL ++ L++E L H L + + + G P+ L QG
Sbjct: 60 HPNIVKLLD--VIHTENKLYLVFEFL-HQDLKKFMDASALTGIPLPLIKSYLFQLL--QG 114
Query: 294 LTFLHEEGPFQAMYNEFSTANIQIDKDFSAKLSGYGCA 331
L F H + ++ + N+ I+ + + KL+ +G A
Sbjct: 115 LAFCHSH---RVLHRDLKPQNLLINTEGAIKLADFGLA 149
>pdb|3QHR|A Chain A, Structure Of A Pcdk2CYCLINA TRANSITION-State Mimic
pdb|3QHR|C Chain C, Structure Of A Pcdk2CYCLINA TRANSITION-State Mimic
pdb|3QHW|A Chain A, Structure Of A Pcdk2CYCLINA TRANSITION-State Mimic
pdb|3QHW|C Chain C, Structure Of A Pcdk2CYCLINA TRANSITION-State Mimic
Length = 298
Score = 42.4 bits (98), Expect = 4e-04, Method: Compositional matrix adjust.
Identities = 41/158 (25%), Positives = 70/158 (44%), Gaps = 13/158 (8%)
Query: 176 NFFSDRCISEGLSSVMYRASFGDDASTSKKFEATVTRLNPSSQGV-KEFINDVNTLASLQ 234
NF I EG V+Y+A + T + RL+ ++GV I +++ L L
Sbjct: 5 NFQKVEKIGEGTYGVVYKAR---NKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELN 61
Query: 235 HPNLCKLLGFHARDGSDQRMLIYERLFHGSLDRLIYGRS-DGPPIDWNTRVKIALCAAQG 293
HPN+ KLL ++ L++E L H L + + + G P+ L QG
Sbjct: 62 HPNIVKLLD--VIHTENKLYLVFEFL-HQDLKKFMDASALTGIPLPLIKSYLFQLL--QG 116
Query: 294 LTFLHEEGPFQAMYNEFSTANIQIDKDFSAKLSGYGCA 331
L F H + ++ + N+ I+ + + KL+ +G A
Sbjct: 117 LAFCHSH---RVLHRDLKPQNLLINTEGAIKLADFGLA 151
>pdb|1AD5|A Chain A, Src Family Kinase Hck-Amp-Pnp Complex
pdb|1AD5|B Chain B, Src Family Kinase Hck-Amp-Pnp Complex
pdb|2HCK|A Chain A, Src Family Kinase Hck-Quercetin Complex
pdb|2HCK|B Chain B, Src Family Kinase Hck-Quercetin Complex
Length = 438
Score = 42.4 bits (98), Expect = 4e-04, Method: Compositional matrix adjust.
Identities = 34/133 (25%), Positives = 61/133 (45%), Gaps = 9/133 (6%)
Query: 200 ASTSKKFEATVTRLNPSSQGVKEFINDVNTLASLQHPNLCKLLGFHARDGSDQRMLIYER 259
A+ +K + V + P S V+ F+ + N + +LQH L KL HA + +I E
Sbjct: 201 ATYNKHTKVAVKTMKPGSMSVEAFLAEANVMKTLQHDKLVKL---HAVVTKEPIYIITEF 257
Query: 260 LFHGSLDRLIYGRSD-GPPIDWNTRVKIALCAAQGLTFLHEEGPFQAMYNEFSTANIQID 318
+ GSL L + +SD G + + A+G+ F+ + ++ + ANI +
Sbjct: 258 MAKGSL--LDFLKSDEGSKQPLPKLIDFSAQIAEGMAFIEQRN---YIHRDLRAANILVS 312
Query: 319 KDFSAKLSGYGCA 331
K++ +G A
Sbjct: 313 ASLVCKIADFGLA 325
>pdb|2JGZ|A Chain A, Crystal Structure Of Phospho-Cdk2 In Complex With Cyclin B
Length = 289
Score = 42.0 bits (97), Expect = 5e-04, Method: Compositional matrix adjust.
Identities = 41/161 (25%), Positives = 71/161 (44%), Gaps = 13/161 (8%)
Query: 173 ACHNFFSDRCISEGLSSVMYRASFGDDASTSKKFEATVTRLNPSSQGV-KEFINDVNTLA 231
+ NF I EG V+Y+A + T + RL+ ++GV I +++ L
Sbjct: 1 SMENFQKVEKIGEGTYGVVYKAR---NKLTGEVVALKKIRLDTETEGVPSTAIREISLLK 57
Query: 232 SLQHPNLCKLLGFHARDGSDQRMLIYERLFHGSLDRLIYGRS-DGPPIDWNTRVKIALCA 290
L HPN+ KLL ++ L++E L H L + + + G P+ L
Sbjct: 58 ELNHPNIVKLLD--VIHTENKLYLVFEFL-HQDLKKFMDASALTGIPLPLIKSYLFQLL- 113
Query: 291 AQGLTFLHEEGPFQAMYNEFSTANIQIDKDFSAKLSGYGCA 331
QGL F H + ++ + N+ I+ + + KL+ +G A
Sbjct: 114 -QGLAFCHSH---RVLHRDLKPQNLLINTEGAIKLADFGLA 150
>pdb|4EOJ|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Human
Cyclin A3 Complex With Atp
pdb|4EOJ|C Chain C, Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Human
Cyclin A3 Complex With Atp
Length = 302
Score = 42.0 bits (97), Expect = 5e-04, Method: Compositional matrix adjust.
Identities = 40/161 (24%), Positives = 68/161 (42%), Gaps = 11/161 (6%)
Query: 172 AACHNFFSDRCISEGLSSVMYRASFGDDASTSKKFEATVTRLNPSSQGV-KEFINDVNTL 230
+ NF I EG V+Y+A + T + RL+ ++GV I +++ L
Sbjct: 3 GSMENFQKVEKIGEGTYGVVYKAR---NKLTGEVVALKKIRLDTETEGVPSTAIREISLL 59
Query: 231 ASLQHPNLCKLLGFHARDGSDQRMLIYERLFHGSLDRLIYGRSDGPPIDWNTRVKIALCA 290
L HPN+ KLL ++ L++E L D + G P+ L
Sbjct: 60 KELNHPNIVKLLD--VIHTENKLYLVFEFLSMDLKDFMDASALTGIPLPLIKSYLFQLL- 116
Query: 291 AQGLTFLHEEGPFQAMYNEFSTANIQIDKDFSAKLSGYGCA 331
QGL F H + ++ + N+ I+ + + KL+ +G A
Sbjct: 117 -QGLAFCHSH---RVLHRDLKPQNLLINTEGAIKLADFGLA 153
>pdb|4EOK|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Human
Cyclin A3 Complex With The Inhibitor Nu6102
pdb|4EOK|C Chain C, Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Human
Cyclin A3 Complex With The Inhibitor Nu6102
pdb|4EOL|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Human
Cyclin A3 Complex With The Inhibitor Ro3306
pdb|4EOL|C Chain C, Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Human
Cyclin A3 Complex With The Inhibitor Ro3306
Length = 300
Score = 42.0 bits (97), Expect = 5e-04, Method: Compositional matrix adjust.
Identities = 40/161 (24%), Positives = 68/161 (42%), Gaps = 11/161 (6%)
Query: 172 AACHNFFSDRCISEGLSSVMYRASFGDDASTSKKFEATVTRLNPSSQGV-KEFINDVNTL 230
+ NF I EG V+Y+A + T + RL+ ++GV I +++ L
Sbjct: 2 GSMENFQKVEKIGEGTYGVVYKAR---NKLTGEVVALKKIRLDTETEGVPSTAIREISLL 58
Query: 231 ASLQHPNLCKLLGFHARDGSDQRMLIYERLFHGSLDRLIYGRSDGPPIDWNTRVKIALCA 290
L HPN+ KLL ++ L++E L D + G P+ L
Sbjct: 59 KELNHPNIVKLLD--VIHTENKLYLVFEFLSMDLKDFMDASALTGIPLPLIKSYLFQLL- 115
Query: 291 AQGLTFLHEEGPFQAMYNEFSTANIQIDKDFSAKLSGYGCA 331
QGL F H + ++ + N+ I+ + + KL+ +G A
Sbjct: 116 -QGLAFCHSH---RVLHRDLKPQNLLINTEGAIKLADFGLA 152
>pdb|2QLU|A Chain A, Crystal Structure Of Activin Receptor Type Ii Kinase
Domain From Human
Length = 314
Score = 41.6 bits (96), Expect = 7e-04, Method: Compositional matrix adjust.
Identities = 28/110 (25%), Positives = 50/110 (45%), Gaps = 14/110 (12%)
Query: 232 SLQHPNLCKLLGFHARDGSDQRMLIYERLFH--GSLDRLIYGRSDGPPIDWNTRVKIALC 289
++H NL + + R + + L FH GSL + G I WN +A
Sbjct: 65 GMKHENLLQFIAAEKRGSNLEVELWLITAFHDKGSLTDYLKGNI----ITWNELCHVAET 120
Query: 290 AAQGLTFLHEEGPF--------QAMYNEFSTANIQIDKDFSAKLSGYGCA 331
++GL++LHE+ P+ + +F + N+ + D +A L+ +G A
Sbjct: 121 MSRGLSYLHEDVPWCRGEGHKPSIAHRDFKSKNVLLKSDLTAVLADFGLA 170
>pdb|3S95|A Chain A, Crystal Structure Of The Human Limk1 Kinase Domain In
Complex With Staurosporine
pdb|3S95|B Chain B, Crystal Structure Of The Human Limk1 Kinase Domain In
Complex With Staurosporine
Length = 310
Score = 41.6 bits (96), Expect = 8e-04, Method: Compositional matrix adjust.
Identities = 29/123 (23%), Positives = 60/123 (48%), Gaps = 11/123 (8%)
Query: 210 VTRLNPSSQGVKEFINDVNTLASLQHPNLCKLLGFHARDGSDQRM-LIYERLFHGSLDRL 268
+ R + +Q + F+ +V + L+HPN+ K +G + D+R+ I E + G+L +
Sbjct: 43 LIRFDEETQ--RTFLKEVKVMRCLEHPNVLKFIGVLYK---DKRLNFITEYIKGGTLRGI 97
Query: 269 IYGRSDGPPIDWNTRVKIALCAAQGLTFLHEEGPFQAMYNEFSTANIQIDKDFSAKLSGY 328
I P W+ RV A A G+ +LH ++ + ++ N + ++ + ++ +
Sbjct: 98 IKSMDSQYP--WSQRVSFAKDIASGMAYLHS---MNIIHRDLNSHNCLVRENKNVVVADF 152
Query: 329 GCA 331
G A
Sbjct: 153 GLA 155
>pdb|2IW6|A Chain A, Structure Of Human Thr160-Phospho Cdk2-Cyclin A Complexed
With A Bisanilinopyrimidine Inhibitor
pdb|2IW6|C Chain C, Structure Of Human Thr160-Phospho Cdk2-Cyclin A Complexed
With A Bisanilinopyrimidine Inhibitor
pdb|2IW9|A Chain A, Structure Of Human Thr160-Phospho Cdk2-Cyclin A Complexed
With A Bisanilinopyrimidine Inhibitor
pdb|2IW9|C Chain C, Structure Of Human Thr160-Phospho Cdk2-Cyclin A Complexed
With A Bisanilinopyrimidine Inhibitor
Length = 302
Score = 41.2 bits (95), Expect = 8e-04, Method: Compositional matrix adjust.
Identities = 41/162 (25%), Positives = 70/162 (43%), Gaps = 13/162 (8%)
Query: 172 AACHNFFSDRCISEGLSSVMYRASFGDDASTSKKFEATVTRLNPSSQGV-KEFINDVNTL 230
+ NF I EG V+Y+A + T + RL+ ++GV I +++ L
Sbjct: 3 GSMENFQKVEKIGEGTYGVVYKAR---NKLTGEVVALKKIRLDTETEGVPSTAIREISLL 59
Query: 231 ASLQHPNLCKLLGFHARDGSDQRMLIYERLFHGSLDRLIYGRS-DGPPIDWNTRVKIALC 289
L HPN+ KLL ++ L++E L H L + + G P+ L
Sbjct: 60 KELNHPNIVKLLD--VIHTENKLYLVFEFL-HQDLKTFMDASALTGIPLPLIKSYLFQLL 116
Query: 290 AAQGLTFLHEEGPFQAMYNEFSTANIQIDKDFSAKLSGYGCA 331
QGL F H + ++ + N+ I+ + + KL+ +G A
Sbjct: 117 --QGLAFCHSH---RVLHRDLKPQNLLINTEGAIKLADFGLA 153
>pdb|2XA4|A Chain A, Inhibitors Of Jak2 Kinase Domain
pdb|2XA4|B Chain B, Inhibitors Of Jak2 Kinase Domain
Length = 298
Score = 41.2 bits (95), Expect = 9e-04, Method: Compositional matrix adjust.
Identities = 32/130 (24%), Positives = 61/130 (46%), Gaps = 6/130 (4%)
Query: 208 ATVTRLNPSSQ-GVKEFINDVNTLASLQHPNLCKLLGFHARDGSDQRMLIYERLFHGSLD 266
V +L S++ +++F ++ L SLQH N+ K G G LI E L +GSL
Sbjct: 45 VAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRRNLKLIMEYLPYGSLR 104
Query: 267 RLIYGRSDGPPIDWNTRVKIALCAAQGLTFLHEEGPFQAMYNEFSTANIQIDKDFSAKLS 326
Y ++ ID ++ +G+ +L G + ++ + +T NI ++ + K+
Sbjct: 105 D--YLQAHAERIDHIKLLQYTSQICKGMEYL---GTKRYIHRDLATRNILVENENRVKIG 159
Query: 327 GYGCAGHIPE 336
+G +P+
Sbjct: 160 DFGLTKVLPQ 169
>pdb|4ASZ|A Chain A, Crystal Structure Of Apo Trkb Kinase Domain
pdb|4AT3|A Chain A, Crystal Structure Of Trkb Kinase Domain In Complex With
Cpd5n
pdb|4AT4|A Chain A, Crystal Structure Of Trkb Kinase Domain In Complex With
Ex429
pdb|4AT5|A Chain A, Crystal Structure Of Trkb Kinase Domain In Complex With
Gw2580
Length = 299
Score = 41.2 bits (95), Expect = 0.001, Method: Compositional matrix adjust.
Identities = 37/177 (20%), Positives = 73/177 (41%), Gaps = 20/177 (11%)
Query: 175 HNFFSDRCISEGLSSVMYRASFGDDASTSKKFEATVTRLNPSSQGV-KEFINDVNTLASL 233
HN R + EG ++ A + K V L +S K+F + L +L
Sbjct: 13 HNIVLKRELGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDASDNARKDFHREAELLTNL 72
Query: 234 QHPNLCKLLGFHARDGSDQRMLIYERLFHGSLDRLIYGRSDGP------------PIDWN 281
QH ++ K G D ++++E + HG L++ + R+ GP + +
Sbjct: 73 QHEHIVKFYGVCVE--GDPLIMVFEYMKHGDLNKFL--RAHGPDAVLMAEGNPPTELTQS 128
Query: 282 TRVKIALCAAQGLTFLHEEGPFQAMYNEFSTANIQIDKDFSAKLSGYGCAGHIPETD 338
+ IA A G+ +L + ++ + +T N + ++ K+ +G + + TD
Sbjct: 129 QMLHIAQQIAAGMVYLASQ---HFVHRDLATRNCLVGENLLVKIGDFGMSRDVYSTD 182
>pdb|1GII|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The Cdk4
Inhibitor
pdb|1GIJ|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The Cdk4
Inhibitor
pdb|2DS1|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The Cdk4
Inhibitor
Length = 298
Score = 41.2 bits (95), Expect = 0.001, Method: Compositional matrix adjust.
Identities = 40/158 (25%), Positives = 69/158 (43%), Gaps = 13/158 (8%)
Query: 176 NFFSDRCISEGLSSVMYRASFGDDASTSKKFEATVTRLNPSSQGV-KEFINDVNTLASLQ 234
NF I EG V+Y+A + T + RL+ ++GV I +++ L L
Sbjct: 3 NFQKVEKIGEGTYGVVYKAR---NKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELN 59
Query: 235 HPNLCKLLGFHARDGSDQRMLIYERLFHGSLDRLIYGRS-DGPPIDWNTRVKIALCAAQG 293
HPN+ KLL ++ L++E + H L + + G P+ L QG
Sbjct: 60 HPNIVKLLD--VIHTENKLYLVFEHV-HQDLKTFMDASALTGIPLPLIKSYLFQLL--QG 114
Query: 294 LTFLHEEGPFQAMYNEFSTANIQIDKDFSAKLSGYGCA 331
L F H + ++ + N+ I+ + + KL+ +G A
Sbjct: 115 LAFCHSH---RVLHRDLKPQNLLINTEGAIKLADFGLA 149
>pdb|3KMW|A Chain A, Crystal Structure Of The IlkALPHA-Parvin Core Complex
(Mgatp)
pdb|3REP|A Chain A, Crystal Structure Of The IlkALPHA-Parvin Core Complex
(Mnatp)
Length = 271
Score = 40.8 bits (94), Expect = 0.001, Method: Compositional matrix adjust.
Identities = 29/111 (26%), Positives = 57/111 (51%), Gaps = 2/111 (1%)
Query: 216 SSQGVKEFINDVNTLASLQHPNLCKLLGFHARDGSDQRMLIYERLFHGSLDRLIYGRSDG 275
S++ ++F + L HPN+ +LG + LI + +GSL +++ ++
Sbjct: 47 STRKSRDFNEECPRLRIFSHPNVLPVLGACQSPPAPHPTLITHWMPYGSLYNVLHEGTNF 106
Query: 276 PPIDWNTRVKIALCAAQGLTFLHEEGPFQAMYNEFSTANIQIDKDFSAKLS 326
+D + VK AL A+G+ FLH P + ++ ++ ID+D +A++S
Sbjct: 107 V-VDQSQAVKFALDMARGMAFLHTLEPLIPRH-ALNSRSVMIDEDMTARIS 155
>pdb|3E62|A Chain A, Fragment Based Discovery Of Jak-2 Inhibitors
pdb|3E63|A Chain A, Fragment Based Discovery Of Jak-2 Inhibitors
pdb|3E64|A Chain A, Fragment Based Discovery Of Jak-2 Inhibitors
Length = 293
Score = 40.4 bits (93), Expect = 0.001, Method: Compositional matrix adjust.
Identities = 32/130 (24%), Positives = 60/130 (46%), Gaps = 6/130 (4%)
Query: 208 ATVTRLNPSSQ-GVKEFINDVNTLASLQHPNLCKLLGFHARDGSDQRMLIYERLFHGSLD 266
V +L S++ +++F ++ L SLQH N+ K G G LI E L +GSL
Sbjct: 41 VAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRRNLKLIMEYLPYGSLR 100
Query: 267 RLIYGRSDGPPIDWNTRVKIALCAAQGLTFLHEEGPFQAMYNEFSTANIQIDKDFSAKLS 326
Y + ID ++ +G+ +L G + ++ + +T NI ++ + K+
Sbjct: 101 D--YLQKHKERIDHIKLLQYTSQICKGMEYL---GTKRYIHRDLATRNILVENENRVKIG 155
Query: 327 GYGCAGHIPE 336
+G +P+
Sbjct: 156 DFGLTKVLPQ 165
>pdb|2B7A|A Chain A, The Structural Basis Of Janus Kinase 2 Inhibition By A
Potent And Specific Pan-Janus Kinase Inhibitor
pdb|2B7A|B Chain B, The Structural Basis Of Janus Kinase 2 Inhibition By A
Potent And Specific Pan-Janus Kinase Inhibitor
pdb|3FUP|A Chain A, Crystal Structures Of Jak1 And Jak2 Inhibitor Complexes
pdb|3FUP|B Chain B, Crystal Structures Of Jak1 And Jak2 Inhibitor Complexes
Length = 293
Score = 40.4 bits (93), Expect = 0.001, Method: Compositional matrix adjust.
Identities = 32/130 (24%), Positives = 60/130 (46%), Gaps = 6/130 (4%)
Query: 208 ATVTRLNPSSQ-GVKEFINDVNTLASLQHPNLCKLLGFHARDGSDQRMLIYERLFHGSLD 266
V +L S++ +++F ++ L SLQH N+ K G G LI E L +GSL
Sbjct: 40 VAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRRNLKLIMEYLPYGSLR 99
Query: 267 RLIYGRSDGPPIDWNTRVKIALCAAQGLTFLHEEGPFQAMYNEFSTANIQIDKDFSAKLS 326
Y + ID ++ +G+ +L G + ++ + +T NI ++ + K+
Sbjct: 100 D--YLQKHKERIDHIKLLQYTSQICKGMEYL---GTKRYIHRDLATRNILVENENRVKIG 154
Query: 327 GYGCAGHIPE 336
+G +P+
Sbjct: 155 DFGLTKVLPQ 164
>pdb|4E6D|A Chain A, Jak2 Kinase (Jh1 Domain) Triple Mutant In Complex With
Compound 7
pdb|4E6D|B Chain B, Jak2 Kinase (Jh1 Domain) Triple Mutant In Complex With
Compound 7
pdb|4E6Q|A Chain A, Jak2 Kinase (Jh1 Domain) Triple Mutant In Complex With
Compound 12
pdb|4E6Q|B Chain B, Jak2 Kinase (Jh1 Domain) Triple Mutant In Complex With
Compound 12
Length = 298
Score = 40.4 bits (93), Expect = 0.001, Method: Compositional matrix adjust.
Identities = 32/130 (24%), Positives = 60/130 (46%), Gaps = 6/130 (4%)
Query: 208 ATVTRLNPSSQ-GVKEFINDVNTLASLQHPNLCKLLGFHARDGSDQRMLIYERLFHGSLD 266
V +L S++ +++F ++ L SLQH N+ K G G LI E L +GSL
Sbjct: 45 VAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRRNLKLIMEFLPYGSLR 104
Query: 267 RLIYGRSDGPPIDWNTRVKIALCAAQGLTFLHEEGPFQAMYNEFSTANIQIDKDFSAKLS 326
Y + ID ++ +G+ +L G + ++ + +T NI ++ + K+
Sbjct: 105 E--YLQKHKERIDHIKLLQYTSQICKGMEYL---GTKRYIHRDLATRNILVENENRVKIG 159
Query: 327 GYGCAGHIPE 336
+G +P+
Sbjct: 160 DFGLTKVLPQ 169
>pdb|3RVG|A Chain A, Crystals Structure Of Jak2 With A
1-Amino-5h-Pyrido[4,3-B]indol-4- Carboxamide Inhibitor
Length = 303
Score = 40.4 bits (93), Expect = 0.002, Method: Compositional matrix adjust.
Identities = 32/130 (24%), Positives = 60/130 (46%), Gaps = 6/130 (4%)
Query: 208 ATVTRLNPSSQ-GVKEFINDVNTLASLQHPNLCKLLGFHARDGSDQRMLIYERLFHGSLD 266
V +L S++ +++F ++ L SLQH N+ K G G LI E L +GSL
Sbjct: 46 VAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRRNLKLIMEYLPYGSLR 105
Query: 267 RLIYGRSDGPPIDWNTRVKIALCAAQGLTFLHEEGPFQAMYNEFSTANIQIDKDFSAKLS 326
Y + ID ++ +G+ +L G + ++ + +T NI ++ + K+
Sbjct: 106 D--YLQKHKERIDHIKLLQYTSQICKGMEYL---GTKRYIHRDLATRNILVENENRVKIG 160
Query: 327 GYGCAGHIPE 336
+G +P+
Sbjct: 161 DFGLTKVLPQ 170
>pdb|3Q32|A Chain A, Structure Of Janus Kinase 2 With A Pyrrolotriazine
Inhibitor
pdb|3Q32|B Chain B, Structure Of Janus Kinase 2 With A Pyrrolotriazine
Inhibitor
Length = 301
Score = 40.4 bits (93), Expect = 0.002, Method: Compositional matrix adjust.
Identities = 32/130 (24%), Positives = 60/130 (46%), Gaps = 6/130 (4%)
Query: 208 ATVTRLNPSSQ-GVKEFINDVNTLASLQHPNLCKLLGFHARDGSDQRMLIYERLFHGSLD 266
V +L S++ +++F ++ L SLQH N+ K G G LI E L +GSL
Sbjct: 42 VAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRRNLKLIMEYLPYGSLR 101
Query: 267 RLIYGRSDGPPIDWNTRVKIALCAAQGLTFLHEEGPFQAMYNEFSTANIQIDKDFSAKLS 326
Y + ID ++ +G+ +L G + ++ + +T NI ++ + K+
Sbjct: 102 D--YLQKHKERIDHIKLLQYTSQICKGMEYL---GTKRYIHRDLATRNILVENENRVKIG 156
Query: 327 GYGCAGHIPE 336
+G +P+
Sbjct: 157 DFGLTKVLPQ 166
>pdb|3TJC|A Chain A, Co-Crystal Structure Of Jak2 With Thienopyridine 8
pdb|3TJC|B Chain B, Co-Crystal Structure Of Jak2 With Thienopyridine 8
pdb|3TJD|A Chain A, Co-Crystal Structure Of Jak2 With Thienopyridine 19
pdb|3TJD|B Chain B, Co-Crystal Structure Of Jak2 With Thienopyridine 19
Length = 298
Score = 40.4 bits (93), Expect = 0.002, Method: Compositional matrix adjust.
Identities = 32/130 (24%), Positives = 60/130 (46%), Gaps = 6/130 (4%)
Query: 208 ATVTRLNPSSQ-GVKEFINDVNTLASLQHPNLCKLLGFHARDGSDQRMLIYERLFHGSLD 266
V +L S++ +++F ++ L SLQH N+ K G G LI E L +GSL
Sbjct: 45 VAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRRNLKLIMEYLPYGSLR 104
Query: 267 RLIYGRSDGPPIDWNTRVKIALCAAQGLTFLHEEGPFQAMYNEFSTANIQIDKDFSAKLS 326
Y + ID ++ +G+ +L G + ++ + +T NI ++ + K+
Sbjct: 105 D--YLQKHKERIDHIKLLQYTSQICKGMEYL---GTKRYIHRDLATRNILVENENRVKIG 159
Query: 327 GYGCAGHIPE 336
+G +P+
Sbjct: 160 DFGLTKVLPQ 169
>pdb|3LPB|A Chain A, Crystal Structure Of Jak2 Complexed With A Potent
2,8-Diaryl Quinoxaline Inhibitor
pdb|3LPB|B Chain B, Crystal Structure Of Jak2 Complexed With A Potent
2,8-Diaryl Quinoxaline Inhibitor
pdb|3KRR|A Chain A, Crystal Structure Of Jak2 Complexed With A Potent
Quinoxaline Atp Site Inhibitor
Length = 295
Score = 40.4 bits (93), Expect = 0.002, Method: Compositional matrix adjust.
Identities = 32/130 (24%), Positives = 60/130 (46%), Gaps = 6/130 (4%)
Query: 208 ATVTRLNPSSQ-GVKEFINDVNTLASLQHPNLCKLLGFHARDGSDQRMLIYERLFHGSLD 266
V +L S++ +++F ++ L SLQH N+ K G G LI E L +GSL
Sbjct: 42 VAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRRNLKLIMEYLPYGSLR 101
Query: 267 RLIYGRSDGPPIDWNTRVKIALCAAQGLTFLHEEGPFQAMYNEFSTANIQIDKDFSAKLS 326
Y + ID ++ +G+ +L G + ++ + +T NI ++ + K+
Sbjct: 102 D--YLQKHKERIDHIKLLQYTSQICKGMEYL---GTKRYIHRDLATRNILVENENRVKIG 156
Query: 327 GYGCAGHIPE 336
+G +P+
Sbjct: 157 DFGLTKVLPQ 166
>pdb|2W1I|A Chain A, Structure Determination Of Aurora Kinase In Complex With
Inhibitor
pdb|2W1I|B Chain B, Structure Determination Of Aurora Kinase In Complex With
Inhibitor
Length = 326
Score = 40.4 bits (93), Expect = 0.002, Method: Compositional matrix adjust.
Identities = 32/130 (24%), Positives = 60/130 (46%), Gaps = 6/130 (4%)
Query: 208 ATVTRLNPSSQ-GVKEFINDVNTLASLQHPNLCKLLGFHARDGSDQRMLIYERLFHGSLD 266
V +L S++ +++F ++ L SLQH N+ K G G LI E L +GSL
Sbjct: 73 VAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRRNLKLIMEYLPYGSLR 132
Query: 267 RLIYGRSDGPPIDWNTRVKIALCAAQGLTFLHEEGPFQAMYNEFSTANIQIDKDFSAKLS 326
Y + ID ++ +G+ +L G + ++ + +T NI ++ + K+
Sbjct: 133 D--YLQKHKERIDHIKLLQYTSQICKGMEYL---GTKRYIHRDLATRNILVENENRVKIG 187
Query: 327 GYGCAGHIPE 336
+G +P+
Sbjct: 188 DFGLTKVLPQ 197
>pdb|4AQC|A Chain A, Triazolopyridine-Based Inhibitor Of Janus Kinase 2
pdb|4AQC|B Chain B, Triazolopyridine-Based Inhibitor Of Janus Kinase 2
Length = 301
Score = 40.4 bits (93), Expect = 0.002, Method: Compositional matrix adjust.
Identities = 32/130 (24%), Positives = 60/130 (46%), Gaps = 6/130 (4%)
Query: 208 ATVTRLNPSSQ-GVKEFINDVNTLASLQHPNLCKLLGFHARDGSDQRMLIYERLFHGSLD 266
V +L S++ +++F ++ L SLQH N+ K G G LI E L +GSL
Sbjct: 48 VAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRRNLKLIMEYLPYGSLR 107
Query: 267 RLIYGRSDGPPIDWNTRVKIALCAAQGLTFLHEEGPFQAMYNEFSTANIQIDKDFSAKLS 326
Y + ID ++ +G+ +L G + ++ + +T NI ++ + K+
Sbjct: 108 D--YLQKHKERIDHIKLLQYTSQICKGMEYL---GTKRYIHRDLATRNILVENENRVKIG 162
Query: 327 GYGCAGHIPE 336
+G +P+
Sbjct: 163 DFGLTKVLPQ 172
>pdb|4HGE|A Chain A, Jak2 Kinase (Jh1 Domain) In Complex With Compound 8
pdb|4HGE|B Chain B, Jak2 Kinase (Jh1 Domain) In Complex With Compound 8
Length = 300
Score = 40.4 bits (93), Expect = 0.002, Method: Compositional matrix adjust.
Identities = 32/130 (24%), Positives = 60/130 (46%), Gaps = 6/130 (4%)
Query: 208 ATVTRLNPSSQ-GVKEFINDVNTLASLQHPNLCKLLGFHARDGSDQRMLIYERLFHGSLD 266
V +L S++ +++F ++ L SLQH N+ K G G LI E L +GSL
Sbjct: 47 VAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRRNLKLIMEYLPYGSLR 106
Query: 267 RLIYGRSDGPPIDWNTRVKIALCAAQGLTFLHEEGPFQAMYNEFSTANIQIDKDFSAKLS 326
Y + ID ++ +G+ +L G + ++ + +T NI ++ + K+
Sbjct: 107 D--YLQKHKERIDHIKLLQYTSQICKGMEYL---GTKRYIHRDLATRNILVENENRVKIG 161
Query: 327 GYGCAGHIPE 336
+G +P+
Sbjct: 162 DFGLTKVLPQ 171
>pdb|3UGC|A Chain A, Structural Basis Of Jak2 Inhibition By The Type Ii
Inhibtor Nvp-Bbt594
Length = 295
Score = 40.4 bits (93), Expect = 0.002, Method: Compositional matrix adjust.
Identities = 32/130 (24%), Positives = 60/130 (46%), Gaps = 6/130 (4%)
Query: 208 ATVTRLNPSSQ-GVKEFINDVNTLASLQHPNLCKLLGFHARDGSDQRMLIYERLFHGSLD 266
V +L S++ +++F ++ L SLQH N+ K G G LI E L +GSL
Sbjct: 42 VAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRRNLKLIMEYLPYGSLR 101
Query: 267 RLIYGRSDGPPIDWNTRVKIALCAAQGLTFLHEEGPFQAMYNEFSTANIQIDKDFSAKLS 326
Y + ID ++ +G+ +L G + ++ + +T NI ++ + K+
Sbjct: 102 D--YLQKHKERIDHIKLLQYTSQICKGMEYL---GTKRYIHRDLATRNILVENENRVKIG 156
Query: 327 GYGCAGHIPE 336
+G +P+
Sbjct: 157 DFGLTKVLPQ 166
>pdb|3V5Q|A Chain A, Discovery Of A Selective Trk Inhibitor With Efficacy In
Rodent Cancer Tumor Models
pdb|3V5Q|B Chain B, Discovery Of A Selective Trk Inhibitor With Efficacy In
Rodent Cancer Tumor Models
Length = 297
Score = 40.4 bits (93), Expect = 0.002, Method: Compositional matrix adjust.
Identities = 38/172 (22%), Positives = 74/172 (43%), Gaps = 19/172 (11%)
Query: 181 RCISEGLSSVMYRASFGDDASTSKKFEATVTRL-NPSSQGVKEFINDVNTLASLQHPNLC 239
R + EG ++ A + + T K V L +P+ K+F + L +LQH ++
Sbjct: 21 RELGEGAFGKVFLAECYNLSPTKDKMLVAVKALKDPTLAARKDFQREAELLTNLQHEHIV 80
Query: 240 KLLGFHARDGSDQRMLIYERLFHGSLDRLIYGRS-------DGPP------IDWNTRVKI 286
K G DG D ++++E + HG L++ + DG P + + + I
Sbjct: 81 KFYGV-CGDG-DPLIMVFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGLSQMLHI 138
Query: 287 ALCAAQGLTFLHEEGPFQAMYNEFSTANIQIDKDFSAKLSGYGCAGHIPETD 338
A A G+ +L + ++ + +T N + + K+ +G + + TD
Sbjct: 139 ASQIASGMVYLASQ---HFVHRDLATRNCLVGANLLVKIGDFGMSRDVYSTD 187
>pdb|4E4M|A Chain A, Jak2 Kinase (Jh1 Domain) In Complex With Compound 30
pdb|4E4M|B Chain B, Jak2 Kinase (Jh1 Domain) In Complex With Compound 30
pdb|4E4M|D Chain D, Jak2 Kinase (Jh1 Domain) In Complex With Compound 30
pdb|4E4M|E Chain E, Jak2 Kinase (Jh1 Domain) In Complex With Compound 30
pdb|4F08|A Chain A, Discovery And Optimization Of C-2 Methyl
Imidazo-Pyrrolopyridines As Potent And Orally
Bioavailable Jak1 Inhibitors With Selectivity Over Jak2
pdb|4F08|B Chain B, Discovery And Optimization Of C-2 Methyl
Imidazo-Pyrrolopyridines As Potent And Orally
Bioavailable Jak1 Inhibitors With Selectivity Over Jak2
pdb|4F09|A Chain A, Discovery And Optimization Of C-2 Methyl
Imidazo-Pyrrolopyridines As Potent And Orally
Bioavailable Jak1 Inhibitors With Selectivity Over Jak2
Length = 302
Score = 40.4 bits (93), Expect = 0.002, Method: Compositional matrix adjust.
Identities = 32/130 (24%), Positives = 60/130 (46%), Gaps = 6/130 (4%)
Query: 208 ATVTRLNPSSQ-GVKEFINDVNTLASLQHPNLCKLLGFHARDGSDQRMLIYERLFHGSLD 266
V +L S++ +++F ++ L SLQH N+ K G G LI E L +GSL
Sbjct: 49 VAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRRNLKLIMEYLPYGSLR 108
Query: 267 RLIYGRSDGPPIDWNTRVKIALCAAQGLTFLHEEGPFQAMYNEFSTANIQIDKDFSAKLS 326
Y + ID ++ +G+ +L G + ++ + +T NI ++ + K+
Sbjct: 109 D--YLQKHKERIDHIKLLQYTSQICKGMEYL---GTKRYIHRDLATRNILVENENRVKIG 163
Query: 327 GYGCAGHIPE 336
+G +P+
Sbjct: 164 DFGLTKVLPQ 173
>pdb|3JY9|A Chain A, Janus Kinase 2 Inhibitors
Length = 311
Score = 40.4 bits (93), Expect = 0.002, Method: Compositional matrix adjust.
Identities = 32/130 (24%), Positives = 60/130 (46%), Gaps = 6/130 (4%)
Query: 208 ATVTRLNPSSQ-GVKEFINDVNTLASLQHPNLCKLLGFHARDGSDQRMLIYERLFHGSLD 266
V +L S++ +++F ++ L SLQH N+ K G G LI E L +GSL
Sbjct: 60 VAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRRNLKLIMEYLPYGSLR 119
Query: 267 RLIYGRSDGPPIDWNTRVKIALCAAQGLTFLHEEGPFQAMYNEFSTANIQIDKDFSAKLS 326
Y + ID ++ +G+ +L G + ++ + +T NI ++ + K+
Sbjct: 120 D--YLQKHKERIDHIKLLQYTSQICKGMEYL---GTKRYIHRDLATRNILVENENRVKIG 174
Query: 327 GYGCAGHIPE 336
+G +P+
Sbjct: 175 DFGLTKVLPQ 184
>pdb|3IO7|A Chain A, 2-Aminopyrazolo[1,5-A]pyrimidines As Potent And Selective
Inhibitors Of Jak2
pdb|3IOK|A Chain A, 2-Aminopyrazolo[1,5-A]pyrimidines As Potent And Selective
Inhibitors Of Jak2
pdb|3KCK|A Chain A, A Novel Chemotype Of Kinase Inhibitors
Length = 313
Score = 40.0 bits (92), Expect = 0.002, Method: Compositional matrix adjust.
Identities = 32/130 (24%), Positives = 60/130 (46%), Gaps = 6/130 (4%)
Query: 208 ATVTRLNPSSQ-GVKEFINDVNTLASLQHPNLCKLLGFHARDGSDQRMLIYERLFHGSLD 266
V +L S++ +++F ++ L SLQH N+ K G G LI E L +GSL
Sbjct: 60 VAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRRNLKLIMEYLPYGSLR 119
Query: 267 RLIYGRSDGPPIDWNTRVKIALCAAQGLTFLHEEGPFQAMYNEFSTANIQIDKDFSAKLS 326
Y + ID ++ +G+ +L G + ++ + +T NI ++ + K+
Sbjct: 120 D--YLQKHKERIDHIKLLQYTSQICKGMEYL---GTKRYIHRDLATRNILVENENRVKIG 174
Query: 327 GYGCAGHIPE 336
+G +P+
Sbjct: 175 DFGLTKVLPQ 184
>pdb|3A4O|X Chain X, Lyn Kinase Domain
Length = 286
Score = 39.7 bits (91), Expect = 0.003, Method: Compositional matrix adjust.
Identities = 29/133 (21%), Positives = 62/133 (46%), Gaps = 8/133 (6%)
Query: 207 EATVTRLNPSSQGVKEFINDVNTLASLQHPNLCKLLGFHARDGSDQRMLIYERLFHGSLD 266
+ V L P + V+ F+ + N + +LQH L +L R+ + +I E + GSL
Sbjct: 39 KVAVKTLKPGTMSVQAFLEEANLMKTLQHDKLVRLYAVVTRE--EPIYIITEYMAKGSL- 95
Query: 267 RLIYGRSD-GPPIDWNTRVKIALCAAQGLTFLHEEGPFQAMYNEFSTANIQIDKDFSAKL 325
L + +SD G + + + A+G+ ++ + ++ + AN+ + + K+
Sbjct: 96 -LDFLKSDEGGKVLLPKLIDFSAQIAEGMAYIERK---NYIHRDLRAANVLVSESLMCKI 151
Query: 326 SGYGCAGHIPETD 338
+ +G A I + +
Sbjct: 152 ADFGLARVIEDNE 164
>pdb|2IW8|A Chain A, Structure Of Human Thr160-Phospho Cdk2-Cyclin A F82h-L83v-
H84d Mutant With An O6-Cyclohexylmethylguanine Inhibitor
pdb|2IW8|C Chain C, Structure Of Human Thr160-Phospho Cdk2-Cyclin A F82h-L83v-
H84d Mutant With An O6-Cyclohexylmethylguanine Inhibitor
Length = 302
Score = 39.7 bits (91), Expect = 0.003, Method: Compositional matrix adjust.
Identities = 38/161 (23%), Positives = 67/161 (41%), Gaps = 11/161 (6%)
Query: 172 AACHNFFSDRCISEGLSSVMYRASFGDDASTSKKFEATVTRLNPSSQGV-KEFINDVNTL 230
+ NF I EG V+Y+A + T + RL+ ++GV I +++ L
Sbjct: 3 GSMENFQKVEKIGEGTYGVVYKAR---NKLTGEVVALKKIRLDTETEGVPSTAIREISLL 59
Query: 231 ASLQHPNLCKLLGFHARDGSDQRMLIYERLFHGSLDRLIYGRSDGPPIDWNTRVKIALCA 290
L HPN+ KLL ++ L++E + + G P+ L
Sbjct: 60 KELNHPNIVKLLD--VIHTENKLYLVFEHVDQDLKKFMDASALTGIPLPLIKSYLFQLL- 116
Query: 291 AQGLTFLHEEGPFQAMYNEFSTANIQIDKDFSAKLSGYGCA 331
QGL F H + ++ + N+ I+ + + KL+ +G A
Sbjct: 117 -QGLAFCHSH---RVLHRDLKPQNLLINTEGAIKLADFGLA 153
>pdb|4EOM|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Human
Cyclin A3 Complex With Atp
pdb|4EOM|C Chain C, Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Human
Cyclin A3 Complex With Atp
Length = 301
Score = 39.7 bits (91), Expect = 0.003, Method: Compositional matrix adjust.
Identities = 39/161 (24%), Positives = 67/161 (41%), Gaps = 11/161 (6%)
Query: 172 AACHNFFSDRCISEGLSSVMYRASFGDDASTSKKFEATVTRLNPSSQGV-KEFINDVNTL 230
+ NF I EG V+Y+A + T + RL+ ++GV I +++ L
Sbjct: 3 GSMENFQKVEKIGEGTYGVVYKAR---NKLTGEVVALKKIRLDTETEGVPSTAIREISLL 59
Query: 231 ASLQHPNLCKLLGFHARDGSDQRMLIYERLFHGSLDRLIYGRSDGPPIDWNTRVKIALCA 290
L HPN+ KLL ++ L++E L + G P+ L
Sbjct: 60 KELNHPNIVKLLD--VIHTENKLYLVFEFLSMDLKKFMDASALTGIPLPLIKSYLFQLL- 116
Query: 291 AQGLTFLHEEGPFQAMYNEFSTANIQIDKDFSAKLSGYGCA 331
QGL F H + ++ + N+ I+ + + KL+ +G A
Sbjct: 117 -QGLAFCHSH---RVLHRDLKPENLLINTEGAIKLADFGLA 153
>pdb|4BBE|A Chain A, Aminoalkylpyrimidine Inhibitor Complexes With Jak2
pdb|4BBE|B Chain B, Aminoalkylpyrimidine Inhibitor Complexes With Jak2
pdb|4BBE|C Chain C, Aminoalkylpyrimidine Inhibitor Complexes With Jak2
pdb|4BBE|D Chain D, Aminoalkylpyrimidine Inhibitor Complexes With Jak2
pdb|4BBF|A Chain A, Aminoalkylpyrimidine Inhibitor Complexes With Jak2
pdb|4BBF|B Chain B, Aminoalkylpyrimidine Inhibitor Complexes With Jak2
pdb|4BBF|C Chain C, Aminoalkylpyrimidine Inhibitor Complexes With Jak2
pdb|4BBF|D Chain D, Aminoalkylpyrimidine Inhibitor Complexes With Jak2
Length = 298
Score = 39.7 bits (91), Expect = 0.003, Method: Compositional matrix adjust.
Identities = 32/130 (24%), Positives = 59/130 (45%), Gaps = 6/130 (4%)
Query: 208 ATVTRLNPSSQ-GVKEFINDVNTLASLQHPNLCKLLGFHARDGSDQRMLIYERLFHGSLD 266
V +L S++ +++F ++ L SLQH N+ K G G LI E L +GSL
Sbjct: 43 VAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRRNLKLIMEYLPYGSLR 102
Query: 267 RLIYGRSDGPPIDWNTRVKIALCAAQGLTFLHEEGPFQAMYNEFSTANIQIDKDFSAKLS 326
Y + ID ++ +G+ +L G + ++ +T NI ++ + K+
Sbjct: 103 D--YLQKHKERIDHIKLLQYTSQICKGMEYL---GTKRYIHRNLATRNILVENENRVKIG 157
Query: 327 GYGCAGHIPE 336
+G +P+
Sbjct: 158 DFGLTKVLPQ 167
>pdb|4EON|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Human
Cyclin A3 Complex With The Inhibitor Ro3306
pdb|4EON|C Chain C, Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Human
Cyclin A3 Complex With The Inhibitor Ro3306
Length = 300
Score = 39.3 bits (90), Expect = 0.003, Method: Compositional matrix adjust.
Identities = 39/161 (24%), Positives = 67/161 (41%), Gaps = 11/161 (6%)
Query: 172 AACHNFFSDRCISEGLSSVMYRASFGDDASTSKKFEATVTRLNPSSQGV-KEFINDVNTL 230
+ NF I EG V+Y+A + T + RL+ ++GV I +++ L
Sbjct: 1 GSMENFQKVEKIGEGTYGVVYKAR---NKLTGEVVALKKIRLDTETEGVPSTAIREISLL 57
Query: 231 ASLQHPNLCKLLGFHARDGSDQRMLIYERLFHGSLDRLIYGRSDGPPIDWNTRVKIALCA 290
L HPN+ KLL ++ L++E L + G P+ L
Sbjct: 58 KELNHPNIVKLLD--VIHTENKLYLVFEFLSMDLKKFMDASALTGIPLPLIKSYLFQLL- 114
Query: 291 AQGLTFLHEEGPFQAMYNEFSTANIQIDKDFSAKLSGYGCA 331
QGL F H + ++ + N+ I+ + + KL+ +G A
Sbjct: 115 -QGLAFCHSH---RVLHRDLKPENLLINTEGAIKLADFGLA 151
>pdb|4F1M|A Chain A, Crystal Structure Of The G1179s Roco4 Kinase Domain Bound
To Appcp From D. Discoideum
Length = 287
Score = 39.3 bits (90), Expect = 0.004, Method: Compositional matrix adjust.
Identities = 22/83 (26%), Positives = 40/83 (48%), Gaps = 8/83 (9%)
Query: 221 KEFINDVNTLASLQHPNLCKLLGF-HARDGSDQRMLIYERLFHGSLDRLIYGRSDGPPID 279
+EF +V +++L HPN+ KL G H + L+H LD+ PI
Sbjct: 68 QEFQREVFIMSNLNHPNIVKLYGLMHNPPRMVMEFVPCGDLYHRLLDK-------AHPIK 120
Query: 280 WNTRVKIALCAAQGLTFLHEEGP 302
W+ ++++ L A G+ ++ + P
Sbjct: 121 WSVKLRLMLDIALGIEYMQNQNP 143
>pdb|4F0F|A Chain A, Crystal Structure Of The Roco4 Kinase Domain Bound To
Appcp From D. Discoideum
pdb|4F0G|A Chain A, Crystal Structure Of The Roco4 Kinase Domain From D.
Discoideum
pdb|4F1T|A Chain A, Crystal Structure Of The Roco4 Kinase Domain From D.
Discoideum Bound To The Rock Inhibitor H1152
Length = 287
Score = 38.9 bits (89), Expect = 0.004, Method: Compositional matrix adjust.
Identities = 28/117 (23%), Positives = 57/117 (48%), Gaps = 14/117 (11%)
Query: 221 KEFINDVNTLASLQHPNLCKLLGF-HARDGSDQRMLIYERLFHGSLDRLIYGRSDGPPID 279
+EF +V +++L HPN+ KL G H + L+H LD+ PI
Sbjct: 68 QEFQREVFIMSNLNHPNIVKLYGLMHNPPRMVMEFVPCGDLYHRLLDK-------AHPIK 120
Query: 280 WNTRVKIALCAAQGLTFLHEEGPFQAMYNEFSTANI---QIDKD--FSAKLSGYGCA 331
W+ ++++ L A G+ ++ + P ++ + + NI +D++ AK++ +G +
Sbjct: 121 WSVKLRLMLDIALGIEYMQNQNP-PIVHRDLRSPNIFLQSLDENAPVCAKVADFGLS 176
>pdb|2R4B|A Chain A, Erbb4 Kinase Domain Complexed With A Thienopyrimidine
Inhibitor
pdb|2R4B|B Chain B, Erbb4 Kinase Domain Complexed With A Thienopyrimidine
Inhibitor
Length = 321
Score = 38.9 bits (89), Expect = 0.004, Method: Compositional matrix adjust.
Identities = 34/155 (21%), Positives = 71/155 (45%), Gaps = 15/155 (9%)
Query: 181 RCISEGLSSVMYRASFGDDASTSKKFEATVTRLNPSS--QGVKEFINDVNTLASLQHPNL 238
+ + G +Y+ + + T K + LN ++ + EF+++ +AS+ HP+L
Sbjct: 44 KVLGSGAFGTVYKGIWVPEGETVK-IPVAIKILNETTGPKANVEFMDEALIMASMDHPHL 102
Query: 239 CKLLGFHARDGSDQRMLIYERLFHGSLDRLIYGRSD--GPPIDWNTRVKIALCAAQGLTF 296
+LLG S L+ + + HG L ++ D G + N V+I A+G+ +
Sbjct: 103 VRLLGVCL---SPTIQLVTQLMPHGCLLEYVHEHKDNIGSQLLLNWCVQI----AKGMMY 155
Query: 297 LHEEGPFQAMYNEFSTANIQIDKDFSAKLSGYGCA 331
L E + ++ + + N+ + K++ +G A
Sbjct: 156 LEER---RLVHRDLAARNVLVKSPNHVKITDFGLA 187
>pdb|4F1O|A Chain A, Crystal Structure Of The L1180t Mutant Roco4 Kinase Domain
From D. Discoideum Bound To Appcp
Length = 287
Score = 38.9 bits (89), Expect = 0.004, Method: Compositional matrix adjust.
Identities = 22/83 (26%), Positives = 40/83 (48%), Gaps = 8/83 (9%)
Query: 221 KEFINDVNTLASLQHPNLCKLLGF-HARDGSDQRMLIYERLFHGSLDRLIYGRSDGPPID 279
+EF +V +++L HPN+ KL G H + L+H LD+ PI
Sbjct: 68 QEFQREVFIMSNLNHPNIVKLYGLMHNPPRMVMEFVPCGDLYHRLLDK-------AHPIK 120
Query: 280 WNTRVKIALCAAQGLTFLHEEGP 302
W+ ++++ L A G+ ++ + P
Sbjct: 121 WSVKLRLMLDIALGIEYMQNQNP 143
>pdb|3G2F|A Chain A, Crystal Structure Of The Kinase Domain Of Bone
Morphogenetic Protein Receptor Type Ii (Bmpr2) At 2.35 A
Resolution
pdb|3G2F|B Chain B, Crystal Structure Of The Kinase Domain Of Bone
Morphogenetic Protein Receptor Type Ii (Bmpr2) At 2.35 A
Resolution
Length = 336
Score = 38.9 bits (89), Expect = 0.005, Method: Compositional matrix adjust.
Identities = 36/160 (22%), Positives = 67/160 (41%), Gaps = 24/160 (15%)
Query: 183 ISEGLSSVMYRASFGDDASTSKKFEATVTRLNPSSQGVKEFINDVNT--LASLQHPNLCK 240
I G +Y+ S + K F S + FIN+ N + ++H N+ +
Sbjct: 21 IGRGRYGAVYKGSLDERPVAVKVF---------SFANRQNFINEKNIYRVPLMEHDNIAR 71
Query: 241 LLGFHARDGSDQRM---LIYERLFHGSLDRLIYGRSDGPPIDWNTRVKIALCAAQGLTFL 297
+ R +D RM L+ E +GSL + + + DW + ++A +GL +L
Sbjct: 72 FIVGDERVTADGRMEYLLVMEYYPNGSLXKYLSLHTS----DWVSSCRLAHSVTRGLAYL 127
Query: 298 HEEGPFQAMYN------EFSTANIQIDKDFSAKLSGYGCA 331
H E P Y + ++ N+ + D + +S +G +
Sbjct: 128 HTELPRGDHYKPAISHRDLNSRNVLVKNDGTCVISDFGLS 167
>pdb|1IR3|A Chain A, Phosphorylated Insulin Receptor Tyrosine Kinase In Complex
With Peptide Substrate And Atp Analog
pdb|1GAG|A Chain A, Crystal Structure Of The Insulin Receptor Kinase In
Complex With A Bisubstrate Inhibitor
Length = 306
Score = 38.5 bits (88), Expect = 0.005, Method: Compositional matrix adjust.
Identities = 35/169 (20%), Positives = 73/169 (43%), Gaps = 18/169 (10%)
Query: 181 RCISEGLSSVMYRASFGDDASTSKKFEATVTRLNPSSQGVK--EFINDVNTLASLQHPNL 238
R + +G ++Y + D + V +N S+ + EF+N+ + + ++
Sbjct: 23 RELGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERIEFLNEASVMKGFTCHHV 82
Query: 239 CKLLGFHARDGSDQRMLIYERLFHGSLDRLIYGRS---------DGPPIDWNTRVKIALC 289
+LLG ++ +++ E + HG L Y RS PP +++A
Sbjct: 83 VRLLGVVSK--GQPTLVVMELMAHGDLKS--YLRSLRPEAENNPGRPPPTLQEMIQMAAE 138
Query: 290 AAQGLTFLHEEGPFQAMYNEFSTANIQIDKDFSAKLSGYGCAGHIPETD 338
A G+ +L+ + + ++ + + N + DF+ K+ +G I ETD
Sbjct: 139 IADGMAYLNAK---KFVHRDLAARNCMVAHDFTVKIGDFGMTRDIXETD 184
>pdb|2Z8C|A Chain A, Phosphorylated Insulin Receptor Tyrosine Kinase In Complex
With (4-{[5-Carbamoyl-4-(3-Methylanilino)pyrimidin-2-
Yl]amino}phenyl)acetic Acid
Length = 303
Score = 38.5 bits (88), Expect = 0.006, Method: Compositional matrix adjust.
Identities = 35/169 (20%), Positives = 73/169 (43%), Gaps = 18/169 (10%)
Query: 181 RCISEGLSSVMYRASFGDDASTSKKFEATVTRLNPSSQGVK--EFINDVNTLASLQHPNL 238
R + +G ++Y + D + V +N S+ + EF+N+ + + ++
Sbjct: 20 RELGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERIEFLNEASVMKGFTCHHV 79
Query: 239 CKLLGFHARDGSDQRMLIYERLFHGSLDRLIYGRS---------DGPPIDWNTRVKIALC 289
+LLG ++ +++ E + HG L Y RS PP +++A
Sbjct: 80 VRLLGVVSK--GQPTLVVMELMAHGDLKS--YLRSLRPEAENNPGRPPPTLQEMIQMAAE 135
Query: 290 AAQGLTFLHEEGPFQAMYNEFSTANIQIDKDFSAKLSGYGCAGHIPETD 338
A G+ +L+ + + ++ + + N + DF+ K+ +G I ETD
Sbjct: 136 IADGMAYLNAK---KFVHRDLAARNCMVAHDFTVKIGDFGMTRDIXETD 181
>pdb|1RQQ|A Chain A, Crystal Structure Of The Insulin Receptor Kinase In
Complex With The Sh2 Domain Of Aps
pdb|1RQQ|B Chain B, Crystal Structure Of The Insulin Receptor Kinase In
Complex With The Sh2 Domain Of Aps
pdb|2AUH|A Chain A, Crystal Structure Of The Grb14 Bps Region In Complex With
The Insulin Receptor Tyrosine Kinase
pdb|2B4S|B Chain B, Crystal Structure Of A Complex Between Ptp1b And The
Insulin Receptor Tyrosine Kinase
pdb|2B4S|D Chain D, Crystal Structure Of A Complex Between Ptp1b And The
Insulin Receptor Tyrosine Kinase
pdb|3BU3|A Chain A, Crystal Structure Of The Insulin Receptor Kinase In
Complex With Irs2 Krlb Peptide
pdb|3BU5|A Chain A, Crystal Structure Of The Insulin Receptor Kinase In
Complex With Irs2 Krlb Peptide And Atp
pdb|3BU6|A Chain A, Crystal Structure Of The Insulin Receptor Kinase In
Complex With Irs2 Krlb Phosphopeptide
Length = 306
Score = 38.5 bits (88), Expect = 0.007, Method: Compositional matrix adjust.
Identities = 35/169 (20%), Positives = 73/169 (43%), Gaps = 18/169 (10%)
Query: 181 RCISEGLSSVMYRASFGDDASTSKKFEATVTRLNPSSQGVK--EFINDVNTLASLQHPNL 238
R + +G ++Y + D + V +N S+ + EF+N+ + + ++
Sbjct: 23 RELGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERIEFLNEASVMKGFTCHHV 82
Query: 239 CKLLGFHARDGSDQRMLIYERLFHGSLDRLIYGRS---------DGPPIDWNTRVKIALC 289
+LLG ++ +++ E + HG L Y RS PP +++A
Sbjct: 83 VRLLGVVSK--GQPTLVVMELMAHGDLKS--YLRSLRPEAENNPGRPPPTLQEMIQMAAE 138
Query: 290 AAQGLTFLHEEGPFQAMYNEFSTANIQIDKDFSAKLSGYGCAGHIPETD 338
A G+ +L+ + + ++ + + N + DF+ K+ +G I ETD
Sbjct: 139 IADGMAYLNAK---KFVHRDLAARNCMVAHDFTVKIGDFGMTRDIXETD 184
>pdb|3BBT|B Chain B, Crystal Structure Of The Erbb4 Kinase In Complex With
Lapatinib
pdb|3BBT|D Chain D, Crystal Structure Of The Erbb4 Kinase In Complex With
Lapatinib
pdb|3BBW|B Chain B, Crystal Structure Of The Erbb4 Kinase In Its Inactive
Conformation
pdb|3BBW|A Chain A, Crystal Structure Of The Erbb4 Kinase In Its Inactive
Conformation
pdb|3BCE|A Chain A, Crystal Structure Of The Erbb4 Kinase
pdb|3BCE|B Chain B, Crystal Structure Of The Erbb4 Kinase
pdb|3BCE|C Chain C, Crystal Structure Of The Erbb4 Kinase
Length = 328
Score = 38.1 bits (87), Expect = 0.008, Method: Compositional matrix adjust.
Identities = 34/155 (21%), Positives = 71/155 (45%), Gaps = 15/155 (9%)
Query: 181 RCISEGLSSVMYRASFGDDASTSKKFEATVTRLNPSS--QGVKEFINDVNTLASLQHPNL 238
+ + G +Y+ + + T K + LN ++ + EF+++ +AS+ HP+L
Sbjct: 21 KVLGSGAFGTVYKGIWVPEGETVK-IPVAIKILNETTGPKANVEFMDEALIMASMDHPHL 79
Query: 239 CKLLGFHARDGSDQRMLIYERLFHGSLDRLIYGRSD--GPPIDWNTRVKIALCAAQGLTF 296
+LLG S L+ + + HG L ++ D G + N V+I A+G+ +
Sbjct: 80 VRLLGVCL---SPTIQLVTQLMPHGCLLEYVHEHKDNIGSQLLLNWCVQI----AKGMMY 132
Query: 297 LHEEGPFQAMYNEFSTANIQIDKDFSAKLSGYGCA 331
L E + ++ + + N+ + K++ +G A
Sbjct: 133 LEER---RLVHRDLAARNVLVKSPNHVKITDFGLA 164
>pdb|2ZV7|A Chain A, Lyn Tyrosine Kinase Domain, Apo Form
pdb|2ZV8|A Chain A, Lyn Tyrosine Kinase Domain-Amp-Pnp Complex
pdb|2ZV9|A Chain A, Lyn Tyrosine Kinase Domain-Pp2 Complex
pdb|2ZVA|A Chain A, Lyn Tyrosine Kinase Domain-dasatinib Complex
Length = 279
Score = 37.7 bits (86), Expect = 0.009, Method: Compositional matrix adjust.
Identities = 28/133 (21%), Positives = 62/133 (46%), Gaps = 8/133 (6%)
Query: 207 EATVTRLNPSSQGVKEFINDVNTLASLQHPNLCKLLGFHARDGSDQRMLIYERLFHGSLD 266
+ V L P + V+ F+ + N + +LQH L +L ++ + +I E + GSL
Sbjct: 38 KVAVKTLKPGTMSVQAFLEEANLMKTLQHDKLVRLYAVVTKE--EPIYIITEFMAKGSL- 94
Query: 267 RLIYGRSD-GPPIDWNTRVKIALCAAQGLTFLHEEGPFQAMYNEFSTANIQIDKDFSAKL 325
L + +SD G + + + A+G+ ++ + ++ + AN+ + + K+
Sbjct: 95 -LDFLKSDEGGKVLLPKLIDFSAQIAEGMAYIERK---NYIHRDLRAANVLVSESLMCKI 150
Query: 326 SGYGCAGHIPETD 338
+ +G A I + +
Sbjct: 151 ADFGLARVIEDNE 163
>pdb|3ETA|A Chain A, Kinase Domain Of Insulin Receptor Complexed With A Pyrrolo
Pyridine Inhibitor
pdb|3ETA|B Chain B, Kinase Domain Of Insulin Receptor Complexed With A Pyrrolo
Pyridine Inhibitor
Length = 317
Score = 37.7 bits (86), Expect = 0.009, Method: Compositional matrix adjust.
Identities = 35/169 (20%), Positives = 73/169 (43%), Gaps = 18/169 (10%)
Query: 181 RCISEGLSSVMYRASFGDDASTSKKFEATVTRLNPSSQGVK--EFINDVNTLASLQHPNL 238
R + +G ++Y + D + V +N S+ + EF+N+ + + ++
Sbjct: 22 RELGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERIEFLNEASVMKGFTCHHV 81
Query: 239 CKLLGFHARDGSDQRMLIYERLFHGSLDRLIYGRS---------DGPPIDWNTRVKIALC 289
+LLG ++ +++ E + HG L Y RS PP +++A
Sbjct: 82 VRLLGVVSK--GQPTLVVMELMAHGDLKS--YLRSLRPEAENNPGRPPPTLQEMIQMAAE 137
Query: 290 AAQGLTFLHEEGPFQAMYNEFSTANIQIDKDFSAKLSGYGCAGHIPETD 338
A G+ +L+ + + ++ + + N + DF+ K+ +G I ETD
Sbjct: 138 IADGMAYLNAK---KFVHRDLAARNCMVAHDFTVKIGDFGMTRDIYETD 183
>pdb|1IRK|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The
Human Insulin Receptor
Length = 306
Score = 37.7 bits (86), Expect = 0.010, Method: Compositional matrix adjust.
Identities = 35/169 (20%), Positives = 73/169 (43%), Gaps = 18/169 (10%)
Query: 181 RCISEGLSSVMYRASFGDDASTSKKFEATVTRLNPSSQGVK--EFINDVNTLASLQHPNL 238
R + +G ++Y + D + V +N S+ + EF+N+ + + ++
Sbjct: 23 RELGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERIEFLNEASVMKGFTCHHV 82
Query: 239 CKLLGFHARDGSDQRMLIYERLFHGSLDRLIYGRS---------DGPPIDWNTRVKIALC 289
+LLG ++ +++ E + HG L Y RS PP +++A
Sbjct: 83 VRLLGVVSK--GQPTLVVMELMAHGDLKS--YLRSLRPEAENNPGRPPPTLQEMIQMAAE 138
Query: 290 AAQGLTFLHEEGPFQAMYNEFSTANIQIDKDFSAKLSGYGCAGHIPETD 338
A G+ +L+ + + ++ + + N + DF+ K+ +G I ETD
Sbjct: 139 IADGMAYLNAK---KFVHRDLAARNCMVAHDFTVKIGDFGMTRDIYETD 184
>pdb|3KMU|A Chain A, Crystal Structure Of The IlkALPHA-Parvin Core Complex
(Apo)
Length = 271
Score = 37.7 bits (86), Expect = 0.011, Method: Compositional matrix adjust.
Identities = 29/111 (26%), Positives = 55/111 (49%), Gaps = 2/111 (1%)
Query: 216 SSQGVKEFINDVNTLASLQHPNLCKLLGFHARDGSDQRMLIYERLFHGSLDRLIYGRSDG 275
S++ ++F + L HPN+ +LG + LI +GSL +++ ++
Sbjct: 47 STRKSRDFNEECPRLRIFSHPNVLPVLGACQSPPAPHPTLITHWXPYGSLYNVLHEGTNF 106
Query: 276 PPIDWNTRVKIALCAAQGLTFLHEEGPFQAMYNEFSTANIQIDKDFSAKLS 326
+D + VK AL A+G FLH P + ++ ++ ID+D +A++S
Sbjct: 107 V-VDQSQAVKFALDXARGXAFLHTLEPLIPRH-ALNSRSVXIDEDXTARIS 155
>pdb|4GS6|A Chain A, Irreversible Inhibition Of Tak1 Kinase By 5z-7-oxozeaenol
Length = 315
Score = 37.7 bits (86), Expect = 0.011, Method: Compositional matrix adjust.
Identities = 29/129 (22%), Positives = 53/129 (41%), Gaps = 4/129 (3%)
Query: 187 LSSVMYRASFGDDASTSKKFEATVTRLNPSSQGVKEFINDVNTLASLQHPNLCKLLGFHA 246
+ V+ R +FG + + + S K FI ++ L+ + HPN+ KL G
Sbjct: 13 VEEVVGRGAFGVVCKAKWRAKDVAIKQIESESERKAFIVELRQLSRVNHPNIVKLYG--- 69
Query: 247 RDGSDQRMLIYERLFHGSLDRLIYGRSDGPPIDWNTRVKIALCAAQGLTFLHEEGPFQAM 306
+ L+ E GSL +++G P + L +QG+ +LH P +
Sbjct: 70 -ACLNPVCLVMEYAEGGSLYNVLHGAEPLPYYTAAHAMSWCLQCSQGVAYLHSMQPKALI 128
Query: 307 YNEFSTANI 315
+ + N+
Sbjct: 129 HRDLKPPNL 137
>pdb|2EVA|A Chain A, Structural Basis For The Interaction Of Tak1 Kinase With
Its Activating Protein Tab1
pdb|2YIY|A Chain A, Crystal Structure Of Compound 8 Bound To Tak1-Tab
Length = 307
Score = 37.4 bits (85), Expect = 0.012, Method: Compositional matrix adjust.
Identities = 29/131 (22%), Positives = 54/131 (41%), Gaps = 4/131 (3%)
Query: 187 LSSVMYRASFGDDASTSKKFEATVTRLNPSSQGVKEFINDVNTLASLQHPNLCKLLGFHA 246
+ V+ R +FG + + + S K FI ++ L+ + HPN+ KL G
Sbjct: 12 VEEVVGRGAFGVVCKAKWRAKDVAIKQIESESERKAFIVELRQLSRVNHPNIVKLYG--- 68
Query: 247 RDGSDQRMLIYERLFHGSLDRLIYGRSDGPPIDWNTRVKIALCAAQGLTFLHEEGPFQAM 306
+ L+ E GSL +++G P + L +QG+ +LH P +
Sbjct: 69 -ACLNPVCLVMEYAEGGSLYNVLHGAEPLPYYTAAHAMSWCLQCSQGVAYLHSMQPKALI 127
Query: 307 YNEFSTANIQI 317
+ + N+ +
Sbjct: 128 HRDLKPPNLLL 138
>pdb|1P14|A Chain A, Crystal Structure Of A Catalytic-Loop Mutant Of The
Insulin Receptor Tyrosine Kinase
Length = 306
Score = 37.0 bits (84), Expect = 0.019, Method: Compositional matrix adjust.
Identities = 35/169 (20%), Positives = 72/169 (42%), Gaps = 18/169 (10%)
Query: 181 RCISEGLSSVMYRASFGDDASTSKKFEATVTRLNPSSQGVK--EFINDVNTLASLQHPNL 238
R + +G ++Y + D + V +N S+ + EF+N+ + + ++
Sbjct: 23 RELGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERIEFLNEASVMKGFTCHHV 82
Query: 239 CKLLGFHARDGSDQRMLIYERLFHGSLDRLIYGRS---------DGPPIDWNTRVKIALC 289
+LLG ++ +++ E + HG L Y RS PP +++A
Sbjct: 83 VRLLGVVSK--GQPTLVVMELMAHGDLKS--YLRSLRPEAENNPGRPPPTLQEMIQMAAE 138
Query: 290 AAQGLTFLHEEGPFQAMYNEFSTANIQIDKDFSAKLSGYGCAGHIPETD 338
A G+ +L+ + + ++ + N + DF+ K+ +G I ETD
Sbjct: 139 IADGMAYLNAK---KFVHRNLAARNCMVAHDFTVKIGDFGMTRDIYETD 184
>pdb|3EKK|A Chain A, Insulin Receptor Kinase Complexed With An Inhibitor
pdb|3EKN|A Chain A, Insulin Receptor Kinase Complexed With An Inhibitor
Length = 307
Score = 37.0 bits (84), Expect = 0.020, Method: Compositional matrix adjust.
Identities = 35/169 (20%), Positives = 72/169 (42%), Gaps = 18/169 (10%)
Query: 181 RCISEGLSSVMYRASFGDDASTSKKFEATVTRLNPSSQGVK--EFINDVNTLASLQHPNL 238
R + +G ++Y + D + V +N S+ + EF+N+ + + ++
Sbjct: 24 RELGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERIEFLNEASVMKGFTCHHV 83
Query: 239 CKLLGFHARDGSDQRMLIYERLFHGSLDRLIYGRS---------DGPPIDWNTRVKIALC 289
+LLG ++ +++ E + HG L Y RS PP +++A
Sbjct: 84 VRLLGVVSK--GQPTLVVMELMAHGDLKS--YLRSLRPEAENNPGRPPPTLQEMIQMAAE 139
Query: 290 AAQGLTFLHEEGPFQAMYNEFSTANIQIDKDFSAKLSGYGCAGHIPETD 338
A G+ +L+ + + ++ + N + DF+ K+ +G I ETD
Sbjct: 140 IADGMAYLNAK---KFVHRNLAARNCMVAHDFTVKIGDFGMTRDIYETD 185
>pdb|2IVT|A Chain A, Crystal Structure Of Phosphorylated Ret Tyrosine Kinase
Domain
pdb|2IVU|A Chain A, Crystal Structure Of Phosphorylated Ret Tyrosine Kinase
Domain Complexed With The Inhibitor Zd6474
pdb|2X2K|A Chain A, Crystal Structure Of Phosphorylated Ret Tyrosine Kinase
Domain With Inhibitor
pdb|2X2L|A Chain A, Crystal Structure Of Phosphorylated Ret Tyrosine Kinase
Domain With Inhibitor
pdb|2X2M|A Chain A, Crystal Structure Of Phosphorylated Ret Tyrosine Kinase
Domain With Inhibitor
pdb|2X2M|B Chain B, Crystal Structure Of Phosphorylated Ret Tyrosine Kinase
Domain With Inhibitor
Length = 314
Score = 36.6 bits (83), Expect = 0.024, Method: Compositional matrix adjust.
Identities = 32/146 (21%), Positives = 62/146 (42%), Gaps = 26/146 (17%)
Query: 214 NPSSQGVKEFINDVNTLASLQHPNLCKLLGFHARDGSDQRMLIYERLFHGSLDRLIY-GR 272
N S +++ +++ N L + HP++ KL G ++DG +LI E +GSL + R
Sbjct: 64 NASPSELRDLLSEFNVLKQVNHPHVIKLYGACSQDGP--LLLIVEYAKYGSLRGFLRESR 121
Query: 273 SDGP--------------------PIDWNTRVKIALCAAQGLTFLHEEGPFQAMYNEFST 312
GP + + A +QG+ +L E + ++ + +
Sbjct: 122 KVGPGYLGSGGSRNSSSLDHPDERALTMGDLISFAWQISQGMQYLAE---MKLVHRDLAA 178
Query: 313 ANIQIDKDFSAKLSGYGCAGHIPETD 338
NI + + K+S +G + + E D
Sbjct: 179 RNILVAEGRKMKISDFGLSRDVYEED 204
>pdb|2IVS|A Chain A, Crystal Structure Of Non-Phosphorylated Ret Tyrosine
Kinase Domain
pdb|2IVS|B Chain B, Crystal Structure Of Non-Phosphorylated Ret Tyrosine
Kinase Domain
Length = 314
Score = 36.6 bits (83), Expect = 0.026, Method: Compositional matrix adjust.
Identities = 32/146 (21%), Positives = 62/146 (42%), Gaps = 26/146 (17%)
Query: 214 NPSSQGVKEFINDVNTLASLQHPNLCKLLGFHARDGSDQRMLIYERLFHGSLDRLIY-GR 272
N S +++ +++ N L + HP++ KL G ++DG +LI E +GSL + R
Sbjct: 64 NASPSELRDLLSEFNVLKQVNHPHVIKLYGACSQDGP--LLLIVEYAKYGSLRGFLRESR 121
Query: 273 SDGP--------------------PIDWNTRVKIALCAAQGLTFLHEEGPFQAMYNEFST 312
GP + + A +QG+ +L E + ++ + +
Sbjct: 122 KVGPGYLGSGGSRNSSSLDHPDERALTMGDLISFAWQISQGMQYLAE---MKLVHRDLAA 178
Query: 313 ANIQIDKDFSAKLSGYGCAGHIPETD 338
NI + + K+S +G + + E D
Sbjct: 179 RNILVAEGRKMKISDFGLSRDVYEED 204
>pdb|3Q4T|A Chain A, Crystal Structure Of Activin Receptor Type-Iia (Acvr2a)
Kinase Domain In Complex With Dorsomorphin
pdb|3Q4T|B Chain B, Crystal Structure Of Activin Receptor Type-Iia (Acvr2a)
Kinase Domain In Complex With Dorsomorphin
pdb|3SOC|A Chain A, Crystal Structure Of Activin Receptor Type-Iia (Acvr2a)
Kinase Domain In Complex With A Quinazolin
pdb|3SOC|B Chain B, Crystal Structure Of Activin Receptor Type-Iia (Acvr2a)
Kinase Domain In Complex With A Quinazolin
pdb|4ASX|A Chain A, Crystal Structure Of Activin Receptor Type-Iia (Acvr2a)
Kinase Domain In Complex With Dihydro-Bauerine C
pdb|4ASX|B Chain B, Crystal Structure Of Activin Receptor Type-Iia (Acvr2a)
Kinase Domain In Complex With Dihydro-Bauerine C
Length = 322
Score = 36.2 bits (82), Expect = 0.028, Method: Compositional matrix adjust.
Identities = 28/115 (24%), Positives = 50/115 (43%), Gaps = 13/115 (11%)
Query: 226 DVNTLASLQHPNLCKLLGFHARDGSDQRMLIYERLFH--GSLDRLIYGRSDGPPIDWNTR 283
+V +L ++H N+ + +G R S L FH GSL + + WN
Sbjct: 68 EVYSLPGMKHENILQFIGAEKRGTSVDVDLWLITAFHEKGSLSDFLKANV----VSWNEL 123
Query: 284 VKIALCAAQGLTFLHEEGPF-------QAMYNEFSTANIQIDKDFSAKLSGYGCA 331
IA A+GL +LHE+ P + + + N+ + + +A ++ +G A
Sbjct: 124 CHIAETMARGLAYLHEDIPGLKDGHKPAISHRDIKSKNVLLKNNLTACIADFGLA 178
>pdb|2IVV|A Chain A, Crystal Structure Of Phosphorylated Ret Tyrosine Kinase
Domain Complexed With The Inhibitor Pp1
Length = 314
Score = 35.8 bits (81), Expect = 0.041, Method: Compositional matrix adjust.
Identities = 32/146 (21%), Positives = 61/146 (41%), Gaps = 26/146 (17%)
Query: 214 NPSSQGVKEFINDVNTLASLQHPNLCKLLGFHARDGSDQRMLIYERLFHGSLDRLIY-GR 272
N S +++ +++ N L + HP++ KL G ++DG +LI E +GSL + R
Sbjct: 64 NASPSELRDLLSEFNVLKQVNHPHVIKLYGACSQDGP--LLLIVEYAKYGSLRGFLRESR 121
Query: 273 SDGP--------------------PIDWNTRVKIALCAAQGLTFLHEEGPFQAMYNEFST 312
GP + + A +QG+ +L E ++ + +
Sbjct: 122 KVGPGYLGSGGSRNSSSLDHPDERALTMGDLISFAWQISQGMQYLAE---MSLVHRDLAA 178
Query: 313 ANIQIDKDFSAKLSGYGCAGHIPETD 338
NI + + K+S +G + + E D
Sbjct: 179 RNILVAEGRKMKISDFGLSRDVYEED 204
>pdb|4BC6|A Chain A, Crystal Structure Of Human Serine Threonine Kinase-10
Bound To Novel Bosutinib Isoform 1, Previously Thought
To Be Bosutinib
Length = 293
Score = 35.8 bits (81), Expect = 0.043, Method: Compositional matrix adjust.
Identities = 26/120 (21%), Positives = 57/120 (47%), Gaps = 13/120 (10%)
Query: 216 SSQGVKEFINDVNTLASLQHPNLCKLLGFHARDGSDQRMLIYERLFHGSLDRLIYGRSDG 275
S + ++++I ++ LA+ HP + KLLG + DG + ++ E G++D ++ G
Sbjct: 48 SEEELEDYIVEIEILATCDHPYIVKLLGAYYHDG--KLWIMIEFCPGGAVDAIMLELDRG 105
Query: 276 ---PPIDWNTRVKIALCAAQGLTFLHEEGPFQAMYNEFSTANIQIDKDFSAKLSGYGCAG 332
P I R + + L FLH + + ++ + N+ + + +L+ +G +
Sbjct: 106 LTEPQIQVVCRQML-----EALNFLHSK---RIIHRDLKAGNVLMTLEGDIRLADFGVSA 157
>pdb|2J7T|A Chain A, Crystal Structure Of Human Serine Threonine Kinase-10
Bound To Su11274
pdb|4AOT|A Chain A, Crystal Structure Of Human Serine Threonine Kinase-10
(Lok) Bound To Gw830263a
pdb|4AOT|B Chain B, Crystal Structure Of Human Serine Threonine Kinase-10
(Lok) Bound To Gw830263a
pdb|4EQU|A Chain A, Human Stk-10 (Lok) Kinase Domain In Dfg-Out Conformation
With Inhibitor Dsa-7
pdb|4EQU|B Chain B, Human Stk-10 (Lok) Kinase Domain In Dfg-Out Conformation
With Inhibitor Dsa-7
Length = 302
Score = 35.4 bits (80), Expect = 0.044, Method: Compositional matrix adjust.
Identities = 26/120 (21%), Positives = 57/120 (47%), Gaps = 13/120 (10%)
Query: 216 SSQGVKEFINDVNTLASLQHPNLCKLLGFHARDGSDQRMLIYERLFHGSLDRLIYGRSDG 275
S + ++++I ++ LA+ HP + KLLG + DG + ++ E G++D ++ G
Sbjct: 56 SEEELEDYIVEIEILATCDHPYIVKLLGAYYHDG--KLWIMIEFCPGGAVDAIMLELDRG 113
Query: 276 ---PPIDWNTRVKIALCAAQGLTFLHEEGPFQAMYNEFSTANIQIDKDFSAKLSGYGCAG 332
P I R + + L FLH + + ++ + N+ + + +L+ +G +
Sbjct: 114 LTEPQIQVVCRQML-----EALNFLHSK---RIIHRDLKAGNVLMTLEGDIRLADFGVSA 165
>pdb|2VWU|A Chain A, Ephb4 Kinase Domain Inhibitor Complex
pdb|2VWV|A Chain A, Ephb4 Kinase Domain Inhibitor Complex
pdb|2VWW|A Chain A, Ephb4 Kinase Domain Inhibitor Complex
pdb|2VWX|A Chain A, Ephb4 Kinase Domain Inhibitor Complex
pdb|2VWY|A Chain A, Ephb4 Kinase Domain Inhibitor Complex
pdb|2VWZ|A Chain A, Ephb4 Kinase Domain Inhibitor Complex
pdb|2VX0|A Chain A, Ephb4 Kinase Domain Inhibitor Complex
pdb|2VX1|A Chain A, Ephb4 Kinase Domain Inhibitor Complex
pdb|2X9F|A Chain A, Ephb4 Kinase Domain Inhibitor Complex
pdb|2XVD|A Chain A, Ephb4 Kinase Domain Inhibitor Complex
pdb|4BB4|A Chain A, Ephb4 Kinase Domain Inhibitor Complex
Length = 302
Score = 35.4 bits (80), Expect = 0.052, Method: Compositional matrix adjust.
Identities = 25/117 (21%), Positives = 55/117 (47%), Gaps = 7/117 (5%)
Query: 221 KEFINDVNTLASLQHPNLCKLLGFHARDGSDQRMLIYERLFHGSLDRLIYGRSDGPPIDW 280
+EF+++ + + +HPN+ +L G S M++ E + +G+LD + R +
Sbjct: 62 REFLSEASIMGQFEHPNIIRLEGVVT--NSMPVMILTEFMENGALDSFL--RLNDGQFTV 117
Query: 281 NTRVKIALCAAQGLTFLHEEGPFQAMYNEFSTANIQIDKDFSAKLSGYGCAGHIPET 337
V + A G+ +L E ++ + + NI ++ + K+S +G + + E
Sbjct: 118 IQLVGMLRGIASGMRYLAE---MSYVHRDLAARNILVNSNLVCKVSDFGLSRFLEEN 171
>pdb|1U54|A Chain A, Crystal Structures Of The Phosphorylated And
Unphosphorylated Kinase Domains Of The Cdc42-Associated
Tyrosine Kinase Ack1 Bound To Amp-Pcp
Length = 291
Score = 35.4 bits (80), Expect = 0.055, Method: Compositional matrix adjust.
Identities = 38/161 (23%), Positives = 69/161 (42%), Gaps = 16/161 (9%)
Query: 183 ISEGLSSVMYRASFGDDASTSKKFEATVTRLNPSS----QGVKEFINDVNTLASLQHPNL 238
+ +G V+ R + DA + K V L P + + +FI +VN + SL H NL
Sbjct: 26 LGDGSFGVVRRGEW--DAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNL 83
Query: 239 CKLLGFHARDGSDQRMLIYERLFHGS-LDRLIYGRSDGPPIDWNTRVKIALCAAQGLTFL 297
+L G + ++ E GS LDRL R T + A+ A+G+ +L
Sbjct: 84 IRLYGVVL---TPPMKMVTELAPLGSLLDRL---RKHQGHFLLGTLSRYAVQVAEGMGYL 137
Query: 298 HEEGPFQAMYNEFSTANIQIDKDFSAKLSGYGCAGHIPETD 338
+ + ++ + + N+ + K+ +G +P+ D
Sbjct: 138 ESK---RFIHRDLAARNLLLATRDLVKIGDFGLMRALPQND 175
>pdb|4AW5|A Chain A, Complex Of The Ephb4 Kinase Domain With An Oxindole
Inhibitor
Length = 291
Score = 35.4 bits (80), Expect = 0.055, Method: Compositional matrix adjust.
Identities = 25/117 (21%), Positives = 55/117 (47%), Gaps = 7/117 (5%)
Query: 221 KEFINDVNTLASLQHPNLCKLLGFHARDGSDQRMLIYERLFHGSLDRLIYGRSDGPPIDW 280
+EF+++ + + +HPN+ +L G S M++ E + +G+LD + R +
Sbjct: 60 REFLSEASIMGQFEHPNIIRLEGVVT--NSMPVMILTEFMENGALDSFL--RLNDGQFTV 115
Query: 281 NTRVKIALCAAQGLTFLHEEGPFQAMYNEFSTANIQIDKDFSAKLSGYGCAGHIPET 337
V + A G+ +L E ++ + + NI ++ + K+S +G + + E
Sbjct: 116 IQLVGMLRGIASGMRYLAE---MSYVHRDLAARNILVNSNLVCKVSDFGLSRFLEEN 169
>pdb|1U46|A Chain A, Crystal Structure Of The Unphosphorylated Kinase Domain Of
The Tyrosine Kinase Ack1
pdb|1U46|B Chain B, Crystal Structure Of The Unphosphorylated Kinase Domain Of
The Tyrosine Kinase Ack1
pdb|1U4D|A Chain A, Structure Of The Ack1 Kinase Domain Bound To
Debromohymenialdisine
pdb|1U4D|B Chain B, Structure Of The Ack1 Kinase Domain Bound To
Debromohymenialdisine
pdb|1U54|B Chain B, Crystal Structures Of The Phosphorylated And
Unphosphorylated Kinase Domains Of The Cdc42-Associated
Tyrosine Kinase Ack1 Bound To Amp-Pcp
Length = 291
Score = 35.0 bits (79), Expect = 0.058, Method: Compositional matrix adjust.
Identities = 38/161 (23%), Positives = 69/161 (42%), Gaps = 16/161 (9%)
Query: 183 ISEGLSSVMYRASFGDDASTSKKFEATVTRLNPSS----QGVKEFINDVNTLASLQHPNL 238
+ +G V+ R + DA + K V L P + + +FI +VN + SL H NL
Sbjct: 26 LGDGSFGVVRRGEW--DAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNL 83
Query: 239 CKLLGFHARDGSDQRMLIYERLFHGS-LDRLIYGRSDGPPIDWNTRVKIALCAAQGLTFL 297
+L G + ++ E GS LDRL R T + A+ A+G+ +L
Sbjct: 84 IRLYGVVL---TPPMKMVTELAPLGSLLDRL---RKHQGHFLLGTLSRYAVQVAEGMGYL 137
Query: 298 HEEGPFQAMYNEFSTANIQIDKDFSAKLSGYGCAGHIPETD 338
+ + ++ + + N+ + K+ +G +P+ D
Sbjct: 138 ESK---RFIHRDLAARNLLLATRDLVKIGDFGLMRALPQND 175
>pdb|4EWH|B Chain B, Co-Crystal Structure Of Ack1 With Inhibitor
pdb|4EWH|A Chain A, Co-Crystal Structure Of Ack1 With Inhibitor
Length = 275
Score = 35.0 bits (79), Expect = 0.063, Method: Compositional matrix adjust.
Identities = 38/161 (23%), Positives = 69/161 (42%), Gaps = 16/161 (9%)
Query: 183 ISEGLSSVMYRASFGDDASTSKKFEATVTRLNPSS----QGVKEFINDVNTLASLQHPNL 238
+ +G V+ R + DA + K V L P + + +FI +VN + SL H NL
Sbjct: 16 LGDGSFGVVRRGEW--DAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNL 73
Query: 239 CKLLGFHARDGSDQRMLIYERLFHGS-LDRLIYGRSDGPPIDWNTRVKIALCAAQGLTFL 297
+L G + ++ E GS LDRL R T + A+ A+G+ +L
Sbjct: 74 IRLYGVVL---TPPMKMVTELAPLGSLLDRL---RKHQGHFLLGTLSRYAVQVAEGMGYL 127
Query: 298 HEEGPFQAMYNEFSTANIQIDKDFSAKLSGYGCAGHIPETD 338
+ + ++ + + N+ + K+ +G +P+ D
Sbjct: 128 ESK---RFIHRDLAARNLLLATRDLVKIGDFGLMRALPQND 165
>pdb|4HZS|A Chain A, Crystal Structure Of Ack1 Kinase Domain With C-terminal
Sh3 Domain
pdb|4HZS|B Chain B, Crystal Structure Of Ack1 Kinase Domain With C-terminal
Sh3 Domain
pdb|4HZS|C Chain C, Crystal Structure Of Ack1 Kinase Domain With C-terminal
Sh3 Domain
pdb|4HZS|D Chain D, Crystal Structure Of Ack1 Kinase Domain With C-terminal
Sh3 Domain
Length = 341
Score = 35.0 bits (79), Expect = 0.068, Method: Compositional matrix adjust.
Identities = 38/161 (23%), Positives = 69/161 (42%), Gaps = 16/161 (9%)
Query: 183 ISEGLSSVMYRASFGDDASTSKKFEATVTRLNPSS----QGVKEFINDVNTLASLQHPNL 238
+ +G V+ R + DA + K V L P + + +FI +VN + SL H NL
Sbjct: 20 LGDGSFGVVRRGEW--DAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNL 77
Query: 239 CKLLGFHARDGSDQRMLIYERLFHGS-LDRLIYGRSDGPPIDWNTRVKIALCAAQGLTFL 297
+L G + ++ E GS LDRL R T + A+ A+G+ +L
Sbjct: 78 IRLYGVVL---TPPMKMVTELAPLGSLLDRL---RKHQGHFLLGTLSRYAVQVAEGMGYL 131
Query: 298 HEEGPFQAMYNEFSTANIQIDKDFSAKLSGYGCAGHIPETD 338
+ + ++ + + N+ + K+ +G +P+ D
Sbjct: 132 ESK---RFIHRDLAARNLLLATRDLVKIGDFGLMRALPQND 169
>pdb|4HZR|A Chain A, Crystal Structure Of Ack1 Kinase Domain
pdb|4HZR|B Chain B, Crystal Structure Of Ack1 Kinase Domain
Length = 277
Score = 35.0 bits (79), Expect = 0.072, Method: Compositional matrix adjust.
Identities = 38/161 (23%), Positives = 69/161 (42%), Gaps = 16/161 (9%)
Query: 183 ISEGLSSVMYRASFGDDASTSKKFEATVTRLNPSS----QGVKEFINDVNTLASLQHPNL 238
+ +G V+ R + DA + K V L P + + +FI +VN + SL H NL
Sbjct: 20 LGDGSFGVVRRGEW--DAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNL 77
Query: 239 CKLLGFHARDGSDQRMLIYERLFHGS-LDRLIYGRSDGPPIDWNTRVKIALCAAQGLTFL 297
+L G + ++ E GS LDRL R T + A+ A+G+ +L
Sbjct: 78 IRLYGVVL---TPPMKMVTELAPLGSLLDRL---RKHQGHFLLGTLSRYAVQVAEGMGYL 131
Query: 298 HEEGPFQAMYNEFSTANIQIDKDFSAKLSGYGCAGHIPETD 338
+ + ++ + + N+ + K+ +G +P+ D
Sbjct: 132 ESK---RFIHRDLAARNLLLATRDLVKIGDFGLMRALPQND 169
>pdb|3EQP|B Chain B, Crystal Structure Of Ack1 With Compound T95
pdb|3EQP|A Chain A, Crystal Structure Of Ack1 With Compound T95
pdb|3EQR|A Chain A, Crystal Structure Of Ack1 With Compound T74
pdb|3EQR|B Chain B, Crystal Structure Of Ack1 With Compound T74
Length = 276
Score = 35.0 bits (79), Expect = 0.073, Method: Compositional matrix adjust.
Identities = 38/161 (23%), Positives = 69/161 (42%), Gaps = 16/161 (9%)
Query: 183 ISEGLSSVMYRASFGDDASTSKKFEATVTRLNPSS----QGVKEFINDVNTLASLQHPNL 238
+ +G V+ R + DA + K V L P + + +FI +VN + SL H NL
Sbjct: 16 LGDGSFGVVRRGEW--DAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNL 73
Query: 239 CKLLGFHARDGSDQRMLIYERLFHGS-LDRLIYGRSDGPPIDWNTRVKIALCAAQGLTFL 297
+L G + ++ E GS LDRL R T + A+ A+G+ +L
Sbjct: 74 IRLYGVVL---TPPMKMVTELAPLGSLLDRL---RKHQGHFLLGTLSRYAVQVAEGMGYL 127
Query: 298 HEEGPFQAMYNEFSTANIQIDKDFSAKLSGYGCAGHIPETD 338
+ + ++ + + N+ + K+ +G +P+ D
Sbjct: 128 ESK---RFIHRDLAARNLLLATRDLVKIGDFGLMRALPQND 165
>pdb|4ID7|A Chain A, Ack1 Kinase In Complex With The Inhibitor
Cis-3-[8-amino-1-(4-
Phenoxyphenyl)imidazo[1,5-a]pyrazin-3-yl]cyclobutanol
Length = 273
Score = 35.0 bits (79), Expect = 0.074, Method: Compositional matrix adjust.
Identities = 38/161 (23%), Positives = 69/161 (42%), Gaps = 16/161 (9%)
Query: 183 ISEGLSSVMYRASFGDDASTSKKFEATVTRLNPSS----QGVKEFINDVNTLASLQHPNL 238
+ +G V+ R + DA + K V L P + + +FI +VN + SL H NL
Sbjct: 16 LGDGSFGVVRRGEW--DAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNL 73
Query: 239 CKLLGFHARDGSDQRMLIYERLFHGS-LDRLIYGRSDGPPIDWNTRVKIALCAAQGLTFL 297
+L G + ++ E GS LDRL R T + A+ A+G+ +L
Sbjct: 74 IRLYGVVL---TPPMKMVTELAPLGSLLDRL---RKHQGHFLLGTLSRYAVQVAEGMGYL 127
Query: 298 HEEGPFQAMYNEFSTANIQIDKDFSAKLSGYGCAGHIPETD 338
+ + ++ + + N+ + K+ +G +P+ D
Sbjct: 128 ESK---RFIHRDLAARNLLLATRDLVKIGDFGLMRALPQND 165
>pdb|1K3A|A Chain A, Structure Of The Insulin-Like Growth Factor 1 Receptor
Kinase
Length = 299
Score = 34.7 bits (78), Expect = 0.080, Method: Compositional matrix adjust.
Identities = 28/126 (22%), Positives = 58/126 (46%), Gaps = 16/126 (12%)
Query: 222 EFINDVNTLASLQHPNLCKLLGFHARDGSDQRMLIYERLFHGSLDRLIYGRSDGPPIDWN 281
EF+N+ + + ++ +LLG ++ ++I E + G L Y RS P ++ N
Sbjct: 59 EFLNEASVMKEFNCHHVVRLLGVVSQ--GQPTLVIMELMTRGDLKS--YLRSLRPEMENN 114
Query: 282 ---------TRVKIALCAAQGLTFLHEEGPFQAMYNEFSTANIQIDKDFSAKLSGYGCAG 332
+++A A G+ +L+ + ++ + + N + +DF+ K+ +G
Sbjct: 115 PVLAPPSLSKMIQMAGEIADGMAYLNAN---KFVHRDLAARNCMVAEDFTVKIGDFGMTR 171
Query: 333 HIPETD 338
I ETD
Sbjct: 172 DIXETD 177
>pdb|2ZM3|A Chain A, Complex Structure Of Insulin-Like Growth Factor Receptor
And Isoquinolinedione Inhibitor
pdb|2ZM3|B Chain B, Complex Structure Of Insulin-Like Growth Factor Receptor
And Isoquinolinedione Inhibitor
pdb|2ZM3|C Chain C, Complex Structure Of Insulin-Like Growth Factor Receptor
And Isoquinolinedione Inhibitor
pdb|2ZM3|D Chain D, Complex Structure Of Insulin-Like Growth Factor Receptor
And Isoquinolinedione Inhibitor
pdb|3F5P|A Chain A, Complex Structure Of Insulin-Like Growth Factor Receptor
And 3- Cyanoquinoline Inhibitor
pdb|3F5P|B Chain B, Complex Structure Of Insulin-Like Growth Factor Receptor
And 3- Cyanoquinoline Inhibitor
pdb|3F5P|C Chain C, Complex Structure Of Insulin-Like Growth Factor Receptor
And 3- Cyanoquinoline Inhibitor
pdb|3F5P|D Chain D, Complex Structure Of Insulin-Like Growth Factor Receptor
And 3- Cyanoquinoline Inhibitor
pdb|3F5P|E Chain E, Complex Structure Of Insulin-Like Growth Factor Receptor
And 3- Cyanoquinoline Inhibitor
pdb|3F5P|F Chain F, Complex Structure Of Insulin-Like Growth Factor Receptor
And 3- Cyanoquinoline Inhibitor
pdb|3F5P|G Chain G, Complex Structure Of Insulin-Like Growth Factor Receptor
And 3- Cyanoquinoline Inhibitor
pdb|3F5P|H Chain H, Complex Structure Of Insulin-Like Growth Factor Receptor
And 3- Cyanoquinoline Inhibitor
pdb|3F5P|I Chain I, Complex Structure Of Insulin-Like Growth Factor Receptor
And 3- Cyanoquinoline Inhibitor
pdb|3F5P|J Chain J, Complex Structure Of Insulin-Like Growth Factor Receptor
And 3- Cyanoquinoline Inhibitor
pdb|3F5P|K Chain K, Complex Structure Of Insulin-Like Growth Factor Receptor
And 3- Cyanoquinoline Inhibitor
pdb|3F5P|M Chain M, Complex Structure Of Insulin-Like Growth Factor Receptor
And 3- Cyanoquinoline Inhibitor
pdb|3F5P|L Chain L, Complex Structure Of Insulin-Like Growth Factor Receptor
And 3- Cyanoquinoline Inhibitor
pdb|3F5P|R Chain R, Complex Structure Of Insulin-Like Growth Factor Receptor
And 3- Cyanoquinoline Inhibitor
pdb|3F5P|S Chain S, Complex Structure Of Insulin-Like Growth Factor Receptor
And 3- Cyanoquinoline Inhibitor
pdb|3F5P|T Chain T, Complex Structure Of Insulin-Like Growth Factor Receptor
And 3- Cyanoquinoline Inhibitor
Length = 308
Score = 34.7 bits (78), Expect = 0.080, Method: Compositional matrix adjust.
Identities = 28/126 (22%), Positives = 58/126 (46%), Gaps = 16/126 (12%)
Query: 222 EFINDVNTLASLQHPNLCKLLGFHARDGSDQRMLIYERLFHGSLDRLIYGRSDGPPIDWN 281
EF+N+ + + ++ +LLG ++ ++I E + G L Y RS P ++ N
Sbjct: 68 EFLNEASVMKEFNCHHVVRLLGVVSQ--GQPTLVIMELMTRGDLKS--YLRSLRPEMENN 123
Query: 282 ---------TRVKIALCAAQGLTFLHEEGPFQAMYNEFSTANIQIDKDFSAKLSGYGCAG 332
+++A A G+ +L+ + ++ + + N + +DF+ K+ +G
Sbjct: 124 PVLAPPSLSKMIQMAGEIADGMAYLNAN---KFVHRDLAARNCMVAEDFTVKIGDFGMTR 180
Query: 333 HIPETD 338
I ETD
Sbjct: 181 DIXETD 186
>pdb|3Q96|A Chain A, B-Raf Kinase Domain In Complex With A
Tetrahydronaphthalene Inhibitor
pdb|3Q96|B Chain B, B-Raf Kinase Domain In Complex With A
Tetrahydronaphthalene Inhibitor
Length = 282
Score = 34.3 bits (77), Expect = 0.10, Method: Compositional matrix adjust.
Identities = 36/158 (22%), Positives = 67/158 (42%), Gaps = 14/158 (8%)
Query: 180 DRCISEGLSSVMYR---ASFGDDASTSKKFEATVTRLN---PSSQGVKEFINDVNTLASL 233
D I +G +V R SFG + V LN P+ Q ++ F N+V L
Sbjct: 4 DWEIPDGQITVGQRIGSGSFGTVYKGKWHGDVAVKMLNVTAPTPQQLQAFKNEVGVLRKT 63
Query: 234 QHPNLCKLLGFHARDGSDQRMLIYERLFHGSLDRLIYGRSDGPPIDWNTRVKIALCAAQG 293
+H N+ +G+ + Q ++ + SL ++ + + IA AQG
Sbjct: 64 RHVNILLFMGYSTK---PQLAIVTQWCEGSSLYHHLHIIE--TKFEMIKLIDIARQTAQG 118
Query: 294 LTFLHEEGPFQAMYNEFSTANIQIDKDFSAKLSGYGCA 331
+ +LH + ++ + + NI + +D + K+ +G A
Sbjct: 119 MDYLHAKS---IIHRDLKSNNIFLHEDLTVKIGDFGLA 153
>pdb|4DBN|A Chain A, Crystal Structure Of The Kinase Domain Of Human B-Raf With
A [1, 3]thiazolo[5,4-B]pyridine Derivative
pdb|4DBN|B Chain B, Crystal Structure Of The Kinase Domain Of Human B-Raf With
A [1, 3]thiazolo[5,4-B]pyridine Derivative
Length = 284
Score = 34.3 bits (77), Expect = 0.11, Method: Compositional matrix adjust.
Identities = 36/158 (22%), Positives = 67/158 (42%), Gaps = 14/158 (8%)
Query: 180 DRCISEGLSSVMYR---ASFGDDASTSKKFEATVTRLN---PSSQGVKEFINDVNTLASL 233
D I +G +V R SFG + V LN P+ Q ++ F N+V L
Sbjct: 7 DWEIPDGQITVGQRIGSGSFGTVYKGKWHGDVAVKMLNVTAPTPQQLQAFKNEVGVLRKT 66
Query: 234 QHPNLCKLLGFHARDGSDQRMLIYERLFHGSLDRLIYGRSDGPPIDWNTRVKIALCAAQG 293
+H N+ +G+ + Q ++ + SL ++ + + IA AQG
Sbjct: 67 RHVNILLFMGYSTK---PQLAIVTQWCEGSSLYHHLHIIE--TKFEMIKLIDIARQTAQG 121
Query: 294 LTFLHEEGPFQAMYNEFSTANIQIDKDFSAKLSGYGCA 331
+ +LH + ++ + + NI + +D + K+ +G A
Sbjct: 122 MDYLHAKS---IIHRDLKSNNIFLHEDLTVKIGDFGLA 156
>pdb|1UWJ|A Chain A, The Complex Of Mutant V599e B-raf And Bay439006
pdb|1UWJ|B Chain B, The Complex Of Mutant V599e B-raf And Bay439006
Length = 276
Score = 34.3 bits (77), Expect = 0.11, Method: Compositional matrix adjust.
Identities = 36/158 (22%), Positives = 67/158 (42%), Gaps = 14/158 (8%)
Query: 180 DRCISEGLSSVMYR---ASFGDDASTSKKFEATVTRLN---PSSQGVKEFINDVNTLASL 233
D I +G +V R SFG + V LN P+ Q ++ F N+V L
Sbjct: 2 DWEIPDGQITVGQRIGSGSFGTVYKGKWHGDVAVKMLNVTAPTPQQLQAFKNEVGVLRKT 61
Query: 234 QHPNLCKLLGFHARDGSDQRMLIYERLFHGSLDRLIYGRSDGPPIDWNTRVKIALCAAQG 293
+H N+ +G+ + Q ++ + SL ++ + + IA AQG
Sbjct: 62 RHVNILLFMGYSTK---PQLAIVTQWCEGSSLYHHLHIIE--TKFEMIKLIDIARQTAQG 116
Query: 294 LTFLHEEGPFQAMYNEFSTANIQIDKDFSAKLSGYGCA 331
+ +LH + ++ + + NI + +D + K+ +G A
Sbjct: 117 MDYLHAKS---IIHRDLKSNNIFLHEDLTVKIGDFGLA 151
>pdb|4H58|A Chain A, Braf In Complex With Compound 3
pdb|4H58|B Chain B, Braf In Complex With Compound 3
pdb|4H58|C Chain C, Braf In Complex With Compound 3
Length = 275
Score = 34.3 bits (77), Expect = 0.12, Method: Compositional matrix adjust.
Identities = 36/158 (22%), Positives = 67/158 (42%), Gaps = 14/158 (8%)
Query: 180 DRCISEGLSSVMYR---ASFGDDASTSKKFEATVTRLN---PSSQGVKEFINDVNTLASL 233
D I +G +V R SFG + V LN P+ Q ++ F N+V L
Sbjct: 2 DWEIPDGQITVGQRIGSGSFGTVYKGKWHGDVAVKMLNVTAPTPQQLQAFKNEVGVLRKT 61
Query: 234 QHPNLCKLLGFHARDGSDQRMLIYERLFHGSLDRLIYGRSDGPPIDWNTRVKIALCAAQG 293
+H N+ +G+ + Q ++ + SL ++ + + IA AQG
Sbjct: 62 RHVNILLFMGYSTK---PQLAIVTQWCEGSSLYHHLHIIE--TKFEMIKLIDIARQTAQG 116
Query: 294 LTFLHEEGPFQAMYNEFSTANIQIDKDFSAKLSGYGCA 331
+ +LH + ++ + + NI + +D + K+ +G A
Sbjct: 117 MDYLHAKS---IIHRDLKSNNIFLHEDLTVKIGDFGLA 151
>pdb|3OY3|A Chain A, Crystal Structure Of Abl T315i Mutant Kinase Domain Bound
With A Dfg- Out Inhibitor Ap24589
pdb|3OY3|B Chain B, Crystal Structure Of Abl T315i Mutant Kinase Domain Bound
With A Dfg- Out Inhibitor Ap24589
Length = 284
Score = 34.3 bits (77), Expect = 0.12, Method: Compositional matrix adjust.
Identities = 16/47 (34%), Positives = 26/47 (55%), Gaps = 2/47 (4%)
Query: 204 KKFEATVT--RLNPSSQGVKEFINDVNTLASLQHPNLCKLLGFHARD 248
KK+ TV L + V+EF+ + + ++HPNL +LLG R+
Sbjct: 35 KKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEIKHPNLVQLLGVCTRE 81
>pdb|2FB8|A Chain A, Structure Of The B-Raf Kinase Domain Bound To Sb-590885
pdb|2FB8|B Chain B, Structure Of The B-Raf Kinase Domain Bound To Sb-590885
Length = 281
Score = 34.3 bits (77), Expect = 0.12, Method: Compositional matrix adjust.
Identities = 36/158 (22%), Positives = 67/158 (42%), Gaps = 14/158 (8%)
Query: 180 DRCISEGLSSVMYR---ASFGDDASTSKKFEATVTRLN---PSSQGVKEFINDVNTLASL 233
D I +G +V R SFG + V LN P+ Q ++ F N+V L
Sbjct: 7 DWEIPDGQITVGQRIGSGSFGTVYKGKWHGDVAVKMLNVTAPTPQQLQAFKNEVGVLRKT 66
Query: 234 QHPNLCKLLGFHARDGSDQRMLIYERLFHGSLDRLIYGRSDGPPIDWNTRVKIALCAAQG 293
+H N+ +G+ + Q ++ + SL ++ + + IA AQG
Sbjct: 67 RHVNILLFMGYSTK---PQLAIVTQWCEGSSLYHHLHIIE--TKFEMIKLIDIARQTAQG 121
Query: 294 LTFLHEEGPFQAMYNEFSTANIQIDKDFSAKLSGYGCA 331
+ +LH + ++ + + NI + +D + K+ +G A
Sbjct: 122 MDYLHAKS---IIHRDLKSNNIFLHEDLTVKIGDFGLA 156
>pdb|3DK7|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex
With Small Molecule Fragment
pdb|3DK7|B Chain B, Crystal Structure Of Mutant Abl Kinase Domain In Complex
With Small Molecule Fragment
Length = 277
Score = 34.3 bits (77), Expect = 0.12, Method: Compositional matrix adjust.
Identities = 16/47 (34%), Positives = 26/47 (55%), Gaps = 2/47 (4%)
Query: 204 KKFEATVT--RLNPSSQGVKEFINDVNTLASLQHPNLCKLLGFHARD 248
KK+ TV L + V+EF+ + + ++HPNL +LLG R+
Sbjct: 33 KKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEIKHPNLVQLLGVCTRE 79
>pdb|1FPU|A Chain A, Crystal Structure Of Abl Kinase Domain In Complex With A
Small Molecule Inhibitor
pdb|1FPU|B Chain B, Crystal Structure Of Abl Kinase Domain In Complex With A
Small Molecule Inhibitor
pdb|1IEP|A Chain A, Crystal Structure Of The C-Abl Kinase Domain In Complex
With Sti-571.
pdb|1IEP|B Chain B, Crystal Structure Of The C-Abl Kinase Domain In Complex
With Sti-571.
pdb|1M52|A Chain A, Crystal Structure Of The C-Abl Kinase Domain In Complex
With Pd173955
pdb|1M52|B Chain B, Crystal Structure Of The C-Abl Kinase Domain In Complex
With Pd173955
pdb|1OPJ|A Chain A, Structural Basis For The Auto-Inhibition Of C-Abl Tyrosine
Kinase
pdb|1OPJ|B Chain B, Structural Basis For The Auto-Inhibition Of C-Abl Tyrosine
Kinase
pdb|2HZN|A Chain A, Abl Kinase Domain In Complex With Nvp-Afg210
pdb|3K5V|A Chain A, Structure Of Abl Kinase In Complex With Imatinib And Gnf-2
pdb|3K5V|B Chain B, Structure Of Abl Kinase In Complex With Imatinib And Gnf-2
pdb|3MS9|A Chain A, Abl Kinase In Complex With Imatinib And A Fragment (Frag1)
I Myristate Pocket
pdb|3MS9|B Chain B, Abl Kinase In Complex With Imatinib And A Fragment (Frag1)
I Myristate Pocket
pdb|3MSS|A Chain A, Abl Kinase In Complex With Imatinib And Fragment (Frag2)
In The Myristate Site
pdb|3MSS|B Chain B, Abl Kinase In Complex With Imatinib And Fragment (Frag2)
In The Myristate Site
pdb|3MSS|C Chain C, Abl Kinase In Complex With Imatinib And Fragment (Frag2)
In The Myristate Site
pdb|3MSS|D Chain D, Abl Kinase In Complex With Imatinib And Fragment (Frag2)
In The Myristate Site
Length = 293
Score = 34.3 bits (77), Expect = 0.12, Method: Compositional matrix adjust.
Identities = 16/47 (34%), Positives = 26/47 (55%), Gaps = 2/47 (4%)
Query: 204 KKFEATVT--RLNPSSQGVKEFINDVNTLASLQHPNLCKLLGFHARD 248
KK+ TV L + V+EF+ + + ++HPNL +LLG R+
Sbjct: 40 KKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEIKHPNLVQLLGVCTRE 86
>pdb|3DK3|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex
With Small Molecule Fragment
pdb|3DK3|B Chain B, Crystal Structure Of Mutant Abl Kinase Domain In Complex
With Small Molecule Fragment
Length = 293
Score = 34.3 bits (77), Expect = 0.13, Method: Compositional matrix adjust.
Identities = 16/47 (34%), Positives = 26/47 (55%), Gaps = 2/47 (4%)
Query: 204 KKFEATVT--RLNPSSQGVKEFINDVNTLASLQHPNLCKLLGFHARD 248
KK+ TV L + V+EF+ + + ++HPNL +LLG R+
Sbjct: 33 KKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEIKHPNLVQLLGVCTRE 79
>pdb|3OXZ|A Chain A, Crystal Structure Of Abl Kinase Domain Bound With A
Dfg-Out Inhibitor Ap24534
Length = 284
Score = 34.3 bits (77), Expect = 0.13, Method: Compositional matrix adjust.
Identities = 16/47 (34%), Positives = 26/47 (55%), Gaps = 2/47 (4%)
Query: 204 KKFEATVT--RLNPSSQGVKEFINDVNTLASLQHPNLCKLLGFHARD 248
KK+ TV L + V+EF+ + + ++HPNL +LLG R+
Sbjct: 35 KKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEIKHPNLVQLLGVCTRE 81
>pdb|3DK6|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex
With Small Molecule Fragment
pdb|3DK6|B Chain B, Crystal Structure Of Mutant Abl Kinase Domain In Complex
With Small Molecule Fragment
Length = 293
Score = 34.3 bits (77), Expect = 0.13, Method: Compositional matrix adjust.
Identities = 16/47 (34%), Positives = 26/47 (55%), Gaps = 2/47 (4%)
Query: 204 KKFEATVT--RLNPSSQGVKEFINDVNTLASLQHPNLCKLLGFHARD 248
KK+ TV L + V+EF+ + + ++HPNL +LLG R+
Sbjct: 33 KKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEIKHPNLVQLLGVCTRE 79
>pdb|1M7N|A Chain A, Crystal Structure Of Unactivated Apo Insulin-Like Growth
Factor-1 Receptor Kinase Domain
pdb|1M7N|B Chain B, Crystal Structure Of Unactivated Apo Insulin-Like Growth
Factor-1 Receptor Kinase Domain
Length = 322
Score = 34.3 bits (77), Expect = 0.13, Method: Compositional matrix adjust.
Identities = 28/126 (22%), Positives = 58/126 (46%), Gaps = 16/126 (12%)
Query: 222 EFINDVNTLASLQHPNLCKLLGFHARDGSDQRMLIYERLFHGSLDRLIYGRSDGPPIDWN 281
EF+N+ + + ++ +LLG ++ ++I E + G L Y RS P ++ N
Sbjct: 74 EFLNEASVMKEFNCHHVVRLLGVVSQ--GQPTLVIMELMTRGDLKS--YLRSLRPEMENN 129
Query: 282 ---------TRVKIALCAAQGLTFLHEEGPFQAMYNEFSTANIQIDKDFSAKLSGYGCAG 332
+++A A G+ +L+ + ++ + + N + +DF+ K+ +G
Sbjct: 130 PVLAPPSLSKMIQMAGEIADGMAYLNAN---KFVHRDLAARNCMVAEDFTVKIGDFGMTR 186
Query: 333 HIPETD 338
I ETD
Sbjct: 187 DIYETD 192
>pdb|2Z60|A Chain A, Crystal Structure Of The T315i Mutant Of Abl Kinase Bound
With Ppy-A
pdb|3IK3|A Chain A, Ap24534, A Pan-Bcr-Abl Inhibitor For Chronic Myeloid
Leukemi Potently Inhibits The T315i Mutant And Overcomes
Mutation-B Resistance
pdb|3IK3|B Chain B, Ap24534, A Pan-Bcr-Abl Inhibitor For Chronic Myeloid
Leukemi Potently Inhibits The T315i Mutant And Overcomes
Mutation-B Resistance
Length = 288
Score = 33.9 bits (76), Expect = 0.13, Method: Compositional matrix adjust.
Identities = 16/47 (34%), Positives = 26/47 (55%), Gaps = 2/47 (4%)
Query: 204 KKFEATVT--RLNPSSQGVKEFINDVNTLASLQHPNLCKLLGFHARD 248
KK+ TV L + V+EF+ + + ++HPNL +LLG R+
Sbjct: 35 KKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEIKHPNLVQLLGVCTRE 81
>pdb|2F4J|A Chain A, Structure Of The Kinase Domain Of An Imatinib-Resistant
Abl Mutant In Complex With The Aurora Kinase Inhibitor
Vx-680
Length = 287
Score = 33.9 bits (76), Expect = 0.13, Method: Compositional matrix adjust.
Identities = 16/47 (34%), Positives = 26/47 (55%), Gaps = 2/47 (4%)
Query: 204 KKFEATVT--RLNPSSQGVKEFINDVNTLASLQHPNLCKLLGFHARD 248
KK+ TV L + V+EF+ + + ++HPNL +LLG R+
Sbjct: 36 KKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEIKHPNLVQLLGVCTRE 82
>pdb|2QOH|A Chain A, Crystal Structure Of Abl Kinase Bound With Ppy-a
pdb|2QOH|B Chain B, Crystal Structure Of Abl Kinase Bound With Ppy-a
pdb|3KF4|A Chain A, Structural Analysis Of Dfg-In And Dfg-Out Dual Src-Abl
Inhibitors Sharing A Common Vinyl Purine Template
pdb|3KF4|B Chain B, Structural Analysis Of Dfg-In And Dfg-Out Dual Src-Abl
Inhibitors Sharing A Common Vinyl Purine Template
pdb|3KFA|A Chain A, Structural Analysis Of Dfg-In And Dfg-Out Dual Src-Abl
Inhibitors Sharing A Common Vinyl Purine Template
pdb|3KFA|B Chain B, Structural Analysis Of Dfg-In And Dfg-Out Dual Src-Abl
Inhibitors Sharing A Common Vinyl Purine Template
Length = 288
Score = 33.9 bits (76), Expect = 0.13, Method: Compositional matrix adjust.
Identities = 16/47 (34%), Positives = 26/47 (55%), Gaps = 2/47 (4%)
Query: 204 KKFEATVT--RLNPSSQGVKEFINDVNTLASLQHPNLCKLLGFHARD 248
KK+ TV L + V+EF+ + + ++HPNL +LLG R+
Sbjct: 35 KKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEIKHPNLVQLLGVCTRE 81
>pdb|3O23|A Chain A, Human Unphosphorylated Igf1-R Kinase Domain In Complex
With An Hydantoin Inhibitor
Length = 305
Score = 33.9 bits (76), Expect = 0.13, Method: Compositional matrix adjust.
Identities = 28/126 (22%), Positives = 58/126 (46%), Gaps = 16/126 (12%)
Query: 222 EFINDVNTLASLQHPNLCKLLGFHARDGSDQRMLIYERLFHGSLDRLIYGRSDGPPIDWN 281
EF+N+ + + ++ +LLG ++ ++I E + G L Y RS P ++ N
Sbjct: 65 EFLNEASVMKEFNCHHVVRLLGVVSQ--GQPTLVIMELMTRGDLKS--YLRSLRPEMENN 120
Query: 282 ---------TRVKIALCAAQGLTFLHEEGPFQAMYNEFSTANIQIDKDFSAKLSGYGCAG 332
+++A A G+ +L+ + ++ + + N + +DF+ K+ +G
Sbjct: 121 PVLAPPSLSKMIQMAGEIADGMAYLNAN---KFVHRDLAARNCMVAEDFTVKIGDFGMTR 177
Query: 333 HIPETD 338
I ETD
Sbjct: 178 DIYETD 183
>pdb|3QQU|A Chain A, Cocrystal Structure Of Unphosphorylated Igf With
Pyrimidine 8
pdb|3QQU|B Chain B, Cocrystal Structure Of Unphosphorylated Igf With
Pyrimidine 8
pdb|3QQU|C Chain C, Cocrystal Structure Of Unphosphorylated Igf With
Pyrimidine 8
pdb|3QQU|D Chain D, Cocrystal Structure Of Unphosphorylated Igf With
Pyrimidine 8
Length = 301
Score = 33.9 bits (76), Expect = 0.13, Method: Compositional matrix adjust.
Identities = 28/126 (22%), Positives = 58/126 (46%), Gaps = 16/126 (12%)
Query: 222 EFINDVNTLASLQHPNLCKLLGFHARDGSDQRMLIYERLFHGSLDRLIYGRSDGPPIDWN 281
EF+N+ + + ++ +LLG ++ ++I E + G L Y RS P ++ N
Sbjct: 61 EFLNEASVMKEFNCHHVVRLLGVVSQ--GQPTLVIMELMTRGDLKS--YLRSLRPEMENN 116
Query: 282 ---------TRVKIALCAAQGLTFLHEEGPFQAMYNEFSTANIQIDKDFSAKLSGYGCAG 332
+++A A G+ +L+ + ++ + + N + +DF+ K+ +G
Sbjct: 117 PVLAPPSLSKMIQMAGEIADGMAYLNAN---KFVHRDLAARNCMVAEDFTVKIGDFGMTR 173
Query: 333 HIPETD 338
I ETD
Sbjct: 174 DIYETD 179
>pdb|2V7A|A Chain A, Crystal Structure Of The T315i Abl Mutant In Complex With
The Inhibitor Pha-739358
pdb|2V7A|B Chain B, Crystal Structure Of The T315i Abl Mutant In Complex With
The Inhibitor Pha-739358
Length = 286
Score = 33.9 bits (76), Expect = 0.13, Method: Compositional matrix adjust.
Identities = 16/47 (34%), Positives = 26/47 (55%), Gaps = 2/47 (4%)
Query: 204 KKFEATVT--RLNPSSQGVKEFINDVNTLASLQHPNLCKLLGFHARD 248
KK+ TV L + V+EF+ + + ++HPNL +LLG R+
Sbjct: 36 KKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEIKHPNLVQLLGVCTRE 82
>pdb|2E2B|A Chain A, Crystal Structure Of The C-Abl Kinase Domain In Complex
With Inno-406
pdb|2E2B|B Chain B, Crystal Structure Of The C-Abl Kinase Domain In Complex
With Inno-406
Length = 293
Score = 33.9 bits (76), Expect = 0.13, Method: Compositional matrix adjust.
Identities = 16/47 (34%), Positives = 26/47 (55%), Gaps = 2/47 (4%)
Query: 204 KKFEATVT--RLNPSSQGVKEFINDVNTLASLQHPNLCKLLGFHARD 248
KK+ TV L + V+EF+ + + ++HPNL +LLG R+
Sbjct: 40 KKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEIKHPNLVQLLGVCTRE 86
>pdb|2OJ9|A Chain A, Structure Of Igf-1r Kinase Domain Complexed With A
Benzimidazole Inhibitor
pdb|3NW5|A Chain A, Crystal Structure Of Insulin-Like Growth Factor 1 Receptor
(Igf-1r-Wt) Complex With A Carbon-Linked Proline
Isostere Inhibitor (11b)
pdb|3NW6|A Chain A, Crystal Structure Of Insulin-Like Growth Factor 1 Receptor
(Igf-1r-Wt) Complex With A Carbon-Linked Proline
Isostere Inhibitor (11a)
pdb|3NW7|A Chain A, Crystal Structure Of Insulin-Like Growth Factor 1 Receptor
(Igf-1r-Wt) Complex With A Carbon-Linked Proline
Isostere Inhibitor (34)
Length = 307
Score = 33.9 bits (76), Expect = 0.13, Method: Compositional matrix adjust.
Identities = 28/126 (22%), Positives = 58/126 (46%), Gaps = 16/126 (12%)
Query: 222 EFINDVNTLASLQHPNLCKLLGFHARDGSDQRMLIYERLFHGSLDRLIYGRSDGPPIDWN 281
EF+N+ + + ++ +LLG ++ ++I E + G L Y RS P ++ N
Sbjct: 67 EFLNEASVMKEFNCHHVVRLLGVVSQ--GQPTLVIMELMTRGDLKS--YLRSLRPEMENN 122
Query: 282 ---------TRVKIALCAAQGLTFLHEEGPFQAMYNEFSTANIQIDKDFSAKLSGYGCAG 332
+++A A G+ +L+ + ++ + + N + +DF+ K+ +G
Sbjct: 123 PVLAPPSLSKMIQMAGEIADGMAYLNAN---KFVHRDLAARNCMVAEDFTVKIGDFGMTR 179
Query: 333 HIPETD 338
I ETD
Sbjct: 180 DIYETD 185
>pdb|1JQH|A Chain A, Igf-1 Receptor Kinase Domain
pdb|1JQH|B Chain B, Igf-1 Receptor Kinase Domain
pdb|1JQH|C Chain C, Igf-1 Receptor Kinase Domain
Length = 308
Score = 33.9 bits (76), Expect = 0.13, Method: Compositional matrix adjust.
Identities = 28/126 (22%), Positives = 58/126 (46%), Gaps = 16/126 (12%)
Query: 222 EFINDVNTLASLQHPNLCKLLGFHARDGSDQRMLIYERLFHGSLDRLIYGRSDGPPIDWN 281
EF+N+ + + ++ +LLG ++ ++I E + G L Y RS P ++ N
Sbjct: 68 EFLNEASVMKEFNCHHVVRLLGVVSQ--GQPTLVIMELMTRGDLKS--YLRSLRPEMENN 123
Query: 282 ---------TRVKIALCAAQGLTFLHEEGPFQAMYNEFSTANIQIDKDFSAKLSGYGCAG 332
+++A A G+ +L+ + ++ + + N + +DF+ K+ +G
Sbjct: 124 PVLAPPSLSKMIQMAGEIADGMAYLNAN---KFVHRDLAARNCMVAEDFTVKIGDFGMTR 180
Query: 333 HIPETD 338
I ETD
Sbjct: 181 DIYETD 186
>pdb|3QRI|A Chain A, The Crystal Structure Of Human Abl1 Kinase Domain In
Complex With Dcc- 2036
pdb|3QRI|B Chain B, The Crystal Structure Of Human Abl1 Kinase Domain In
Complex With Dcc- 2036
pdb|3QRK|A Chain A, The Crystal Structure Of Human Abl1 Kinase Domain In
Complex With Dp- 987
Length = 277
Score = 33.9 bits (76), Expect = 0.13, Method: Compositional matrix adjust.
Identities = 16/47 (34%), Positives = 26/47 (55%), Gaps = 2/47 (4%)
Query: 204 KKFEATVT--RLNPSSQGVKEFINDVNTLASLQHPNLCKLLGFHARD 248
KK+ TV L + V+EF+ + + ++HPNL +LLG R+
Sbjct: 40 KKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEIKHPNLVQLLGVCTRE 86
>pdb|3I81|A Chain A, Crystal Structure Of Insulin-Like Growth Factor 1 Receptor
(Igf-1r-Wt) Complex With Bms-754807
[1-(4-((5-Cyclopropyl-
1h-Pyrazol-3-Yl)amino)pyrrolo[2,1-F][1,2,
4]triazin-2-Yl)-N-
(6-Fluoro-3-Pyridinyl)-2-Methyl-L-Prolinamide]
Length = 315
Score = 33.9 bits (76), Expect = 0.13, Method: Compositional matrix adjust.
Identities = 28/126 (22%), Positives = 58/126 (46%), Gaps = 16/126 (12%)
Query: 222 EFINDVNTLASLQHPNLCKLLGFHARDGSDQRMLIYERLFHGSLDRLIYGRSDGPPIDWN 281
EF+N+ + + ++ +LLG ++ ++I E + G L Y RS P ++ N
Sbjct: 67 EFLNEASVMKEFNCHHVVRLLGVVSQ--GQPTLVIMELMTRGDLKS--YLRSLRPEMENN 122
Query: 282 ---------TRVKIALCAAQGLTFLHEEGPFQAMYNEFSTANIQIDKDFSAKLSGYGCAG 332
+++A A G+ +L+ + ++ + + N + +DF+ K+ +G
Sbjct: 123 PVLAPPSLSKMIQMAGEIADGMAYLNAN---KFVHRDLAARNCMVAEDFTVKIGDFGMTR 179
Query: 333 HIPETD 338
I ETD
Sbjct: 180 DIYETD 185
>pdb|2HIW|A Chain A, Crystal Structure Of Inactive Conformation Abl Kinase
Catalytic Domain Complexed With Type Ii Inhibitor
pdb|2HIW|B Chain B, Crystal Structure Of Inactive Conformation Abl Kinase
Catalytic Domain Complexed With Type Ii Inhibitor
Length = 287
Score = 33.9 bits (76), Expect = 0.13, Method: Compositional matrix adjust.
Identities = 16/47 (34%), Positives = 26/47 (55%), Gaps = 2/47 (4%)
Query: 204 KKFEATVT--RLNPSSQGVKEFINDVNTLASLQHPNLCKLLGFHARD 248
KK+ TV L + V+EF+ + + ++HPNL +LLG R+
Sbjct: 37 KKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEIKHPNLVQLLGVCTRE 83
>pdb|2G2F|A Chain A, A Src-Like Inactive Conformation In The Abl Tyrosine
Kinase Domain
pdb|2G2F|B Chain B, A Src-Like Inactive Conformation In The Abl Tyrosine
Kinase Domain
pdb|2G2H|A Chain A, A Src-Like Inactive Conformation In The Abl Tyrosine
Kinase Domain
pdb|2G2H|B Chain B, A Src-Like Inactive Conformation In The Abl Tyrosine
Kinase Domain
pdb|2G2I|A Chain A, A Src-Like Inactive Conformation In The Abl Tyrosine
Kinase Domain
pdb|2G2I|B Chain B, A Src-Like Inactive Conformation In The Abl Tyrosine
Kinase Domain
Length = 287
Score = 33.9 bits (76), Expect = 0.13, Method: Compositional matrix adjust.
Identities = 16/47 (34%), Positives = 26/47 (55%), Gaps = 2/47 (4%)
Query: 204 KKFEATVT--RLNPSSQGVKEFINDVNTLASLQHPNLCKLLGFHARD 248
KK+ TV L + V+EF+ + + ++HPNL +LLG R+
Sbjct: 37 KKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEIKHPNLVQLLGVCTRE 83
>pdb|2GQG|A Chain A, X-Ray Crystal Structure Of Dasatinib (Bms-354825) Bound To
Activated Abl Kinase Domain
pdb|2GQG|B Chain B, X-Ray Crystal Structure Of Dasatinib (Bms-354825) Bound To
Activated Abl Kinase Domain
Length = 278
Score = 33.9 bits (76), Expect = 0.14, Method: Compositional matrix adjust.
Identities = 16/47 (34%), Positives = 26/47 (55%), Gaps = 2/47 (4%)
Query: 204 KKFEATVT--RLNPSSQGVKEFINDVNTLASLQHPNLCKLLGFHARD 248
KK+ TV L + V+EF+ + + ++HPNL +LLG R+
Sbjct: 40 KKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEIKHPNLVQLLGVCTRE 86
>pdb|3PYY|A Chain A, Discovery And Characterization Of A Cell-Permeable,
Small-Molecule C- Abl Kinase Activator That Binds To The
Myristoyl Binding Site
pdb|3PYY|B Chain B, Discovery And Characterization Of A Cell-Permeable,
Small-Molecule C- Abl Kinase Activator That Binds To The
Myristoyl Binding Site
Length = 298
Score = 33.9 bits (76), Expect = 0.14, Method: Compositional matrix adjust.
Identities = 16/47 (34%), Positives = 26/47 (55%), Gaps = 2/47 (4%)
Query: 204 KKFEATVT--RLNPSSQGVKEFINDVNTLASLQHPNLCKLLGFHARD 248
KK+ TV L + V+EF+ + + ++HPNL +LLG R+
Sbjct: 48 KKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEIKHPNLVQLLGVCTRE 94
>pdb|3D4Q|A Chain A, Pyrazole-Based Inhibitors Of B-Raf Kinase
pdb|3D4Q|B Chain B, Pyrazole-Based Inhibitors Of B-Raf Kinase
pdb|3PSB|A Chain A, Furo[2,3-C]pyridine-Based Indanone Oximes As Potent And
Selective B- Raf Inhibitors
pdb|3PSB|B Chain B, Furo[2,3-C]pyridine-Based Indanone Oximes As Potent And
Selective B- Raf Inhibitors
pdb|3PPJ|A Chain A, Human B-Raf Kinase In Complex With A Furopyridine
Inhibitor
pdb|3PPJ|B Chain B, Human B-Raf Kinase In Complex With A Furopyridine
Inhibitor
pdb|3PPK|A Chain A, Human B-Raf Kinase In Complex With A Non-Oxime
Furopyridine Inhibitor
pdb|3PPK|B Chain B, Human B-Raf Kinase In Complex With A Non-Oxime
Furopyridine Inhibitor
pdb|3PRF|A Chain A, Crystal Structure Of Human B-Raf Kinase Domain In Complex
With A Non- Oxime Furopyridine Inhibitor
pdb|3PRF|B Chain B, Crystal Structure Of Human B-Raf Kinase Domain In Complex
With A Non- Oxime Furopyridine Inhibitor
pdb|3PRI|A Chain A, Crystal Structure Of Human B-Raf Kinase In Complex With A
Non-Oxime Furopyridine Inhibitor
pdb|3PRI|B Chain B, Crystal Structure Of Human B-Raf Kinase In Complex With A
Non-Oxime Furopyridine Inhibitor
pdb|3Q4C|A Chain A, Crystal Structure Of Wild Type Braf Kinase Domain In
Complex With Organometallic Inhibitor Cns292
pdb|3Q4C|B Chain B, Crystal Structure Of Wild Type Braf Kinase Domain In
Complex With Organometallic Inhibitor Cns292
pdb|3PSD|A Chain A, Non-Oxime Pyrazole Based Inhibitors Of B-Raf Kinase
pdb|3PSD|B Chain B, Non-Oxime Pyrazole Based Inhibitors Of B-Raf Kinase
pdb|3SKC|A Chain A, Human B-Raf Kinase In Complex With An Amide Linked
Pyrazolopyridine Inhibitor
pdb|3SKC|B Chain B, Human B-Raf Kinase In Complex With An Amide Linked
Pyrazolopyridine Inhibitor
pdb|3TV4|A Chain A, Human B-Raf Kinase Domain In Complex With An Bromopyridine
Benzamide Inhibitor
pdb|3TV4|B Chain B, Human B-Raf Kinase Domain In Complex With An Bromopyridine
Benzamide Inhibitor
pdb|3TV6|A Chain A, Human B-Raf Kinase Domain In Complex With A
Methoxypyrazolopyridinyl Benzamide Inhibitor
pdb|3TV6|B Chain B, Human B-Raf Kinase Domain In Complex With A
Methoxypyrazolopyridinyl Benzamide Inhibitor
pdb|4E26|A Chain A, Braf In Complex With An Organic Inhibitor 7898734
pdb|4E26|B Chain B, Braf In Complex With An Organic Inhibitor 7898734
pdb|4E4X|A Chain A, Crystal Structure Of B-Raf Kinase Domain In Complex With A
Dihydropyrido[2,3-D]pyrimidinone-Based Inhibitor
pdb|4E4X|B Chain B, Crystal Structure Of B-Raf Kinase Domain In Complex With A
Dihydropyrido[2,3-D]pyrimidinone-Based Inhibitor
pdb|4G9C|A Chain A, Human B-Raf Kinase Domain Bound To A Type Ii
Pyrazolopyridine Inhibitor
pdb|4G9C|B Chain B, Human B-Raf Kinase Domain Bound To A Type Ii
Pyrazolopyridine Inhibitor
Length = 307
Score = 33.9 bits (76), Expect = 0.14, Method: Compositional matrix adjust.
Identities = 31/141 (21%), Positives = 60/141 (42%), Gaps = 11/141 (7%)
Query: 194 ASFGDDASTSKKFEATVTRLN---PSSQGVKEFINDVNTLASLQHPNLCKLLGFHARDGS 250
SFG + V LN P+ Q ++ F N+V L +H N+ +G+ +
Sbjct: 47 GSFGTVYKGKWHGDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYSTK--- 103
Query: 251 DQRMLIYERLFHGSLDRLIYGRSDGPPIDWNTRVKIALCAAQGLTFLHEEGPFQAMYNEF 310
Q ++ + SL ++ + + IA AQG+ +LH + ++ +
Sbjct: 104 PQLAIVTQWCEGSSLYHHLHIIE--TKFEMIKLIDIARQTAQGMDYLHAKS---IIHRDL 158
Query: 311 STANIQIDKDFSAKLSGYGCA 331
+ NI + +D + K+ +G A
Sbjct: 159 KSNNIFLHEDLTVKIGDFGLA 179
>pdb|2HZI|A Chain A, Abl Kinase Domain In Complex With Pd180970
pdb|2HZI|B Chain B, Abl Kinase Domain In Complex With Pd180970
pdb|3CS9|A Chain A, Human Abl Kinase In Complex With Nilotinib
pdb|3CS9|B Chain B, Human Abl Kinase In Complex With Nilotinib
pdb|3CS9|C Chain C, Human Abl Kinase In Complex With Nilotinib
pdb|3CS9|D Chain D, Human Abl Kinase In Complex With Nilotinib
Length = 277
Score = 33.9 bits (76), Expect = 0.14, Method: Compositional matrix adjust.
Identities = 16/47 (34%), Positives = 26/47 (55%), Gaps = 2/47 (4%)
Query: 204 KKFEATVT--RLNPSSQGVKEFINDVNTLASLQHPNLCKLLGFHARD 248
KK+ TV L + V+EF+ + + ++HPNL +LLG R+
Sbjct: 39 KKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEIKHPNLVQLLGVCTRE 85
>pdb|3QRJ|A Chain A, The Crystal Structure Of Human Abl1 Kinase Domain T315i
Mutant In Complex With Dcc-2036
pdb|3QRJ|B Chain B, The Crystal Structure Of Human Abl1 Kinase Domain T315i
Mutant In Complex With Dcc-2036
Length = 277
Score = 33.9 bits (76), Expect = 0.14, Method: Compositional matrix adjust.
Identities = 16/47 (34%), Positives = 26/47 (55%), Gaps = 2/47 (4%)
Query: 204 KKFEATVT--RLNPSSQGVKEFINDVNTLASLQHPNLCKLLGFHARD 248
KK+ TV L + V+EF+ + + ++HPNL +LLG R+
Sbjct: 40 KKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEIKHPNLVQLLGVCTRE 86
>pdb|3II5|A Chain A, The Complex Of Wild-Type B-Raf With Pyrazolo Pyrimidine
Inhibitor
pdb|3II5|B Chain B, The Complex Of Wild-Type B-Raf With Pyrazolo Pyrimidine
Inhibitor
Length = 306
Score = 33.9 bits (76), Expect = 0.14, Method: Compositional matrix adjust.
Identities = 31/141 (21%), Positives = 60/141 (42%), Gaps = 11/141 (7%)
Query: 194 ASFGDDASTSKKFEATVTRLN---PSSQGVKEFINDVNTLASLQHPNLCKLLGFHARDGS 250
SFG + V LN P+ Q ++ F N+V L +H N+ +G+ +
Sbjct: 46 GSFGTVYKGKWHGDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYSTK--- 102
Query: 251 DQRMLIYERLFHGSLDRLIYGRSDGPPIDWNTRVKIALCAAQGLTFLHEEGPFQAMYNEF 310
Q ++ + SL ++ + + IA AQG+ +LH + ++ +
Sbjct: 103 PQLAIVTQWCEGSSLYHHLHIIE--TKFEMIKLIDIARQTAQGMDYLHAKS---IIHRDL 157
Query: 311 STANIQIDKDFSAKLSGYGCA 331
+ NI + +D + K+ +G A
Sbjct: 158 KSNNIFLHEDLTVKIGDFGLA 178
>pdb|2G1T|A Chain A, A Src-Like Inactive Conformation In The Abl Tyrosine
Kinase Domain
pdb|2G1T|B Chain B, A Src-Like Inactive Conformation In The Abl Tyrosine
Kinase Domain
pdb|2G1T|C Chain C, A Src-Like Inactive Conformation In The Abl Tyrosine
Kinase Domain
pdb|2G1T|D Chain D, A Src-Like Inactive Conformation In The Abl Tyrosine
Kinase Domain
pdb|3UE4|A Chain A, Structural And Spectroscopic Analysis Of The Kinase
Inhibitor Bosutinib Binding To The Abl Tyrosine Kinase
Domain
pdb|3UE4|B Chain B, Structural And Spectroscopic Analysis Of The Kinase
Inhibitor Bosutinib Binding To The Abl Tyrosine Kinase
Domain
Length = 287
Score = 33.9 bits (76), Expect = 0.14, Method: Compositional matrix adjust.
Identities = 16/47 (34%), Positives = 26/47 (55%), Gaps = 2/47 (4%)
Query: 204 KKFEATVT--RLNPSSQGVKEFINDVNTLASLQHPNLCKLLGFHARD 248
KK+ TV L + V+EF+ + + ++HPNL +LLG R+
Sbjct: 37 KKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEIKHPNLVQLLGVCTRE 83
>pdb|1UWH|A Chain A, The Complex Of Wild Type B-Raf And Bay439006
pdb|1UWH|B Chain B, The Complex Of Wild Type B-Raf And Bay439006
Length = 276
Score = 33.9 bits (76), Expect = 0.14, Method: Compositional matrix adjust.
Identities = 36/158 (22%), Positives = 67/158 (42%), Gaps = 14/158 (8%)
Query: 180 DRCISEGLSSVMYR---ASFGDDASTSKKFEATVTRLN---PSSQGVKEFINDVNTLASL 233
D I +G +V R SFG + V LN P+ Q ++ F N+V L
Sbjct: 2 DWEIPDGQITVGQRIGSGSFGTVYKGKWHGDVAVKMLNVTAPTPQQLQAFKNEVGVLRKT 61
Query: 234 QHPNLCKLLGFHARDGSDQRMLIYERLFHGSLDRLIYGRSDGPPIDWNTRVKIALCAAQG 293
+H N+ +G+ + Q ++ + SL ++ + + IA AQG
Sbjct: 62 RHVNILLFMGYST---APQLAIVTQWCEGSSLYHHLHIIE--TKFEMIKLIDIARQTAQG 116
Query: 294 LTFLHEEGPFQAMYNEFSTANIQIDKDFSAKLSGYGCA 331
+ +LH + ++ + + NI + +D + K+ +G A
Sbjct: 117 MDYLHAKS---IIHRDLKSNNIFLHEDLTVKIGDFGLA 151
>pdb|2HYY|A Chain A, Human Abl Kinase Domain In Complex With Imatinib (Sti571,
Glivec)
pdb|2HYY|B Chain B, Human Abl Kinase Domain In Complex With Imatinib (Sti571,
Glivec)
pdb|2HYY|C Chain C, Human Abl Kinase Domain In Complex With Imatinib (Sti571,
Glivec)
pdb|2HYY|D Chain D, Human Abl Kinase Domain In Complex With Imatinib (Sti571,
Glivec)
pdb|2HZ4|A Chain A, Abl Kinase Domain Unligated And In Complex With
Tetrahydrostaurosporine
pdb|2HZ4|B Chain B, Abl Kinase Domain Unligated And In Complex With
Tetrahydrostaurosporine
pdb|2HZ4|C Chain C, Abl Kinase Domain Unligated And In Complex With
Tetrahydrostaurosporine
Length = 273
Score = 33.9 bits (76), Expect = 0.15, Method: Compositional matrix adjust.
Identities = 16/47 (34%), Positives = 26/47 (55%), Gaps = 2/47 (4%)
Query: 204 KKFEATVT--RLNPSSQGVKEFINDVNTLASLQHPNLCKLLGFHARD 248
KK+ TV L + V+EF+ + + ++HPNL +LLG R+
Sbjct: 35 KKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEIKHPNLVQLLGVCTRE 81
>pdb|2HZ0|A Chain A, Abl Kinase Domain In Complex With Nvp-Aeg082
pdb|2HZ0|B Chain B, Abl Kinase Domain In Complex With Nvp-Aeg082
Length = 270
Score = 33.9 bits (76), Expect = 0.15, Method: Compositional matrix adjust.
Identities = 16/47 (34%), Positives = 26/47 (55%), Gaps = 2/47 (4%)
Query: 204 KKFEATVT--RLNPSSQGVKEFINDVNTLASLQHPNLCKLLGFHARD 248
KK+ TV L + V+EF+ + + ++HPNL +LLG R+
Sbjct: 35 KKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEIKHPNLVQLLGVCTRE 81
>pdb|4G9R|A Chain A, B-Raf V600e Kinase Domain Bound To A Type Ii
Dihydroquinazoline Inhibitor
pdb|4G9R|B Chain B, B-Raf V600e Kinase Domain Bound To A Type Ii
Dihydroquinazoline Inhibitor
Length = 307
Score = 33.9 bits (76), Expect = 0.15, Method: Compositional matrix adjust.
Identities = 31/141 (21%), Positives = 60/141 (42%), Gaps = 11/141 (7%)
Query: 194 ASFGDDASTSKKFEATVTRLN---PSSQGVKEFINDVNTLASLQHPNLCKLLGFHARDGS 250
SFG + V LN P+ Q ++ F N+V L +H N+ +G+ +
Sbjct: 47 GSFGTVYKGKWHGDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYSTK--- 103
Query: 251 DQRMLIYERLFHGSLDRLIYGRSDGPPIDWNTRVKIALCAAQGLTFLHEEGPFQAMYNEF 310
Q ++ + SL ++ + + IA AQG+ +LH + ++ +
Sbjct: 104 PQLAIVTQWCEGSSLYHHLHIIE--TKFEMIKLIDIARQTAQGMDYLHAKS---IIHRDL 158
Query: 311 STANIQIDKDFSAKLSGYGCA 331
+ NI + +D + K+ +G A
Sbjct: 159 KSNNIFLHEDLTVKIGDFGLA 179
>pdb|3IDP|A Chain A, B-Raf V600e Kinase Domain In Complex With An
Aminoisoquinoline Inhibitor
pdb|3IDP|B Chain B, B-Raf V600e Kinase Domain In Complex With An
Aminoisoquinoline Inhibitor
Length = 300
Score = 33.9 bits (76), Expect = 0.15, Method: Compositional matrix adjust.
Identities = 31/141 (21%), Positives = 60/141 (42%), Gaps = 11/141 (7%)
Query: 194 ASFGDDASTSKKFEATVTRLN---PSSQGVKEFINDVNTLASLQHPNLCKLLGFHARDGS 250
SFG + V LN P+ Q ++ F N+V L +H N+ +G+ +
Sbjct: 39 GSFGTVYKGKWHGDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYSTK--- 95
Query: 251 DQRMLIYERLFHGSLDRLIYGRSDGPPIDWNTRVKIALCAAQGLTFLHEEGPFQAMYNEF 310
Q ++ + SL ++ + + IA AQG+ +LH + ++ +
Sbjct: 96 PQLAIVTQWCEGSSLYHHLHIIE--TKFEMIKLIDIARQTAQGMDYLHAKS---IIHRDL 150
Query: 311 STANIQIDKDFSAKLSGYGCA 331
+ NI + +D + K+ +G A
Sbjct: 151 KSNNIFLHEDLTVKIGDFGLA 171
>pdb|3C4C|A Chain A, B-Raf Kinase In Complex With Plx4720
pdb|3C4C|B Chain B, B-Raf Kinase In Complex With Plx4720
Length = 280
Score = 33.9 bits (76), Expect = 0.15, Method: Compositional matrix adjust.
Identities = 35/158 (22%), Positives = 67/158 (42%), Gaps = 14/158 (8%)
Query: 180 DRCISEGLSSVMYR---ASFGDDASTSKKFEATVTRLN---PSSQGVKEFINDVNTLASL 233
D I +G +V R SFG + V LN P+ Q ++ F N+V L
Sbjct: 6 DWEIPDGQITVGQRIGSGSFGTVYKGKWHGDVAVKMLNVTAPTPQQLQAFKNEVGVLRKT 65
Query: 234 QHPNLCKLLGFHARDGSDQRMLIYERLFHGSLDRLIYGRSDGPPIDWNTRVKIALCAAQG 293
+H N+ +G+ + Q ++ + SL ++ + + IA A+G
Sbjct: 66 RHVNILLFMGYSTK---PQLAIVTQWCEGSSLYHHLHASE--TKFEMKKLIDIARQTARG 120
Query: 294 LTFLHEEGPFQAMYNEFSTANIQIDKDFSAKLSGYGCA 331
+ +LH + ++ + + NI + +D + K+ +G A
Sbjct: 121 MDYLHAKS---IIHRDLKSNNIFLHEDNTVKIGDFGLA 155
>pdb|3CD3|A Chain A, Crystal Structure Of Phosphorylated Human Feline Sarcoma
Viral Oncogene Homologue (V-Fes) In Complex With
Staurosporine And A Consensus Peptide
Length = 377
Score = 33.9 bits (76), Expect = 0.15, Method: Compositional matrix adjust.
Identities = 29/144 (20%), Positives = 64/144 (44%), Gaps = 12/144 (8%)
Query: 193 RASFGDDASTSKKFEATVTRLNPSSQGV-----KEFINDVNTLASLQHPNLCKLLGFHAR 247
R +FG+ S + + T+ + + + +F+ + L HPN+ +L+G +
Sbjct: 124 RGNFGEVFSGRLRADNTLVAVKSCRETLPPDLKAKFLQEARILKQYSHPNIVRLIGVCTQ 183
Query: 248 DGSDQRMLIYERLFHGSLDRLIYGRSDGPPIDWNTRVKIALCAAQGLTFLHEEGPFQAMY 307
Q + I L G D L + R++G + T +++ AA G+ +L + ++
Sbjct: 184 ---KQPIYIVMELVQGG-DFLTFLRTEGARLRVKTLLQMVGDAAAGMEYLESKC---CIH 236
Query: 308 NEFSTANIQIDKDFSAKLSGYGCA 331
+ + N + + K+S +G +
Sbjct: 237 RDLAARNCLVTEKNVLKISDFGMS 260
>pdb|4FK3|A Chain A, B-Raf Kinase V600e Oncogenic Mutant In Complex With
Plx3203
pdb|4FK3|B Chain B, B-Raf Kinase V600e Oncogenic Mutant In Complex With
Plx3203
Length = 292
Score = 33.9 bits (76), Expect = 0.16, Method: Compositional matrix adjust.
Identities = 35/158 (22%), Positives = 67/158 (42%), Gaps = 14/158 (8%)
Query: 180 DRCISEGLSSVMYR---ASFGDDASTSKKFEATVTRLN---PSSQGVKEFINDVNTLASL 233
D I +G +V R SFG + V LN P+ Q ++ F N+V L
Sbjct: 18 DWEIPDGQITVGQRIGSGSFGTVYKGKWHGDVAVKMLNVTAPTPQQLQAFKNEVGVLRKT 77
Query: 234 QHPNLCKLLGFHARDGSDQRMLIYERLFHGSLDRLIYGRSDGPPIDWNTRVKIALCAAQG 293
+H N+ +G+ + Q ++ + SL ++ + + IA A+G
Sbjct: 78 RHVNILLFMGYSTK---PQLAIVTQWCEGSSLYHHLHASE--TKFEMKKLIDIARQTARG 132
Query: 294 LTFLHEEGPFQAMYNEFSTANIQIDKDFSAKLSGYGCA 331
+ +LH + ++ + + NI + +D + K+ +G A
Sbjct: 133 MDYLHAK---SIIHRDLKSNNIFLHEDNTVKIGDFGLA 167
>pdb|3D94|A Chain A, Crystal Structure Of The Insulin-Like Growth Factor-1
Receptor Kinase In Complex With Pqip
Length = 301
Score = 33.9 bits (76), Expect = 0.16, Method: Compositional matrix adjust.
Identities = 28/126 (22%), Positives = 58/126 (46%), Gaps = 16/126 (12%)
Query: 222 EFINDVNTLASLQHPNLCKLLGFHARDGSDQRMLIYERLFHGSLDRLIYGRSDGPPIDWN 281
EF+N+ + + ++ +LLG ++ ++I E + G L Y RS P ++ N
Sbjct: 61 EFLNEASVMKEFNCHHVVRLLGVVSQ--GQPTLVIMELMTRGDLKS--YLRSLRPEMENN 116
Query: 282 ---------TRVKIALCAAQGLTFLHEEGPFQAMYNEFSTANIQIDKDFSAKLSGYGCAG 332
+++A A G+ +L+ + ++ + + N + +DF+ K+ +G
Sbjct: 117 PVLAPPSLSKMIQMAGEIADGMAYLNAN---KFVHRDLAARNCXVAEDFTVKIGDFGMTR 173
Query: 333 HIPETD 338
I ETD
Sbjct: 174 DIYETD 179
>pdb|3LVP|A Chain A, Crystal Structure Of Bisphosphorylated Igf1-R Kinase
Domain (2p) In Complex With A Bis-Azaindole Inhibitor
pdb|3LVP|B Chain B, Crystal Structure Of Bisphosphorylated Igf1-R Kinase
Domain (2p) In Complex With A Bis-Azaindole Inhibitor
pdb|3LVP|C Chain C, Crystal Structure Of Bisphosphorylated Igf1-R Kinase
Domain (2p) In Complex With A Bis-Azaindole Inhibitor
pdb|3LVP|D Chain D, Crystal Structure Of Bisphosphorylated Igf1-R Kinase
Domain (2p) In Complex With A Bis-Azaindole Inhibitor
Length = 336
Score = 33.9 bits (76), Expect = 0.16, Method: Compositional matrix adjust.
Identities = 28/126 (22%), Positives = 58/126 (46%), Gaps = 16/126 (12%)
Query: 222 EFINDVNTLASLQHPNLCKLLGFHARDGSDQRMLIYERLFHGSLDRLIYGRSDGPPIDWN 281
EF+N+ + + ++ +LLG ++ ++I E + G L Y RS P ++ N
Sbjct: 96 EFLNEASVMKEFNCHHVVRLLGVVSQ--GQPTLVIMELMTRGDLKS--YLRSLRPEMENN 151
Query: 282 ---------TRVKIALCAAQGLTFLHEEGPFQAMYNEFSTANIQIDKDFSAKLSGYGCAG 332
+++A A G+ +L+ + ++ + + N + +DF+ K+ +G
Sbjct: 152 PVLAPPSLSKMIQMAGEIADGMAYLNAN---KFVHRDLAARNCMVAEDFTVKIGDFGMTR 208
Query: 333 HIPETD 338
I ETD
Sbjct: 209 DIYETD 214
>pdb|3BKB|A Chain A, Crystal Structure Of Human Feline Sarcoma Viral Oncogene
Homologue (V- Fes)
pdb|3CBL|A Chain A, Crystal Structure Of Human Feline Sarcoma Viral Oncogene
Homologue (v- Fes) In Complex With Staurosporine And A
Consensus Peptide
pdb|4E93|A Chain A, Crystal Structure Of Human Feline Sarcoma Viral Oncogene
Homologue (V- Fes)in Complex With Tae684
Length = 377
Score = 33.9 bits (76), Expect = 0.16, Method: Compositional matrix adjust.
Identities = 29/144 (20%), Positives = 64/144 (44%), Gaps = 12/144 (8%)
Query: 193 RASFGDDASTSKKFEATVTRLNPSSQGV-----KEFINDVNTLASLQHPNLCKLLGFHAR 247
R +FG+ S + + T+ + + + +F+ + L HPN+ +L+G +
Sbjct: 124 RGNFGEVFSGRLRADNTLVAVKSCRETLPPDLKAKFLQEARILKQYSHPNIVRLIGVCTQ 183
Query: 248 DGSDQRMLIYERLFHGSLDRLIYGRSDGPPIDWNTRVKIALCAAQGLTFLHEEGPFQAMY 307
Q + I L G D L + R++G + T +++ AA G+ +L + ++
Sbjct: 184 ---KQPIYIVMELVQGG-DFLTFLRTEGARLRVKTLLQMVGDAAAGMEYLESKC---CIH 236
Query: 308 NEFSTANIQIDKDFSAKLSGYGCA 331
+ + N + + K+S +G +
Sbjct: 237 RDLAARNCLVTEKNVLKISDFGMS 260
>pdb|1OPK|A Chain A, Structural Basis For The Auto-Inhibition Of C-Abl Tyrosine
Kinase
Length = 495
Score = 33.5 bits (75), Expect = 0.18, Method: Compositional matrix adjust.
Identities = 16/47 (34%), Positives = 26/47 (55%), Gaps = 2/47 (4%)
Query: 204 KKFEATVT--RLNPSSQGVKEFINDVNTLASLQHPNLCKLLGFHARD 248
KK+ TV L + V+EF+ + + ++HPNL +LLG R+
Sbjct: 242 KKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEIKHPNLVQLLGVCTRE 288
>pdb|1K9A|A Chain A, Crystal Structure Analysis Of Full-Length
Carboxyl-Terminal Src Kinase At 2.5 A Resolution
pdb|1K9A|B Chain B, Crystal Structure Analysis Of Full-Length
Carboxyl-Terminal Src Kinase At 2.5 A Resolution
pdb|1K9A|C Chain C, Crystal Structure Analysis Of Full-Length
Carboxyl-Terminal Src Kinase At 2.5 A Resolution
pdb|1K9A|D Chain D, Crystal Structure Analysis Of Full-Length
Carboxyl-Terminal Src Kinase At 2.5 A Resolution
pdb|1K9A|E Chain E, Crystal Structure Analysis Of Full-Length
Carboxyl-Terminal Src Kinase At 2.5 A Resolution
pdb|1K9A|F Chain F, Crystal Structure Analysis Of Full-Length
Carboxyl-Terminal Src Kinase At 2.5 A Resolution
Length = 450
Score = 33.5 bits (75), Expect = 0.20, Method: Compositional matrix adjust.
Identities = 30/138 (21%), Positives = 62/138 (44%), Gaps = 7/138 (5%)
Query: 193 RASFGDDASTSKKFEATVTRLNPSSQGVKEFINDVNTLASLQHPNLCKLLGFHARDGSDQ 252
+ FGD + + + + F+ + + + L+H NL +LLG +
Sbjct: 203 KGEFGDVMLGDYRGNKVAVKCIKNDATAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGL 262
Query: 253 RMLIYERLFHGSLDRLIYGRSDGPPI-DWNTRVKIALCAAQGLTFLHEEGPFQAMYNEFS 311
++ E + GSL + Y RS G + + +K +L + + +L EG ++ + +
Sbjct: 263 -YIVTEYMAKGSL--VDYLRSRGRSVLGGDCLLKFSLDVCEAMEYL--EGN-NFVHRDLA 316
Query: 312 TANIQIDKDFSAKLSGYG 329
N+ + +D AK+S +G
Sbjct: 317 ARNVLVSEDNVAKVSDFG 334
>pdb|3OG7|A Chain A, B-Raf Kinase V600e Oncogenic Mutant In Complex With
Plx4032
pdb|3OG7|B Chain B, B-Raf Kinase V600e Oncogenic Mutant In Complex With
Plx4032
Length = 289
Score = 33.5 bits (75), Expect = 0.20, Method: Compositional matrix adjust.
Identities = 35/158 (22%), Positives = 67/158 (42%), Gaps = 14/158 (8%)
Query: 180 DRCISEGLSSVMYR---ASFGDDASTSKKFEATVTRLN---PSSQGVKEFINDVNTLASL 233
D I +G +V R SFG + V LN P+ Q ++ F N+V L
Sbjct: 18 DWEIPDGQITVGQRIGSGSFGTVYKGKWHGDVAVKMLNVTAPTPQQLQAFKNEVGVLRKT 77
Query: 234 QHPNLCKLLGFHARDGSDQRMLIYERLFHGSLDRLIYGRSDGPPIDWNTRVKIALCAAQG 293
+H N+ +G+ + Q ++ + SL ++ + + IA A+G
Sbjct: 78 RHVNILLFMGYST---APQLAIVTQWCEGSSLYHHLHASE--TKFEMKKLIDIARQTARG 132
Query: 294 LTFLHEEGPFQAMYNEFSTANIQIDKDFSAKLSGYGCA 331
+ +LH + ++ + + NI + +D + K+ +G A
Sbjct: 133 MDYLHAKS---IIHRDLKSNNIFLHEDNTVKIGDFGLA 167
>pdb|2FO0|A Chain A, Organization Of The Sh3-Sh2 Unit In Active And Inactive
Forms Of The C-Abl Tyrosine Kinase
Length = 495
Score = 33.5 bits (75), Expect = 0.21, Method: Compositional matrix adjust.
Identities = 16/47 (34%), Positives = 26/47 (55%), Gaps = 2/47 (4%)
Query: 204 KKFEATVT--RLNPSSQGVKEFINDVNTLASLQHPNLCKLLGFHARD 248
KK+ TV L + V+EF+ + + ++HPNL +LLG R+
Sbjct: 239 KKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEIKHPNLVQLLGVCTRE 285
>pdb|3NIZ|A Chain A, Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5_2510
With Adp Bound
Length = 311
Score = 33.1 bits (74), Expect = 0.23, Method: Compositional matrix adjust.
Identities = 34/152 (22%), Positives = 63/152 (41%), Gaps = 17/152 (11%)
Query: 183 ISEGLSSVMYRASFGDDASTSKKFEATVTRLNPSSQGV-KEFINDVNTLASLQHPNLCKL 241
+ EG V+Y+A S + RL+ +G+ I +++ L L HPN+ L
Sbjct: 29 VGEGTYGVVYKAK----DSQGRIVALKRIRLDAEDEGIPSTAIREISLLKELHHPNIVSL 84
Query: 242 LG-FHARDGSDQRMLIYERLFHGSLDRLIYGRSDGPPIDWNTRVKIALCA-AQGLTFLHE 299
+ H+ E+ LD G D +++KI L +G+ H+
Sbjct: 85 IDVIHSERCLTLVFEFMEKDLKKVLDENKTGLQD-------SQIKIYLYQLLRGVAHCHQ 137
Query: 300 EGPFQAMYNEFSTANIQIDKDFSAKLSGYGCA 331
+ ++ + N+ I+ D + KL+ +G A
Sbjct: 138 H---RILHRDLKPQNLLINSDGALKLADFGLA 166
>pdb|1OPL|A Chain A, Structural Basis For The Auto-Inhibition Of C-Abl Tyrosine
Kinase
pdb|1OPL|B Chain B, Structural Basis For The Auto-Inhibition Of C-Abl Tyrosine
Kinase
Length = 537
Score = 33.1 bits (74), Expect = 0.24, Method: Compositional matrix adjust.
Identities = 16/47 (34%), Positives = 26/47 (55%), Gaps = 2/47 (4%)
Query: 204 KKFEATVT--RLNPSSQGVKEFINDVNTLASLQHPNLCKLLGFHARD 248
KK+ TV L + V+EF+ + + ++HPNL +LLG R+
Sbjct: 281 KKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEIKHPNLVQLLGVCTRE 327
>pdb|1P4O|A Chain A, Structure Of Apo Unactivated Igf-1r Kinase Domain At 1.5a
Resolution.
pdb|1P4O|B Chain B, Structure Of Apo Unactivated Igf-1r Kinase Domain At 1.5a
Resolution
Length = 322
Score = 33.1 bits (74), Expect = 0.25, Method: Compositional matrix adjust.
Identities = 28/126 (22%), Positives = 57/126 (45%), Gaps = 16/126 (12%)
Query: 222 EFINDVNTLASLQHPNLCKLLGFHARDGSDQRMLIYERLFHGSLDRLIYGRSDGP----- 276
EF+N+ + + ++ +LLG ++ ++I E + G L Y RS P
Sbjct: 74 EFLNEASVMKEFNCHHVVRLLGVVSQ--GQPTLVIMELMTRGDLKS--YLRSLRPAMANN 129
Query: 277 ----PIDWNTRVKIALCAAQGLTFLHEEGPFQAMYNEFSTANIQIDKDFSAKLSGYGCAG 332
P + +++A A G+ +L+ + ++ + + N + +DF+ K+ +G
Sbjct: 130 PVLAPPSLSKMIQMAGEIADGMAYLNAN---KFVHRDLAARNCMVAEDFTVKIGDFGMTR 186
Query: 333 HIPETD 338
I ETD
Sbjct: 187 DIYETD 192
>pdb|2QKR|A Chain A, Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5_2510
With Indirubin 3'-Monoxime Bound
Length = 313
Score = 33.1 bits (74), Expect = 0.26, Method: Compositional matrix adjust.
Identities = 34/152 (22%), Positives = 63/152 (41%), Gaps = 17/152 (11%)
Query: 183 ISEGLSSVMYRASFGDDASTSKKFEATVTRLNPSSQGV-KEFINDVNTLASLQHPNLCKL 241
+ EG V+Y+A S + RL+ +G+ I +++ L L HPN+ L
Sbjct: 29 VGEGTYGVVYKAK----DSQGRIVALKRIRLDAEDEGIPSTAIREISLLKELHHPNIVSL 84
Query: 242 LG-FHARDGSDQRMLIYERLFHGSLDRLIYGRSDGPPIDWNTRVKIALCA-AQGLTFLHE 299
+ H+ E+ LD G D +++KI L +G+ H+
Sbjct: 85 IDVIHSERCLTLVFEFMEKDLKKVLDENKTGLQD-------SQIKIYLYQLLRGVAHCHQ 137
Query: 300 EGPFQAMYNEFSTANIQIDKDFSAKLSGYGCA 331
+ ++ + N+ I+ D + KL+ +G A
Sbjct: 138 H---RILHRDLKPQNLLINSDGALKLADFGLA 166
>pdb|3D7U|A Chain A, Structural Basis For The Recognition Of C-Src By Its
Inactivator Csk
pdb|3D7U|C Chain C, Structural Basis For The Recognition Of C-Src By Its
Inactivator Csk
Length = 263
Score = 33.1 bits (74), Expect = 0.27, Method: Compositional matrix adjust.
Identities = 30/138 (21%), Positives = 62/138 (44%), Gaps = 7/138 (5%)
Query: 193 RASFGDDASTSKKFEATVTRLNPSSQGVKEFINDVNTLASLQHPNLCKLLGFHARDGSDQ 252
+ FGD + + + + F+ + + + L+H NL +LLG +
Sbjct: 16 KGEFGDVMLGDYRGNKVAVKCIKNDATAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGL 75
Query: 253 RMLIYERLFHGSLDRLIYGRSDGPPI-DWNTRVKIALCAAQGLTFLHEEGPFQAMYNEFS 311
++ E + GSL + Y RS G + + +K +L + + +L E F ++ + +
Sbjct: 76 -YIVTEYMAKGSL--VDYLRSRGRSVLGGDCLLKFSLDVCEAMEYL-EGNNF--VHRDLA 129
Query: 312 TANIQIDKDFSAKLSGYG 329
N+ + +D AK+S +G
Sbjct: 130 ARNVLVSEDNVAKVSDFG 147
>pdb|2BDF|A Chain A, Src Kinase In Complex With Inhibitor Ap23451
pdb|2BDF|B Chain B, Src Kinase In Complex With Inhibitor Ap23451
pdb|2BDJ|A Chain A, Src Kinase In Complex With Inhibitor Ap23464
Length = 279
Score = 33.1 bits (74), Expect = 0.28, Method: Compositional matrix adjust.
Identities = 25/131 (19%), Positives = 56/131 (42%), Gaps = 7/131 (5%)
Query: 208 ATVTRLNPSSQGVKEFINDVNTLASLQHPNLCKLLGFHARDGSDQRMLIYERLFHGSLDR 267
+ L P + + F+ + + L+H L +L +A + ++ E + GSL
Sbjct: 38 VAIKTLKPGTMSPEAFLQEAQVMKKLRHEKLVQL---YAVVSEEPIYIVTEYMSKGSLLD 94
Query: 268 LIYGRSDGPPIDWNTRVKIALCAAQGLTFLHEEGPFQAMYNEFSTANIQIDKDFSAKLSG 327
+ G + G + V +A A G+ ++ ++ + ANI + ++ K++
Sbjct: 95 FLKGET-GKYLRLPQLVDMAAQIASGMAYVER---MNYVHRDLRAANILVGENLVCKVAD 150
Query: 328 YGCAGHIPETD 338
+G A I + +
Sbjct: 151 FGLARLIEDNE 161
>pdb|3D7T|A Chain A, Structural Basis For The Recognition Of C-Src By Its
Inactivator Csk
Length = 269
Score = 33.1 bits (74), Expect = 0.29, Method: Compositional matrix adjust.
Identities = 30/138 (21%), Positives = 62/138 (44%), Gaps = 7/138 (5%)
Query: 193 RASFGDDASTSKKFEATVTRLNPSSQGVKEFINDVNTLASLQHPNLCKLLGFHARDGSDQ 252
+ FGD + + + + F+ + + + L+H NL +LLG +
Sbjct: 22 KGEFGDVMLGDYRGNKVAVKCIKNDATAQAFLAEASVMTQLRHSNLVQLLGVIVEE-KGG 80
Query: 253 RMLIYERLFHGSLDRLIYGRSDGPPI-DWNTRVKIALCAAQGLTFLHEEGPFQAMYNEFS 311
++ E + GSL + Y RS G + + +K +L + + +L E F ++ + +
Sbjct: 81 LYIVTEYMAKGSL--VDYLRSRGRSVLGGDCLLKFSLDVCEAMEYL-EGNNF--VHRDLA 135
Query: 312 TANIQIDKDFSAKLSGYG 329
N+ + +D AK+S +G
Sbjct: 136 ARNVLVSEDNVAKVSDFG 153
>pdb|3LW0|A Chain A, Igf-1rk In Complex With Ligand Msc1609119a-1
pdb|3LW0|B Chain B, Igf-1rk In Complex With Ligand Msc1609119a-1
pdb|3LW0|C Chain C, Igf-1rk In Complex With Ligand Msc1609119a-1
pdb|3LW0|D Chain D, Igf-1rk In Complex With Ligand Msc1609119a-1
Length = 304
Score = 32.7 bits (73), Expect = 0.30, Method: Compositional matrix adjust.
Identities = 28/126 (22%), Positives = 57/126 (45%), Gaps = 16/126 (12%)
Query: 222 EFINDVNTLASLQHPNLCKLLGFHARDGSDQRMLIYERLFHGSLDRLIYGRSDGP----- 276
EF+N+ + + ++ +LLG ++ ++I E + G L Y RS P
Sbjct: 64 EFLNEASVMKEFNCHHVVRLLGVVSQ--GQPTLVIMELMTRGDLKS--YLRSLRPAMANN 119
Query: 277 ----PIDWNTRVKIALCAAQGLTFLHEEGPFQAMYNEFSTANIQIDKDFSAKLSGYGCAG 332
P + +++A A G+ +L+ + ++ + + N + +DF+ K+ +G
Sbjct: 120 PVLAPPSLSKMIQMAGEIADGMAYLNAN---KFVHRDLAARNCMVAEDFTVKIGDFGMTR 176
Query: 333 HIPETD 338
I ETD
Sbjct: 177 DIYETD 182
>pdb|1YI6|A Chain A, C-Term Tail Segment Of Human Tyrosine Kinase (258-533)
pdb|1YI6|B Chain B, C-Term Tail Segment Of Human Tyrosine Kinase (258-533)
Length = 276
Score = 32.7 bits (73), Expect = 0.30, Method: Compositional matrix adjust.
Identities = 25/131 (19%), Positives = 56/131 (42%), Gaps = 7/131 (5%)
Query: 208 ATVTRLNPSSQGVKEFINDVNTLASLQHPNLCKLLGFHARDGSDQRMLIYERLFHGSLDR 267
+ L P + + F+ + + L+H L +L +A + ++ E + GSL
Sbjct: 35 VAIKTLKPGTMSPEAFLQEAQVMKKLRHEKLVQL---YAVVSEEPIXIVTEYMSKGSLLD 91
Query: 268 LIYGRSDGPPIDWNTRVKIALCAAQGLTFLHEEGPFQAMYNEFSTANIQIDKDFSAKLSG 327
+ G + G + V +A A G+ ++ ++ + ANI + ++ K++
Sbjct: 92 FLKGET-GKYLRLPQLVDMAAQIASGMAYVER---MNYVHRDLRAANILVGENLVCKVAD 147
Query: 328 YGCAGHIPETD 338
+G A I + +
Sbjct: 148 FGLARLIEDNE 158
>pdb|3GVU|A Chain A, The Crystal Structure Of Human Abl2 In Complex With
Gleevec
pdb|3HMI|A Chain A, The Crystal Structure Of Human Abl2 In Complex With
5-Amino-3-{[4-
(Aminosulfonyl)phenyl]amino}-N-(2,
6-Difluorophenyl)-1h-1,2,4- Triazole-1-Carbothioamide
pdb|2XYN|A Chain A, Human Abl2 In Complex With Aurora Kinase Inhibitor Vx-680
pdb|2XYN|B Chain B, Human Abl2 In Complex With Aurora Kinase Inhibitor Vx-680
pdb|2XYN|C Chain C, Human Abl2 In Complex With Aurora Kinase Inhibitor Vx-680
Length = 292
Score = 32.7 bits (73), Expect = 0.31, Method: Compositional matrix adjust.
Identities = 15/42 (35%), Positives = 24/42 (57%), Gaps = 2/42 (4%)
Query: 204 KKFEATVT--RLNPSSQGVKEFINDVNTLASLQHPNLCKLLG 243
KK+ TV L + V+EF+ + + ++HPNL +LLG
Sbjct: 54 KKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEIKHPNLVQLLG 95
>pdb|1BYG|A Chain A, Kinase Domain Of Human C-Terminal Src Kinase (Csk) In
Complex With Inhibitor Staurosporine
Length = 278
Score = 32.7 bits (73), Expect = 0.31, Method: Compositional matrix adjust.
Identities = 30/138 (21%), Positives = 62/138 (44%), Gaps = 7/138 (5%)
Query: 193 RASFGDDASTSKKFEATVTRLNPSSQGVKEFINDVNTLASLQHPNLCKLLGFHARDGSDQ 252
+ FGD + + + + F+ + + + L+H NL +LLG +
Sbjct: 31 KGEFGDVMLGDYRGNKVAVKCIKNDATAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGL 90
Query: 253 RMLIYERLFHGSLDRLIYGRSDGPPI-DWNTRVKIALCAAQGLTFLHEEGPFQAMYNEFS 311
++ E + GSL + Y RS G + + +K +L + + +L E F ++ + +
Sbjct: 91 -YIVTEYMAKGSL--VDYLRSRGRSVLGGDCLLKFSLDVCEAMEYL-EGNNF--VHRDLA 144
Query: 312 TANIQIDKDFSAKLSGYG 329
N+ + +D AK+S +G
Sbjct: 145 ARNVLVSEDNVAKVSDFG 162
>pdb|3NYX|A Chain A, Non-Phosphorylated Tyk2 Jh1 Domain With
Quinoline-Thiadiazole- Thiophene Inhibitor
Length = 302
Score = 32.7 bits (73), Expect = 0.35, Method: Compositional matrix adjust.
Identities = 27/115 (23%), Positives = 49/115 (42%), Gaps = 13/115 (11%)
Query: 225 NDVNTLASLQHPNLCKLLGFHARDGSDQRMLIYERLFHGSLDRLIYGRSDGPPIDWNTRV 284
+++ L +L H ++ K G G L+ E + GSL + S G
Sbjct: 65 QEIDILRTLYHEHIIKYKGCCEDQGEKSLQLVMEYVPLGSLRDYLPRHSIG-------LA 117
Query: 285 KIALCAAQ---GLTFLHEEGPFQAMYNEFSTANIQIDKDFSAKLSGYGCAGHIPE 336
++ L A Q G+ +LH + ++ + N+ +D D K+ +G A +PE
Sbjct: 118 QLLLFAQQICEGMAYLHSQ---HYIHRNLAARNVLLDNDRLVKIGDFGLAKAVPE 169
>pdb|3LXN|A Chain A, Structural And Thermodynamic Characterization Of The Tyk2
And Jak3 Kinase Domains In Complex With Cp-690550 And
Cmp-6
pdb|3LXP|A Chain A, Structural And Thermodynamic Characterization Of The Tyk2
And Jak3 Kinase Domains In Complex With Cp-690550 And
Cmp-6
Length = 318
Score = 32.7 bits (73), Expect = 0.35, Method: Compositional matrix adjust.
Identities = 27/115 (23%), Positives = 51/115 (44%), Gaps = 13/115 (11%)
Query: 225 NDVNTLASLQHPNLCKLLGFHARDGSDQRMLIYERLFHGSLDRLIYGRSDGPPIDWNTRV 284
+++ L +L H ++ K G G+ L+ E + GSL + S G
Sbjct: 82 QEIDILRTLYHEHIIKYKGCCEDAGAASLQLVMEYVPLGSLRDYLPRHSIG-------LA 134
Query: 285 KIALCAAQ---GLTFLHEEGPFQAMYNEFSTANIQIDKDFSAKLSGYGCAGHIPE 336
++ L A Q G+ +LH + ++ + + N+ +D D K+ +G A +PE
Sbjct: 135 QLLLFAQQICEGMAYLHAQ---HYIHRDLAARNVLLDNDRLVKIGDFGLAKAVPE 186
>pdb|3QUP|A Chain A, Inhibitor Bound Structure Of The Kinase Domain Of The
Murine Receptor Tyrosine Kinase Tyro3 (Sky)
Length = 323
Score = 32.7 bits (73), Expect = 0.36, Method: Compositional matrix adjust.
Identities = 26/130 (20%), Positives = 55/130 (42%), Gaps = 10/130 (7%)
Query: 216 SSQGVKEFINDVNTLASLQHPNLCKLLGFHARDGSDQR----MLIYERLFHGSLDRLIYG 271
+S ++EF+ + + HP++ KL+G R + R M+I + HG L +
Sbjct: 65 ASSDIEEFLREAACMKEFDHPHVAKLVGVSLRSRAKGRLPIPMVILPFMKHGDLHAFLLA 124
Query: 272 RSDGP---PIDWNTRVKIALCAAQGLTFLHEEGPFQAMYNEFSTANIQIDKDFSAKLSGY 328
G + T V+ + A G+ +L ++ + + N + +D + ++ +
Sbjct: 125 SRIGENPFNLPLQTLVRFMVDIACGMEYLSSR---NFIHRDLAARNCMLAEDMTVCVADF 181
Query: 329 GCAGHIPETD 338
G + I D
Sbjct: 182 GLSRKIYSGD 191
>pdb|2H8H|A Chain A, Src Kinase In Complex With A Quinazoline Inhibitor
Length = 535
Score = 32.3 bits (72), Expect = 0.38, Method: Compositional matrix adjust.
Identities = 25/129 (19%), Positives = 56/129 (43%), Gaps = 7/129 (5%)
Query: 210 VTRLNPSSQGVKEFINDVNTLASLQHPNLCKLLGFHARDGSDQRMLIYERLFHGSLDRLI 269
+ L P + + F+ + + L+H L +L +A + ++ E + GSL +
Sbjct: 296 IKTLKPGTMSPEAFLQEAQVMKKLRHEKLVQL---YAVVSEEPIYIVTEYMSKGSLLDFL 352
Query: 270 YGRSDGPPIDWNTRVKIALCAAQGLTFLHEEGPFQAMYNEFSTANIQIDKDFSAKLSGYG 329
G + G + V +A A G+ ++ ++ + ANI + ++ K++ +G
Sbjct: 353 KGET-GKYLRLPQLVDMAAQIASGMAYVER---MNYVHRDLRAANILVGENLVCKVADFG 408
Query: 330 CAGHIPETD 338
A I + +
Sbjct: 409 LARLIEDNE 417
>pdb|1LUF|A Chain A, Crystal Structure Of The Musk Tyrosine Kinase: Insights
Into Receptor Autoregulation
Length = 343
Score = 32.3 bits (72), Expect = 0.39, Method: Compositional matrix adjust.
Identities = 28/138 (20%), Positives = 57/138 (41%), Gaps = 26/138 (18%)
Query: 222 EFINDVNTLASLQHPNLCKLLGFHARDGSDQRMLIYERLFHGSLDRLIYGRS-------- 273
+F + +A +PN+ KLLG A L++E + +G L+ + S
Sbjct: 96 DFQREAALMAEFDNPNIVKLLGVCAV--GKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLS 153
Query: 274 -------------DGPPIDWNTRVKIALCAAQGLTFLHEEGPFQAMYNEFSTANIQIDKD 320
PP+ ++ IA A G+ +L E + ++ + +T N + ++
Sbjct: 154 HSDLSTRARVSSPGPPPLSCAEQLCIARQVAAGMAYLSER---KFVHRDLATRNCLVGEN 210
Query: 321 FSAKLSGYGCAGHIPETD 338
K++ +G + +I D
Sbjct: 211 MVVKIADFGLSRNIYSAD 228
>pdb|3OMV|A Chain A, Crystal Structure Of C-Raf (Raf-1)
pdb|3OMV|B Chain B, Crystal Structure Of C-Raf (Raf-1)
Length = 307
Score = 32.3 bits (72), Expect = 0.39, Method: Compositional matrix adjust.
Identities = 29/150 (19%), Positives = 64/150 (42%), Gaps = 15/150 (10%)
Query: 183 ISEGLSSVMYRASFGDDASTSKKFEATVTRLNPSSQGVKEFINDVNTLASLQHPNLCKLL 242
I G +Y+ + D + + ++P+ + + F N+V L +H N+ +
Sbjct: 44 IGSGSFGTVYKGKWHGDVAVK-----ILKVVDPTPEQFQAFRNEVAVLRKTRHVNILLFM 98
Query: 243 GFHARDGSDQRMLIYERLFHG-SLDRLIYGRSDGPPIDWNTRVKIALCAAQGLTFLHEEG 301
G+ +D + I + G SL + ++ + + IA AQG+ +LH +
Sbjct: 99 GYMTKDN----LAIVTQWCEGSSLYKHLHVQE--TKFQMFQLIDIARQTAQGMDYLHAKN 152
Query: 302 PFQAMYNEFSTANIQIDKDFSAKLSGYGCA 331
++ + + NI + + + K+ +G A
Sbjct: 153 ---IIHRDMKSNNIFLHEGLTVKIGDFGLA 179
>pdb|3GEQ|A Chain A, Structural Basis For The Chemical Rescue Of Src Kinase
Activity
pdb|3GEQ|B Chain B, Structural Basis For The Chemical Rescue Of Src Kinase
Activity
Length = 286
Score = 32.3 bits (72), Expect = 0.40, Method: Compositional matrix adjust.
Identities = 25/131 (19%), Positives = 56/131 (42%), Gaps = 7/131 (5%)
Query: 208 ATVTRLNPSSQGVKEFINDVNTLASLQHPNLCKLLGFHARDGSDQRMLIYERLFHGSLDR 267
+ L P + + F+ + + L+H L +L +A + ++ E + GSL
Sbjct: 45 VAIKTLKPGTMSPEAFLQEAQVMKKLRHEKLVQL---YAVVSEEPIYIVTEYMSKGSLLD 101
Query: 268 LIYGRSDGPPIDWNTRVKIALCAAQGLTFLHEEGPFQAMYNEFSTANIQIDKDFSAKLSG 327
+ G G + V +A A G+ ++ ++ + + ANI + ++ K++
Sbjct: 102 FLKGEM-GKYLRLPQLVDMAAQIASGMAYVER---MNYVHRDLAAANILVGENLVCKVAD 157
Query: 328 YGCAGHIPETD 338
+G A I + +
Sbjct: 158 FGLARLIEDNE 168
>pdb|3NZ0|A Chain A, Non-Phosphorylated Tyk2 Kinase With Cmp6
Length = 302
Score = 32.3 bits (72), Expect = 0.41, Method: Compositional matrix adjust.
Identities = 27/115 (23%), Positives = 49/115 (42%), Gaps = 13/115 (11%)
Query: 225 NDVNTLASLQHPNLCKLLGFHARDGSDQRMLIYERLFHGSLDRLIYGRSDGPPIDWNTRV 284
+++ L +L H ++ K G G L+ E + GSL + S G
Sbjct: 65 QEIDILRTLYHEHIIKYKGCCEDQGEKSLQLVMEYVPLGSLRDYLPRHSIG-------LA 117
Query: 285 KIALCAAQ---GLTFLHEEGPFQAMYNEFSTANIQIDKDFSAKLSGYGCAGHIPE 336
++ L A Q G+ +LH + ++ + N+ +D D K+ +G A +PE
Sbjct: 118 QLLLFAQQICEGMAYLHAQ---HYIHRNLAARNVLLDNDRLVKIGDFGLAKAVPE 169
>pdb|1FMK|A Chain A, Crystal Structure Of Human Tyrosine-Protein Kinase C-Src
pdb|2SRC|A Chain A, Crystal Structure Of Human Tyrosine-protein Kinase C-src,
In Complex With Amp-pnp
Length = 452
Score = 32.3 bits (72), Expect = 0.41, Method: Compositional matrix adjust.
Identities = 25/129 (19%), Positives = 56/129 (43%), Gaps = 7/129 (5%)
Query: 210 VTRLNPSSQGVKEFINDVNTLASLQHPNLCKLLGFHARDGSDQRMLIYERLFHGSLDRLI 269
+ L P + + F+ + + L+H L +L +A + ++ E + GSL +
Sbjct: 213 IKTLKPGTMSPEAFLQEAQVMKKLRHEKLVQL---YAVVSEEPIYIVTEYMSKGSLLDFL 269
Query: 270 YGRSDGPPIDWNTRVKIALCAAQGLTFLHEEGPFQAMYNEFSTANIQIDKDFSAKLSGYG 329
G + G + V +A A G+ ++ ++ + ANI + ++ K++ +G
Sbjct: 270 KGET-GKYLRLPQLVDMAAQIASGMAYVER---MNYVHRDLRAANILVGENLVCKVADFG 325
Query: 330 CAGHIPETD 338
A I + +
Sbjct: 326 LARLIEDNE 334
>pdb|1Y57|A Chain A, Structure Of Unphosphorylated C-Src In Complex With An
Inhibitor
Length = 452
Score = 32.3 bits (72), Expect = 0.44, Method: Compositional matrix adjust.
Identities = 25/129 (19%), Positives = 56/129 (43%), Gaps = 7/129 (5%)
Query: 210 VTRLNPSSQGVKEFINDVNTLASLQHPNLCKLLGFHARDGSDQRMLIYERLFHGSLDRLI 269
+ L P + + F+ + + L+H L +L +A + ++ E + GSL +
Sbjct: 213 IKTLKPGTMSPEAFLQEAQVMKKLRHEKLVQL---YAVVSEEPIYIVTEYMSKGSLLDFL 269
Query: 270 YGRSDGPPIDWNTRVKIALCAAQGLTFLHEEGPFQAMYNEFSTANIQIDKDFSAKLSGYG 329
G + G + V +A A G+ ++ ++ + ANI + ++ K++ +G
Sbjct: 270 KGET-GKYLRLPQLVDMAAQIASGMAYVER---MNYVHRDLRAANILVGENLVCKVADFG 325
Query: 330 CAGHIPETD 338
A I + +
Sbjct: 326 LARLIEDNE 334
>pdb|2UV2|A Chain A, Crystal Structure Of Human Ste20-Like Kinase Bound To
4-(4-(
5-Cyclopropyl-1h-Pyrazol-3-Ylamino)-Quinazolin-2-
Ylamino)- Phenyl)-Acetonitrile
Length = 287
Score = 32.3 bits (72), Expect = 0.45, Method: Compositional matrix adjust.
Identities = 29/128 (22%), Positives = 59/128 (46%), Gaps = 15/128 (11%)
Query: 216 SSQGVKEFINDVNTLASLQHPNLCKLL-GFHARDGSDQRMLIYERLFHGSLDRLIYGRSD 274
S + +++++ +++ LAS HPN+ KLL F+ + ++ E G++D ++
Sbjct: 47 SEEELEDYMVEIDILASCDHPNIVKLLDAFYYENN---LWILIEFCAGGAVDAVMLELE- 102
Query: 275 GPPIDWNTRVKIALCAAQ---GLTFLHEEGPFQAMYNEFSTANIQIDKDFSAKLSGYGCA 331
P+ T +I + Q L +LH+ + ++ + NI D KL+ +G +
Sbjct: 103 -RPL---TESQIQVVCKQTLDALNYLHDN---KIIHRDLKAGNILFTLDGDIKLADFGVS 155
Query: 332 GHIPETDI 339
T I
Sbjct: 156 AKNTRTXI 163
>pdb|3DQW|A Chain A, C-Src Kinase Domain Thr338ile Mutant In Complex With Atpgs
pdb|3DQW|B Chain B, C-Src Kinase Domain Thr338ile Mutant In Complex With Atpgs
pdb|3DQW|C Chain C, C-Src Kinase Domain Thr338ile Mutant In Complex With Atpgs
pdb|3DQW|D Chain D, C-Src Kinase Domain Thr338ile Mutant In Complex With Atpgs
Length = 286
Score = 32.3 bits (72), Expect = 0.46, Method: Compositional matrix adjust.
Identities = 25/131 (19%), Positives = 55/131 (41%), Gaps = 7/131 (5%)
Query: 208 ATVTRLNPSSQGVKEFINDVNTLASLQHPNLCKLLGFHARDGSDQRMLIYERLFHGSLDR 267
+ L P + + F+ + + L+H L +L +A + ++ E + GSL
Sbjct: 45 VAIKTLKPGTMSPEAFLQEAQVMKKLRHEKLVQL---YAVVSEEPIYIVIEYMSKGSLLD 101
Query: 268 LIYGRSDGPPIDWNTRVKIALCAAQGLTFLHEEGPFQAMYNEFSTANIQIDKDFSAKLSG 327
+ G G + V +A A G+ ++ ++ + ANI + ++ K++
Sbjct: 102 FLKGEM-GKYLRLPQLVDMAAQIASGMAYVER---MNYVHRDLRAANILVGENLVCKVAD 157
Query: 328 YGCAGHIPETD 338
+G A I + +
Sbjct: 158 FGLARLIEDNE 168
>pdb|3G6H|A Chain A, Src Thr338ile Inhibited In The Dfg-Asp-Out Conformation
pdb|3G6H|B Chain B, Src Thr338ile Inhibited In The Dfg-Asp-Out Conformation
Length = 286
Score = 32.0 bits (71), Expect = 0.49, Method: Compositional matrix adjust.
Identities = 25/131 (19%), Positives = 55/131 (41%), Gaps = 7/131 (5%)
Query: 208 ATVTRLNPSSQGVKEFINDVNTLASLQHPNLCKLLGFHARDGSDQRMLIYERLFHGSLDR 267
+ L P + + F+ + + L+H L +L +A + ++ E + GSL
Sbjct: 45 VAIKTLKPGTMSPEAFLQEAQVMKKLRHEKLVQL---YAVVSEEPIYIVIEYMSKGSLLD 101
Query: 268 LIYGRSDGPPIDWNTRVKIALCAAQGLTFLHEEGPFQAMYNEFSTANIQIDKDFSAKLSG 327
+ G G + V +A A G+ ++ ++ + ANI + ++ K++
Sbjct: 102 FLKGEM-GKYLRLPQLVDMAAQIASGMAYVER---MNYVHRDLRAANILVGENLVCKVAD 157
Query: 328 YGCAGHIPETD 338
+G A I + +
Sbjct: 158 FGLARLIEDNE 168
>pdb|4GT4|A Chain A, Structure Of Unliganded, Inactive Ror2 Kinase Domain
pdb|4GT4|B Chain B, Structure Of Unliganded, Inactive Ror2 Kinase Domain
Length = 308
Score = 32.0 bits (71), Expect = 0.50, Method: Compositional matrix adjust.
Identities = 32/122 (26%), Positives = 51/122 (41%), Gaps = 18/122 (14%)
Query: 221 KEFINDVNTLASLQHPNLCKLLGFHARDGSDQRMLIYERLFHGSLDRLIYGR---SDGPP 277
+EF ++ A LQHPN+ LLG +D +I+ HG L + R SD
Sbjct: 74 EEFRHEAMLRARLQHPNVVCLLGVVTKD--QPLSMIFSYCSHGDLHEFLVMRSPHSDVGS 131
Query: 278 IDWNTRVKIAL----------CAAQGLTFLHEEGPFQAMYNEFSTANIQIDKDFSAKLSG 327
D + VK AL A G+ +L ++ + +T N+ + + K+S
Sbjct: 132 TDDDRTVKSALEPPDFVHLVAQIAAGMEYLSSH---HVVHKDLATRNVLVYDKLNVKISD 188
Query: 328 YG 329
G
Sbjct: 189 LG 190
>pdb|3ZZW|A Chain A, Crystal Structure Of The Kinase Domain Of Ror2
pdb|3ZZW|B Chain B, Crystal Structure Of The Kinase Domain Of Ror2
Length = 289
Score = 32.0 bits (71), Expect = 0.51, Method: Compositional matrix adjust.
Identities = 32/122 (26%), Positives = 51/122 (41%), Gaps = 18/122 (14%)
Query: 221 KEFINDVNTLASLQHPNLCKLLGFHARDGSDQRMLIYERLFHGSLDRLIYGR---SDGPP 277
+EF ++ A LQHPN+ LLG +D +I+ HG L + R SD
Sbjct: 57 EEFRHEAMLRARLQHPNVVCLLGVVTKD--QPLSMIFSYCSHGDLHEFLVMRSPHSDVGS 114
Query: 278 IDWNTRVKIAL----------CAAQGLTFLHEEGPFQAMYNEFSTANIQIDKDFSAKLSG 327
D + VK AL A G+ +L ++ + +T N+ + + K+S
Sbjct: 115 TDDDRTVKSALEPPDFVHLVAQIAAGMEYLSSH---HVVHKDLATRNVLVYDKLNVKISD 171
Query: 328 YG 329
G
Sbjct: 172 LG 173
>pdb|3FE3|A Chain A, Crystal Structure Of The Kinase Mark3PAR-1: T211a-S215a
Double Mutant
pdb|3FE3|B Chain B, Crystal Structure Of The Kinase Mark3PAR-1: T211a-S215a
Double Mutant
Length = 328
Score = 32.0 bits (71), Expect = 0.53, Method: Compositional matrix adjust.
Identities = 25/119 (21%), Positives = 54/119 (45%), Gaps = 10/119 (8%)
Query: 211 TRLNPSSQGVKEFINDVNTLASLQHPNLCKLLGFHARDGSDQRMLIYERLFHGSLDRLIY 270
T+LNP+S +++ +V + L HPN+ KL F + LI E G + +
Sbjct: 51 TQLNPTS--LQKLFREVRIMKILNHPNIVKL--FEVIETEKTLYLIMEYASGGEVFDYLV 106
Query: 271 GRSDGPPIDWNTRVKIALCAAQGLTFLHEEGPFQAMYNEFSTANIQIDKDFSAKLSGYG 329
+ ++ + + A Q + H++ + ++ + N+ +D D + K++ +G
Sbjct: 107 AHGRMKEKEARSKFRQIVSAVQ---YCHQK---RIVHRDLKAENLLLDADMNIKIADFG 159
>pdb|2QNJ|A Chain A, Kinase And Ubiquitin-Associated Domains Of Mark3PAR-1
pdb|2QNJ|B Chain B, Kinase And Ubiquitin-Associated Domains Of Mark3PAR-1
Length = 328
Score = 32.0 bits (71), Expect = 0.54, Method: Compositional matrix adjust.
Identities = 25/119 (21%), Positives = 54/119 (45%), Gaps = 10/119 (8%)
Query: 211 TRLNPSSQGVKEFINDVNTLASLQHPNLCKLLGFHARDGSDQRMLIYERLFHGSLDRLIY 270
T+LNP+S +++ +V + L HPN+ KL F + LI E G + +
Sbjct: 48 TQLNPTS--LQKLFREVRIMKILNHPNIVKL--FEVIETEKTLYLIMEYASGGEVFDYLV 103
Query: 271 GRSDGPPIDWNTRVKIALCAAQGLTFLHEEGPFQAMYNEFSTANIQIDKDFSAKLSGYG 329
+ ++ + + A Q + H++ + ++ + N+ +D D + K++ +G
Sbjct: 104 AHGRMKEKEARSKFRQIVSAVQ---YCHQK---RIVHRDLKAENLLLDADMNIKIADFG 156
>pdb|2J51|A Chain A, Crystal Structure Of Human Ste20-Like Kinase Bound To 5-
Amino-3-((4-(Aminosulfonyl)phenyl)amino)-N-(2,6-
Difluorophenyl)-1h-1,2,4-Triazole-1-Carbothioamide
Length = 325
Score = 32.0 bits (71), Expect = 0.55, Method: Compositional matrix adjust.
Identities = 27/121 (22%), Positives = 57/121 (47%), Gaps = 15/121 (12%)
Query: 216 SSQGVKEFINDVNTLASLQHPNLCKLL-GFHARDGSDQRMLIYERLFHGSLDRLIYGRSD 274
S + +++++ +++ LAS HPN+ KLL F+ + ++ E G++D ++
Sbjct: 74 SEEELEDYMVEIDILASCDHPNIVKLLDAFYYENN---LWILIEFCAGGAVDAVMLELE- 129
Query: 275 GPPIDWNTRVKIALCAAQ---GLTFLHEEGPFQAMYNEFSTANIQIDKDFSAKLSGYGCA 331
P+ T +I + Q L +LH+ + ++ + NI D KL+ +G +
Sbjct: 130 -RPL---TESQIQVVCKQTLDALNYLHDN---KIIHRDLKAGNILFTLDGDIKLADFGVS 182
Query: 332 G 332
Sbjct: 183 A 183
>pdb|3U4W|A Chain A, Src In Complex With Dna-Templated Macrocyclic Inhibitor
Mc4b
pdb|3U51|A Chain A, Src In Complex With Dna-Templated Macrocyclic Inhibitor
Mc1
pdb|3U51|B Chain B, Src In Complex With Dna-Templated Macrocyclic Inhibitor
Mc1
Length = 275
Score = 32.0 bits (71), Expect = 0.56, Method: Compositional matrix adjust.
Identities = 25/131 (19%), Positives = 55/131 (41%), Gaps = 7/131 (5%)
Query: 208 ATVTRLNPSSQGVKEFINDVNTLASLQHPNLCKLLGFHARDGSDQRMLIYERLFHGSLDR 267
+ L P + + F+ + + L+H L +L +A + ++ E + GSL
Sbjct: 34 VAIKTLKPGTMSPEAFLQEAQVMKKLRHEKLVQL---YAVVSEEPIYIVTEYMSKGSLLD 90
Query: 268 LIYGRSDGPPIDWNTRVKIALCAAQGLTFLHEEGPFQAMYNEFSTANIQIDKDFSAKLSG 327
+ G G + V +A A G+ ++ ++ + ANI + ++ K++
Sbjct: 91 FLKGEM-GKYLRLPQLVDMAAQIASGMAYVER---MNYVHRDLRAANILVGENLVCKVAD 146
Query: 328 YGCAGHIPETD 338
+G A I + +
Sbjct: 147 FGLARLIEDNE 157
>pdb|1KSW|A Chain A, Structure Of Human C-Src Tyrosine Kinase (Thr338gly
Mutant) In Complex With N6-Benzyl Adp
Length = 452
Score = 32.0 bits (71), Expect = 0.57, Method: Compositional matrix adjust.
Identities = 25/129 (19%), Positives = 56/129 (43%), Gaps = 7/129 (5%)
Query: 210 VTRLNPSSQGVKEFINDVNTLASLQHPNLCKLLGFHARDGSDQRMLIYERLFHGSLDRLI 269
+ L P + + F+ + + L+H L +L +A + ++ E + GSL +
Sbjct: 213 IKTLKPGTMSPEAFLQEAQVMKKLRHEKLVQL---YAVVSEEPIYIVGEYMSKGSLLDFL 269
Query: 270 YGRSDGPPIDWNTRVKIALCAAQGLTFLHEEGPFQAMYNEFSTANIQIDKDFSAKLSGYG 329
G + G + V +A A G+ ++ ++ + ANI + ++ K++ +G
Sbjct: 270 KGET-GKYLRLPQLVDMAAQIASGMAYVER---MNYVHRDLRAANILVGENLVCKVADFG 325
Query: 330 CAGHIPETD 338
A I + +
Sbjct: 326 LARLIEDNE 334
>pdb|3D7U|B Chain B, Structural Basis For The Recognition Of C-Src By Its
Inactivator Csk
pdb|3D7U|D Chain D, Structural Basis For The Recognition Of C-Src By Its
Inactivator Csk
Length = 277
Score = 32.0 bits (71), Expect = 0.60, Method: Compositional matrix adjust.
Identities = 25/131 (19%), Positives = 55/131 (41%), Gaps = 7/131 (5%)
Query: 208 ATVTRLNPSSQGVKEFINDVNTLASLQHPNLCKLLGFHARDGSDQRMLIYERLFHGSLDR 267
+ L P + + F+ + + L+H L +L +A + ++ E + GSL
Sbjct: 36 VAIKTLKPGTMSPEAFLQEAQVMKKLRHEKLVQL---YAVVSEEPIYIVTEYMSKGSLLD 92
Query: 268 LIYGRSDGPPIDWNTRVKIALCAAQGLTFLHEEGPFQAMYNEFSTANIQIDKDFSAKLSG 327
+ G G + V +A A G+ ++ ++ + ANI + ++ K++
Sbjct: 93 FLKGEM-GKYLRLPQLVDMAAQIASGMAYVER---MNYVHRDLRAANILVGENLVCKVAD 148
Query: 328 YGCAGHIPETD 338
+G A I + +
Sbjct: 149 FGLARLIEDNE 159
>pdb|2JFM|A Chain A, Crystal Structure Of Human Ste20-Like Kinase (Unliganded
Form)
Length = 325
Score = 32.0 bits (71), Expect = 0.62, Method: Compositional matrix adjust.
Identities = 27/121 (22%), Positives = 57/121 (47%), Gaps = 15/121 (12%)
Query: 216 SSQGVKEFINDVNTLASLQHPNLCKLL-GFHARDGSDQRMLIYERLFHGSLDRLIYGRSD 274
S + +++++ +++ LAS HPN+ KLL F+ + ++ E G++D ++
Sbjct: 74 SEEELEDYMVEIDILASCDHPNIVKLLDAFYYENN---LWILIEFCAGGAVDAVMLELE- 129
Query: 275 GPPIDWNTRVKIALCAAQ---GLTFLHEEGPFQAMYNEFSTANIQIDKDFSAKLSGYGCA 331
P+ T +I + Q L +LH+ + ++ + NI D KL+ +G +
Sbjct: 130 -RPL---TESQIQVVCKQTLDALNYLHDN---KIIHRDLKAGNILFTLDGDIKLADFGVS 182
Query: 332 G 332
Sbjct: 183 A 183
>pdb|3IKA|A Chain A, Crystal Structure Of Egfr 696-1022 T790m Mutant Covalently
Binding To Wz4002
pdb|3IKA|B Chain B, Crystal Structure Of Egfr 696-1022 T790m Mutant Covalently
Binding To Wz4002
Length = 331
Score = 32.0 bits (71), Expect = 0.62, Method: Compositional matrix adjust.
Identities = 25/116 (21%), Positives = 54/116 (46%), Gaps = 8/116 (6%)
Query: 216 SSQGVKEFINDVNTLASLQHPNLCKLLGFHARDGSDQRMLIYERLFHGSLDRLIYGRSDG 275
S + KE +++ +AS+ +P++C+LLG + LI + + G L L Y R
Sbjct: 61 SPKANKEILDEAYVMASVDNPHVCRLLGICL---TSTVQLIMQLMPFGCL--LDYVREHK 115
Query: 276 PPIDWNTRVKIALCAAQGLTFLHEEGPFQAMYNEFSTANIQIDKDFSAKLSGYGCA 331
I + + A+G+ +L + + ++ + + N+ + K++ +G A
Sbjct: 116 DNIGSQYLLNWCVQIAKGMNYLEDR---RLVHRDLAARNVLVKTPQHVKITDFGLA 168
>pdb|2JFL|A Chain A, Crystal Structure Of Human Ste20-Like Kinase (
Diphosphorylated Form) Bound To 5- Amino-3-((4-(
Aminosulfonyl)phenyl)amino)-N-(2,6-
Difluorophenyl)-1h-1,2, 4-Triazole-1-Carbothioamide
Length = 325
Score = 32.0 bits (71), Expect = 0.62, Method: Compositional matrix adjust.
Identities = 27/121 (22%), Positives = 57/121 (47%), Gaps = 15/121 (12%)
Query: 216 SSQGVKEFINDVNTLASLQHPNLCKLL-GFHARDGSDQRMLIYERLFHGSLDRLIYGRSD 274
S + +++++ +++ LAS HPN+ KLL F+ + ++ E G++D ++
Sbjct: 74 SEEELEDYMVEIDILASCDHPNIVKLLDAFYYENN---LWILIEFCAGGAVDAVMLELE- 129
Query: 275 GPPIDWNTRVKIALCAAQ---GLTFLHEEGPFQAMYNEFSTANIQIDKDFSAKLSGYGCA 331
P+ T +I + Q L +LH+ + ++ + NI D KL+ +G +
Sbjct: 130 -RPL---TESQIQVVCKQTLDALNYLHDN---KIIHRDLKAGNILFTLDGDIKLADFGVS 182
Query: 332 G 332
Sbjct: 183 A 183
>pdb|2JIV|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation In
Compex With Hki-272
pdb|2JIV|B Chain B, Crystal Structure Of Egfr Kinase Domain T790m Mutation In
Compex With Hki-272
Length = 328
Score = 32.0 bits (71), Expect = 0.63, Method: Compositional matrix adjust.
Identities = 25/116 (21%), Positives = 54/116 (46%), Gaps = 8/116 (6%)
Query: 216 SSQGVKEFINDVNTLASLQHPNLCKLLGFHARDGSDQRMLIYERLFHGSLDRLIYGRSDG 275
S + KE +++ +AS+ +P++C+LLG + LI + + G L L Y R
Sbjct: 58 SPKANKEILDEAYVMASVDNPHVCRLLGICL---TSTVQLIMQLMPFGXL--LDYVREHK 112
Query: 276 PPIDWNTRVKIALCAAQGLTFLHEEGPFQAMYNEFSTANIQIDKDFSAKLSGYGCA 331
I + + A+G+ +L + + ++ + + N+ + K++ +G A
Sbjct: 113 DNIGSQYLLNWCVQIAKGMNYLEDR---RLVHRDLAARNVLVKTPQHVKITDFGLA 165
>pdb|2OIQ|A Chain A, Crystal Structure Of Chicken C-Src Kinase Domain In
Complex With The Cancer Drug Imatinib.
pdb|2OIQ|B Chain B, Crystal Structure Of Chicken C-Src Kinase Domain In
Complex With The Cancer Drug Imatinib.
pdb|3D7T|B Chain B, Structural Basis For The Recognition Of C-Src By Its
Inactivator Csk
pdb|3DQX|A Chain A, Chicken C-Src Kinase Domain In Complex With Atpgs
pdb|3DQX|B Chain B, Chicken C-Src Kinase Domain In Complex With Atpgs
pdb|3EN4|A Chain A, Targeted Polypharmacology: Crystal Structure Of The C-Src
Kinase Domain In Complex With Pp121, A Multitargeted
Kinase Inhibitor
pdb|3EN4|B Chain B, Targeted Polypharmacology: Crystal Structure Of The C-Src
Kinase Domain In Complex With Pp121, A Multitargeted
Kinase Inhibitor
pdb|3EN5|A Chain A, Targeted Polypharmacology: Crystal Structure Of The C-Src
Kinase Domain In Complex With Pp494, A Multitargeted
Kinase Inhibitor
pdb|3EN5|B Chain B, Targeted Polypharmacology: Crystal Structure Of The C-Src
Kinase Domain In Complex With Pp494, A Multitargeted
Kinase Inhibitor
pdb|3EN6|A Chain A, Targeted Polypharmacology: Crystal Structure Of The C-Src
Kinase Domain In Complex With Pp102, A Multitargeted
Kinase Inhibitor
pdb|3EN6|B Chain B, Targeted Polypharmacology: Crystal Structure Of The C-Src
Kinase Domain In Complex With Pp102, A Multitargeted
Kinase Inhibitor
pdb|3EN7|A Chain A, Targeted Polypharmacology: Crystal Structure Of The C-Src
Kinase Domain In Complex With S1, A Multitargeted Kinase
Inhibitor
pdb|3EN7|B Chain B, Targeted Polypharmacology: Crystal Structure Of The C-Src
Kinase Domain In Complex With S1, A Multitargeted Kinase
Inhibitor
pdb|3EL7|A Chain A, Crystal Structure Of C-Src In Complex With
Pyrazolopyrimidine 3
pdb|3EL8|A Chain A, Crystal Structure Of C-Src In Complex With
Pyrazolopyrimidine 5
pdb|3EL8|B Chain B, Crystal Structure Of C-Src In Complex With
Pyrazolopyrimidine 5
pdb|3F6X|A Chain A, C-Src Kinase Domain In Complex With Small Molecule
Inhibitor
pdb|3F6X|B Chain B, C-Src Kinase Domain In Complex With Small Molecule
Inhibitor
pdb|3F6X|C Chain C, C-Src Kinase Domain In Complex With Small Molecule
Inhibitor
pdb|3F6X|D Chain D, C-Src Kinase Domain In Complex With Small Molecule
Inhibitor
pdb|3G6G|A Chain A, Equally Potent Inhibition Of C-Src And Abl By Compounds
That Recognize Inactive Kinase Conformations
pdb|3G6G|B Chain B, Equally Potent Inhibition Of C-Src And Abl By Compounds
That Recognize Inactive Kinase Conformations
pdb|4AGW|A Chain A, Discovery Of A Small Molecule Type Ii Inhibitor Of Wild-
Type And Gatekeeper Mutants Of Bcr-Abl, Pdgfralpha, Kit,
And Src Kinases
pdb|4AGW|B Chain B, Discovery Of A Small Molecule Type Ii Inhibitor Of Wild-
Type And Gatekeeper Mutants Of Bcr-Abl, Pdgfralpha, Kit,
And Src Kinases
pdb|3UQF|A Chain A, C-Src Kinase Domain In Complex With Bki Rm-1-89
pdb|3UQF|B Chain B, C-Src Kinase Domain In Complex With Bki Rm-1-89
pdb|3UQG|A Chain A, C-Src Kinase Domain In Complex With Bumpless Bki Analog
Uw1243
pdb|3UQG|B Chain B, C-Src Kinase Domain In Complex With Bumpless Bki Analog
Uw1243
pdb|4DGG|A Chain A, C-Src Kinase Domain In Complex With Rm-1-176
pdb|4DGG|B Chain B, C-Src Kinase Domain In Complex With Rm-1-176
Length = 286
Score = 31.6 bits (70), Expect = 0.65, Method: Compositional matrix adjust.
Identities = 25/131 (19%), Positives = 55/131 (41%), Gaps = 7/131 (5%)
Query: 208 ATVTRLNPSSQGVKEFINDVNTLASLQHPNLCKLLGFHARDGSDQRMLIYERLFHGSLDR 267
+ L P + + F+ + + L+H L +L +A + ++ E + GSL
Sbjct: 45 VAIKTLKPGTMSPEAFLQEAQVMKKLRHEKLVQL---YAVVSEEPIYIVTEYMSKGSLLD 101
Query: 268 LIYGRSDGPPIDWNTRVKIALCAAQGLTFLHEEGPFQAMYNEFSTANIQIDKDFSAKLSG 327
+ G G + V +A A G+ ++ ++ + ANI + ++ K++
Sbjct: 102 FLKGEM-GKYLRLPQLVDMAAQIASGMAYVER---MNYVHRDLRAANILVGENLVCKVAD 157
Query: 328 YGCAGHIPETD 338
+G A I + +
Sbjct: 158 FGLARLIEDNE 168
>pdb|3UG1|A Chain A, Crystal Structure Of The Mutated Egfr Kinase Domain
(G719sT790M) IN The Apo Form
pdb|3UG2|A Chain A, Crystal Structure Of The Mutated Egfr Kinase Domain
(G719sT790M) IN Complex With Gefitinib
pdb|3VJN|A Chain A, Crystal Structure Of The Mutated Egfr Kinase Domain
(G719sT790M) IN Complex With Amppnp
Length = 334
Score = 31.6 bits (70), Expect = 0.67, Method: Compositional matrix adjust.
Identities = 25/116 (21%), Positives = 54/116 (46%), Gaps = 8/116 (6%)
Query: 216 SSQGVKEFINDVNTLASLQHPNLCKLLGFHARDGSDQRMLIYERLFHGSLDRLIYGRSDG 275
S + KE +++ +AS+ +P++C+LLG + LI + + G L L Y R
Sbjct: 64 SPKANKEILDEAYVMASVDNPHVCRLLGICL---TSTVQLIMQLMPFGCL--LDYVREHK 118
Query: 276 PPIDWNTRVKIALCAAQGLTFLHEEGPFQAMYNEFSTANIQIDKDFSAKLSGYGCA 331
I + + A+G+ +L + + ++ + + N+ + K++ +G A
Sbjct: 119 DNIGSQYLLNWCVQIAKGMNYLEDR---RLVHRDLAARNVLVKTPQHVKITDFGLA 171
>pdb|3QGW|A Chain A, Crystal Structure Of Itk Kinase Bound To An Inhibitor
pdb|3QGW|B Chain B, Crystal Structure Of Itk Kinase Bound To An Inhibitor
pdb|3QGY|A Chain A, Crystal Structure Of Itk Inhibitor Complex
pdb|3QGY|B Chain B, Crystal Structure Of Itk Inhibitor Complex
Length = 286
Score = 31.6 bits (70), Expect = 0.67, Method: Compositional matrix adjust.
Identities = 26/125 (20%), Positives = 51/125 (40%), Gaps = 7/125 (5%)
Query: 205 KFEATVTRLNPSSQGVKEFINDVNTLASLQHPNLCKLLGFHARDGSDQRMLIYERLFHGS 264
K + + + S +FI + + L HP L +L G L++E + HG
Sbjct: 51 KDKVAIKTIKEGSMSEDDFIEEAEVMMKLSHPKLVQLYGVCLEQAP--ICLVFEFMEHGC 108
Query: 265 LDRLIYGRSDGPPIDWNTRVKIALCAAQGLTFLHEEGPFQAMYNEFSTANIQIDKDFSAK 324
L Y R+ T + + L +G+ +L E ++ + + N + ++ K
Sbjct: 109 LSD--YLRTQRGLFAAETLLGMCLDVCEGMAYLEEAC---VIHRDLAARNCLVGENQVIK 163
Query: 325 LSGYG 329
+S +G
Sbjct: 164 VSDFG 168
>pdb|2JIU|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation In
Complex With Aee788
pdb|2JIU|B Chain B, Crystal Structure Of Egfr Kinase Domain T790m Mutation In
Complex With Aee788
Length = 328
Score = 31.6 bits (70), Expect = 0.68, Method: Compositional matrix adjust.
Identities = 25/116 (21%), Positives = 54/116 (46%), Gaps = 8/116 (6%)
Query: 216 SSQGVKEFINDVNTLASLQHPNLCKLLGFHARDGSDQRMLIYERLFHGSLDRLIYGRSDG 275
S + KE +++ +AS+ +P++C+LLG + LI + + G L L Y R
Sbjct: 58 SPKANKEILDEAYVMASVDNPHVCRLLGICL---TSTVQLIMQLMPFGCL--LDYVREHK 112
Query: 276 PPIDWNTRVKIALCAAQGLTFLHEEGPFQAMYNEFSTANIQIDKDFSAKLSGYGCA 331
I + + A+G+ +L + + ++ + + N+ + K++ +G A
Sbjct: 113 DNIGSQYLLNWCVQIAKGMNYLEDR---RLVHRDLAARNVLVKTPQHVKITDFGLA 165
>pdb|3MIY|A Chain A, X-Ray Crystal Structure Of Itk Complexed With Sunitinib
pdb|3MIY|B Chain B, X-Ray Crystal Structure Of Itk Complexed With Sunitinib
pdb|3MJ1|A Chain A, X-Ray Crystal Structure Of Itk Complexed With Inhibitor
Ro5191614
pdb|3MJ2|A Chain A, X-Ray Crystal Structure Of Itk Complexed With Inhibitor
Bms-509744
Length = 266
Score = 31.6 bits (70), Expect = 0.70, Method: Compositional matrix adjust.
Identities = 25/125 (20%), Positives = 52/125 (41%), Gaps = 7/125 (5%)
Query: 205 KFEATVTRLNPSSQGVKEFINDVNTLASLQHPNLCKLLGFHARDGSDQRMLIYERLFHGS 264
K + + + + ++FI + + L HP L +L G L++E + HG
Sbjct: 31 KDKVAIKTIREGAMSEEDFIEEAEVMMKLSHPKLVQLYGVCLEQAP--ICLVFEFMEHGC 88
Query: 265 LDRLIYGRSDGPPIDWNTRVKIALCAAQGLTFLHEEGPFQAMYNEFSTANIQIDKDFSAK 324
L Y R+ T + + L +G+ +L E ++ + + N + ++ K
Sbjct: 89 LSD--YLRTQRGLFAAETLLGMCLDVCEGMAYLEEA---SVIHRDLAARNCLVGENQVIK 143
Query: 325 LSGYG 329
+S +G
Sbjct: 144 VSDFG 148
>pdb|4G5P|A Chain A, Crystal Structure Of Egfr Kinase T790m In Complex With
Bibw2992
pdb|4G5P|B Chain B, Crystal Structure Of Egfr Kinase T790m In Complex With
Bibw2992
Length = 330
Score = 31.6 bits (70), Expect = 0.71, Method: Compositional matrix adjust.
Identities = 25/116 (21%), Positives = 54/116 (46%), Gaps = 8/116 (6%)
Query: 216 SSQGVKEFINDVNTLASLQHPNLCKLLGFHARDGSDQRMLIYERLFHGSLDRLIYGRSDG 275
S + KE +++ +AS+ +P++C+LLG + LI + + G L L Y R
Sbjct: 60 SPKANKEILDEAYVMASVDNPHVCRLLGICL---TSTVQLIMQLMPFGCL--LDYVREHK 114
Query: 276 PPIDWNTRVKIALCAAQGLTFLHEEGPFQAMYNEFSTANIQIDKDFSAKLSGYGCA 331
I + + A+G+ +L + + ++ + + N+ + K++ +G A
Sbjct: 115 DNIGSQYLLNWCVQIAKGMNYLEDR---RLVHRDLAARNVLVKTPQHVKITDFGLA 167
>pdb|4I24|A Chain A, Structure Of T790m Egfr Kinase Domain Co-crystallized With
Dacomitinib
pdb|4I24|B Chain B, Structure Of T790m Egfr Kinase Domain Co-crystallized With
Dacomitinib
Length = 329
Score = 31.6 bits (70), Expect = 0.73, Method: Compositional matrix adjust.
Identities = 25/116 (21%), Positives = 54/116 (46%), Gaps = 8/116 (6%)
Query: 216 SSQGVKEFINDVNTLASLQHPNLCKLLGFHARDGSDQRMLIYERLFHGSLDRLIYGRSDG 275
S + KE +++ +AS+ +P++C+LLG + LI + + G L L Y R
Sbjct: 59 SPKANKEILDEAYVMASVDNPHVCRLLGICL---TSTVQLIMQLMPFGCL--LDYVREHK 113
Query: 276 PPIDWNTRVKIALCAAQGLTFLHEEGPFQAMYNEFSTANIQIDKDFSAKLSGYGCA 331
I + + A+G+ +L + + ++ + + N+ + K++ +G A
Sbjct: 114 DNIGSQYLLNWCVQIAKGMNYLEDR---RLVHRDLAARNVLVKTPQHVKITDFGLA 166
>pdb|2JIT|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation
pdb|2JIT|B Chain B, Crystal Structure Of Egfr Kinase Domain T790m Mutation
Length = 327
Score = 31.6 bits (70), Expect = 0.74, Method: Compositional matrix adjust.
Identities = 25/116 (21%), Positives = 54/116 (46%), Gaps = 8/116 (6%)
Query: 216 SSQGVKEFINDVNTLASLQHPNLCKLLGFHARDGSDQRMLIYERLFHGSLDRLIYGRSDG 275
S + KE +++ +AS+ +P++C+LLG + LI + + G L L Y R
Sbjct: 57 SPKANKEILDEAYVMASVDNPHVCRLLGICL---TSTVQLIMQLMPFGCL--LDYVREHK 111
Query: 276 PPIDWNTRVKIALCAAQGLTFLHEEGPFQAMYNEFSTANIQIDKDFSAKLSGYGCA 331
I + + A+G+ +L + + ++ + + N+ + K++ +G A
Sbjct: 112 DNIGSQYLLNWCVQIAKGMNYLEDR---RLVHRDLAARNVLVKTPQHVKITDFGLA 164
>pdb|3GOP|A Chain A, Crystal Structure Of The Egf Receptor Juxtamembrane And
Kinase Domains
Length = 361
Score = 31.6 bits (70), Expect = 0.80, Method: Compositional matrix adjust.
Identities = 25/116 (21%), Positives = 54/116 (46%), Gaps = 8/116 (6%)
Query: 216 SSQGVKEFINDVNTLASLQHPNLCKLLGFHARDGSDQRMLIYERLFHGSLDRLIYGRSDG 275
S + KE +++ +AS+ +P++C+LLG + LI + + G L L Y R
Sbjct: 91 SPKANKEILDEAYVMASVDNPHVCRLLGICL---TSTVQLITQLMPFGCL--LDYVREHK 145
Query: 276 PPIDWNTRVKIALCAAQGLTFLHEEGPFQAMYNEFSTANIQIDKDFSAKLSGYGCA 331
I + + A+G+ +L + + ++ + + N+ + K++ +G A
Sbjct: 146 DNIGSQYLLNWCVQIAKGMNYLEDR---RLVHRDLAARNVLVKTPQHVKITDFGLA 198
>pdb|1YOL|A Chain A, Crystal Structure Of Src Kinase Domain In Complex With
Cgp77675
pdb|1YOL|B Chain B, Crystal Structure Of Src Kinase Domain In Complex With
Cgp77675
Length = 283
Score = 31.6 bits (70), Expect = 0.81, Method: Compositional matrix adjust.
Identities = 24/131 (18%), Positives = 56/131 (42%), Gaps = 7/131 (5%)
Query: 208 ATVTRLNPSSQGVKEFINDVNTLASLQHPNLCKLLGFHARDGSDQRMLIYERLFHGSLDR 267
+ L P + + F+ + + L+H L +L +A + ++ E + GSL
Sbjct: 42 VAIKTLKPGTMSPEAFLQEAQVMKKLRHEKLVQL---YAVVSEEPIYIVTEYMNKGSLLD 98
Query: 268 LIYGRSDGPPIDWNTRVKIALCAAQGLTFLHEEGPFQAMYNEFSTANIQIDKDFSAKLSG 327
+ G + G + V ++ A G+ ++ ++ + ANI + ++ K++
Sbjct: 99 FLKGET-GKYLRLPQLVDMSAQIASGMAYVER---MNYVHRDLRAANILVGENLVCKVAD 154
Query: 328 YGCAGHIPETD 338
+G A I + +
Sbjct: 155 FGLARLIEDNE 165
>pdb|1U5Q|A Chain A, Crystal Structure Of The Tao2 Kinase Domain: Activation
And Specifity Of A Ste20p Map3k
pdb|1U5Q|B Chain B, Crystal Structure Of The Tao2 Kinase Domain: Activation
And Specifity Of A Ste20p Map3k
pdb|1U5R|A Chain A, Crystal Structure Of The Tao2 Kinase Domain: Activation
And Specifity Of A Ste20p Map3k
pdb|1U5R|B Chain B, Crystal Structure Of The Tao2 Kinase Domain: Activation
And Specifity Of A Ste20p Map3k
Length = 348
Score = 31.6 bits (70), Expect = 0.81, Method: Compositional matrix adjust.
Identities = 27/116 (23%), Positives = 49/116 (42%), Gaps = 8/116 (6%)
Query: 216 SSQGVKEFINDVNTLASLQHPNLCKLLGFHARDGSDQRMLIYERLFHGSLDRLIYGRSDG 275
S++ ++ I +V L L+HPN + G + R+ + L+ E + D L +
Sbjct: 94 SNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLREHT--AWLVMEYCLGSASDLLEVHKK-- 149
Query: 276 PPIDWNTRVKIALCAAQGLTFLHEEGPFQAMYNEFSTANIQIDKDFSAKLSGYGCA 331
P+ + A QGL +LH ++ + NI + + KL +G A
Sbjct: 150 -PLQEVEIAAVTHGALQGLAYLHSH---NMIHRDVKAGNILLSEPGLVKLGDFGSA 201
>pdb|3SVV|A Chain A, Crystal Structure Of T338c C-Src Covalently Bound To
Vinylsulfonamide- Pyrazolopyrimidine 9
pdb|3SVV|B Chain B, Crystal Structure Of T338c C-Src Covalently Bound To
Vinylsulfonamide- Pyrazolopyrimidine 9
Length = 286
Score = 31.6 bits (70), Expect = 0.81, Method: Compositional matrix adjust.
Identities = 25/131 (19%), Positives = 55/131 (41%), Gaps = 7/131 (5%)
Query: 208 ATVTRLNPSSQGVKEFINDVNTLASLQHPNLCKLLGFHARDGSDQRMLIYERLFHGSLDR 267
+ L P + + F+ + + L+H L +L +A + ++ E + GSL
Sbjct: 45 VAIKTLKPGTMSPEAFLQEAQVMKKLRHEKLVQL---YAVVSEEPIYIVCEYMSKGSLLD 101
Query: 268 LIYGRSDGPPIDWNTRVKIALCAAQGLTFLHEEGPFQAMYNEFSTANIQIDKDFSAKLSG 327
+ G G + V +A A G+ ++ ++ + ANI + ++ K++
Sbjct: 102 FLKGEM-GKYLRLPQLVDMAAQIASGMAYVER---MNYVHRDLRAANILVGENLVCKVAD 157
Query: 328 YGCAGHIPETD 338
+G A I + +
Sbjct: 158 FGLARLIEDNE 168
>pdb|1YOJ|A Chain A, Crystal Structure Of Src Kinase Domain
pdb|1YOJ|B Chain B, Crystal Structure Of Src Kinase Domain
pdb|1YOM|A Chain A, Crystal Structure Of Src Kinase Domain In Complex With
Purvalanol A
pdb|1YOM|B Chain B, Crystal Structure Of Src Kinase Domain In Complex With
Purvalanol A
Length = 283
Score = 31.2 bits (69), Expect = 0.86, Method: Compositional matrix adjust.
Identities = 24/131 (18%), Positives = 56/131 (42%), Gaps = 7/131 (5%)
Query: 208 ATVTRLNPSSQGVKEFINDVNTLASLQHPNLCKLLGFHARDGSDQRMLIYERLFHGSLDR 267
+ L P + + F+ + + L+H L +L +A + ++ E + GSL
Sbjct: 42 VAIKTLKPGTMSPEAFLQEAQVMKKLRHEKLVQL---YAVVSEEPIYIVTEYMNKGSLLD 98
Query: 268 LIYGRSDGPPIDWNTRVKIALCAAQGLTFLHEEGPFQAMYNEFSTANIQIDKDFSAKLSG 327
+ G + G + V ++ A G+ ++ ++ + ANI + ++ K++
Sbjct: 99 FLKGET-GKYLRLPQLVDMSAQIASGMAYVER---MNYVHRDLRAANILVGENLVCKVAD 154
Query: 328 YGCAGHIPETD 338
+G A I + +
Sbjct: 155 FGLARLIEDNE 165
>pdb|1SM2|A Chain A, Crystal Structure Of The Phosphorylated Interleukin-2
Tyrosine Kinase Catalytic Domain
pdb|1SM2|B Chain B, Crystal Structure Of The Phosphorylated Interleukin-2
Tyrosine Kinase Catalytic Domain
pdb|1SNU|A Chain A, Crystal Structure Of The Unphosphorylated Interleukin-2
Tyrosine Kinase Catalytic Domain
pdb|1SNU|B Chain B, Crystal Structure Of The Unphosphorylated Interleukin-2
Tyrosine Kinase Catalytic Domain
pdb|1SNX|A Chain A, Crystal Structure Of Apo Interleukin-2 Tyrosine Kinase
Catalytic Domain
pdb|1SNX|B Chain B, Crystal Structure Of Apo Interleukin-2 Tyrosine Kinase
Catalytic Domain
Length = 264
Score = 31.2 bits (69), Expect = 0.86, Method: Compositional matrix adjust.
Identities = 25/125 (20%), Positives = 52/125 (41%), Gaps = 7/125 (5%)
Query: 205 KFEATVTRLNPSSQGVKEFINDVNTLASLQHPNLCKLLGFHARDGSDQRMLIYERLFHGS 264
K + + + + ++FI + + L HP L +L G L++E + HG
Sbjct: 29 KDKVAIKTIREGAMSEEDFIEEAEVMMKLSHPKLVQLYGVCLEQAP--ICLVFEFMEHGC 86
Query: 265 LDRLIYGRSDGPPIDWNTRVKIALCAAQGLTFLHEEGPFQAMYNEFSTANIQIDKDFSAK 324
L Y R+ T + + L +G+ +L E ++ + + N + ++ K
Sbjct: 87 LSD--YLRTQRGLFAAETLLGMCLDVCEGMAYLEEAC---VIHRDLAARNCLVGENQVIK 141
Query: 325 LSGYG 329
+S +G
Sbjct: 142 VSDFG 146
>pdb|3V5J|A Chain A, Crystal Structure Of Interleukin-2 Inducible T-Cell Kinase
Itk Catalytic Domain With Thienopyrazolylindole
Inhibitor 090
pdb|3V5J|B Chain B, Crystal Structure Of Interleukin-2 Inducible T-Cell Kinase
Itk Catalytic Domain With Thienopyrazolylindole
Inhibitor 090
pdb|3V5L|A Chain A, Crystal Structure Of Interleukin-2 Inducible T-Cell Kinase
Itk Catalytic Domain With Thienopyrazolylindole
Inhibitor 542
pdb|3V5L|B Chain B, Crystal Structure Of Interleukin-2 Inducible T-Cell Kinase
Itk Catalytic Domain With Thienopyrazolylindole
Inhibitor 542
pdb|3V5L|C Chain C, Crystal Structure Of Interleukin-2 Inducible T-Cell Kinase
Itk Catalytic Domain With Thienopyrazolylindole
Inhibitor 542
pdb|3V5L|D Chain D, Crystal Structure Of Interleukin-2 Inducible T-Cell Kinase
Itk Catalytic Domain With Thienopyrazolylindole
Inhibitor 542
pdb|3V8T|A Chain A, Crystal Structure Of Interleukin-2 Inducible T-Cell Kinase
Itk Catalytic Domain With Thienopyrazolylindole
Inhibitor 477
pdb|3V8T|B Chain B, Crystal Structure Of Interleukin-2 Inducible T-Cell Kinase
Itk Catalytic Domain With Thienopyrazolylindole
Inhibitor 477
pdb|3V8W|A Chain A, Crystal Structure Of Interleukin-2 Inducible T-Cell Kinase
Itk Catalytic Domain With Thienopyrazolylindole
Inhibitor 469
pdb|3V8W|B Chain B, Crystal Structure Of Interleukin-2 Inducible T-Cell Kinase
Itk Catalytic Domain With Thienopyrazolylindole
Inhibitor 469
Length = 266
Score = 31.2 bits (69), Expect = 0.87, Method: Compositional matrix adjust.
Identities = 25/125 (20%), Positives = 52/125 (41%), Gaps = 7/125 (5%)
Query: 205 KFEATVTRLNPSSQGVKEFINDVNTLASLQHPNLCKLLGFHARDGSDQRMLIYERLFHGS 264
K + + + + ++FI + + L HP L +L G L++E + HG
Sbjct: 31 KDKVAIKTIREGAMSEEDFIEEAEVMMKLSHPKLVQLYGVCLEQAP--ICLVFEFMEHGC 88
Query: 265 LDRLIYGRSDGPPIDWNTRVKIALCAAQGLTFLHEEGPFQAMYNEFSTANIQIDKDFSAK 324
L Y R+ T + + L +G+ +L E ++ + + N + ++ K
Sbjct: 89 LSD--YLRTQRGLFAAETLLGMCLDVCEGMAYLEEAC---VIHRDLAARNCLVGENQVIK 143
Query: 325 LSGYG 329
+S +G
Sbjct: 144 VSDFG 148
>pdb|4HJO|A Chain A, Crystal Structure Of The Inactive Egfr Tyrosine Kinase
Domain With Erlotinib
Length = 337
Score = 31.2 bits (69), Expect = 0.89, Method: Compositional matrix adjust.
Identities = 25/116 (21%), Positives = 54/116 (46%), Gaps = 8/116 (6%)
Query: 216 SSQGVKEFINDVNTLASLQHPNLCKLLGFHARDGSDQRMLIYERLFHGSLDRLIYGRSDG 275
S + KE +++ +AS+ +P++C+LLG + LI + + G L L Y R
Sbjct: 67 SPKANKEILDEAYVMASVDNPHVCRLLGICL---TSTVQLITQLMPFGCL--LDYVREHK 121
Query: 276 PPIDWNTRVKIALCAAQGLTFLHEEGPFQAMYNEFSTANIQIDKDFSAKLSGYGCA 331
I + + A+G+ +L + + ++ + + N+ + K++ +G A
Sbjct: 122 DNIGSQYLLNWCVQIAKGMNYLEDR---RLVHRDLAARNVLVKTPQHVKITDFGLA 174
>pdb|2ITN|A Chain A, Crystal Structure Of Egfr Kinase Domain G719s Mutation In
Complex With Amp-Pnp
pdb|2ITO|A Chain A, Crystal Structure Of Egfr Kinase Domain G719s Mutation In
Complex With Iressa
pdb|2ITP|A Chain A, Crystal Structure Of Egfr Kinase Domain G719s Mutation In
Complex With Aee788
pdb|2ITQ|A Chain A, Crystal Structure Of Egfr Kinase Domain G719s Mutation In
Complex With Afn941
Length = 327
Score = 31.2 bits (69), Expect = 0.89, Method: Compositional matrix adjust.
Identities = 25/116 (21%), Positives = 54/116 (46%), Gaps = 8/116 (6%)
Query: 216 SSQGVKEFINDVNTLASLQHPNLCKLLGFHARDGSDQRMLIYERLFHGSLDRLIYGRSDG 275
S + KE +++ +AS+ +P++C+LLG + LI + + G L L Y R
Sbjct: 57 SPKANKEILDEAYVMASVDNPHVCRLLGICL---TSTVQLITQLMPFGCL--LDYVREHK 111
Query: 276 PPIDWNTRVKIALCAAQGLTFLHEEGPFQAMYNEFSTANIQIDKDFSAKLSGYGCA 331
I + + A+G+ +L + + ++ + + N+ + K++ +G A
Sbjct: 112 DNIGSQYLLNWCVQIAKGMNYLEDR---RLVHRDLAARNVLVKTPQHVKITDFGLA 164
>pdb|2J5E|A Chain A, Crystal Structure Of Egfr Kinase Domain In Complex With An
Irreversible Inhibitor 13-Jab
Length = 327
Score = 31.2 bits (69), Expect = 0.89, Method: Compositional matrix adjust.
Identities = 25/116 (21%), Positives = 54/116 (46%), Gaps = 8/116 (6%)
Query: 216 SSQGVKEFINDVNTLASLQHPNLCKLLGFHARDGSDQRMLIYERLFHGSLDRLIYGRSDG 275
S + KE +++ +AS+ +P++C+LLG + LI + + G L L Y R
Sbjct: 57 SPKANKEILDEAYVMASVDNPHVCRLLGICL---TSTVQLITQLMPFGXL--LDYVREHK 111
Query: 276 PPIDWNTRVKIALCAAQGLTFLHEEGPFQAMYNEFSTANIQIDKDFSAKLSGYGCA 331
I + + A+G+ +L + + ++ + + N+ + K++ +G A
Sbjct: 112 DNIGSQYLLNWCVQIAKGMNYLEDR---RLVHRDLAARNVLVKTPQHVKITDFGLA 164
>pdb|2RFD|A Chain A, Crystal Structure Of The Complex Between The Egfr Kinase
Domain And A Mig6 Peptide
pdb|2RFD|B Chain B, Crystal Structure Of The Complex Between The Egfr Kinase
Domain And A Mig6 Peptide
pdb|2RFE|A Chain A, Crystal Structure Of The Complex Between The Egfr Kinase
Domain And A Mig6 Peptide
pdb|2RFE|B Chain B, Crystal Structure Of The Complex Between The Egfr Kinase
Domain And A Mig6 Peptide
pdb|2RFE|C Chain C, Crystal Structure Of The Complex Between The Egfr Kinase
Domain And A Mig6 Peptide
pdb|2RFE|D Chain D, Crystal Structure Of The Complex Between The Egfr Kinase
Domain And A Mig6 Peptide
Length = 324
Score = 31.2 bits (69), Expect = 0.93, Method: Compositional matrix adjust.
Identities = 25/116 (21%), Positives = 54/116 (46%), Gaps = 8/116 (6%)
Query: 216 SSQGVKEFINDVNTLASLQHPNLCKLLGFHARDGSDQRMLIYERLFHGSLDRLIYGRSDG 275
S + KE +++ +AS+ +P++C+LLG + LI + + G L L Y R
Sbjct: 54 SPKANKEILDEAYVMASVDNPHVCRLLGICL---TSTVQLITQLMPFGCL--LDYVREHK 108
Query: 276 PPIDWNTRVKIALCAAQGLTFLHEEGPFQAMYNEFSTANIQIDKDFSAKLSGYGCA 331
I + + A+G+ +L + + ++ + + N+ + K++ +G A
Sbjct: 109 DNIGSQYLLNWCVQIAEGMNYLEDR---RLVHRDLAARNVLVKTPQHVKITDFGLA 161
>pdb|4APC|A Chain A, Crystal Structure Of Human Nima-Related Kinase 1 (Nek1)
pdb|4APC|B Chain B, Crystal Structure Of Human Nima-Related Kinase 1 (Nek1)
pdb|4B9D|A Chain A, Crystal Structure Of Human Nima-Related Kinase 1 (Nek1)
With Inhibitor.
pdb|4B9D|B Chain B, Crystal Structure Of Human Nima-Related Kinase 1 (Nek1)
With Inhibitor
Length = 350
Score = 31.2 bits (69), Expect = 0.95, Method: Compositional matrix adjust.
Identities = 29/130 (22%), Positives = 57/130 (43%), Gaps = 18/130 (13%)
Query: 207 EATVTRLNPSSQGVKEFINDVNTLASLQHPNLCKLLGFHARDGSDQRMLIYERLFHGSLD 266
E ++R+ SS+ +E +V LA+++HPN+ + +GS ++ + G L
Sbjct: 56 EINISRM--SSKEREESRREVAVLANMKHPNIVQYRESFEENGS--LYIVMDYCEGGDLF 111
Query: 267 RLIYGR-----SDGPPIDWNTRVKIALCAAQGLTFLHEEGPFQAMYNEFSTANIQIDKDF 321
+ I + + +DW ++ +AL LH + + NI + KD
Sbjct: 112 KRINAQKGVLFQEDQILDWFVQICLALKHVHDRKILHR---------DIKSQNIFLTKDG 162
Query: 322 SAKLSGYGCA 331
+ +L +G A
Sbjct: 163 TVQLGDFGIA 172
>pdb|2EB2|A Chain A, Crystal Structure Of Mutated Egfr Kinase Domain (G719s)
Length = 334
Score = 31.2 bits (69), Expect = 0.95, Method: Compositional matrix adjust.
Identities = 25/116 (21%), Positives = 54/116 (46%), Gaps = 8/116 (6%)
Query: 216 SSQGVKEFINDVNTLASLQHPNLCKLLGFHARDGSDQRMLIYERLFHGSLDRLIYGRSDG 275
S + KE +++ +AS+ +P++C+LLG + LI + + G L L Y R
Sbjct: 64 SPKANKEILDEAYVMASVDNPHVCRLLGICL---TSTVQLITQLMPFGCL--LDYVREHK 118
Query: 276 PPIDWNTRVKIALCAAQGLTFLHEEGPFQAMYNEFSTANIQIDKDFSAKLSGYGCA 331
I + + A+G+ +L + + ++ + + N+ + K++ +G A
Sbjct: 119 DNIGSQYLLNWCVQIAKGMNYLEDR---RLVHRDLAARNVLVKTPQHVKITDFGLA 171
>pdb|4H1J|A Chain A, Crystal Structure Of Pyk2 With The Pyrazole 13a
pdb|4H1M|A Chain A, Crystal Structure Of Pyk2 With The Indole 10c
Length = 293
Score = 31.2 bits (69), Expect = 0.96, Method: Compositional matrix adjust.
Identities = 27/159 (16%), Positives = 64/159 (40%), Gaps = 8/159 (5%)
Query: 180 DRCISEGLSSVMYRASFGDDASTSKKFEATVTRLNPSSQGVKEFINDVNTLASLQHPNLC 239
+R + EG +Y + + + + + ++F+++ + +L HP++
Sbjct: 29 NRILGEGFFGEVYEGVYTNHKGEKINVAVKTCKKDCTLDNKEKFMSEAVIMKNLDHPHIV 88
Query: 240 KLLGFHARDGSDQRMLIYERLFHGSLDRLIYGRSDGPPIDWNTRVKIALCAAQGLTFLHE 299
KL+G + + +I E +G L Y + + T V +L + + +L
Sbjct: 89 KLIGIIEEEPT---WIIMELYPYGELGH--YLERNKNSLKVLTLVLYSLQICKAMAYLES 143
Query: 300 EGPFQAMYNEFSTANIQIDKDFSAKLSGYGCAGHIPETD 338
++ + + NI + KL +G + +I + D
Sbjct: 144 ---INCVHRDIAVRNILVASPECVKLGDFGLSRYIEDED 179
>pdb|2J5F|A Chain A, Crystal Structure Of Egfr Kinase Domain In Complex With An
Irreversible Inhibitor 34-Jab
pdb|2ITW|A Chain A, Crystal Structure Of Egfr Kinase Domain In Complex With
Afn941
pdb|2ITX|A Chain A, Crystal Structure Of Egfr Kinase Domain In Complex With
Amp- Pnp
pdb|2ITY|A Chain A, Crystal Structure Of Egfr Kinase Domain In Complex With
Iressa
pdb|2J6M|A Chain A, Crystal Structure Of Egfr Kinase Domain In Complex With
Aee788
pdb|3POZ|A Chain A, Egfr Kinase Domain Complexed With Tak-285
Length = 327
Score = 31.2 bits (69), Expect = 0.96, Method: Compositional matrix adjust.
Identities = 25/116 (21%), Positives = 54/116 (46%), Gaps = 8/116 (6%)
Query: 216 SSQGVKEFINDVNTLASLQHPNLCKLLGFHARDGSDQRMLIYERLFHGSLDRLIYGRSDG 275
S + KE +++ +AS+ +P++C+LLG + LI + + G L L Y R
Sbjct: 57 SPKANKEILDEAYVMASVDNPHVCRLLGICL---TSTVQLITQLMPFGCL--LDYVREHK 111
Query: 276 PPIDWNTRVKIALCAAQGLTFLHEEGPFQAMYNEFSTANIQIDKDFSAKLSGYGCA 331
I + + A+G+ +L + + ++ + + N+ + K++ +G A
Sbjct: 112 DNIGSQYLLNWCVQIAKGMNYLEDR---RLVHRDLAARNVLVKTPQHVKITDFGLA 164
>pdb|2GCD|A Chain A, Tao2 Kinase Domain-Staurosporine Structure
pdb|2GCD|B Chain B, Tao2 Kinase Domain-Staurosporine Structure
Length = 309
Score = 31.2 bits (69), Expect = 1.00, Method: Compositional matrix adjust.
Identities = 27/116 (23%), Positives = 49/116 (42%), Gaps = 8/116 (6%)
Query: 216 SSQGVKEFINDVNTLASLQHPNLCKLLGFHARDGSDQRMLIYERLFHGSLDRLIYGRSDG 275
S++ ++ I +V L L+HPN + G + R+ + L+ E + D L +
Sbjct: 55 SNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLREHT--AWLVMEYCLGSASDLLEVHKK-- 110
Query: 276 PPIDWNTRVKIALCAAQGLTFLHEEGPFQAMYNEFSTANIQIDKDFSAKLSGYGCA 331
P+ + A QGL +LH ++ + NI + + KL +G A
Sbjct: 111 -PLQEVEIAAVTHGALQGLAYLHSHN---MIHRDVKAGNILLSEPGLVKLGDFGSA 162
>pdb|2GS7|A Chain A, Crystal Structure Of The Inactive Egfr Kinase Domain In
Complex With Amp-Pnp
pdb|2GS7|B Chain B, Crystal Structure Of The Inactive Egfr Kinase Domain In
Complex With Amp-Pnp
pdb|3GT8|A Chain A, Crystal Structure Of The Inactive Egfr Kinase Domain In
Complex With Amp-Pnp
pdb|3GT8|B Chain B, Crystal Structure Of The Inactive Egfr Kinase Domain In
Complex With Amp-Pnp
pdb|3GT8|C Chain C, Crystal Structure Of The Inactive Egfr Kinase Domain In
Complex With Amp-Pnp
pdb|3GT8|D Chain D, Crystal Structure Of The Inactive Egfr Kinase Domain In
Complex With Amp-Pnp
Length = 330
Score = 31.2 bits (69), Expect = 1.00, Method: Compositional matrix adjust.
Identities = 25/116 (21%), Positives = 54/116 (46%), Gaps = 8/116 (6%)
Query: 216 SSQGVKEFINDVNTLASLQHPNLCKLLGFHARDGSDQRMLIYERLFHGSLDRLIYGRSDG 275
S + KE +++ +AS+ +P++C+LLG + LI + + G L L Y R
Sbjct: 60 SPKANKEILDEAYVMASVDNPHVCRLLGICL---TSTVQLITQLMPFGCL--LDYVREHK 114
Query: 276 PPIDWNTRVKIALCAAQGLTFLHEEGPFQAMYNEFSTANIQIDKDFSAKLSGYGCA 331
I + + A+G+ +L + + ++ + + N+ + K++ +G A
Sbjct: 115 DNIGSQYLLNWCVQIAKGMNYLEDR---RLVHRDLAARNVLVKTPQHVKITDFGLA 167
>pdb|1M14|A Chain A, Tyrosine Kinase Domain From Epidermal Growth Factor
Receptor
pdb|1M17|A Chain A, Epidermal Growth Factor Receptor Tyrosine Kinase Domain
With 4-Anilinoquinazoline Inhibitor Erlotinib
Length = 333
Score = 31.2 bits (69), Expect = 1.0, Method: Compositional matrix adjust.
Identities = 25/116 (21%), Positives = 54/116 (46%), Gaps = 8/116 (6%)
Query: 216 SSQGVKEFINDVNTLASLQHPNLCKLLGFHARDGSDQRMLIYERLFHGSLDRLIYGRSDG 275
S + KE +++ +AS+ +P++C+LLG + LI + + G L L Y R
Sbjct: 63 SPKANKEILDEAYVMASVDNPHVCRLLGICL---TSTVQLITQLMPFGCL--LDYVREHK 117
Query: 276 PPIDWNTRVKIALCAAQGLTFLHEEGPFQAMYNEFSTANIQIDKDFSAKLSGYGCA 331
I + + A+G+ +L + + ++ + + N+ + K++ +G A
Sbjct: 118 DNIGSQYLLNWCVQIAKGMNYLEDR---RLVHRDLAARNVLVKTPQHVKITDFGLA 170
>pdb|4G5J|A Chain A, Crystal Structure Of Egfr Kinase In Complex With Bibw2992
Length = 330
Score = 31.2 bits (69), Expect = 1.0, Method: Compositional matrix adjust.
Identities = 25/116 (21%), Positives = 54/116 (46%), Gaps = 8/116 (6%)
Query: 216 SSQGVKEFINDVNTLASLQHPNLCKLLGFHARDGSDQRMLIYERLFHGSLDRLIYGRSDG 275
S + KE +++ +AS+ +P++C+LLG + LI + + G L L Y R
Sbjct: 60 SPKANKEILDEAYVMASVDNPHVCRLLGICL---TSTVQLITQLMPFGCL--LDYVREHK 114
Query: 276 PPIDWNTRVKIALCAAQGLTFLHEEGPFQAMYNEFSTANIQIDKDFSAKLSGYGCA 331
I + + A+G+ +L + + ++ + + N+ + K++ +G A
Sbjct: 115 DNIGSQYLLNWCVQIAKGMNYLEDR---RLVHRDLAARNVLVKTPQHVKITDFGLA 167
>pdb|3BEL|A Chain A, X-Ray Structure Of Egfr In Complex With Oxime Inhibitor
pdb|2RGP|A Chain A, Structure Of Egfr In Complex With Hydrazone, A Potent Dual
Inhibitor
Length = 315
Score = 31.2 bits (69), Expect = 1.0, Method: Compositional matrix adjust.
Identities = 25/116 (21%), Positives = 54/116 (46%), Gaps = 8/116 (6%)
Query: 216 SSQGVKEFINDVNTLASLQHPNLCKLLGFHARDGSDQRMLIYERLFHGSLDRLIYGRSDG 275
S + KE +++ +AS+ +P++C+LLG + LI + + G L L Y R
Sbjct: 51 SPKANKEILDEAYVMASVDNPHVCRLLGICL---TSTVQLITQLMPFGCL--LDYVREHK 105
Query: 276 PPIDWNTRVKIALCAAQGLTFLHEEGPFQAMYNEFSTANIQIDKDFSAKLSGYGCA 331
I + + A+G+ +L + + ++ + + N+ + K++ +G A
Sbjct: 106 DNIGSQYLLNWCVQIAKGMNYLEDR---RLVHRDLAARNVLVKTPQHVKITDFGLA 158
>pdb|4I23|A Chain A, Crystal Structure Of The Wild-type Egfr Kinase Domain In
Complex With Dacomitinib (soaked)
Length = 329
Score = 31.2 bits (69), Expect = 1.0, Method: Compositional matrix adjust.
Identities = 25/116 (21%), Positives = 54/116 (46%), Gaps = 8/116 (6%)
Query: 216 SSQGVKEFINDVNTLASLQHPNLCKLLGFHARDGSDQRMLIYERLFHGSLDRLIYGRSDG 275
S + KE +++ +AS+ +P++C+LLG + LI + + G L L Y R
Sbjct: 59 SPKANKEILDEAYVMASVDNPHVCRLLGICL---TSTVQLITQLMPFGCL--LDYVREHK 113
Query: 276 PPIDWNTRVKIALCAAQGLTFLHEEGPFQAMYNEFSTANIQIDKDFSAKLSGYGCA 331
I + + A+G+ +L + + ++ + + N+ + K++ +G A
Sbjct: 114 DNIGSQYLLNWCVQIAKGMNYLEDR---RLVHRDLAARNVLVKTPQHVKITDFGLA 166
>pdb|3VJO|A Chain A, Crystal Structure Of The Wild-Type Egfr Kinase Domain In
Complex With Amppnp
Length = 334
Score = 31.2 bits (69), Expect = 1.0, Method: Compositional matrix adjust.
Identities = 25/116 (21%), Positives = 54/116 (46%), Gaps = 8/116 (6%)
Query: 216 SSQGVKEFINDVNTLASLQHPNLCKLLGFHARDGSDQRMLIYERLFHGSLDRLIYGRSDG 275
S + KE +++ +AS+ +P++C+LLG + LI + + G L L Y R
Sbjct: 64 SPKANKEILDEAYVMASVDNPHVCRLLGICL---TSTVQLITQLMPFGCL--LDYVREHK 118
Query: 276 PPIDWNTRVKIALCAAQGLTFLHEEGPFQAMYNEFSTANIQIDKDFSAKLSGYGCA 331
I + + A+G+ +L + + ++ + + N+ + K++ +G A
Sbjct: 119 DNIGSQYLLNWCVQIAKGMNYLEDR---RLVHRDLAARNVLVKTPQHVKITDFGLA 171
>pdb|3FZO|A Chain A, Crystal Structure Of Pyk2-Apo, Proline-Rich Tyrosine
Kinase
pdb|3FZP|A Chain A, Crystal Structure Of Pyk2 Complexed With Atpgs
pdb|3FZR|A Chain A, Crystal Structure Of Pyk2 Complexed With Pf-431396
pdb|3FZS|A Chain A, Crystal Structure Of Pyk2 Complexed With Birb796
pdb|3FZT|A Chain A, Crystal Structure Of Pyk2 Complexed With Pf-4618433
pdb|3H3C|A Chain A, Crystal Structure Of Pyk2 In Complex With Sulfoximine-
Substituted Trifluoromethylpyrimidine Analog
pdb|3ET7|A Chain A, Crystal Structure Of Pyk2 Complexed With Pf-2318841
Length = 277
Score = 31.2 bits (69), Expect = 1.0, Method: Compositional matrix adjust.
Identities = 27/159 (16%), Positives = 64/159 (40%), Gaps = 8/159 (5%)
Query: 180 DRCISEGLSSVMYRASFGDDASTSKKFEATVTRLNPSSQGVKEFINDVNTLASLQHPNLC 239
+R + EG +Y + + + + + ++F+++ + +L HP++
Sbjct: 13 NRILGEGFFGEVYEGVYTNHKGEKINVAVKTCKKDCTLDNKEKFMSEAVIMKNLDHPHIV 72
Query: 240 KLLGFHARDGSDQRMLIYERLFHGSLDRLIYGRSDGPPIDWNTRVKIALCAAQGLTFLHE 299
KL+G + + +I E +G L Y + + T V +L + + +L
Sbjct: 73 KLIGIIEEEPT---WIIMELYPYGELGH--YLERNKNSLKVLTLVLYSLQICKAMAYLES 127
Query: 300 EGPFQAMYNEFSTANIQIDKDFSAKLSGYGCAGHIPETD 338
++ + + NI + KL +G + +I + D
Sbjct: 128 ---INCVHRDIAVRNILVASPECVKLGDFGLSRYIEDED 163
>pdb|1XKK|A Chain A, Egfr Kinase Domain Complexed With A Quinazoline Inhibitor-
Gw572016
Length = 352
Score = 31.2 bits (69), Expect = 1.0, Method: Compositional matrix adjust.
Identities = 25/116 (21%), Positives = 54/116 (46%), Gaps = 8/116 (6%)
Query: 216 SSQGVKEFINDVNTLASLQHPNLCKLLGFHARDGSDQRMLIYERLFHGSLDRLIYGRSDG 275
S + KE +++ +AS+ +P++C+LLG + LI + + G L L Y R
Sbjct: 82 SPKANKEILDEAYVMASVDNPHVCRLLGICL---TSTVQLITQLMPFGCL--LDYVREHK 136
Query: 276 PPIDWNTRVKIALCAAQGLTFLHEEGPFQAMYNEFSTANIQIDKDFSAKLSGYGCA 331
I + + A+G+ +L + + ++ + + N+ + K++ +G A
Sbjct: 137 DNIGSQYLLNWCVQIAKGMNYLEDR---RLVHRDLAARNVLVKTPQHVKITDFGLA 189
>pdb|4HCT|A Chain A, Crystal Structure Of Itk In Complex With Compound 52
pdb|4HCU|A Chain A, Crystal Structure Of Itk In Complext With Compound 40
pdb|4HCV|A Chain A, Crystal Structure Of Itk In Complex With Compound 53
Length = 269
Score = 31.2 bits (69), Expect = 1.0, Method: Compositional matrix adjust.
Identities = 25/125 (20%), Positives = 52/125 (41%), Gaps = 7/125 (5%)
Query: 205 KFEATVTRLNPSSQGVKEFINDVNTLASLQHPNLCKLLGFHARDGSDQRMLIYERLFHGS 264
K + + + + ++FI + + L HP L +L G L++E + HG
Sbjct: 34 KDKVAIKTIREGAMSEEDFIEEAEVMMKLSHPKLVQLYGVCLEQAP--ICLVFEFMEHGC 91
Query: 265 LDRLIYGRSDGPPIDWNTRVKIALCAAQGLTFLHEEGPFQAMYNEFSTANIQIDKDFSAK 324
L Y R+ T + + L +G+ +L E ++ + + N + ++ K
Sbjct: 92 LSD--YLRTQRGLFAAETLLGMCLDVCEGMAYLEEAC---VIHRDLAARNCLVGENQVIK 146
Query: 325 LSGYG 329
+S +G
Sbjct: 147 VSDFG 151
>pdb|2GS2|A Chain A, Crystal Structure Of The Active Egfr Kinase Domain
pdb|2GS6|A Chain A, Crystal Structure Of The Active Egfr Kinase Domain In
Complex With An Atp Analog-Peptide Conjugate
pdb|2RF9|A Chain A, Crystal Structure Of The Complex Between The Egfr Kinase
Domain And A Mig6 Peptide
pdb|2RF9|B Chain B, Crystal Structure Of The Complex Between The Egfr Kinase
Domain And A Mig6 Peptide
pdb|3W2S|A Chain A, Egfr Kinase Domain With Compound4
Length = 330
Score = 31.2 bits (69), Expect = 1.1, Method: Compositional matrix adjust.
Identities = 25/116 (21%), Positives = 54/116 (46%), Gaps = 8/116 (6%)
Query: 216 SSQGVKEFINDVNTLASLQHPNLCKLLGFHARDGSDQRMLIYERLFHGSLDRLIYGRSDG 275
S + KE +++ +AS+ +P++C+LLG + LI + + G L L Y R
Sbjct: 60 SPKANKEILDEAYVMASVDNPHVCRLLGICL---TSTVQLITQLMPFGCL--LDYVREHK 114
Query: 276 PPIDWNTRVKIALCAAQGLTFLHEEGPFQAMYNEFSTANIQIDKDFSAKLSGYGCA 331
I + + A+G+ +L + + ++ + + N+ + K++ +G A
Sbjct: 115 DNIGSQYLLNWCVQIAKGMNYLEDR---RLVHRDLAARNVLVKTPQHVKITDFGLA 167
>pdb|3LZB|A Chain A, Egfr Kinase Domain Complexed With An
Imidazo[2,1-B]thiazole Inhibitor
pdb|3LZB|B Chain B, Egfr Kinase Domain Complexed With An
Imidazo[2,1-B]thiazole Inhibitor
pdb|3LZB|C Chain C, Egfr Kinase Domain Complexed With An
Imidazo[2,1-B]thiazole Inhibitor
pdb|3LZB|D Chain D, Egfr Kinase Domain Complexed With An
Imidazo[2,1-B]thiazole Inhibitor
pdb|3LZB|E Chain E, Egfr Kinase Domain Complexed With An
Imidazo[2,1-B]thiazole Inhibitor
pdb|3LZB|F Chain F, Egfr Kinase Domain Complexed With An
Imidazo[2,1-B]thiazole Inhibitor
pdb|3LZB|G Chain G, Egfr Kinase Domain Complexed With An
Imidazo[2,1-B]thiazole Inhibitor
pdb|3LZB|H Chain H, Egfr Kinase Domain Complexed With An
Imidazo[2,1-B]thiazole Inhibitor
Length = 327
Score = 30.8 bits (68), Expect = 1.1, Method: Compositional matrix adjust.
Identities = 25/116 (21%), Positives = 54/116 (46%), Gaps = 8/116 (6%)
Query: 216 SSQGVKEFINDVNTLASLQHPNLCKLLGFHARDGSDQRMLIYERLFHGSLDRLIYGRSDG 275
S + KE +++ +AS+ +P++C+LLG + LI + + G L L Y R
Sbjct: 57 SPKANKEILDEAYVMASVDNPHVCRLLGICL---TSTVQLITQLMPFGCL--LDYVREHK 111
Query: 276 PPIDWNTRVKIALCAAQGLTFLHEEGPFQAMYNEFSTANIQIDKDFSAKLSGYGCA 331
I + + A+G+ +L + + ++ + + N+ + K++ +G A
Sbjct: 112 DNIGSQYLLNWCVQIAKGMNYLEDR---RLVHRDLAARNVLVKTPQHVKITDFGLA 164
>pdb|3CC6|A Chain A, Crystal Structure Of Kinase Domain Of Protein Tyrosine
Kinase 2 Beta (ptk2b)
Length = 281
Score = 30.8 bits (68), Expect = 1.1, Method: Compositional matrix adjust.
Identities = 27/159 (16%), Positives = 64/159 (40%), Gaps = 8/159 (5%)
Query: 180 DRCISEGLSSVMYRASFGDDASTSKKFEATVTRLNPSSQGVKEFINDVNTLASLQHPNLC 239
+R + EG +Y + + + + + ++F+++ + +L HP++
Sbjct: 17 NRILGEGFFGEVYEGVYTNHKGEKINVAVKTCKKDCTLDNKEKFMSEAVIMKNLDHPHIV 76
Query: 240 KLLGFHARDGSDQRMLIYERLFHGSLDRLIYGRSDGPPIDWNTRVKIALCAAQGLTFLHE 299
KL+G + + +I E +G L Y + + T V +L + + +L
Sbjct: 77 KLIGIIEEEPT---WIIMELYPYGELGH--YLERNKNSLKVLTLVLYSLQICKAMAYLES 131
Query: 300 EGPFQAMYNEFSTANIQIDKDFSAKLSGYGCAGHIPETD 338
++ + + NI + KL +G + +I + D
Sbjct: 132 ---INCVHRDIAVRNILVASPECVKLGDFGLSRYIEDED 167
>pdb|4E1Z|A Chain A, Structure Of Mouse Tyk-2 Complexed To A 3-Aminoindazole
Inhibitor
Length = 291
Score = 30.8 bits (68), Expect = 1.1, Method: Compositional matrix adjust.
Identities = 27/114 (23%), Positives = 47/114 (41%), Gaps = 13/114 (11%)
Query: 226 DVNTLASLQHPNLCKLLGFHARDGSDQRMLIYERLFHGSLDRLIYGRSDGPPIDWNTRVK 285
++ L +L H ++ K G G L+ E + GSL D P +
Sbjct: 61 EIEILRTLYHEHIVKYKGCCEDQGEKSVQLVMEYVPLGSL-------RDYLPRHCVGLAQ 113
Query: 286 IALCAAQ---GLTFLHEEGPFQAMYNEFSTANIQIDKDFSAKLSGYGCAGHIPE 336
+ L A Q G+ +LH + ++ + N+ +D D K+ +G A +PE
Sbjct: 114 LLLFAQQICEGMAYLHAQ---HYIHRALAARNVLLDNDRLVKIGDFGLAKAVPE 164
>pdb|4E20|A Chain A, Structure Of Mouse Tyk-2 Complexed To A 3-Aminoindazole
Inhibitor
Length = 290
Score = 30.8 bits (68), Expect = 1.2, Method: Compositional matrix adjust.
Identities = 27/114 (23%), Positives = 47/114 (41%), Gaps = 13/114 (11%)
Query: 226 DVNTLASLQHPNLCKLLGFHARDGSDQRMLIYERLFHGSLDRLIYGRSDGPPIDWNTRVK 285
++ L +L H ++ K G G L+ E + GSL D P +
Sbjct: 60 EIEILRTLYHEHIVKYKGCCEDQGEKSVQLVMEYVPLGSL-------RDYLPRHCVGLAQ 112
Query: 286 IALCAAQ---GLTFLHEEGPFQAMYNEFSTANIQIDKDFSAKLSGYGCAGHIPE 336
+ L A Q G+ +LH + ++ + N+ +D D K+ +G A +PE
Sbjct: 113 LLLFAQQICEGMAYLHAQ---HYIHRALAARNVLLDNDRLVKIGDFGLAKAVPE 163
>pdb|3W2O|A Chain A, Egfr Kinase Domain T790m/l858r Mutant With Tak-285
pdb|3W2P|A Chain A, Egfr Kinase Domain T790m/l858r Mutant With Compound 2
pdb|3W2Q|A Chain A, Egfr Kinase Domain T790m/l858r Mutant With Hki-272
pdb|3W2R|A Chain A, Egfr Kinase Domain T790m/l858r Mutant With Compound 4
Length = 331
Score = 30.8 bits (68), Expect = 1.3, Method: Compositional matrix adjust.
Identities = 25/116 (21%), Positives = 54/116 (46%), Gaps = 8/116 (6%)
Query: 216 SSQGVKEFINDVNTLASLQHPNLCKLLGFHARDGSDQRMLIYERLFHGSLDRLIYGRSDG 275
S + KE +++ +AS+ +P++C+LLG + LI + + G L L Y R
Sbjct: 61 SPKANKEILDEAYVMASVDNPHVCRLLGICL---TSTVQLIMQLMPFGCL--LDYVREHK 115
Query: 276 PPIDWNTRVKIALCAAQGLTFLHEEGPFQAMYNEFSTANIQIDKDFSAKLSGYGCA 331
I + + A+G+ +L + + ++ + + N+ + K++ +G A
Sbjct: 116 DNIGSQYLLNWCVQIAKGMNYLEDR---RLVHRDLAARNVLVKTPQHVKITDFGRA 168
>pdb|4I1Z|A Chain A, Crystal Structure Of The Monomeric (v948r) Form Of The
Gefitinib/erlotinib Resistant Egfr Kinase Domain
L858r+t790m
pdb|4I22|A Chain A, Structure Of The Monomeric (v948r)gefitinib/erlotinib
Resistant Double Mutant (l858r+t790m) Egfr Kinase Domain
Co-crystallized With Gefitinib
Length = 329
Score = 30.8 bits (68), Expect = 1.4, Method: Compositional matrix adjust.
Identities = 25/116 (21%), Positives = 54/116 (46%), Gaps = 8/116 (6%)
Query: 216 SSQGVKEFINDVNTLASLQHPNLCKLLGFHARDGSDQRMLIYERLFHGSLDRLIYGRSDG 275
S + KE +++ +AS+ +P++C+LLG + LI + + G L L Y R
Sbjct: 59 SPKANKEILDEAYVMASVDNPHVCRLLGICL---TSTVQLIMQLMPFGCL--LDYVREHK 113
Query: 276 PPIDWNTRVKIALCAAQGLTFLHEEGPFQAMYNEFSTANIQIDKDFSAKLSGYGCA 331
I + + A+G+ +L + + ++ + + N+ + K++ +G A
Sbjct: 114 DNIGSQYLLNWCVQIAKGMNYLEDR---RLVHRDLAARNVLVKTPQHVKITDFGRA 166
>pdb|3MA6|A Chain A, Crystal Structure Of Kinase Domain Of Tgcdpk1 In Presence
Of 3brb-Pp1
pdb|3MA6|B Chain B, Crystal Structure Of Kinase Domain Of Tgcdpk1 In Presence
Of 3brb-Pp1
Length = 298
Score = 30.4 bits (67), Expect = 1.4, Method: Compositional matrix adjust.
Identities = 38/167 (22%), Positives = 67/167 (40%), Gaps = 21/167 (12%)
Query: 177 FFSDRCISEGLSSVMYRASFGD-----DASTSKKFEATVTRLNPSSQGVKE--FINDVNT 229
FSDR + V+ + SFG+ D T ++ V Q + + +V
Sbjct: 29 IFSDRYKGQ---RVLGKGSFGEVILCKDKITGQECAVKVISKRQVKQKTDKESLLREVQL 85
Query: 230 LASLQHPNLCKLLGFHARDGSDQRMLIYERLFHGSLDRLIYGRSDGPPIDWNTRVKIALC 289
L L HPN+ KL F G L+ E G L I R +D +I
Sbjct: 86 LKQLDHPNIMKLYEFFEDKGY--FYLVGEVYTGGELFDEIISRKRFSEVD---AARIIRQ 140
Query: 290 AAQGLTFLHEEGPFQAMYNEFSTANIQID---KDFSAKLSGYGCAGH 333
G+T++H+ + ++ + N+ ++ KD + ++ +G + H
Sbjct: 141 VLSGITYMHKN---KIVHRDLKPENLLLESKSKDANIRIIDFGLSTH 184
>pdb|4I21|A Chain A, Crystal Structure Of L858r + T790m Egfr Kinase Domain In
Complex With Mig6 Peptide
pdb|4I21|B Chain B, Crystal Structure Of L858r + T790m Egfr Kinase Domain In
Complex With Mig6 Peptide
Length = 329
Score = 30.4 bits (67), Expect = 1.5, Method: Compositional matrix adjust.
Identities = 25/116 (21%), Positives = 54/116 (46%), Gaps = 8/116 (6%)
Query: 216 SSQGVKEFINDVNTLASLQHPNLCKLLGFHARDGSDQRMLIYERLFHGSLDRLIYGRSDG 275
S + KE +++ +AS+ +P++C+LLG + LI + + G L L Y R
Sbjct: 59 SPKANKEILDEAYVMASVDNPHVCRLLGICL---TSTVQLIMQLMPFGCL--LDYVREHK 113
Query: 276 PPIDWNTRVKIALCAAQGLTFLHEEGPFQAMYNEFSTANIQIDKDFSAKLSGYGCA 331
I + + A+G+ +L + + ++ + + N+ + K++ +G A
Sbjct: 114 DNIGSQYLLNWCVQIAKGMNYLEDR---RLVHRDLAARNVLVKTPQHVKITDFGRA 166
>pdb|2QQ7|A Chain A, Crystal Structure Of Drug Resistant Src Kinase Domain With
Irreversible Inhibitor
pdb|2QQ7|B Chain B, Crystal Structure Of Drug Resistant Src Kinase Domain With
Irreversible Inhibitor
pdb|2QI8|A Chain A, Crystal Structure Of Drug Resistant Src Kinase Domain
pdb|2QI8|B Chain B, Crystal Structure Of Drug Resistant Src Kinase Domain
pdb|3F3W|A Chain A, Drug Resistant Csrc Kinase Domain In Complex With
Inhibitor Rl45 (Type Ii)
pdb|3F3W|B Chain B, Drug Resistant Csrc Kinase Domain In Complex With
Inhibitor Rl45 (Type Ii)
pdb|3LOK|A Chain A, Drug Resistant Csrc Kinase Domain In Complex With Covalent
Inhibitor Pd168393
pdb|3LOK|B Chain B, Drug Resistant Csrc Kinase Domain In Complex With Covalent
Inhibitor Pd168393
Length = 286
Score = 30.4 bits (67), Expect = 1.6, Method: Compositional matrix adjust.
Identities = 24/131 (18%), Positives = 54/131 (41%), Gaps = 7/131 (5%)
Query: 208 ATVTRLNPSSQGVKEFINDVNTLASLQHPNLCKLLGFHARDGSDQRMLIYERLFHGSLDR 267
+ L P + + F+ + + L+H L +L +A + ++ E + G L
Sbjct: 45 VAIKTLKPGTMSPEAFLQEAQVMKKLRHEKLVQL---YAVVSEEPIYIVMEYMSKGCLLD 101
Query: 268 LIYGRSDGPPIDWNTRVKIALCAAQGLTFLHEEGPFQAMYNEFSTANIQIDKDFSAKLSG 327
+ G G + V +A A G+ ++ ++ + ANI + ++ K++
Sbjct: 102 FLKGEM-GKYLRLPQLVDMAAQIASGMAYVER---MNYVHRDLRAANILVGENLVCKVAD 157
Query: 328 YGCAGHIPETD 338
+G A I + +
Sbjct: 158 FGLARLIEDNE 168
>pdb|1B6C|B Chain B, Crystal Structure Of The Cytoplasmic Domain Of The Type I
Tgf-Beta Receptor In Complex With Fkbp12
pdb|1B6C|D Chain D, Crystal Structure Of The Cytoplasmic Domain Of The Type I
Tgf-Beta Receptor In Complex With Fkbp12
pdb|1B6C|F Chain F, Crystal Structure Of The Cytoplasmic Domain Of The Type I
Tgf-Beta Receptor In Complex With Fkbp12
pdb|1B6C|H Chain H, Crystal Structure Of The Cytoplasmic Domain Of The Type I
Tgf-Beta Receptor In Complex With Fkbp12
pdb|1IAS|A Chain A, Cytoplasmic Domain Of Unphosphorylated Type I Tgf-Beta
Receptor Crystallized Without Fkbp12
pdb|1IAS|B Chain B, Cytoplasmic Domain Of Unphosphorylated Type I Tgf-Beta
Receptor Crystallized Without Fkbp12
pdb|1IAS|C Chain C, Cytoplasmic Domain Of Unphosphorylated Type I Tgf-Beta
Receptor Crystallized Without Fkbp12
pdb|1IAS|D Chain D, Cytoplasmic Domain Of Unphosphorylated Type I Tgf-Beta
Receptor Crystallized Without Fkbp12
pdb|1IAS|E Chain E, Cytoplasmic Domain Of Unphosphorylated Type I Tgf-Beta
Receptor Crystallized Without Fkbp12
pdb|3FAA|A Chain A, Crystal Structure Of Tgfbri Complexed With A 2-
Aminoimidazole Inhibitor
pdb|3FAA|B Chain B, Crystal Structure Of Tgfbri Complexed With A 2-
Aminoimidazole Inhibitor
pdb|3FAA|C Chain C, Crystal Structure Of Tgfbri Complexed With A 2-
Aminoimidazole Inhibitor
pdb|3FAA|D Chain D, Crystal Structure Of Tgfbri Complexed With A 2-
Aminoimidazole Inhibitor
pdb|3FAA|E Chain E, Crystal Structure Of Tgfbri Complexed With A 2-
Aminoimidazole Inhibitor
pdb|3KCF|A Chain A, Crystal Structure Of Tgfbri Complexed With A Pyrazolone
Inhibitor
pdb|3KCF|B Chain B, Crystal Structure Of Tgfbri Complexed With A Pyrazolone
Inhibitor
pdb|3KCF|C Chain C, Crystal Structure Of Tgfbri Complexed With A Pyrazolone
Inhibitor
pdb|3KCF|D Chain D, Crystal Structure Of Tgfbri Complexed With A Pyrazolone
Inhibitor
pdb|3KCF|E Chain E, Crystal Structure Of Tgfbri Complexed With A Pyrazolone
Inhibitor
pdb|2X7O|A Chain A, Crystal Structure Of Tgfbri Complexed With An Indolinone
Inhibitor
pdb|2X7O|B Chain B, Crystal Structure Of Tgfbri Complexed With An Indolinone
Inhibitor
pdb|2X7O|C Chain C, Crystal Structure Of Tgfbri Complexed With An Indolinone
Inhibitor
pdb|2X7O|D Chain D, Crystal Structure Of Tgfbri Complexed With An Indolinone
Inhibitor
pdb|2X7O|E Chain E, Crystal Structure Of Tgfbri Complexed With An Indolinone
Inhibitor
Length = 342
Score = 30.4 bits (67), Expect = 1.6, Method: Compositional matrix adjust.
Identities = 30/109 (27%), Positives = 47/109 (43%), Gaps = 17/109 (15%)
Query: 233 LQHPNLCKLLGFHARDGSD-----QRMLIYERLFHGSLDRLIYGRSDGPPIDWNTRVKIA 287
L+H N+ LGF A D D Q L+ + HGSL + + + +K+A
Sbjct: 93 LRHENI---LGFIAADNKDNGTWTQLWLVSDYHEHGSL----FDYLNRYTVTVEGMIKLA 145
Query: 288 LCAAQGLTFLHEE-----GPFQAMYNEFSTANIQIDKDFSAKLSGYGCA 331
L A GL LH E G + + + NI + K+ + ++ G A
Sbjct: 146 LSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLA 194
>pdb|1PY5|A Chain A, Crystal Structure Of Tgf-Beta Receptor I Kinase With
Inhibitor
Length = 326
Score = 30.4 bits (67), Expect = 1.7, Method: Compositional matrix adjust.
Identities = 30/109 (27%), Positives = 47/109 (43%), Gaps = 17/109 (15%)
Query: 233 LQHPNLCKLLGFHARDGSD-----QRMLIYERLFHGSLDRLIYGRSDGPPIDWNTRVKIA 287
L+H N+ LGF A D D Q L+ + HGSL + + + +K+A
Sbjct: 80 LRHENI---LGFIAADNKDNGTWTQLWLVSDYHEHGSL----FDYLNRYTVTVEGMIKLA 132
Query: 288 LCAAQGLTFLHEE-----GPFQAMYNEFSTANIQIDKDFSAKLSGYGCA 331
L A GL LH E G + + + NI + K+ + ++ G A
Sbjct: 133 LSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLA 181
>pdb|2DQ7|X Chain X, Crystal Structure Of Fyn Kinase Domain Complexed With
Staurosporine
Length = 283
Score = 30.4 bits (67), Expect = 1.7, Method: Compositional matrix adjust.
Identities = 27/133 (20%), Positives = 57/133 (42%), Gaps = 9/133 (6%)
Query: 207 EATVTRLNPSSQGVKEFINDVNTLASLQHPNLCKLLGFHARDGSDQRMLIYERLFHGS-L 265
+ + L P + + F+ + + L+H L +L +A + ++ E + GS L
Sbjct: 35 KVAIKTLKPGTMSPESFLEEAQIMKKLKHDKLVQL---YAVVSEEPIYIVTEYMNKGSLL 91
Query: 266 DRLIYGRSDGPPIDWNTRVKIALCAAQGLTFLHEEGPFQAMYNEFSTANIQIDKDFSAKL 325
D L G +G + V +A A G+ ++ ++ + +ANI + K+
Sbjct: 92 DFLKDG--EGRALKLPNLVDMAAQVAAGMAYIER---MNYIHRDLRSANILVGNGLICKI 146
Query: 326 SGYGCAGHIPETD 338
+ +G A I + +
Sbjct: 147 ADFGLARLIEDNE 159
>pdb|1VJY|A Chain A, Crystal Structure Of A Naphthyridine Inhibitor Of Human
Tgf- Beta Type I Receptor
pdb|3GXL|A Chain A, Alk-5 Kinase Complex With Gw857175
pdb|3HMM|A Chain A, Structure Of Alk5 + Gw855857
Length = 303
Score = 30.4 bits (67), Expect = 1.8, Method: Compositional matrix adjust.
Identities = 30/109 (27%), Positives = 47/109 (43%), Gaps = 17/109 (15%)
Query: 233 LQHPNLCKLLGFHARDGSD-----QRMLIYERLFHGSLDRLIYGRSDGPPIDWNTRVKIA 287
L+H N+ LGF A D D Q L+ + HGSL + + + +K+A
Sbjct: 54 LRHENI---LGFIAADNKDNGTWTQLWLVSDYHEHGSL----FDYLNRYTVTVEGMIKLA 106
Query: 288 LCAAQGLTFLHEE-----GPFQAMYNEFSTANIQIDKDFSAKLSGYGCA 331
L A GL LH E G + + + NI + K+ + ++ G A
Sbjct: 107 LSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLA 155
>pdb|4I20|A Chain A, Crystal Structure Of Monomeric (v948r) Primary Oncogenic
Mutant L858r Egfr Kinase Domain
Length = 329
Score = 30.0 bits (66), Expect = 1.9, Method: Compositional matrix adjust.
Identities = 25/116 (21%), Positives = 54/116 (46%), Gaps = 8/116 (6%)
Query: 216 SSQGVKEFINDVNTLASLQHPNLCKLLGFHARDGSDQRMLIYERLFHGSLDRLIYGRSDG 275
S + KE +++ +AS+ +P++C+LLG + LI + + G L L Y R
Sbjct: 59 SPKANKEILDEAYVMASVDNPHVCRLLGICL---TSTVQLITQLMPFGCL--LDYVREHK 113
Query: 276 PPIDWNTRVKIALCAAQGLTFLHEEGPFQAMYNEFSTANIQIDKDFSAKLSGYGCA 331
I + + A+G+ +L + + ++ + + N+ + K++ +G A
Sbjct: 114 DNIGSQYLLNWCVQIAKGMNYLEDR---RLVHRDLAARNVLVKTPQHVKITDFGRA 166
>pdb|3TZM|A Chain A, Tgf-Beta Receptor Type 1 In Complex With Sb431542
Length = 309
Score = 30.0 bits (66), Expect = 2.0, Method: Compositional matrix adjust.
Identities = 30/109 (27%), Positives = 47/109 (43%), Gaps = 17/109 (15%)
Query: 233 LQHPNLCKLLGFHARDGSD-----QRMLIYERLFHGSLDRLIYGRSDGPPIDWNTRVKIA 287
L+H N+ LGF A D D Q L+ + HGSL + + + +K+A
Sbjct: 60 LRHENI---LGFIAADNKDNGTWTQLWLVSDYHEHGSL----FDYLNRYTVTVEGMIKLA 112
Query: 288 LCAAQGLTFLHEE-----GPFQAMYNEFSTANIQIDKDFSAKLSGYGCA 331
L A GL LH E G + + + NI + K+ + ++ G A
Sbjct: 113 LSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLA 161
>pdb|2ITT|A Chain A, Crystal Structure Of Egfr Kinase Domain L858r Mutation In
Complex With Aee788
pdb|2ITU|A Chain A, Crystal Structure Of Egfr Kinase Domain L858r Mutation In
Complex With Afn941
pdb|2ITV|A Chain A, Crystal Structure Of Egfr Kinase Domain L858r Mutation In
Complex With Amp-pnp
pdb|2ITZ|A Chain A, Crystal Structure Of Egfr Kinase Domain L858r Mutation In
Complex With Iressa
Length = 327
Score = 30.0 bits (66), Expect = 2.0, Method: Compositional matrix adjust.
Identities = 25/116 (21%), Positives = 54/116 (46%), Gaps = 8/116 (6%)
Query: 216 SSQGVKEFINDVNTLASLQHPNLCKLLGFHARDGSDQRMLIYERLFHGSLDRLIYGRSDG 275
S + KE +++ +AS+ +P++C+LLG + LI + + G L L Y R
Sbjct: 57 SPKANKEILDEAYVMASVDNPHVCRLLGICL---TSTVQLITQLMPFGCL--LDYVREHK 111
Query: 276 PPIDWNTRVKIALCAAQGLTFLHEEGPFQAMYNEFSTANIQIDKDFSAKLSGYGCA 331
I + + A+G+ +L + + ++ + + N+ + K++ +G A
Sbjct: 112 DNIGSQYLLNWCVQIAKGMNYLEDR---RLVHRDLAARNVLVKTPQHVKITDFGRA 164
>pdb|1RW8|A Chain A, Crystal Structure Of Tgf-Beta Receptor I Kinase With Atp
Site Inhibitor
Length = 301
Score = 30.0 bits (66), Expect = 2.0, Method: Compositional matrix adjust.
Identities = 30/109 (27%), Positives = 47/109 (43%), Gaps = 17/109 (15%)
Query: 233 LQHPNLCKLLGFHARDGSD-----QRMLIYERLFHGSLDRLIYGRSDGPPIDWNTRVKIA 287
L+H N+ LGF A D D Q L+ + HGSL + + + +K+A
Sbjct: 55 LRHENI---LGFIAADNKDNGTWTQLWLVSDYHEHGSL----FDYLNRYTVTVEGMIKLA 107
Query: 288 LCAAQGLTFLHEE-----GPFQAMYNEFSTANIQIDKDFSAKLSGYGCA 331
L A GL LH E G + + + NI + K+ + ++ G A
Sbjct: 108 LSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLA 156
>pdb|2WOT|A Chain A, Alk5 In Complex With 4-((5,6-Dimethyl-2-(2-Pyridyl)-3-
Pyridyl)oxy)-N-(3,4,5-Trimethoxyphenyl)pyridin-2-Amine
pdb|2WOU|A Chain A, Alk5 In Complex With
4-((4-((2,6-Dimethyl-3-Pyridyl)oxy)-2-
Pyridyl)amino)benzenesulfonamide
Length = 306
Score = 30.0 bits (66), Expect = 2.1, Method: Compositional matrix adjust.
Identities = 30/109 (27%), Positives = 47/109 (43%), Gaps = 17/109 (15%)
Query: 233 LQHPNLCKLLGFHARDGSD-----QRMLIYERLFHGSLDRLIYGRSDGPPIDWNTRVKIA 287
L+H N+ LGF A D D Q L+ + HGSL + + + +K+A
Sbjct: 57 LRHENI---LGFIAADNKDNGTWTQLWLVSDYHEHGSL----FDYLNRYTVTVEGMIKLA 109
Query: 288 LCAAQGLTFLHEE-----GPFQAMYNEFSTANIQIDKDFSAKLSGYGCA 331
L A GL LH E G + + + NI + K+ + ++ G A
Sbjct: 110 LSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLA 158
>pdb|2EB3|A Chain A, Crystal Structure Of Mutated Egfr Kinase Domain (L858r) In
Complex With Amppnp
Length = 334
Score = 30.0 bits (66), Expect = 2.2, Method: Compositional matrix adjust.
Identities = 25/116 (21%), Positives = 54/116 (46%), Gaps = 8/116 (6%)
Query: 216 SSQGVKEFINDVNTLASLQHPNLCKLLGFHARDGSDQRMLIYERLFHGSLDRLIYGRSDG 275
S + KE +++ +AS+ +P++C+LLG + LI + + G L L Y R
Sbjct: 64 SPKANKEILDEAYVMASVDNPHVCRLLGICL---TSTVQLITQLMPFGCL--LDYVREHK 118
Query: 276 PPIDWNTRVKIALCAAQGLTFLHEEGPFQAMYNEFSTANIQIDKDFSAKLSGYGCA 331
I + + A+G+ +L + + ++ + + N+ + K++ +G A
Sbjct: 119 DNIGSQYLLNWCVQIAKGMNYLEDR---RLVHRDLAARNVLVKTPQHVKITDFGRA 171
>pdb|2HWO|A Chain A, Crystal Structure Of Src Kinase Domain In Complex With
Covalent Inhibitor
pdb|2HWO|B Chain B, Crystal Structure Of Src Kinase Domain In Complex With
Covalent Inhibitor
pdb|2HWP|A Chain A, Crystal Structure Of Src Kinase Domain In Complex With
Covalent Inhibitor Pd168393
pdb|2HWP|B Chain B, Crystal Structure Of Src Kinase Domain In Complex With
Covalent Inhibitor Pd168393
pdb|2QLQ|A Chain A, Crystal Structure Of Src Kinase Domain With Covalent
Inhibitor Rl3
pdb|2QLQ|B Chain B, Crystal Structure Of Src Kinase Domain With Covalent
Inhibitor Rl3
pdb|3F3T|A Chain A, Kinase Domain Of Csrc In Complex With Inhibitor Rl38 (Type
Iii)
pdb|3F3T|B Chain B, Kinase Domain Of Csrc In Complex With Inhibitor Rl38 (Type
Iii)
pdb|3F3U|A Chain A, Kinase Domain Of Csrc In Complex With Inhibitor Rl37 (Type
Iii)
pdb|3F3U|B Chain B, Kinase Domain Of Csrc In Complex With Inhibitor Rl37 (Type
Iii)
pdb|3F3V|A Chain A, Kinase Domain Of Csrc In Complex With Inhibitor Rl45 (Type
Ii)
pdb|3F3V|B Chain B, Kinase Domain Of Csrc In Complex With Inhibitor Rl45 (Type
Ii)
pdb|3G5D|A Chain A, Kinase Domain Of Csrc In Complex With Dasatinib
pdb|3G5D|B Chain B, Kinase Domain Of Csrc In Complex With Dasatinib
pdb|3TZ7|A Chain A, Kinase Domain Of Csrc In Complex With Rl103
pdb|3TZ7|B Chain B, Kinase Domain Of Csrc In Complex With Rl103
pdb|3TZ8|A Chain A, Kinase Domain Of Csrc In Complex With Rl104
pdb|3TZ8|B Chain B, Kinase Domain Of Csrc In Complex With Rl104
pdb|3TZ9|A Chain A, Kinase Domain Of Csrc In Complex With Rl130
pdb|3TZ9|B Chain B, Kinase Domain Of Csrc In Complex With Rl130
Length = 286
Score = 29.6 bits (65), Expect = 2.4, Method: Compositional matrix adjust.
Identities = 24/131 (18%), Positives = 54/131 (41%), Gaps = 7/131 (5%)
Query: 208 ATVTRLNPSSQGVKEFINDVNTLASLQHPNLCKLLGFHARDGSDQRMLIYERLFHGSLDR 267
+ L P + + F+ + + L+H L +L +A + ++ E + G L
Sbjct: 45 VAIKTLKPGTMSPEAFLQEAQVMKKLRHEKLVQL---YAVVSEEPIYIVTEYMSKGCLLD 101
Query: 268 LIYGRSDGPPIDWNTRVKIALCAAQGLTFLHEEGPFQAMYNEFSTANIQIDKDFSAKLSG 327
+ G G + V +A A G+ ++ ++ + ANI + ++ K++
Sbjct: 102 FLKGEM-GKYLRLPQLVDMAAQIASGMAYVER---MNYVHRDLRAANILVGENLVCKVAD 157
Query: 328 YGCAGHIPETD 338
+G A I + +
Sbjct: 158 FGLARLIEDNE 168
>pdb|1UA2|A Chain A, Crystal Structure Of Human Cdk7
pdb|1UA2|B Chain B, Crystal Structure Of Human Cdk7
pdb|1UA2|C Chain C, Crystal Structure Of Human Cdk7
pdb|1UA2|D Chain D, Crystal Structure Of Human Cdk7
Length = 346
Score = 29.6 bits (65), Expect = 2.5, Method: Compositional matrix adjust.
Identities = 35/155 (22%), Positives = 66/155 (42%), Gaps = 19/155 (12%)
Query: 183 ISEGLSSVMYRASFGDDASTSKKFEATVTRLNPSSQGVKEFIN-----DVNTLASLQHPN 237
+ EG + +Y+A D +T++ +L S+ K+ IN ++ L L HPN
Sbjct: 18 LGEGQFATVYKAR---DKNTNQIVAIKKIKLGHRSEA-KDGINRTALREIKLLQELSHPN 73
Query: 238 LCKLLGFHARDGSDQRMLIYERLFHGSLDRLIYGRSDGPPIDWNTRVK-IALCAAQGLTF 296
+ LL G + + L+ +I D + + +K L QGL +
Sbjct: 74 IIGLLDAF---GHKSNISLVFDFMETDLEVII---KDNSLVLTPSHIKAYMLMTLQGLEY 127
Query: 297 LHEEGPFQAMYNEFSTANIQIDKDFSAKLSGYGCA 331
LH+ ++ + N+ +D++ KL+ +G A
Sbjct: 128 LHQH---WILHRDLKPNNLLLDENGVLKLADFGLA 159
>pdb|2HAK|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark1PAR-1
pdb|2HAK|B Chain B, Catalytic And Ubiqutin-Associated Domains Of Mark1PAR-1
pdb|2HAK|C Chain C, Catalytic And Ubiqutin-Associated Domains Of Mark1PAR-1
pdb|2HAK|D Chain D, Catalytic And Ubiqutin-Associated Domains Of Mark1PAR-1
pdb|2HAK|E Chain E, Catalytic And Ubiqutin-Associated Domains Of Mark1PAR-1
pdb|2HAK|F Chain F, Catalytic And Ubiqutin-Associated Domains Of Mark1PAR-1
pdb|2HAK|G Chain G, Catalytic And Ubiqutin-Associated Domains Of Mark1PAR-1
pdb|2HAK|H Chain H, Catalytic And Ubiqutin-Associated Domains Of Mark1PAR-1
Length = 328
Score = 29.6 bits (65), Expect = 2.5, Method: Compositional matrix adjust.
Identities = 27/120 (22%), Positives = 55/120 (45%), Gaps = 12/120 (10%)
Query: 211 TRLNPSSQGVKEFINDVNTLASLQHPNLCKLLGFHARDGSDQRMLIYERLFHGSL-DRLI 269
T+LNP+S +++ +V + L HPN+ KL F + L+ E G + D L+
Sbjct: 51 TQLNPTS--LQKLFREVRIMKILNHPNIVKL--FEVIETEKTLYLVMEYASGGEVFDYLV 106
Query: 270 YGRSDGPPIDWNTRVKIALCAAQGLTFLHEEGPFQAMYNEFSTANIQIDKDFSAKLSGYG 329
+ G + R K + + + H++ ++ + N+ +D D + K++ +G
Sbjct: 107 ---AHGRMKEKEARAKFRQIVS-AVQYCHQK---YIVHRDLKAENLLLDGDMNIKIADFG 159
>pdb|3KU2|A Chain A, Crystal Structure Of Inactivated Form Of Cdpk1 From
Toxoplasma Gondii, Tgme49.101440
Length = 507
Score = 29.6 bits (65), Expect = 2.7, Method: Compositional matrix adjust.
Identities = 38/167 (22%), Positives = 68/167 (40%), Gaps = 21/167 (12%)
Query: 177 FFSDRCISEGLSSVMYRASFGD-----DASTSKKFEATVTRLNPSSQGVKE--FINDVNT 229
FSDR + V+ + SFG+ D T ++ V Q + + +V
Sbjct: 46 IFSDRYKGQ---RVLGKGSFGEVILCKDKITGQECAVKVISKRQVKQKTDKESLLREVQL 102
Query: 230 LASLQHPNLCKLLGFHARDGSDQRMLIYERLFHGSLDRLIYGRSDGPPIDWNTRVKIALC 289
L L HPN+ KL F G L+ E G L I R +D ++ L
Sbjct: 103 LKQLDHPNIMKLYEFFEDKGY--FYLVGEVYTGGELFDEIISRKRFSEVDAARIIRQVLS 160
Query: 290 AAQGLTFLHEEGPFQAMYNEFSTANIQID---KDFSAKLSGYGCAGH 333
G+T++H+ + ++ + N+ ++ KD + ++ +G + H
Sbjct: 161 ---GITYMHKN---KIVHRDLKPENLLLESKSKDANIRIIDFGLSTH 201
>pdb|3HX4|A Chain A, Crystal Structure Of Cdpk1 Of Toxoplasma Gondii,
Tgme49_101440, In Presence Of Calcium
Length = 508
Score = 29.6 bits (65), Expect = 2.9, Method: Compositional matrix adjust.
Identities = 38/167 (22%), Positives = 68/167 (40%), Gaps = 21/167 (12%)
Query: 177 FFSDRCISEGLSSVMYRASFGD-----DASTSKKFEATVTRLNPSSQGVKE--FINDVNT 229
FSDR + V+ + SFG+ D T ++ V Q + + +V
Sbjct: 47 IFSDRYKGQ---RVLGKGSFGEVILCKDKITGQECAVKVISKRQVKQKTDKESLLREVQL 103
Query: 230 LASLQHPNLCKLLGFHARDGSDQRMLIYERLFHGSLDRLIYGRSDGPPIDWNTRVKIALC 289
L L HPN+ KL F G L+ E G L I R +D ++ L
Sbjct: 104 LKQLDHPNIMKLYEFFEDKGY--FYLVGEVYTGGELFDEIISRKRFSEVDAARIIRQVLS 161
Query: 290 AAQGLTFLHEEGPFQAMYNEFSTANIQID---KDFSAKLSGYGCAGH 333
G+T++H+ + ++ + N+ ++ KD + ++ +G + H
Sbjct: 162 ---GITYMHKN---KIVHRDLKPENLLLESKSKDANIRIIDFGLSTH 202
>pdb|3I79|A Chain A, Calcium-Dependent Protein Kinase 1 From Toxoplasma Gondii
(Tgcdpk1)
pdb|3I7B|A Chain A, Calcium-Dependent Protein Kinase 1 From Toxoplasma Gondii
(Tgcdpk1) In Complex With Bumped Kinase Inhibitor Nm-Pp1
pdb|3N51|A Chain A, Calcium-Dependent Protein Kinase 1 From Toxoplasma Gondii
(Tgcdpk1) In Complex With Bumped Kinase Inhibitor
Rm-1-95
pdb|3SX9|A Chain A, Calcium-Dependent Protein Kinase 1 From Toxoplasma Gondii
(Tgcdpk1) In Complex With Bumped Kinase Inhibitor,
Rm-1-132
pdb|3SXF|A Chain A, Calcium-Dependent Protein Kinase 1 From Toxoplasma Gondii
(Tgcdpk1) In Complex With Bumped Kinase Inhibitor,
Rm-1-89
pdb|3T3U|A Chain A, Calcium-Dependent Protein Kinase 1 From Toxoplasma Gondii
(Tgcdpk1) In Complex With Bumped Kinase Inhibitor,
Rm-1-130
pdb|3T3V|A Chain A, Calcium-Dependent Protein Kinase 1 From Toxoplasma Gondii
(Tgcdpk1) In Complex With Bumped Kinase Inhibitor,
Rm-1-87
pdb|3UPX|A Chain A, Calcium-Dependent Protein Kinase 1 From Toxoplasma Gondii
(Tgcdpk1) In Complex With Inhibitor Uw1300
pdb|3UPZ|A Chain A, Calcium-Dependent Protein Kinase 1 From Toxoplasma Gondii
(Tgcdpk1) In Complex With Bumpless Bki Analog Uw1243
pdb|3V51|A Chain A, Calcium-Dependent Protein Kinase 1 From Toxoplasma Gondii
(Tgcdpk1) In Complex With Inhibitor Rm-1-176
pdb|3V5P|A Chain A, Calcium-Dependent Protein Kinase 1 From Toxoplasma Gondii
(Tgcdpk1) In Complex With Inhibitor Uw1288
pdb|3V5T|A Chain A, Calcium-Dependent Protein Kinase 1 From Toxoplasma Gondii
(Tgcdpk1) In Complex With Inhibitor Uw1299
Length = 484
Score = 29.6 bits (65), Expect = 2.9, Method: Compositional matrix adjust.
Identities = 38/167 (22%), Positives = 67/167 (40%), Gaps = 21/167 (12%)
Query: 177 FFSDRCISEGLSSVMYRASFGD-----DASTSKKFEATVTRLNPSSQGVKE--FINDVNT 229
FSDR + V+ + SFG+ D T ++ V Q + + +V
Sbjct: 23 IFSDRYKGQ---RVLGKGSFGEVILCKDKITGQECAVKVISKRQVKQKTDKESLLREVQL 79
Query: 230 LASLQHPNLCKLLGFHARDGSDQRMLIYERLFHGSLDRLIYGRSDGPPIDWNTRVKIALC 289
L L HPN+ KL F G L+ E G L I R +D +I
Sbjct: 80 LKQLDHPNIMKLYEFFEDKGY--FYLVGEVYTGGELFDEIISRKRFSEVD---AARIIRQ 134
Query: 290 AAQGLTFLHEEGPFQAMYNEFSTANIQID---KDFSAKLSGYGCAGH 333
G+T++H+ + ++ + N+ ++ KD + ++ +G + H
Sbjct: 135 VLSGITYMHKN---KIVHRDLKPENLLLESKSKDANIRIIDFGLSTH 178
>pdb|2PTK|A Chain A, Chicken Src Tyrosine Kinase
Length = 453
Score = 29.6 bits (65), Expect = 3.0, Method: Compositional matrix adjust.
Identities = 24/129 (18%), Positives = 54/129 (41%), Gaps = 7/129 (5%)
Query: 210 VTRLNPSSQGVKEFINDVNTLASLQHPNLCKLLGFHARDGSDQRMLIYERLFHGSLDRLI 269
+ L P + + F+ + + L+H L +L +A + ++ E + GSL +
Sbjct: 214 IKTLKPGNMSPEAFLQEAQVMKKLRHEKLVQL---YAVVSEEPIYIVTEYMSKGSLLDFL 270
Query: 270 YGRSDGPPIDWNTRVKIALCAAQGLTFLHEEGPFQAMYNEFSTANIQIDKDFSAKLSGYG 329
G G + V +A A G+ ++ ++ + ANI + ++ K++ +G
Sbjct: 271 KGEM-GKYLRLPQLVDMAAQIASGMAYVER---MNYVHRDLRAANILVGENLVCKVADFG 326
Query: 330 CAGHIPETD 338
I + +
Sbjct: 327 LGRLIEDNE 335
>pdb|2OGV|A Chain A, Crystal Structure Of The Autoinhibited Human C-Fms Kinase
Domain
Length = 317
Score = 29.3 bits (64), Expect = 3.4, Method: Compositional matrix adjust.
Identities = 25/108 (23%), Positives = 45/108 (41%), Gaps = 12/108 (11%)
Query: 234 QHPNLCKLLGFHARDGSDQRMLIYERLFHGSLDRLI-------YGRSDGPPIDWNTRVKI 286
QH N+ LLG G ++I E +G L + + DG P++ +
Sbjct: 100 QHENIVNLLGACTHGGP--VLVITEYCCYGDLLNFLRRKAEADLDKEDGRPLELRDLLHF 157
Query: 287 ALCAAQGLTFLHEEGPFQAMYNEFSTANIQIDKDFSAKLSGYGCAGHI 334
+ AQG+ FL + ++ + + N+ + AK+ +G A I
Sbjct: 158 SSQVAQGMAFLASK---NCIHRDVAARNVLLTNGHVAKIGDFGLARDI 202
>pdb|4AGU|A Chain A, Crystal Structure Of The Human Cdkl1 Kinase Domain
pdb|4AGU|B Chain B, Crystal Structure Of The Human Cdkl1 Kinase Domain
pdb|4AGU|C Chain C, Crystal Structure Of The Human Cdkl1 Kinase Domain
Length = 311
Score = 29.3 bits (64), Expect = 3.4, Method: Compositional matrix adjust.
Identities = 29/113 (25%), Positives = 43/113 (38%), Gaps = 18/113 (15%)
Query: 224 INDVNTLASLQHPNLCKLLGFHARDGSDQRMLIYERLFHGSLDRLIYGRSDGPP-----I 278
+ ++ L L+HPNL LL R + L++E H L L + P I
Sbjct: 50 LREIRMLKQLKHPNLVNLLEVFRR--KRRLHLVFEYCDHTVLHELDRYQRGVPEHLVKSI 107
Query: 279 DWNTRVKIALCAAQGLTFLHEEGPFQAMYNEFSTANIQIDKDFSAKLSGYGCA 331
W T Q + F H+ ++ + NI I K KL +G A
Sbjct: 108 TWQT--------LQAVNFCHKHN---CIHRDVKPENILITKHSVIKLCDFGFA 149
>pdb|3DXN|A Chain A, Crystal Structure Of The Calcium-dependent Kinase From
Toxoplasma Gondii, 541.m00134, Kinase Domain
Length = 287
Score = 29.3 bits (64), Expect = 3.6, Method: Compositional matrix adjust.
Identities = 29/116 (25%), Positives = 49/116 (42%), Gaps = 15/116 (12%)
Query: 223 FINDVNTLASLQHPNLCKLLGFHARDGSDQR--MLIYERLFHGSLDRLIYGRSDGPPIDW 280
+++V L L HPN+ KL F D+R L+ E G L I R +D
Sbjct: 68 LLDEVAVLKQLDHPNIMKLYEFF----EDKRNYYLVMEVYRGGELFDEIILRQKFSEVDA 123
Query: 281 NTRVKIALCAAQGLTFLHEEGPFQAMYNEFSTANIQID---KDFSAKLSGYGCAGH 333
+K L G T+LH+ ++ + N+ ++ +D K+ +G + H
Sbjct: 124 AVIMKQVL---SGTTYLHKH---NIVHRDLKPENLLLESKSRDALIKIVDFGLSAH 173
>pdb|3T9T|A Chain A, Crystal Structure Of Btk Mutant (F435t,K596r) Complexed
With Imidazo[1,5-A]quinoxaline
Length = 267
Score = 29.3 bits (64), Expect = 3.9, Method: Compositional matrix adjust.
Identities = 25/125 (20%), Positives = 51/125 (40%), Gaps = 7/125 (5%)
Query: 205 KFEATVTRLNPSSQGVKEFINDVNTLASLQHPNLCKLLGFHARDGSDQRMLIYERLFHGS 264
K + + + + ++FI + + L HP L +L G L+ E + HG
Sbjct: 32 KDKVAIKTIREGAMSEEDFIEEAEVMMKLSHPKLVQLYGVCLEQAP--ICLVTEFMEHGC 89
Query: 265 LDRLIYGRSDGPPIDWNTRVKIALCAAQGLTFLHEEGPFQAMYNEFSTANIQIDKDFSAK 324
L Y R+ T + + L +G+ +L E ++ + + N + ++ K
Sbjct: 90 LSD--YLRTQRGLFAAETLLGMCLDVCEGMAYLEEAC---VIHRDLAARNCLVGENQVIK 144
Query: 325 LSGYG 329
+S +G
Sbjct: 145 VSDFG 149
>pdb|3LCD|A Chain A, Inhibitor Bound To A Dfg-In Structure Of The Kinase Domain
Of Csf-1r
Length = 329
Score = 29.3 bits (64), Expect = 4.1, Method: Compositional matrix adjust.
Identities = 25/108 (23%), Positives = 45/108 (41%), Gaps = 12/108 (11%)
Query: 234 QHPNLCKLLGFHARDGSDQRMLIYERLFHGSLDRLI-------YGRSDGPPIDWNTRVKI 286
QH N+ LLG G ++I E +G L + + DG P++ +
Sbjct: 108 QHENIVNLLGACTHGGP--VLVITEYCCYGDLLNFLRRKAEADLDKEDGRPLELRDLLHF 165
Query: 287 ALCAAQGLTFLHEEGPFQAMYNEFSTANIQIDKDFSAKLSGYGCAGHI 334
+ AQG+ FL + ++ + + N+ + AK+ +G A I
Sbjct: 166 SSQVAQGMAFLASK---NCIHRDVAARNVLLTNGHVAKIGDFGLARDI 210
>pdb|2WQM|A Chain A, Structure Of Apo Human Nek7
pdb|2WQN|A Chain A, Structure Of Adp-Bound Human Nek7
Length = 310
Score = 28.9 bits (63), Expect = 4.3, Method: Compositional matrix adjust.
Identities = 38/157 (24%), Positives = 65/157 (41%), Gaps = 11/157 (7%)
Query: 176 NFFSDRCISEGLSSVMYRASFGDDASTSKKFEATVTRLNPSSQGVKEFINDVNTLASLQH 235
NF ++ I G S +YRA+ D + + L ++ + I +++ L L H
Sbjct: 33 NFRIEKKIGRGQFSEVYRAACLLDGVPVALKKVQIFDLM-DAKARADCIKEIDLLKQLNH 91
Query: 236 PNLCKLLGFHARDGSDQRMLIYERLFHGSLDRLI-YGRSDGPPIDWNTRVK--IALCAAQ 292
PN+ K D ++ ++ E G L R+I + + I T K + LC+A
Sbjct: 92 PNVIKYYASFIED--NELNIVLELADAGDLSRMIKHFKKQKRLIPERTVWKYFVQLCSA- 148
Query: 293 GLTFLHEEGPFQAMYNEFSTANIQIDKDFSAKLSGYG 329
L +H + M+ + AN+ I KL G
Sbjct: 149 -LEHMHSR---RVMHRDIKPANVFITATGVVKLGDLG 181
>pdb|2JKM|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With
Bis- Anilino Pyrimidine Inhibitor
Length = 276
Score = 28.9 bits (63), Expect = 4.9, Method: Compositional matrix adjust.
Identities = 31/158 (19%), Positives = 68/158 (43%), Gaps = 10/158 (6%)
Query: 181 RCISEGLSSVMYRASFGDDASTSKKFEATVTRLNPSSQGVKE-FINDVNTLASLQHPNLC 239
RCI EG +++ + + + A T N +S V+E F+ + T+ HP++
Sbjct: 16 RCIGEGQFGDVHQGIYMSPENPAMAV-AIKTCKNCTSDSVREKFLQEALTMRQFDHPHIV 74
Query: 240 KLLGFHARDGSDQRMLIYERLFHGSLDRLIYGRSDGPPIDWNTRVKIALCAAQGLTFLHE 299
KL+G + +I E G L + R +D + + A + L +L
Sbjct: 75 KLIGVITENPV---WIIMELCTLGELRSFLQVRKYS--LDLASLILYAYQLSTALAYLES 129
Query: 300 EGPFQAMYNEFSTANIQIDKDFSAKLSGYGCAGHIPET 337
+ + ++ + + N+ + + KL +G + ++ ++
Sbjct: 130 K---RFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDS 164
>pdb|2J0L|A Chain A, Crystal Structure Of A The Active Conformation Of The
Kinase Domain Of Focal Adhesion Kinase With A
Phosphorylated Activation Loop
Length = 276
Score = 28.9 bits (63), Expect = 5.1, Method: Compositional matrix adjust.
Identities = 31/158 (19%), Positives = 68/158 (43%), Gaps = 10/158 (6%)
Query: 181 RCISEGLSSVMYRASFGDDASTSKKFEATVTRLNPSSQGVKE-FINDVNTLASLQHPNLC 239
RCI EG +++ + + + A T N +S V+E F+ + T+ HP++
Sbjct: 16 RCIGEGQFGDVHQGIYMSPENPAMAV-AIKTCKNCTSDSVREKFLQEALTMRQFDHPHIV 74
Query: 240 KLLGFHARDGSDQRMLIYERLFHGSLDRLIYGRSDGPPIDWNTRVKIALCAAQGLTFLHE 299
KL+G + +I E G L + R +D + + A + L +L
Sbjct: 75 KLIGVITENPV---WIIMELCTLGELRSFLQVRKFS--LDLASLILYAYQLSTALAYLES 129
Query: 300 EGPFQAMYNEFSTANIQIDKDFSAKLSGYGCAGHIPET 337
+ + ++ + + N+ + + KL +G + ++ ++
Sbjct: 130 K---RFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDS 164
>pdb|1FOT|A Chain A, Structure Of The Unliganded Camp-Dependent Protein Kinase
Catalytic Subunit From Saccharomyces Cerevisiae
Length = 318
Score = 28.9 bits (63), Expect = 5.3, Method: Compositional matrix adjust.
Identities = 14/50 (28%), Positives = 27/50 (54%), Gaps = 5/50 (10%)
Query: 288 LCAAQGLTFLHEEGPFQAMYNEFSTANIQIDKDFSAKLSGYGCAGHIPET 337
+C A L +LH + +Y + NI +DK+ K++ +G A ++P+
Sbjct: 115 VCLA--LEYLHSK---DIIYRDLKPENILLDKNGHIKITDFGFAKYVPDV 159
>pdb|3HZT|A Chain A, Crystal Structure Of Toxoplasma Gondii Cdpk3,
Tgme49_105860
Length = 467
Score = 28.5 bits (62), Expect = 5.7, Method: Compositional matrix adjust.
Identities = 29/116 (25%), Positives = 49/116 (42%), Gaps = 15/116 (12%)
Query: 223 FINDVNTLASLQHPNLCKLLGFHARDGSDQR--MLIYERLFHGSLDRLIYGRSDGPPIDW 280
+++V L L HPN+ KL F D+R L+ E G L I R +D
Sbjct: 51 LLDEVAVLKQLDHPNIMKLYEFF----EDKRNYYLVMEVYRGGELFDEIILRQKFSEVDA 106
Query: 281 NTRVKIALCAAQGLTFLHEEGPFQAMYNEFSTANIQID---KDFSAKLSGYGCAGH 333
+K L G T+LH+ ++ + N+ ++ +D K+ +G + H
Sbjct: 107 AVIMKQVLS---GTTYLHKHN---IVHRDLKPENLLLESKSRDALIKIVDFGLSAH 156
>pdb|3BZ3|A Chain A, Crystal Structure Analysis Of Focal Adhesion Kinase With A
Methanesulfonamide Diaminopyrimidine Inhibitor
Length = 276
Score = 28.5 bits (62), Expect = 6.5, Method: Compositional matrix adjust.
Identities = 31/158 (19%), Positives = 68/158 (43%), Gaps = 10/158 (6%)
Query: 181 RCISEGLSSVMYRASFGDDASTSKKFEATVTRLNPSSQGVKE-FINDVNTLASLQHPNLC 239
RCI EG +++ + + + A T N +S V+E F+ + T+ HP++
Sbjct: 13 RCIGEGQFGDVHQGIYMSPENPALAV-AIKTCKNCTSDSVREKFLQEALTMRQFDHPHIV 71
Query: 240 KLLGFHARDGSDQRMLIYERLFHGSLDRLIYGRSDGPPIDWNTRVKIALCAAQGLTFLHE 299
KL+G + +I E G L + R +D + + A + L +L
Sbjct: 72 KLIGVITENPV---WIIMELCTLGELRSFLQVRKYS--LDLASLILYAYQLSTALAYLES 126
Query: 300 EGPFQAMYNEFSTANIQIDKDFSAKLSGYGCAGHIPET 337
+ + ++ + + N+ + + KL +G + ++ ++
Sbjct: 127 K---RFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDS 161
>pdb|2ETM|A Chain A, Crystal Structure Of Focal Adhesion Kinase Domain
Complexed With 7h-Pyrrolo [2,3-D] Pyrimidine Derivative
pdb|2ETM|B Chain B, Crystal Structure Of Focal Adhesion Kinase Domain
Complexed With 7h-Pyrrolo [2,3-D] Pyrimidine Derivative
pdb|2IJM|A Chain A, Crystal Structure Of Focal Adhesion Kinase Domain With 2
Molecules In The Asymmetric Unit Complexed With Adp And
Atp
pdb|2IJM|B Chain B, Crystal Structure Of Focal Adhesion Kinase Domain With 2
Molecules In The Asymmetric Unit Complexed With Adp And
Atp
Length = 281
Score = 28.5 bits (62), Expect = 6.9, Method: Compositional matrix adjust.
Identities = 31/158 (19%), Positives = 68/158 (43%), Gaps = 10/158 (6%)
Query: 181 RCISEGLSSVMYRASFGDDASTSKKFEATVTRLNPSSQGVKE-FINDVNTLASLQHPNLC 239
RCI EG +++ + + + A T N +S V+E F+ + T+ HP++
Sbjct: 18 RCIGEGQFGDVHQGIYMSPENPALAV-AIKTCKNCTSDSVREKFLQEALTMRQFDHPHIV 76
Query: 240 KLLGFHARDGSDQRMLIYERLFHGSLDRLIYGRSDGPPIDWNTRVKIALCAAQGLTFLHE 299
KL+G + +I E G L + R +D + + A + L +L
Sbjct: 77 KLIGVITENPV---WIIMELCTLGELRSFLQVRKYS--LDLASLILYAYQLSTALAYLES 131
Query: 300 EGPFQAMYNEFSTANIQIDKDFSAKLSGYGCAGHIPET 337
+ + ++ + + N+ + + KL +G + ++ ++
Sbjct: 132 K---RFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDS 166
>pdb|2J0M|B Chain B, Crystal Structure A Two-Chain Complex Between The Ferm And
Kinase Domains Of Focal Adhesion Kinase.
pdb|2JKQ|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With
Bis- Anilino Pyrimidine Inhibitor
Length = 276
Score = 28.1 bits (61), Expect = 7.1, Method: Compositional matrix adjust.
Identities = 31/158 (19%), Positives = 68/158 (43%), Gaps = 10/158 (6%)
Query: 181 RCISEGLSSVMYRASFGDDASTSKKFEATVTRLNPSSQGVKE-FINDVNTLASLQHPNLC 239
RCI EG +++ + + + A T N +S V+E F+ + T+ HP++
Sbjct: 16 RCIGEGQFGDVHQGIYMSPENPALAV-AIKTCKNCTSDSVREKFLQEALTMRQFDHPHIV 74
Query: 240 KLLGFHARDGSDQRMLIYERLFHGSLDRLIYGRSDGPPIDWNTRVKIALCAAQGLTFLHE 299
KL+G + +I E G L + R +D + + A + L +L
Sbjct: 75 KLIGVITENPV---WIIMELCTLGELRSFLQVRKYS--LDLASLILYAYQLSTALAYLES 129
Query: 300 EGPFQAMYNEFSTANIQIDKDFSAKLSGYGCAGHIPET 337
+ + ++ + + N+ + + KL +G + ++ ++
Sbjct: 130 K---RFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDS 164
>pdb|3PXK|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With
Pyrrolo[2,3- D]thiazole
pdb|3PXK|B Chain B, Focal Adhesion Kinase Catalytic Domain In Complex With
Pyrrolo[2,3- D]thiazole
Length = 282
Score = 28.1 bits (61), Expect = 7.3, Method: Compositional matrix adjust.
Identities = 31/158 (19%), Positives = 68/158 (43%), Gaps = 10/158 (6%)
Query: 181 RCISEGLSSVMYRASFGDDASTSKKFEATVTRLNPSSQGVKE-FINDVNTLASLQHPNLC 239
RCI EG +++ + + + A T N +S V+E F+ + T+ HP++
Sbjct: 19 RCIGEGQFGDVHQGIYMSPENPALAV-AIKTCKNCTSDSVREKFLQEALTMRQFDHPHIV 77
Query: 240 KLLGFHARDGSDQRMLIYERLFHGSLDRLIYGRSDGPPIDWNTRVKIALCAAQGLTFLHE 299
KL+G + +I E G L + R +D + + A + L +L
Sbjct: 78 KLIGVITENPV---WIIMELCTLGELRSFLQVRKYS--LDLASLILYAYQLSTALAYLES 132
Query: 300 EGPFQAMYNEFSTANIQIDKDFSAKLSGYGCAGHIPET 337
+ + ++ + + N+ + + KL +G + ++ ++
Sbjct: 133 K---RFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDS 167
>pdb|4EBW|A Chain A, Structure Of Focal Adhesion Kinase Catalytic Domain In
Complex With Novel Allosteric Inhibitor
pdb|4EBV|A Chain A, Structure Of Focal Adhesion Kinase Catalytic Domain In
Complex With Novel Allosteric Inhibitor
Length = 304
Score = 28.1 bits (61), Expect = 7.3, Method: Compositional matrix adjust.
Identities = 31/158 (19%), Positives = 68/158 (43%), Gaps = 10/158 (6%)
Query: 181 RCISEGLSSVMYRASFGDDASTSKKFEATVTRLNPSSQGVKE-FINDVNTLASLQHPNLC 239
RCI EG +++ + + + A T N +S V+E F+ + T+ HP++
Sbjct: 44 RCIGEGQFGDVHQGIYMSPENPALAV-AIKTCKNCTSDSVREKFLQEALTMRQFDHPHIV 102
Query: 240 KLLGFHARDGSDQRMLIYERLFHGSLDRLIYGRSDGPPIDWNTRVKIALCAAQGLTFLHE 299
KL+G + +I E G L + R +D + + A + L +L
Sbjct: 103 KLIGVITENPV---WIIMELCTLGELRSFLQVRKYS--LDLASLILYAYQLSTALAYLES 157
Query: 300 EGPFQAMYNEFSTANIQIDKDFSAKLSGYGCAGHIPET 337
+ + ++ + + N+ + + KL +G + ++ ++
Sbjct: 158 K---RFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDS 192
>pdb|2J0J|A Chain A, Crystal Structure Of A Fragment Of Focal Adhesion Kinase
Containing The Ferm And Kinase Domains
Length = 656
Score = 28.1 bits (61), Expect = 7.6, Method: Compositional matrix adjust.
Identities = 31/158 (19%), Positives = 68/158 (43%), Gaps = 10/158 (6%)
Query: 181 RCISEGLSSVMYRASFGDDASTSKKFEATVTRLNPSSQGVKE-FINDVNTLASLQHPNLC 239
RCI EG +++ + + + A T N +S V+E F+ + T+ HP++
Sbjct: 396 RCIGEGQFGDVHQGIYMSPENPAMAV-AIKTCKNCTSDSVREKFLQEALTMRQFDHPHIV 454
Query: 240 KLLGFHARDGSDQRMLIYERLFHGSLDRLIYGRSDGPPIDWNTRVKIALCAAQGLTFLHE 299
KL+G + +I E G L + R +D + + A + L +L
Sbjct: 455 KLIGVITENPV---WIIMELCTLGELRSFLQVRKFS--LDLASLILYAYQLSTALAYLES 509
Query: 300 EGPFQAMYNEFSTANIQIDKDFSAKLSGYGCAGHIPET 337
+ + ++ + + N+ + + KL +G + ++ ++
Sbjct: 510 K---RFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDS 544
>pdb|1MP8|A Chain A, Crystal Structure Of Focal Adhesion Kinase (Fak)
pdb|4I4F|A Chain A, Structure Of Focal Adhesion Kinase Catalytic Domain In
Complex With An Allosteric Binding Pyrazolobenzothiazine
Compound
Length = 281
Score = 28.1 bits (61), Expect = 8.0, Method: Compositional matrix adjust.
Identities = 31/158 (19%), Positives = 68/158 (43%), Gaps = 10/158 (6%)
Query: 181 RCISEGLSSVMYRASFGDDASTSKKFEATVTRLNPSSQGVKE-FINDVNTLASLQHPNLC 239
RCI EG +++ + + + A T N +S V+E F+ + T+ HP++
Sbjct: 21 RCIGEGQFGDVHQGIYMSPENPALAV-AIKTCKNCTSDSVREKFLQEALTMRQFDHPHIV 79
Query: 240 KLLGFHARDGSDQRMLIYERLFHGSLDRLIYGRSDGPPIDWNTRVKIALCAAQGLTFLHE 299
KL+G + +I E G L + R +D + + A + L +L
Sbjct: 80 KLIGVITENPV---WIIMELCTLGELRSFLQVRKYS--LDLASLILYAYQLSTALAYLES 134
Query: 300 EGPFQAMYNEFSTANIQIDKDFSAKLSGYGCAGHIPET 337
+ + ++ + + N+ + + KL +G + ++ ++
Sbjct: 135 K---RFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDS 169
>pdb|3I7C|A Chain A, Calcium-Dependent Protein Kinase 1 From Toxoplasma Gondii
(Tgcdpk1) In Complex With Bumped Kinase Inhibitor Na-Pp2
pdb|3NYV|A Chain A, Calcium-Dependent Protein Kinase 1 From Toxoplasma Gondii
(Tgcdpk1) In Complex With Non-Specific Inhibitor
Whi-P180
Length = 484
Score = 27.7 bits (60), Expect = 9.3, Method: Compositional matrix adjust.
Identities = 38/167 (22%), Positives = 66/167 (39%), Gaps = 21/167 (12%)
Query: 177 FFSDRCISEGLSSVMYRASFGD-----DASTSKKFEATVTRLNPSSQGVKE--FINDVNT 229
FSDR + V+ + SFG+ D T ++ V Q + + +V
Sbjct: 23 IFSDRYKGQ---RVLGKGSFGEVILCKDKITGQECAVKVISKRQVKQKTDKESLLREVQL 79
Query: 230 LASLQHPNLCKLLGFHARDGSDQRMLIYERLFHGSLDRLIYGRSDGPPIDWNTRVKIALC 289
L L HPN+ KL F G L+ E G L I R +D +I
Sbjct: 80 LKQLDHPNIXKLYEFFEDKGY--FYLVGEVYTGGELFDEIISRKRFSEVD---AARIIRQ 134
Query: 290 AAQGLTFLHEEGPFQAMYNEFSTANIQID---KDFSAKLSGYGCAGH 333
G+T+ H+ + ++ + N+ ++ KD + ++ +G + H
Sbjct: 135 VLSGITYXHKN---KIVHRDLKPENLLLESKSKDANIRIIDFGLSTH 178
Database: pdbaa
Posted date: Mar 3, 2013 10:34 PM
Number of letters in database: 14,973,337
Number of sequences in database: 62,578
Lambda K H
0.318 0.132 0.391
Lambda K H
0.267 0.0410 0.140
Matrix: BLOSUM62
Gap Penalties: Existence: 11, Extension: 1
Number of Hits to DB: 8,333,123
Number of Sequences: 62578
Number of extensions: 284379
Number of successful extensions: 885
Number of sequences better than 100.0: 298
Number of HSP's better than 100.0 without gapping: 63
Number of HSP's successfully gapped in prelim test: 235
Number of HSP's that attempted gapping in prelim test: 799
Number of HSP's gapped (non-prelim): 300
length of query: 366
length of database: 14,973,337
effective HSP length: 100
effective length of query: 266
effective length of database: 8,715,537
effective search space: 2318332842
effective search space used: 2318332842
T: 11
A: 40
X1: 16 ( 7.3 bits)
X2: 38 (14.6 bits)
X3: 64 (24.7 bits)
S1: 41 (21.7 bits)
S2: 52 (24.6 bits)